id	sid	tid	token	lemma	pos
fnp-3790	1	1	neuroinflammation	neuroinflammation	NOUN
fnp-3790	1	2	:	:	PUNCT
fnp-3790	1	3	2022	2022	NUM
fnp-3790	1	4	update	update	NOUN
fnp-3790	1	5	feel	feel	VERB
fnp-3790	1	6	free	free	ADJ
fnp-3790	1	7	to	to	PART
fnp-3790	1	8	add	add	VERB
fnp-3790	1	9	comments	comment	NOUN
fnp-3790	1	10	by	by	ADP
fnp-3790	1	11	clicking	click	VERB
fnp-3790	1	12	these	these	DET
fnp-3790	1	13	icons	icon	NOUN
fnp-3790	1	14	on	on	ADP
fnp-3790	1	15	the	the	DET
fnp-3790	1	16	sidebar	sidebar	NOUN
fnp-3790	1	17	free	free	ADJ
fnp-3790	1	18	neuropathology	neuropathology	NOUN
fnp-3790	1	19	3:3	3:3	NUM
fnp-3790	1	20	(	(	PUNCT
fnp-3790	1	21	2022	2022	NUM
fnp-3790	1	22	)	)	PUNCT
fnp-3790	1	23	review	review	VERB
fnp-3790	1	24	neuroinflammation	neuroinflammation	NOUN
fnp-3790	1	25	:	:	PUNCT
fnp-3790	1	26	2022	2022	NUM
fnp-3790	1	27	update	update	NOUN
fnp-3790	1	28	hans	hans	PROPN
fnp-3790	1	29	lassmann1	lassmann1	PROPN
fnp-3790	1	30	1	1	NUM
fnp-3790	1	31	center	center	NOUN
fnp-3790	1	32	for	for	ADP
fnp-3790	1	33	brain	brain	NOUN
fnp-3790	1	34	research	research	NOUN
fnp-3790	1	35	,	,	PUNCT
fnp-3790	1	36	medical	medical	ADJ
fnp-3790	1	37	university	university	PROPN
fnp-3790	1	38	of	of	ADP
fnp-3790	1	39	vienna	vienna	PROPN
fnp-3790	1	40	,	,	PUNCT
fnp-3790	1	41	austria	austria	PROPN
fnp-3790	1	42	address	address	NOUN
fnp-3790	1	43	for	for	ADP
fnp-3790	1	44	correspondence	correspondence	NOUN
fnp-3790	1	45	:	:	PUNCT
fnp-3790	2	1	hans	hans	PROPN
fnp-3790	2	2	lassmann	lassmann	PROPN
fnp-3790	2	3	·	·	PUNCT
fnp-3790	2	4	center	center	NOUN
fnp-3790	2	5	for	for	ADP
fnp-3790	2	6	brain	brain	NOUN
fnp-3790	2	7	research	research	NOUN
fnp-3790	2	8	·	·	PUNCT
fnp-3790	2	9	medical	medical	ADJ
fnp-3790	2	10	university	university	PROPN
fnp-3790	2	11	of	of	ADP
fnp-3790	2	12	vienna	vienna	PROPN
fnp-3790	2	13	·	·	PUNCT
fnp-3790	2	14	spitalgasse	spitalgasse	NOUN
fnp-3790	2	15	4	4	NUM
fnp-3790	2	16	·	·	SYM
fnp-3790	2	17	1090	1090	NUM
fnp-3790	2	18	wien	wien	PROPN
fnp-3790	2	19	·	·	PUNCT
fnp-3790	2	20	austria	austria	PROPN
fnp-3790	2	21	hans.lassmann@meduniwien.ac.at	hans.lassmann@meduniwien.ac.at	VERB
fnp-3790	2	22	submitted	submit	VERB
fnp-3790	2	23	:	:	PUNCT
fnp-3790	2	24	20	20	NUM
fnp-3790	2	25	january	january	PROPN
fnp-3790	2	26	2022	2022	NUM
fnp-3790	2	27	accepted	accept	VERB
fnp-3790	2	28	:	:	PUNCT
fnp-3790	2	29	08	08	NUM
fnp-3790	2	30	february	february	PROPN
fnp-3790	2	31	2022	2022	NUM
fnp-3790	2	32	copyedited	copyedit	VERB
fnp-3790	2	33	by	by	ADP
fnp-3790	2	34	:	:	PUNCT
fnp-3790	2	35	shino	shino	PROPN
fnp-3790	2	36	magaki	magaki	PROPN
fnp-3790	2	37	published	publish	VERB
fnp-3790	2	38	:	:	PUNCT
fnp-3790	2	39	10	10	NUM
fnp-3790	2	40	february	february	NOUN
fnp-3790	2	41	2022	2022	NUM
fnp-3790	2	42	https://doi.org/10.17879/freeneuropathology-2022-3790	https://doi.org/10.17879/freeneuropathology-2022-3790	NOUN
fnp-3790	2	43	keywords	keyword	NOUN
fnp-3790	2	44	:	:	PUNCT
fnp-3790	2	45	covid-19	covid-19	PROPN
fnp-3790	2	46	,	,	PUNCT
fnp-3790	2	47	multiple	multiple	ADJ
fnp-3790	2	48	sclerosis	sclerosis	NOUN
fnp-3790	2	49	,	,	PUNCT
fnp-3790	2	50	alzheimer	alzheimer	PROPN
fnp-3790	2	51	’s	’s	PART
fnp-3790	2	52	disease	disease	NOUN
fnp-3790	2	53	,	,	PUNCT
fnp-3790	2	54	microglia	microglia	NOUN
fnp-3790	2	55	,	,	PUNCT
fnp-3790	2	56	neurodegeneration	neurodegeneration	NOUN
fnp-3790	2	57	abstract	abstract	NOUN
fnp-3790	2	58	besides	besides	SCONJ
fnp-3790	2	59	important	important	ADJ
fnp-3790	2	60	progress	progress	NOUN
fnp-3790	2	61	in	in	ADP
fnp-3790	2	62	the	the	DET
fnp-3790	2	63	understanding	understanding	NOUN
fnp-3790	2	64	of	of	ADP
fnp-3790	2	65	the	the	DET
fnp-3790	2	66	pathological	pathological	ADJ
fnp-3790	2	67	substrate	substrate	NOUN
fnp-3790	2	68	of	of	ADP
fnp-3790	2	69	covid-19	covid-19	PROPN
fnp-3790	2	70	-	-	PUNCT
fnp-3790	2	71	associated	associate	VERB
fnp-3790	2	72	brain	brain	NOUN
fnp-3790	2	73	disease	disease	NOUN
fnp-3790	2	74	,	,	PUNCT
fnp-3790	2	75	major	major	ADJ
fnp-3790	2	76	insights	insight	NOUN
fnp-3790	2	77	into	into	ADP
fnp-3790	2	78	mechanisms	mechanism	NOUN
fnp-3790	2	79	of	of	ADP
fnp-3790	2	80	neurodegeneration	neurodegeneration	NOUN
fnp-3790	2	81	in	in	ADP
fnp-3790	2	82	human	human	ADJ
fnp-3790	2	83	disease	disease	NOUN
fnp-3790	2	84	have	have	AUX
fnp-3790	2	85	been	be	AUX
fnp-3790	2	86	provided	provide	VERB
fnp-3790	2	87	in	in	ADP
fnp-3790	2	88	neuropathological	neuropathological	ADJ
fnp-3790	2	89	studies	study	NOUN
fnp-3790	2	90	published	publish	VERB
fnp-3790	2	91	in	in	ADP
fnp-3790	2	92	2021	2021	NUM
fnp-3790	2	93	.	.	PUNCT
fnp-3790	3	1	recently	recently	ADV
fnp-3790	3	2	developed	develop	VERB
fnp-3790	3	3	techniques	technique	NOUN
fnp-3790	3	4	,	,	PUNCT
fnp-3790	3	5	which	which	PRON
fnp-3790	3	6	allow	allow	VERB
fnp-3790	3	7	the	the	DET
fnp-3790	3	8	simultaneous	simultaneous	ADJ
fnp-3790	3	9	detection	detection	NOUN
fnp-3790	3	10	of	of	ADP
fnp-3790	3	11	a	a	DET
fnp-3790	3	12	large	large	ADJ
fnp-3790	3	13	battery	battery	NOUN
fnp-3790	3	14	of	of	ADP
fnp-3790	3	15	different	different	ADJ
fnp-3790	3	16	molecules	molecule	NOUN
fnp-3790	3	17	within	within	ADP
fnp-3790	3	18	single	single	ADJ
fnp-3790	3	19	cells	cell	NOUN
fnp-3790	3	20	,	,	PUNCT
fnp-3790	3	21	have	have	AUX
fnp-3790	3	22	proven	prove	VERB
fnp-3790	3	23	useful	useful	ADJ
fnp-3790	3	24	in	in	ADP
fnp-3790	3	25	the	the	DET
fnp-3790	3	26	analysis	analysis	NOUN
fnp-3790	3	27	of	of	ADP
fnp-3790	3	28	disease	disease	NOUN
fnp-3790	3	29	mechanisms	mechanism	NOUN
fnp-3790	3	30	in	in	ADP
fnp-3790	3	31	experimental	experimental	ADJ
fnp-3790	3	32	and	and	CCONJ
fnp-3790	3	33	human	human	ADJ
fnp-3790	3	34	neuroinflammatory	neuroinflammatory	ADJ
fnp-3790	3	35	conditions	condition	NOUN
fnp-3790	3	36	.	.	PUNCT
fnp-3790	4	1	they	they	PRON
fnp-3790	4	2	have	have	AUX
fnp-3790	4	3	elucidated	elucidate	VERB
fnp-3790	4	4	protective	protective	ADJ
fnp-3790	4	5	and	and	CCONJ
fnp-3790	4	6	detrimental	detrimental	ADJ
fnp-3790	4	7	effects	effect	NOUN
fnp-3790	4	8	of	of	ADP
fnp-3790	4	9	activated	activated	ADJ
fnp-3790	4	10	microglia	microglia	NOUN
fnp-3790	4	11	,	,	PUNCT
fnp-3790	4	12	which	which	PRON
fnp-3790	4	13	act	act	VERB
fnp-3790	4	14	in	in	ADP
fnp-3790	4	15	a	a	DET
fnp-3790	4	16	stage	stage	NOUN
fnp-3790	4	17	and	and	CCONJ
fnp-3790	4	18	context	context	NOUN
fnp-3790	4	19	-	-	PUNCT
fnp-3790	4	20	dependent	dependent	ADJ
fnp-3790	4	21	manner	manner	NOUN
fnp-3790	4	22	in	in	ADP
fnp-3790	4	23	the	the	DET
fnp-3790	4	24	induction	induction	NOUN
fnp-3790	4	25	and	and	CCONJ
fnp-3790	4	26	propagation	propagation	NOUN
fnp-3790	4	27	of	of	ADP
fnp-3790	4	28	neurodegeneration	neurodegeneration	NOUN
fnp-3790	4	29	.	.	PUNCT
fnp-3790	5	1	in	in	ADP
fnp-3790	5	2	addition	addition	NOUN
fnp-3790	5	3	,	,	PUNCT
fnp-3790	5	4	they	they	PRON
fnp-3790	5	5	emphasize	emphasize	VERB
fnp-3790	5	6	the	the	DET
fnp-3790	5	7	importance	importance	NOUN
fnp-3790	5	8	of	of	ADP
fnp-3790	5	9	synaptic	synaptic	ADJ
fnp-3790	5	10	damage	damage	NOUN
fnp-3790	5	11	and	and	CCONJ
fnp-3790	5	12	of	of	ADP
fnp-3790	5	13	selective	selective	ADJ
fnp-3790	5	14	neuronal	neuronal	ADJ
fnp-3790	5	15	vulnerability	vulnerability	NOUN
fnp-3790	5	16	in	in	ADP
fnp-3790	5	17	the	the	DET
fnp-3790	5	18	respective	respective	ADJ
fnp-3790	5	19	diseases	disease	NOUN
fnp-3790	5	20	.	.	PUNCT
fnp-3790	6	1	the	the	DET
fnp-3790	6	2	results	result	NOUN
fnp-3790	6	3	provide	provide	VERB
fnp-3790	6	4	important	important	ADJ
fnp-3790	6	5	new	new	ADJ
fnp-3790	6	6	insights	insight	NOUN
fnp-3790	6	7	with	with	ADP
fnp-3790	6	8	high	high	ADJ
fnp-3790	6	9	clinical	clinical	ADJ
fnp-3790	6	10	relevance	relevance	NOUN
fnp-3790	6	11	.	.	PUNCT
fnp-3790	7	1	introduction	introduction	NOUN
fnp-3790	7	2	many	many	ADJ
fnp-3790	7	3	manuscripts	manuscript	NOUN
fnp-3790	7	4	published	publish	VERB
fnp-3790	7	5	in	in	ADP
fnp-3790	7	6	2021	2021	NUM
fnp-3790	7	7	focused	focus	VERB
fnp-3790	7	8	on	on	ADP
fnp-3790	7	9	neuropathological	neuropathological	ADJ
fnp-3790	7	10	aspects	aspect	NOUN
fnp-3790	7	11	of	of	ADP
fnp-3790	7	12	brain	brain	NOUN
fnp-3790	7	13	diseases	disease	NOUN
fnp-3790	7	14	,	,	PUNCT
fnp-3790	7	15	and	and	CCONJ
fnp-3790	7	16	it	it	PRON
fnp-3790	7	17	is	be	AUX
fnp-3790	7	18	thus	thus	ADV
fnp-3790	7	19	difficult	difficult	ADJ
fnp-3790	7	20	to	to	PART
fnp-3790	7	21	select	select	VERB
fnp-3790	7	22	studies	study	NOUN
fnp-3790	7	23	for	for	ADP
fnp-3790	7	24	a	a	DET
fnp-3790	7	25	review	review	NOUN
fnp-3790	7	26	article	article	NOUN
fnp-3790	7	27	providing	provide	VERB
fnp-3790	7	28	an	an	DET
fnp-3790	7	29	update	update	NOUN
fnp-3790	7	30	on	on	ADP
fnp-3790	7	31	their	their	PRON
fnp-3790	7	32	immunopathology	immunopathology	NOUN
fnp-3790	7	33	.	.	PUNCT
fnp-3790	8	1	the	the	DET
fnp-3790	8	2	manuscripts	manuscript	NOUN
fnp-3790	8	3	were	be	AUX
fnp-3790	8	4	identified	identify	VERB
fnp-3790	8	5	by	by	ADP
fnp-3790	8	6	the	the	DET
fnp-3790	8	7	frequent	frequent	ADJ
fnp-3790	8	8	screening	screening	NOUN
fnp-3790	8	9	of	of	ADP
fnp-3790	8	10	the	the	DET
fnp-3790	8	11	journals	journal	NOUN
fnp-3790	8	12	of	of	ADP
fnp-3790	8	13	neuropathology	neuropathology	NOUN
fnp-3790	8	14	,	,	PUNCT
fnp-3790	8	15	neuroimmunology	neuroimmunology	NOUN
fnp-3790	8	16	and	and	CCONJ
fnp-3790	8	17	clinical	clinical	ADJ
fnp-3790	8	18	neurology	neurology	NOUN
fnp-3790	8	19	,	,	PUNCT
fnp-3790	8	20	supplemented	supplement	VERB
fnp-3790	8	21	by	by	ADP
fnp-3790	8	22	the	the	DET
fnp-3790	8	23	search	search	NOUN
fnp-3790	8	24	for	for	ADP
fnp-3790	8	25	articles	article	NOUN
fnp-3790	8	26	in	in	ADP
fnp-3790	8	27	pubmed	pubmed	PROPN
fnp-3790	8	28	,	,	PUNCT
fnp-3790	8	29	dealing	deal	VERB
fnp-3790	8	30	with	with	ADP
fnp-3790	8	31	immunopathology	immunopathology	NOUN
fnp-3790	8	32	of	of	ADP
fnp-3790	8	33	human	human	ADJ
fnp-3790	8	34	diseases	disease	NOUN
fnp-3790	8	35	.	.	PUNCT
fnp-3790	9	1	obviously	obviously	ADV
fnp-3790	9	2	,	,	PUNCT
fnp-3790	9	3	all	all	DET
fnp-3790	9	4	aspects	aspect	NOUN
fnp-3790	9	5	related	relate	VERB
fnp-3790	9	6	to	to	ADP
fnp-3790	9	7	the	the	DET
fnp-3790	9	8	covid-19	covid-19	PROPN
fnp-3790	9	9	pandemic	pandemic	NOUN
fnp-3790	9	10	raised	raise	VERB
fnp-3790	9	11	major	major	ADJ
fnp-3790	9	12	attention	attention	NOUN
fnp-3790	9	13	,	,	PUNCT
fnp-3790	9	14	and	and	CCONJ
fnp-3790	9	15	key	key	ADJ
fnp-3790	9	16	elements	element	NOUN
fnp-3790	9	17	of	of	ADP
fnp-3790	9	18	this	this	DET
fnp-3790	9	19	work	work	NOUN
fnp-3790	9	20	deserve	deserve	VERB
fnp-3790	9	21	to	to	PART
fnp-3790	9	22	be	be	AUX
fnp-3790	9	23	presented	present	VERB
fnp-3790	9	24	here	here	ADV
fnp-3790	9	25	.	.	PUNCT
fnp-3790	10	1	in	in	ADP
fnp-3790	10	2	addition	addition	NOUN
fnp-3790	10	3	,	,	PUNCT
fnp-3790	10	4	i	i	PRON
fnp-3790	10	5	have	have	AUX
fnp-3790	10	6	focused	focus	VERB
fnp-3790	10	7	this	this	DET
fnp-3790	10	8	year	year	NOUN
fnp-3790	10	9	mainly	mainly	ADV
fnp-3790	10	10	on	on	ADP
fnp-3790	10	11	aspects	aspect	NOUN
fnp-3790	10	12	of	of	ADP
fnp-3790	10	13	neurodegeneration	neurodegeneration	NOUN
fnp-3790	10	14	,	,	PUNCT
fnp-3790	10	15	which	which	PRON
fnp-3790	10	16	not	not	PART
fnp-3790	10	17	only	only	ADV
fnp-3790	10	18	describe	describe	VERB
fnp-3790	10	19	a	a	DET
fnp-3790	10	20	specific	specific	ADJ
fnp-3790	10	21	feature	feature	NOUN
fnp-3790	10	22	in	in	ADP
fnp-3790	10	23	a	a	DET
fnp-3790	10	24	single	single	ADJ
fnp-3790	10	25	disease	disease	NOUN
fnp-3790	10	26	,	,	PUNCT
fnp-3790	10	27	but	but	CCONJ
fnp-3790	10	28	have	have	VERB
fnp-3790	10	29	relevance	relevance	NOUN
fnp-3790	10	30	for	for	ADP
fnp-3790	10	31	a	a	DET
fnp-3790	10	32	broad	broad	ADJ
fnp-3790	10	33	spectrum	spectrum	NOUN
fnp-3790	10	34	of	of	ADP
fnp-3790	10	35	different	different	ADJ
fnp-3790	10	36	disorders	disorder	NOUN
fnp-3790	10	37	.	.	PUNCT
fnp-3790	11	1	covid-19	covid-19	PROPN
fnp-3790	11	2	and	and	CCONJ
fnp-3790	11	3	the	the	DET
fnp-3790	11	4	brain	brain	NOUN
fnp-3790	11	5	not	not	PART
fnp-3790	11	6	quite	quite	ADV
fnp-3790	11	7	unexpected	unexpected	ADJ
fnp-3790	11	8	,	,	PUNCT
fnp-3790	11	9	a	a	DET
fnp-3790	11	10	major	major	ADJ
fnp-3790	11	11	focus	focus	NOUN
fnp-3790	11	12	in	in	ADP
fnp-3790	11	13	neuropathological	neuropathological	ADJ
fnp-3790	11	14	research	research	NOUN
fnp-3790	11	15	in	in	ADP
fnp-3790	11	16	2021	2021	NUM
fnp-3790	11	17	focused	focus	VERB
fnp-3790	11	18	on	on	ADP
fnp-3790	11	19	the	the	DET
fnp-3790	11	20	changes	change	NOUN
fnp-3790	11	21	in	in	ADP
fnp-3790	11	22	the	the	DET
fnp-3790	11	23	central	central	ADJ
fnp-3790	11	24	nervous	nervous	ADJ
fnp-3790	11	25	system	system	NOUN
fnp-3790	11	26	(	(	PUNCT
fnp-3790	11	27	cns	cns	NOUN
fnp-3790	11	28	)	)	PUNCT
fnp-3790	11	29	present	present	NOUN
fnp-3790	11	30	in	in	ADP
fnp-3790	11	31	patients	patient	NOUN
fnp-3790	11	32	with	with	ADP
fnp-3790	11	33	covid-19	covid-19	PROPN
fnp-3790	11	34	.	.	PUNCT
fnp-3790	11	35	insight	insight	NOUN
fnp-3790	11	36	into	into	ADP
fnp-3790	11	37	the	the	DET
fnp-3790	11	38	nature	nature	NOUN
fnp-3790	11	39	of	of	ADP
fnp-3790	11	40	the	the	DET
fnp-3790	11	41	respective	respective	ADJ
fnp-3790	11	42	damage	damage	NOUN
fnp-3790	11	43	in	in	ADP
fnp-3790	11	44	the	the	DET
fnp-3790	11	45	nervous	nervous	ADJ
fnp-3790	11	46	system	system	NOUN
fnp-3790	11	47	is	be	AUX
fnp-3790	11	48	of	of	ADP
fnp-3790	11	49	critical	critical	ADJ
fnp-3790	11	50	importance	importance	NOUN
fnp-3790	11	51	to	to	PART
fnp-3790	11	52	develop	develop	VERB
fnp-3790	11	53	strategies	strategy	NOUN
fnp-3790	11	54	to	to	PART
fnp-3790	11	55	prevent	prevent	VERB
fnp-3790	11	56	neurological	neurological	ADJ
fnp-3790	11	57	disease	disease	NOUN
fnp-3790	11	58	complications	complication	NOUN
fnp-3790	11	59	.	.	PUNCT
fnp-3790	12	1	in	in	ADP
fnp-3790	12	2	addition	addition	NOUN
fnp-3790	12	3	,	,	PUNCT
fnp-3790	12	4	it	it	PRON
fnp-3790	12	5	may	may	AUX
fnp-3790	12	6	provide	provide	VERB
fnp-3790	12	7	a	a	DET
fnp-3790	12	8	new	new	ADJ
fnp-3790	12	9	understanding	understanding	NOUN
fnp-3790	12	10	of	of	ADP
fnp-3790	12	11	the	the	DET
fnp-3790	12	12	pathogenetic	pathogenetic	ADJ
fnp-3790	12	13	substrate	substrate	NOUN
fnp-3790	12	14	of	of	ADP
fnp-3790	12	15	the	the	DET
fnp-3790	12	16	long	long	ADJ
fnp-3790	12	17	covid	covid	PROPN
fnp-3790	12	18	syndrome	syndrome	PROPN
fnp-3790	12	19	.	.	PUNCT
fnp-3790	13	1	consensus	consensus	NOUN
fnp-3790	13	2	was	be	AUX
fnp-3790	13	3	reached	reach	VERB
fnp-3790	13	4	during	during	ADP
fnp-3790	13	5	2021	2021	NUM
fnp-3790	13	6	that	that	PRON
fnp-3790	13	7	two	two	NUM
fnp-3790	13	8	different	different	ADJ
fnp-3790	13	9	pathologies	pathology	NOUN
fnp-3790	13	10	dominate	dominate	VERB
fnp-3790	13	11	in	in	ADP
fnp-3790	13	12	patients	patient	NOUN
fnp-3790	13	13	who	who	PRON
fnp-3790	13	14	died	die	VERB
fnp-3790	13	15	in	in	ADP
fnp-3790	13	16	the	the	DET
fnp-3790	13	17	course	course	NOUN
fnp-3790	13	18	of	of	ADP
fnp-3790	13	19	covid-19	covid-19	PROPN
fnp-3790	13	20	:	:	PUNCT
fnp-3790	13	21	vascular	vascular	ADJ
fnp-3790	13	22	hypoxic	hypoxic	ADJ
fnp-3790	13	23	/	/	SYM
fnp-3790	13	24	ischemic	ischemic	ADJ
fnp-3790	13	25	brain	brain	NOUN
fnp-3790	13	26	lesions	lesion	NOUN
fnp-3790	13	27	and	and	CCONJ
fnp-3790	13	28	global	global	ADJ
fnp-3790	13	29	microglia	microglia	ADJ
fnp-3790	13	30	activation	activation	NOUN
fnp-3790	13	31	(	(	PUNCT
fnp-3790	13	32	matschke	matschke	NOUN
fnp-3790	13	33	et	et	PROPN
fnp-3790	13	34	al	al	PROPN
fnp-3790	13	35	.	.	PROPN
fnp-3790	13	36	2020	2020	NUM
fnp-3790	13	37	,	,	PUNCT
fnp-3790	13	38	maiese	maiese	NOUN
fnp-3790	13	39	et	et	PROPN
fnp-3790	13	40	al	al	PROPN
fnp-3790	13	41	.	.	PROPN
fnp-3790	13	42	2021	2021	NUM
fnp-3790	13	43	,	,	PUNCT
fnp-3790	13	44	pajo	pajo	INTJ
fnp-3790	13	45	et	et	PROPN
fnp-3790	13	46	al	al	PROPN
fnp-3790	13	47	.	.	PROPN
fnp-3790	13	48	2021	2021	NUM
fnp-3790	13	49	,	,	PUNCT
fnp-3790	13	50	al	al	PROPN
fnp-3790	13	51	-	-	PUNCT
fnp-3790	13	52	sarraj	sarraj	VERB
fnp-3790	13	53	et	et	PROPN
fnp-3790	13	54	al	al	PROPN
fnp-3790	13	55	.	.	PROPN
fnp-3790	13	56	2021	2021	NUM
fnp-3790	13	57	)	)	PUNCT
fnp-3790	13	58	.	.	PUNCT
fnp-3790	14	1	vascular	vascular	ADJ
fnp-3790	14	2	pathology	pathology	NOUN
fnp-3790	14	3	included	include	VERB
fnp-3790	14	4	endotheliitis	endotheliiti	NOUN
fnp-3790	14	5	,	,	PUNCT
fnp-3790	14	6	associated	associate	VERB
fnp-3790	14	7	with	with	ADP
fnp-3790	14	8	a	a	DET
fnp-3790	14	9	variable	variable	ADJ
fnp-3790	14	10	degree	degree	NOUN
fnp-3790	14	11	of	of	ADP
fnp-3790	14	12	focal	focal	ADJ
fnp-3790	14	13	ischemic	ischemic	ADJ
fnp-3790	14	14	or	or	CCONJ
fnp-3790	14	15	hemorrhagic	hemorrhagic	ADJ
fnp-3790	14	16	lesions	lesion	NOUN
fnp-3790	14	17	and	and	CCONJ
fnp-3790	14	18	diffuse	diffuse	NOUN
fnp-3790	14	19	or	or	CCONJ
fnp-3790	14	20	focal	focal	ADJ
fnp-3790	14	21	hypoxic	hypoxic	ADJ
fnp-3790	14	22	alterations	alteration	NOUN
fnp-3790	14	23	of	of	ADP
fnp-3790	14	24	neurons	neuron	NOUN
fnp-3790	14	25	and	and	CCONJ
fnp-3790	14	26	glia	glia	NOUN
fnp-3790	14	27	(	(	PUNCT
fnp-3790	14	28	thakur	thakur	PROPN
fnp-3790	14	29	et	et	PROPN
fnp-3790	14	30	al	al	PROPN
fnp-3790	14	31	.	.	PROPN
fnp-3790	14	32	2021	2021	NUM
fnp-3790	14	33	,	,	PUNCT
fnp-3790	14	34	lee	lee	PROPN
fnp-3790	14	35	et	et	PROPN
fnp-3790	14	36	al	al	PROPN
fnp-3790	14	37	.	.	PROPN
fnp-3790	14	38	2021	2021	NUM
fnp-3790	14	39	,	,	PUNCT
fnp-3790	14	40	fabbri	fabbri	NOUN
fnp-3790	14	41	et	et	PROPN
fnp-3790	14	42	al	al	PROPN
fnp-3790	14	43	.	.	PROPN
fnp-3790	14	44	2021	2021	NUM
fnp-3790	14	45	)	)	PUNCT
fnp-3790	14	46	.	.	PUNCT
fnp-3790	15	1	microglia	microglia	ADJ
fnp-3790	15	2	activation	activation	NOUN
fnp-3790	15	3	was	be	AUX
fnp-3790	15	4	most	most	ADV
fnp-3790	15	5	prominent	prominent	ADJ
fnp-3790	15	6	in	in	ADP
fnp-3790	15	7	the	the	DET
fnp-3790	15	8	brain	brain	NOUN
fnp-3790	15	9	stem	stem	NOUN
fnp-3790	15	10	and	and	CCONJ
fnp-3790	15	11	the	the	DET
fnp-3790	15	12	hippocampus	hippocampus	NOUN
fnp-3790	15	13	.	.	PUNCT
fnp-3790	16	1	it	it	PRON
fnp-3790	16	2	consisted	consist	VERB
fnp-3790	16	3	of	of	ADP
fnp-3790	16	4	a	a	DET
fnp-3790	16	5	diffuse	diffuse	ADJ
fnp-3790	16	6	increase	increase	NOUN
fnp-3790	16	7	of	of	ADP
fnp-3790	16	8	microglia	microglia	ADJ
fnp-3790	16	9	density	density	NOUN
fnp-3790	16	10	with	with	ADP
fnp-3790	16	11	cellular	cellular	ADJ
fnp-3790	16	12	activation	activation	NOUN
fnp-3790	16	13	and	and	CCONJ
fnp-3790	16	14	the	the	DET
fnp-3790	16	15	appearance	appearance	NOUN
fnp-3790	16	16	of	of	ADP
fnp-3790	16	17	microglia	microglia	ADJ
fnp-3790	16	18	nodules	nodule	NOUN
fnp-3790	16	19	(	(	PUNCT
fnp-3790	16	20	thakur	thakur	PROPN
fnp-3790	16	21	et	et	PROPN
fnp-3790	16	22	al	al	PROPN
fnp-3790	16	23	.	.	PROPN
fnp-3790	16	24	2021	2021	NUM
fnp-3790	16	25	,	,	PUNCT
fnp-3790	16	26	maiese	maiese	NOUN
fnp-3790	16	27	et	et	PROPN
fnp-3790	16	28	al	al	PROPN
fnp-3790	16	29	.	.	PROPN
fnp-3790	16	30	2021	2021	NUM
fnp-3790	16	31	)	)	PUNCT
fnp-3790	16	32	.	.	PUNCT
fnp-3790	17	1	overall	overall	ADV
fnp-3790	17	2	,	,	PUNCT
fnp-3790	17	3	neither	neither	CCONJ
fnp-3790	17	4	the	the	DET
fnp-3790	17	5	vascular	vascular	ADJ
fnp-3790	17	6	changes	change	NOUN
fnp-3790	17	7	nor	nor	CCONJ
fnp-3790	17	8	the	the	DET
fnp-3790	17	9	patterns	pattern	NOUN
fnp-3790	17	10	of	of	ADP
fnp-3790	17	11	microglia	microglia	ADJ
fnp-3790	17	12	activation	activation	NOUN
fnp-3790	17	13	are	be	AUX
fnp-3790	17	14	considered	consider	VERB
fnp-3790	17	15	specific	specific	ADJ
fnp-3790	17	16	for	for	ADP
fnp-3790	17	17	sars	sar	NOUN
fnp-3790	17	18	-	-	PUNCT
fnp-3790	17	19	cov-2	cov-2	PART
fnp-3790	17	20	infection	infection	NOUN
fnp-3790	17	21	,	,	PUNCT
fnp-3790	17	22	but	but	CCONJ
fnp-3790	17	23	can	can	AUX
fnp-3790	17	24	also	also	ADV
fnp-3790	17	25	be	be	AUX
fnp-3790	17	26	found	find	VERB
fnp-3790	17	27	in	in	ADP
fnp-3790	17	28	other	other	ADJ
fnp-3790	17	29	virus	virus	NOUN
fnp-3790	17	30	infections	infection	NOUN
fnp-3790	17	31	of	of	ADP
fnp-3790	17	32	the	the	DET
fnp-3790	17	33	cns	cns	NOUN
fnp-3790	17	34	,	,	PUNCT
fnp-3790	17	35	in	in	ADP
fnp-3790	17	36	conditions	condition	NOUN
fnp-3790	17	37	of	of	ADP
fnp-3790	17	38	systemic	systemic	ADJ
fnp-3790	17	39	immune	immune	ADJ
fnp-3790	17	40	activation	activation	NOUN
fnp-3790	17	41	or	or	CCONJ
fnp-3790	17	42	sepsis	sepsis	NOUN
fnp-3790	17	43	and	and	CCONJ
fnp-3790	17	44	in	in	ADP
fnp-3790	17	45	patients	patient	NOUN
fnp-3790	17	46	dying	die	VERB
fnp-3790	17	47	in	in	ADP
fnp-3790	17	48	intensive	intensive	ADJ
fnp-3790	17	49	care	care	NOUN
fnp-3790	17	50	units	unit	NOUN
fnp-3790	17	51	(	(	PUNCT
fnp-3790	17	52	thakur	thakur	PROPN
fnp-3790	17	53	et	et	PROPN
fnp-3790	17	54	al	al	PROPN
fnp-3790	17	55	.	.	PROPN
fnp-3790	17	56	2021	2021	NUM
fnp-3790	17	57	,	,	PUNCT
fnp-3790	17	58	al	al	PROPN
fnp-3790	17	59	-	-	PUNCT
fnp-3790	17	60	sarraj	sarraj	VERB
fnp-3790	17	61	et	et	PROPN
fnp-3790	17	62	al	al	PROPN
fnp-3790	17	63	.	.	PROPN
fnp-3790	17	64	2021	2021	NUM
fnp-3790	17	65	)	)	PUNCT
fnp-3790	17	66	.	.	PUNCT
fnp-3790	18	1	thus	thus	ADV
fnp-3790	18	2	,	,	PUNCT
fnp-3790	18	3	systemic	systemic	ADJ
fnp-3790	18	4	cytokine	cytokine	NOUN
fnp-3790	18	5	storm	storm	NOUN
fnp-3790	18	6	in	in	ADP
fnp-3790	18	7	the	the	DET
fnp-3790	18	8	course	course	NOUN
fnp-3790	18	9	of	of	ADP
fnp-3790	18	10	the	the	DET
fnp-3790	18	11	disease	disease	NOUN
fnp-3790	18	12	together	together	ADV
fnp-3790	18	13	with	with	ADP
fnp-3790	18	14	episodes	episode	NOUN
fnp-3790	18	15	of	of	ADP
fnp-3790	18	16	general	general	ADJ
fnp-3790	18	17	hypoxia	hypoxia	NOUN
fnp-3790	18	18	or	or	CCONJ
fnp-3790	18	19	metabolic	metabolic	NOUN
fnp-3790	18	20	derangement	derangement	NOUN
fnp-3790	18	21	are	be	AUX
fnp-3790	18	22	likely	likely	ADJ
fnp-3790	18	23	to	to	PART
fnp-3790	18	24	be	be	AUX
fnp-3790	18	25	at	at	ADP
fnp-3790	18	26	least	least	ADJ
fnp-3790	18	27	in	in	ADP
fnp-3790	18	28	part	part	NOUN
fnp-3790	18	29	responsible	responsible	ADJ
fnp-3790	18	30	for	for	ADP
fnp-3790	18	31	the	the	DET
fnp-3790	18	32	respective	respective	ADJ
fnp-3790	18	33	damage	damage	NOUN
fnp-3790	18	34	in	in	ADP
fnp-3790	18	35	the	the	DET
fnp-3790	18	36	nervous	nervous	ADJ
fnp-3790	18	37	system	system	NOUN
fnp-3790	18	38	.	.	PUNCT
fnp-3790	19	1	since	since	SCONJ
fnp-3790	19	2	the	the	DET
fnp-3790	19	3	mean	mean	ADJ
fnp-3790	19	4	age	age	NOUN
fnp-3790	19	5	of	of	ADP
fnp-3790	19	6	the	the	DET
fnp-3790	19	7	patients	patient	NOUN
fnp-3790	19	8	in	in	ADP
fnp-3790	19	9	the	the	DET
fnp-3790	19	10	larger	large	ADJ
fnp-3790	19	11	autopsy	autopsy	ADJ
fnp-3790	19	12	series	series	NOUN
fnp-3790	19	13	was	be	AUX
fnp-3790	19	14	beyond	beyond	ADP
fnp-3790	19	15	seventy	seventy	NUM
fnp-3790	19	16	years	year	NOUN
fnp-3790	19	17	,	,	PUNCT
fnp-3790	19	18	it	it	PRON
fnp-3790	19	19	was	be	AUX
fnp-3790	19	20	not	not	PART
fnp-3790	19	21	a	a	DET
fnp-3790	19	22	surprise	surprise	NOUN
fnp-3790	19	23	that	that	SCONJ
fnp-3790	19	24	about	about	ADV
fnp-3790	19	25	half	half	NOUN
fnp-3790	19	26	of	of	ADP
fnp-3790	19	27	them	they	PRON
fnp-3790	19	28	exhibited	exhibit	VERB
fnp-3790	19	29	pathologies	pathology	NOUN
fnp-3790	19	30	related	relate	VERB
fnp-3790	19	31	to	to	ADP
fnp-3790	19	32	age	age	NOUN
fnp-3790	19	33	-	-	PUNCT
fnp-3790	19	34	related	relate	VERB
fnp-3790	19	35	neurodegenerative	neurodegenerative	ADJ
fnp-3790	19	36	diseases	disease	NOUN
fnp-3790	19	37	.	.	PUNCT
fnp-3790	20	1	all	all	DET
fnp-3790	20	2	these	these	DET
fnp-3790	20	3	pathological	pathological	ADJ
fnp-3790	20	4	changes	change	NOUN
fnp-3790	20	5	are	be	AUX
fnp-3790	20	6	also	also	ADV
fnp-3790	20	7	in	in	ADP
fnp-3790	20	8	line	line	NOUN
fnp-3790	20	9	with	with	ADP
fnp-3790	20	10	the	the	DET
fnp-3790	20	11	overall	overall	ADJ
fnp-3790	20	12	clinical	clinical	ADJ
fnp-3790	20	13	appearance	appearance	NOUN
fnp-3790	20	14	of	of	ADP
fnp-3790	20	15	neurological	neurological	ADJ
fnp-3790	20	16	complications	complication	NOUN
fnp-3790	20	17	of	of	ADP
fnp-3790	20	18	covid-19	covid-19	PROPN
fnp-3790	20	19	(	(	PUNCT
fnp-3790	20	20	thakur	thakur	PROPN
fnp-3790	20	21	et	et	PROPN
fnp-3790	20	22	al	al	PROPN
fnp-3790	20	23	.	.	PROPN
fnp-3790	20	24	2021	2021	NUM
fnp-3790	20	25	)	)	PUNCT
fnp-3790	20	26	.	.	PUNCT
fnp-3790	21	1	the	the	DET
fnp-3790	21	2	prevalence	prevalence	NOUN
fnp-3790	21	3	and	and	CCONJ
fnp-3790	21	4	potential	potential	ADJ
fnp-3790	21	5	role	role	NOUN
fnp-3790	21	6	of	of	ADP
fnp-3790	21	7	direct	direct	ADJ
fnp-3790	21	8	sars	sar	NOUN
fnp-3790	21	9	-	-	PUNCT
fnp-3790	21	10	cov-2	cov-2	PART
fnp-3790	21	11	infection	infection	NOUN
fnp-3790	21	12	in	in	ADP
fnp-3790	21	13	the	the	DET
fnp-3790	21	14	cns	cns	NOUN
fnp-3790	21	15	is	be	AUX
fnp-3790	21	16	still	still	ADV
fnp-3790	21	17	controversial	controversial	ADJ
fnp-3790	21	18	(	(	PUNCT
fnp-3790	21	19	al	al	PROPN
fnp-3790	21	20	-	-	PUNCT
fnp-3790	21	21	sarraj	sarraj	VERB
fnp-3790	21	22	et	et	PROPN
fnp-3790	21	23	al	al	PROPN
fnp-3790	21	24	.	.	PROPN
fnp-3790	21	25	2021	2021	NUM
fnp-3790	21	26	)	)	PUNCT
fnp-3790	21	27	.	.	PUNCT
fnp-3790	22	1	in	in	ADP
fnp-3790	22	2	the	the	DET
fnp-3790	22	3	majority	majority	NOUN
fnp-3790	22	4	of	of	ADP
fnp-3790	22	5	cases	case	NOUN
fnp-3790	22	6	no	no	DET
fnp-3790	22	7	virus	virus	NOUN
fnp-3790	22	8	rna	rna	NOUN
fnp-3790	22	9	or	or	CCONJ
fnp-3790	22	10	antigen	antigen	NOUN
fnp-3790	22	11	in	in	ADP
fnp-3790	22	12	the	the	DET
fnp-3790	22	13	cns	cns	NOUN
fnp-3790	22	14	has	have	AUX
fnp-3790	22	15	been	be	AUX
fnp-3790	22	16	detected	detect	VERB
fnp-3790	22	17	,	,	PUNCT
fnp-3790	22	18	and	and	CCONJ
fnp-3790	22	19	when	when	SCONJ
fnp-3790	22	20	it	it	PRON
fnp-3790	22	21	was	be	AUX
fnp-3790	22	22	present	present	ADJ
fnp-3790	22	23	,	,	PUNCT
fnp-3790	22	24	the	the	DET
fnp-3790	22	25	virus	virus	NOUN
fnp-3790	22	26	titers	titer	NOUN
fnp-3790	22	27	were	be	AUX
fnp-3790	22	28	low	low	ADJ
fnp-3790	22	29	even	even	ADV
fnp-3790	22	30	in	in	ADP
fnp-3790	22	31	cases	case	NOUN
fnp-3790	22	32	with	with	ADP
fnp-3790	22	33	persistent	persistent	ADJ
fnp-3790	22	34	active	active	ADJ
fnp-3790	22	35	infection	infection	NOUN
fnp-3790	22	36	in	in	ADP
fnp-3790	22	37	the	the	DET
fnp-3790	22	38	respiratory	respiratory	ADJ
fnp-3790	22	39	organs	organ	NOUN
fnp-3790	22	40	(	(	PUNCT
fnp-3790	22	41	maiese	maiese	NOUN
fnp-3790	22	42	et	et	PROPN
fnp-3790	22	43	al	al	PROPN
fnp-3790	22	44	.	.	PROPN
fnp-3790	22	45	2021	2021	NUM
fnp-3790	22	46	,	,	PUNCT
fnp-3790	22	47	thakur	thakur	PROPN
fnp-3790	22	48	et	et	PROPN
fnp-3790	22	49	al	al	PROPN
fnp-3790	22	50	.	.	PROPN
fnp-3790	22	51	2021	2021	NUM
fnp-3790	22	52	,	,	PUNCT
fnp-3790	22	53	fabbri	fabbri	NOUN
fnp-3790	22	54	et	et	PROPN
fnp-3790	22	55	al	al	PROPN
fnp-3790	22	56	.	.	PROPN
fnp-3790	22	57	2021	2021	NUM
fnp-3790	22	58	)	)	PUNCT
fnp-3790	22	59	.	.	PUNCT
fnp-3790	23	1	this	this	PRON
fnp-3790	23	2	,	,	PUNCT
fnp-3790	23	3	however	however	ADV
fnp-3790	23	4	,	,	PUNCT
fnp-3790	23	5	does	do	AUX
fnp-3790	23	6	not	not	PART
fnp-3790	23	7	exclude	exclude	VERB
fnp-3790	23	8	a	a	DET
fnp-3790	23	9	transient	transient	ADJ
fnp-3790	23	10	endothelial	endothelial	ADJ
fnp-3790	23	11	infection	infection	NOUN
fnp-3790	23	12	,	,	PUNCT
fnp-3790	23	13	which	which	PRON
fnp-3790	23	14	triggers	trigger	VERB
fnp-3790	23	15	endotheliitis	endotheliitis	PRON
fnp-3790	23	16	and	and	CCONJ
fnp-3790	23	17	vascular	vascular	ADJ
fnp-3790	23	18	occlusion	occlusion	NOUN
fnp-3790	23	19	at	at	ADP
fnp-3790	23	20	early	early	ADJ
fnp-3790	23	21	lesion	lesion	NOUN
fnp-3790	23	22	stages	stage	NOUN
fnp-3790	23	23	(	(	PUNCT
fnp-3790	23	24	kirschenbaum	kirschenbaum	PROPN
fnp-3790	23	25	et	et	PROPN
fnp-3790	23	26	al	al	PROPN
fnp-3790	23	27	.	.	PROPN
fnp-3790	23	28	2021	2021	NUM
fnp-3790	23	29	,	,	PUNCT
fnp-3790	23	30	nalugo	nalugo	VERB
fnp-3790	23	31	et	et	PROPN
fnp-3790	23	32	al	al	PROPN
fnp-3790	23	33	.	.	PROPN
fnp-3790	23	34	2021	2021	NUM
fnp-3790	23	35	)	)	PUNCT
fnp-3790	23	36	.	.	PUNCT
fnp-3790	24	1	another	another	DET
fnp-3790	24	2	potential	potential	ADJ
fnp-3790	24	3	route	route	NOUN
fnp-3790	24	4	of	of	ADP
fnp-3790	24	5	virus	virus	NOUN
fnp-3790	24	6	invasion	invasion	NOUN
fnp-3790	24	7	of	of	ADP
fnp-3790	24	8	the	the	DET
fnp-3790	24	9	brain	brain	NOUN
fnp-3790	24	10	may	may	AUX
fnp-3790	24	11	occur	occur	VERB
fnp-3790	24	12	through	through	ADP
fnp-3790	24	13	the	the	DET
fnp-3790	24	14	olfactory	olfactory	ADJ
fnp-3790	24	15	system	system	NOUN
fnp-3790	24	16	.	.	PUNCT
fnp-3790	25	1	however	however	ADV
fnp-3790	25	2	,	,	PUNCT
fnp-3790	25	3	a	a	DET
fnp-3790	25	4	recent	recent	ADJ
fnp-3790	25	5	very	very	ADV
fnp-3790	25	6	systematic	systematic	ADJ
fnp-3790	25	7	analysis	analysis	NOUN
fnp-3790	25	8	of	of	ADP
fnp-3790	25	9	experimental	experimental	ADJ
fnp-3790	25	10	and	and	CCONJ
fnp-3790	25	11	clinical	clinical	ADJ
fnp-3790	25	12	data	datum	NOUN
fnp-3790	25	13	on	on	ADP
fnp-3790	25	14	this	this	DET
fnp-3790	25	15	topic	topic	NOUN
fnp-3790	25	16	came	come	VERB
fnp-3790	25	17	to	to	ADP
fnp-3790	25	18	the	the	DET
fnp-3790	25	19	conclusion	conclusion	NOUN
fnp-3790	25	20	that	that	SCONJ
fnp-3790	25	21	brain	brain	NOUN
fnp-3790	25	22	infection	infection	NOUN
fnp-3790	25	23	via	via	ADP
fnp-3790	25	24	olfactory	olfactory	ADJ
fnp-3790	25	25	nerves	nerve	NOUN
fnp-3790	25	26	and	and	CCONJ
fnp-3790	25	27	a	a	DET
fnp-3790	25	28	trans	trans	ADJ
fnp-3790	25	29	-	-	ADJ
fnp-3790	25	30	neuronal	neuronal	ADJ
fnp-3790	25	31	spreading	spreading	NOUN
fnp-3790	25	32	of	of	ADP
fnp-3790	25	33	infection	infection	NOUN
fnp-3790	25	34	through	through	ADP
fnp-3790	25	35	the	the	DET
fnp-3790	25	36	olfactory	olfactory	ADJ
fnp-3790	25	37	system	system	NOUN
fnp-3790	25	38	is	be	AUX
fnp-3790	25	39	unlikely	unlikely	ADJ
fnp-3790	25	40	(	(	PUNCT
fnp-3790	25	41	butowt	butowt	NOUN
fnp-3790	25	42	et	et	PROPN
fnp-3790	25	43	al	al	PROPN
fnp-3790	25	44	.	.	PROPN
fnp-3790	25	45	2021	2021	NUM
fnp-3790	25	46	)	)	PUNCT
fnp-3790	25	47	.	.	PUNCT
fnp-3790	26	1	yet	yet	ADV
fnp-3790	26	2	,	,	PUNCT
fnp-3790	26	3	neuronal	neuronal	ADJ
fnp-3790	26	4	spread	spread	NOUN
fnp-3790	26	5	of	of	ADP
fnp-3790	26	6	the	the	DET
fnp-3790	26	7	virus	virus	NOUN
fnp-3790	26	8	by	by	ADP
fnp-3790	26	9	retrograde	retrograde	ADJ
fnp-3790	26	10	axonal	axonal	ADJ
fnp-3790	26	11	transport	transport	NOUN
fnp-3790	26	12	in	in	ADP
fnp-3790	26	13	sensory	sensory	ADJ
fnp-3790	26	14	nerves	nerve	NOUN
fnp-3790	26	15	from	from	ADP
fnp-3790	26	16	the	the	DET
fnp-3790	26	17	infected	infected	ADJ
fnp-3790	26	18	mucosa	mucosa	NOUN
fnp-3790	26	19	is	be	AUX
fnp-3790	26	20	still	still	ADV
fnp-3790	26	21	an	an	DET
fnp-3790	26	22	option	option	NOUN
fnp-3790	26	23	in	in	ADP
fnp-3790	26	24	some	some	DET
fnp-3790	26	25	cases	case	NOUN
fnp-3790	26	26	.	.	PUNCT
fnp-3790	27	1	importantly	importantly	ADV
fnp-3790	27	2	,	,	PUNCT
fnp-3790	27	3	this	this	DET
fnp-3790	27	4	study	study	NOUN
fnp-3790	27	5	also	also	ADV
fnp-3790	27	6	pinpoints	pinpoint	NOUN
fnp-3790	27	7	to	to	ADP
fnp-3790	27	8	the	the	DET
fnp-3790	27	9	limits	limit	NOUN
fnp-3790	27	10	of	of	ADP
fnp-3790	27	11	experimental	experimental	ADJ
fnp-3790	27	12	research	research	NOUN
fnp-3790	27	13	in	in	ADP
fnp-3790	27	14	this	this	DET
fnp-3790	27	15	topic	topic	NOUN
fnp-3790	27	16	,	,	PUNCT
fnp-3790	27	17	since	since	SCONJ
fnp-3790	27	18	those	those	DET
fnp-3790	27	19	models	model	NOUN
fnp-3790	27	20	,	,	PUNCT
fnp-3790	27	21	which	which	PRON
fnp-3790	27	22	mimic	mimic	VERB
fnp-3790	27	23	human	human	ADJ
fnp-3790	27	24	disease	disease	NOUN
fnp-3790	27	25	best	well	ADV
fnp-3790	27	26	,	,	PUNCT
fnp-3790	27	27	are	be	AUX
fnp-3790	27	28	induced	induce	VERB
fnp-3790	27	29	in	in	ADP
fnp-3790	27	30	animal	animal	NOUN
fnp-3790	27	31	species	specie	NOUN
fnp-3790	27	32	,	,	PUNCT
fnp-3790	27	33	which	which	PRON
fnp-3790	27	34	are	be	AUX
fnp-3790	27	35	only	only	ADV
fnp-3790	27	36	poorly	poorly	ADV
fnp-3790	27	37	suitable	suitable	ADJ
fnp-3790	27	38	for	for	ADP
fnp-3790	27	39	currently	currently	ADV
fnp-3790	27	40	available	available	ADJ
fnp-3790	27	41	immunological	immunological	ADJ
fnp-3790	27	42	and	and	CCONJ
fnp-3790	27	43	molecular	molecular	ADJ
fnp-3790	27	44	research	research	NOUN
fnp-3790	27	45	tools	tool	NOUN
fnp-3790	27	46	(	(	PUNCT
fnp-3790	27	47	butowt	butowt	NOUN
fnp-3790	27	48	et	et	PROPN
fnp-3790	27	49	al	al	PROPN
fnp-3790	27	50	.	.	PROPN
fnp-3790	27	51	2021	2021	NUM
fnp-3790	27	52	)	)	PUNCT
fnp-3790	27	53	.	.	PUNCT
fnp-3790	28	1	an	an	DET
fnp-3790	28	2	important	important	ADJ
fnp-3790	28	3	question	question	NOUN
fnp-3790	28	4	is	be	AUX
fnp-3790	28	5	whether	whether	SCONJ
fnp-3790	28	6	structural	structural	ADJ
fnp-3790	28	7	brain	brain	NOUN
fnp-3790	28	8	damage	damage	NOUN
fnp-3790	28	9	in	in	ADP
fnp-3790	28	10	the	the	DET
fnp-3790	28	11	disease	disease	NOUN
fnp-3790	28	12	course	course	NOUN
fnp-3790	28	13	of	of	ADP
fnp-3790	28	14	covid-19	covid-19	PROPN
fnp-3790	28	15	could	could	AUX
fnp-3790	28	16	in	in	ADP
fnp-3790	28	17	part	part	NOUN
fnp-3790	28	18	explain	explain	VERB
fnp-3790	28	19	long	long	ADJ
fnp-3790	28	20	-	-	PUNCT
fnp-3790	28	21	term	term	NOUN
fnp-3790	28	22	sequelae	sequelae	NOUN
fnp-3790	28	23	of	of	ADP
fnp-3790	28	24	the	the	DET
fnp-3790	28	25	disease	disease	NOUN
fnp-3790	28	26	(	(	PUNCT
fnp-3790	28	27	long	long	PROPN
fnp-3790	28	28	covid	covid	PROPN
fnp-3790	28	29	;	;	PUNCT
fnp-3790	28	30	baig	baig	PROPN
fnp-3790	28	31	2021	2021	NUM
fnp-3790	28	32	)	)	PUNCT
fnp-3790	28	33	.	.	PUNCT
fnp-3790	29	1	ischemic	ischemic	ADJ
fnp-3790	29	2	changes	change	NOUN
fnp-3790	29	3	and	and	CCONJ
fnp-3790	29	4	microglial	microglial	ADJ
fnp-3790	29	5	activation	activation	NOUN
fnp-3790	29	6	were	be	AUX
fnp-3790	29	7	seen	see	VERB
fnp-3790	29	8	in	in	ADP
fnp-3790	29	9	40	40	NUM
fnp-3790	29	10	%	%	NOUN
fnp-3790	29	11	and	and	CCONJ
fnp-3790	29	12	80	80	NUM
fnp-3790	29	13	%	%	NOUN
fnp-3790	29	14	of	of	ADP
fnp-3790	29	15	brains	brain	NOUN
fnp-3790	29	16	,	,	PUNCT
fnp-3790	29	17	respectively	respectively	ADV
fnp-3790	29	18	.	.	PUNCT
fnp-3790	30	1	however	however	ADV
fnp-3790	30	2	,	,	PUNCT
fnp-3790	30	3	only	only	ADV
fnp-3790	30	4	17	17	NUM
fnp-3790	30	5	%	%	NOUN
fnp-3790	30	6	of	of	ADP
fnp-3790	30	7	these	these	DET
fnp-3790	30	8	patients	patient	NOUN
fnp-3790	30	9	had	have	VERB
fnp-3790	30	10	neurological	neurological	ADJ
fnp-3790	30	11	manifestations	manifestation	NOUN
fnp-3790	30	12	that	that	PRON
fnp-3790	30	13	were	be	AUX
fnp-3790	30	14	severe	severe	ADJ
fnp-3790	30	15	enough	enough	ADV
fnp-3790	30	16	to	to	PART
fnp-3790	30	17	involve	involve	VERB
fnp-3790	30	18	a	a	DET
fnp-3790	30	19	neurological	neurological	ADJ
fnp-3790	30	20	consultant	consultant	NOUN
fnp-3790	30	21	during	during	ADP
fnp-3790	30	22	life	life	NOUN
fnp-3790	30	23	(	(	PUNCT
fnp-3790	30	24	thakur	thakur	PROPN
fnp-3790	30	25	et	et	PROPN
fnp-3790	30	26	al	al	PROPN
fnp-3790	30	27	.	.	PROPN
fnp-3790	30	28	2021	2021	NUM
fnp-3790	30	29	)	)	PUNCT
fnp-3790	30	30	.	.	PUNCT
fnp-3790	31	1	this	this	PRON
fnp-3790	31	2	suggests	suggest	VERB
fnp-3790	31	3	that	that	SCONJ
fnp-3790	31	4	brain	brain	NOUN
fnp-3790	31	5	damage	damage	NOUN
fnp-3790	31	6	in	in	ADP
fnp-3790	31	7	the	the	DET
fnp-3790	31	8	course	course	NOUN
fnp-3790	31	9	of	of	ADP
fnp-3790	31	10	covid-19	covid-19	PROPN
fnp-3790	31	11	is	be	AUX
fnp-3790	31	12	more	more	ADV
fnp-3790	31	13	frequent	frequent	ADJ
fnp-3790	31	14	and	and	CCONJ
fnp-3790	31	15	widespread	widespread	ADJ
fnp-3790	31	16	than	than	SCONJ
fnp-3790	31	17	reflected	reflect	VERB
fnp-3790	31	18	in	in	ADP
fnp-3790	31	19	clinically	clinically	ADV
fnp-3790	31	20	overt	overt	ADJ
fnp-3790	31	21	neurological	neurological	ADJ
fnp-3790	31	22	disease	disease	NOUN
fnp-3790	31	23	.	.	PUNCT
fnp-3790	32	1	this	this	PRON
fnp-3790	32	2	is	be	AUX
fnp-3790	32	3	in	in	ADP
fnp-3790	32	4	line	line	NOUN
fnp-3790	32	5	with	with	ADP
fnp-3790	32	6	the	the	DET
fnp-3790	32	7	results	result	NOUN
fnp-3790	32	8	of	of	ADP
fnp-3790	32	9	a	a	DET
fnp-3790	32	10	very	very	ADV
fnp-3790	32	11	large	large	ADJ
fnp-3790	32	12	clinical	clinical	ADJ
fnp-3790	32	13	study	study	NOUN
fnp-3790	32	14	on	on	ADP
fnp-3790	32	15	a	a	DET
fnp-3790	32	16	cohort	cohort	NOUN
fnp-3790	32	17	of	of	ADP
fnp-3790	32	18	more	more	ADJ
fnp-3790	32	19	than	than	ADP
fnp-3790	32	20	10,000	10,000	NUM
fnp-3790	32	21	covid-19	covid-19	PROPN
fnp-3790	32	22	patients	patient	NOUN
fnp-3790	32	23	from	from	ADP
fnp-3790	32	24	the	the	DET
fnp-3790	32	25	philippines	philippine	NOUN
fnp-3790	32	26	,	,	PUNCT
fnp-3790	32	27	which	which	PRON
fnp-3790	32	28	describes	describe	VERB
fnp-3790	32	29	a	a	DET
fnp-3790	32	30	high	high	ADJ
fnp-3790	32	31	prevalence	prevalence	NOUN
fnp-3790	32	32	of	of	ADP
fnp-3790	32	33	mild	mild	ADJ
fnp-3790	32	34	neurological	neurological	ADJ
fnp-3790	32	35	deficits	deficit	NOUN
fnp-3790	32	36	(	(	PUNCT
fnp-3790	32	37	espiritu	espiritu	PROPN
fnp-3790	32	38	et	et	PROPN
fnp-3790	32	39	al	al	PROPN
fnp-3790	32	40	.	.	PROPN
fnp-3790	32	41	2021	2021	NUM
fnp-3790	32	42	)	)	PUNCT
fnp-3790	32	43	.	.	PUNCT
fnp-3790	33	1	clinically	clinically	ADV
fnp-3790	33	2	,	,	PUNCT
fnp-3790	33	3	mild	mild	ADJ
fnp-3790	33	4	cognitive	cognitive	ADJ
fnp-3790	33	5	impairment	impairment	NOUN
fnp-3790	33	6	,	,	PUNCT
fnp-3790	33	7	encephalopathy	encephalopathy	ADJ
fnp-3790	33	8	and	and	CCONJ
fnp-3790	33	9	cerebrovascular	cerebrovascular	ADJ
fnp-3790	33	10	disease	disease	NOUN
fnp-3790	33	11	were	be	AUX
fnp-3790	33	12	the	the	DET
fnp-3790	33	13	most	most	ADV
fnp-3790	33	14	common	common	ADJ
fnp-3790	33	15	manifestations	manifestation	NOUN
fnp-3790	33	16	.	.	PUNCT
fnp-3790	34	1	the	the	DET
fnp-3790	34	2	high	high	ADJ
fnp-3790	34	3	incidence	incidence	NOUN
fnp-3790	34	4	of	of	ADP
fnp-3790	34	5	microglia	microglia	ADJ
fnp-3790	34	6	activation	activation	NOUN
fnp-3790	34	7	in	in	ADP
fnp-3790	34	8	the	the	DET
fnp-3790	34	9	hippocampus	hippocampus	NOUN
fnp-3790	34	10	and	and	CCONJ
fnp-3790	34	11	brain	brain	NOUN
fnp-3790	34	12	stem	stem	NOUN
fnp-3790	34	13	may	may	AUX
fnp-3790	34	14	be	be	AUX
fnp-3790	34	15	related	relate	VERB
fnp-3790	34	16	to	to	ADP
fnp-3790	34	17	neuropsychiatric	neuropsychiatric	ADJ
fnp-3790	34	18	symptoms	symptom	NOUN
fnp-3790	34	19	in	in	ADP
fnp-3790	34	20	covid-19	covid-19	PROPN
fnp-3790	34	21	survivors	survivor	NOUN
fnp-3790	34	22	,	,	PUNCT
fnp-3790	34	23	including	include	VERB
fnp-3790	34	24	memory	memory	NOUN
fnp-3790	34	25	disturbances	disturbance	NOUN
fnp-3790	34	26	,	,	PUNCT
fnp-3790	34	27	somnolence	somnolence	NOUN
fnp-3790	34	28	and	and	CCONJ
fnp-3790	34	29	fatigue	fatigue	NOUN
fnp-3790	34	30	(	(	PUNCT
fnp-3790	34	31	thakur	thakur	PROPN
fnp-3790	34	32	et	et	PROPN
fnp-3790	34	33	al	al	PROPN
fnp-3790	34	34	.	.	PROPN
fnp-3790	34	35	2021	2021	NUM
fnp-3790	34	36	)	)	PUNCT
fnp-3790	34	37	.	.	PUNCT
fnp-3790	35	1	the	the	DET
fnp-3790	35	2	immunopathology	immunopathology	NOUN
fnp-3790	35	3	of	of	ADP
fnp-3790	35	4	the	the	DET
fnp-3790	35	5	covid-19	covid-19	PROPN
fnp-3790	35	6	brain	brain	NOUN
fnp-3790	35	7	the	the	DET
fnp-3790	35	8	studies	study	NOUN
fnp-3790	35	9	discussed	discuss	VERB
fnp-3790	35	10	above	above	ADV
fnp-3790	35	11	describe	describe	VERB
fnp-3790	35	12	the	the	DET
fnp-3790	35	13	basic	basic	ADJ
fnp-3790	35	14	neuropathology	neuropathology	NOUN
fnp-3790	35	15	of	of	ADP
fnp-3790	35	16	the	the	DET
fnp-3790	35	17	central	central	ADJ
fnp-3790	35	18	nervous	nervous	ADJ
fnp-3790	35	19	system	system	NOUN
fnp-3790	35	20	of	of	ADP
fnp-3790	35	21	patients	patient	NOUN
fnp-3790	35	22	with	with	ADP
fnp-3790	35	23	covid-19	covid-19	PROPN
fnp-3790	35	24	,	,	PUNCT
fnp-3790	35	25	but	but	CCONJ
fnp-3790	35	26	they	they	PRON
fnp-3790	35	27	have	have	AUX
fnp-3790	35	28	not	not	PART
fnp-3790	35	29	addressed	address	VERB
fnp-3790	35	30	the	the	DET
fnp-3790	35	31	phenotype	phenotype	NOUN
fnp-3790	35	32	of	of	ADP
fnp-3790	35	33	the	the	DET
fnp-3790	35	34	immune	immune	ADJ
fnp-3790	35	35	reaction	reaction	NOUN
fnp-3790	35	36	within	within	ADP
fnp-3790	35	37	the	the	DET
fnp-3790	35	38	brain	brain	NOUN
fnp-3790	35	39	,	,	PUNCT
fnp-3790	35	40	and	and	CCONJ
fnp-3790	35	41	its	its	PRON
fnp-3790	35	42	relation	relation	NOUN
fnp-3790	35	43	to	to	ADP
fnp-3790	35	44	a	a	DET
fnp-3790	35	45	possible	possible	ADJ
fnp-3790	35	46	infection	infection	NOUN
fnp-3790	35	47	with	with	ADP
fnp-3790	35	48	sars	sar	NOUN
fnp-3790	35	49	-	-	PUNCT
fnp-3790	35	50	cov-2	cov-2	NOUN
fnp-3790	35	51	.	.	PUNCT
fnp-3790	36	1	this	this	DET
fnp-3790	36	2	gap	gap	NOUN
fnp-3790	36	3	has	have	AUX
fnp-3790	36	4	recently	recently	ADV
fnp-3790	36	5	been	be	AUX
fnp-3790	36	6	filled	fill	VERB
fnp-3790	36	7	by	by	ADP
fnp-3790	36	8	a	a	DET
fnp-3790	36	9	broad	broad	ADJ
fnp-3790	36	10	and	and	CCONJ
fnp-3790	36	11	systematic	systematic	ADJ
fnp-3790	36	12	study	study	NOUN
fnp-3790	36	13	,	,	PUNCT
fnp-3790	36	14	which	which	PRON
fnp-3790	36	15	was	be	AUX
fnp-3790	36	16	performed	perform	VERB
fnp-3790	36	17	on	on	ADP
fnp-3790	36	18	a	a	DET
fnp-3790	36	19	large	large	ADJ
fnp-3790	36	20	sample	sample	NOUN
fnp-3790	36	21	of	of	ADP
fnp-3790	36	22	brain	brain	NOUN
fnp-3790	36	23	autopsies	autopsy	NOUN
fnp-3790	36	24	from	from	ADP
fnp-3790	36	25	covid-19	covid-19	PROPN
fnp-3790	36	26	patients	patient	NOUN
fnp-3790	36	27	,	,	PUNCT
fnp-3790	36	28	in	in	ADP
fnp-3790	36	29	comparison	comparison	NOUN
fnp-3790	36	30	to	to	ADP
fnp-3790	36	31	patients	patient	NOUN
fnp-3790	36	32	who	who	PRON
fnp-3790	36	33	died	die	VERB
fnp-3790	36	34	in	in	ADP
fnp-3790	36	35	intensive	intensive	ADJ
fnp-3790	36	36	care	care	NOUN
fnp-3790	36	37	units	unit	NOUN
fnp-3790	36	38	under	under	ADP
fnp-3790	36	39	conditions	condition	NOUN
fnp-3790	36	40	of	of	ADP
fnp-3790	36	41	respiratory	respiratory	ADJ
fnp-3790	36	42	distress	distress	NOUN
fnp-3790	36	43	or	or	CCONJ
fnp-3790	36	44	to	to	ADP
fnp-3790	36	45	patients	patient	NOUN
fnp-3790	36	46	with	with	ADP
fnp-3790	36	47	multiple	multiple	ADJ
fnp-3790	36	48	sclerosis	sclerosis	NOUN
fnp-3790	36	49	(	(	PUNCT
fnp-3790	36	50	schwabenland	schwabenland	NOUN
fnp-3790	36	51	et	et	PROPN
fnp-3790	36	52	al	al	PROPN
fnp-3790	36	53	.	.	PROPN
fnp-3790	36	54	2021	2021	NUM
fnp-3790	36	55	)	)	PUNCT
fnp-3790	36	56	.	.	PUNCT
fnp-3790	37	1	the	the	DET
fnp-3790	37	2	study	study	NOUN
fnp-3790	37	3	used	use	VERB
fnp-3790	37	4	imaging	imaging	NOUN
fnp-3790	37	5	mass	mass	PROPN
fnp-3790	37	6	spectrometry	spectrometry	NOUN
fnp-3790	37	7	,	,	PUNCT
fnp-3790	37	8	which	which	PRON
fnp-3790	37	9	allows	allow	VERB
fnp-3790	37	10	simultaneous	simultaneous	ADJ
fnp-3790	37	11	detection	detection	NOUN
fnp-3790	37	12	of	of	ADP
fnp-3790	37	13	multiple	multiple	ADJ
fnp-3790	37	14	antigens	antigen	NOUN
fnp-3790	37	15	,	,	PUNCT
fnp-3790	37	16	their	their	PRON
fnp-3790	37	17	spatial	spatial	ADJ
fnp-3790	37	18	distribution	distribution	NOUN
fnp-3790	37	19	in	in	ADP
fnp-3790	37	20	relation	relation	NOUN
fnp-3790	37	21	to	to	ADP
fnp-3790	37	22	lesion	lesion	NOUN
fnp-3790	37	23	architecture	architecture	NOUN
fnp-3790	37	24	and	and	CCONJ
fnp-3790	37	25	their	their	PRON
fnp-3790	37	26	vicinity	vicinity	NOUN
fnp-3790	37	27	to	to	ADP
fnp-3790	37	28	other	other	ADJ
fnp-3790	37	29	immune	immune	ADJ
fnp-3790	37	30	or	or	CCONJ
fnp-3790	37	31	resident	resident	ADJ
fnp-3790	37	32	cells	cell	NOUN
fnp-3790	37	33	within	within	ADP
fnp-3790	37	34	the	the	DET
fnp-3790	37	35	tissue	tissue	NOUN
fnp-3790	37	36	.	.	PUNCT
fnp-3790	38	1	searching	search	VERB
fnp-3790	38	2	for	for	ADP
fnp-3790	38	3	sars	sar	NOUN
fnp-3790	38	4	-	-	PUNCT
fnp-3790	38	5	cov-2	cov-2	NOUN
fnp-3790	38	6	antigen	antigen	NOUN
fnp-3790	38	7	within	within	ADP
fnp-3790	38	8	the	the	DET
fnp-3790	38	9	brain	brain	NOUN
fnp-3790	38	10	tissue	tissue	NOUN
fnp-3790	38	11	,	,	PUNCT
fnp-3790	38	12	the	the	DET
fnp-3790	38	13	study	study	NOUN
fnp-3790	38	14	reached	reach	VERB
fnp-3790	38	15	similar	similar	ADJ
fnp-3790	38	16	conclusions	conclusion	NOUN
fnp-3790	38	17	,	,	PUNCT
fnp-3790	38	18	as	as	SCONJ
fnp-3790	38	19	described	describe	VERB
fnp-3790	38	20	above	above	ADV
fnp-3790	38	21	,	,	PUNCT
fnp-3790	38	22	by	by	ADP
fnp-3790	38	23	showing	show	VERB
fnp-3790	38	24	only	only	ADV
fnp-3790	38	25	sparse	sparse	ADJ
fnp-3790	38	26	virus	virus	NOUN
fnp-3790	38	27	antigen	antigen	ADV
fnp-3790	38	28	in	in	ADP
fnp-3790	38	29	the	the	DET
fnp-3790	38	30	central	central	ADJ
fnp-3790	38	31	nervous	nervous	ADJ
fnp-3790	38	32	system	system	NOUN
fnp-3790	38	33	.	.	PUNCT
fnp-3790	39	1	when	when	SCONJ
fnp-3790	39	2	present	present	ADJ
fnp-3790	39	3	,	,	PUNCT
fnp-3790	39	4	it	it	PRON
fnp-3790	39	5	was	be	AUX
fnp-3790	39	6	mainly	mainly	ADV
fnp-3790	39	7	seen	see	VERB
fnp-3790	39	8	in	in	ADP
fnp-3790	39	9	endothelial	endothelial	ADJ
fnp-3790	39	10	cells	cell	NOUN
fnp-3790	39	11	of	of	ADP
fnp-3790	39	12	cerebral	cerebral	ADJ
fnp-3790	39	13	vessels	vessel	NOUN
fnp-3790	39	14	.	.	PUNCT
fnp-3790	40	1	displaying	display	VERB
fnp-3790	40	2	leukocyte	leukocyte	NOUN
fnp-3790	40	3	-	-	PUNCT
fnp-3790	40	4	related	relate	VERB
fnp-3790	40	5	molecules	molecule	NOUN
fnp-3790	40	6	revealed	reveal	VERB
fnp-3790	40	7	a	a	DET
fnp-3790	40	8	remarkable	remarkable	ADJ
fnp-3790	40	9	inflammatory	inflammatory	ADJ
fnp-3790	40	10	reaction	reaction	NOUN
fnp-3790	40	11	in	in	ADP
fnp-3790	40	12	the	the	DET
fnp-3790	40	13	brain	brain	NOUN
fnp-3790	40	14	.	.	PUNCT
fnp-3790	41	1	it	it	PRON
fnp-3790	41	2	was	be	AUX
fnp-3790	41	3	characterized	characterize	VERB
fnp-3790	41	4	by	by	ADP
fnp-3790	41	5	cell	cell	NOUN
fnp-3790	41	6	clusters	cluster	NOUN
fnp-3790	41	7	,	,	PUNCT
fnp-3790	41	8	representing	represent	VERB
fnp-3790	41	9	different	different	ADJ
fnp-3790	41	10	stages	stage	NOUN
fnp-3790	41	11	of	of	ADP
fnp-3790	41	12	microglia	microglia	ADJ
fnp-3790	41	13	activation	activation	NOUN
fnp-3790	41	14	and	and	CCONJ
fnp-3790	41	15	perivascular	perivascular	ADJ
fnp-3790	41	16	myeloid	myeloid	ADJ
fnp-3790	41	17	cells	cell	NOUN
fnp-3790	41	18	recruited	recruit	VERB
fnp-3790	41	19	from	from	ADP
fnp-3790	41	20	the	the	DET
fnp-3790	41	21	circulation	circulation	NOUN
fnp-3790	41	22	.	.	PUNCT
fnp-3790	42	1	most	most	ADJ
fnp-3790	42	2	profound	profound	ADJ
fnp-3790	42	3	pro	pro	ADJ
fnp-3790	42	4	-	-	ADJ
fnp-3790	42	5	inflammatory	inflammatory	ADJ
fnp-3790	42	6	microglia	microglia	ADJ
fnp-3790	42	7	activation	activation	NOUN
fnp-3790	42	8	was	be	AUX
fnp-3790	42	9	seen	see	VERB
fnp-3790	42	10	in	in	ADP
fnp-3790	42	11	the	the	DET
fnp-3790	42	12	microglia	microglia	ADJ
fnp-3790	42	13	nodules	nodule	NOUN
fnp-3790	42	14	.	.	PUNCT
fnp-3790	43	1	microglia	microglia	ADJ
fnp-3790	43	2	and	and	CCONJ
fnp-3790	43	3	myeloid	myeloid	ADJ
fnp-3790	43	4	cell	cell	NOUN
fnp-3790	43	5	activation	activation	NOUN
fnp-3790	43	6	was	be	AUX
fnp-3790	43	7	associated	associate	VERB
fnp-3790	43	8	with	with	ADP
fnp-3790	43	9	infiltration	infiltration	NOUN
fnp-3790	43	10	of	of	ADP
fnp-3790	43	11	the	the	DET
fnp-3790	43	12	tissue	tissue	NOUN
fnp-3790	43	13	by	by	ADP
fnp-3790	43	14	t	t	PROPN
fnp-3790	43	15	-	-	PUNCT
fnp-3790	43	16	lymphocytes	lymphocyte	NOUN
fnp-3790	43	17	with	with	ADP
fnp-3790	43	18	a	a	DET
fnp-3790	43	19	dominance	dominance	NOUN
fnp-3790	43	20	of	of	ADP
fnp-3790	43	21	cd8	cd8	PROPN
fnp-3790	43	22	+	+	PROPN
fnp-3790	43	23	cells	cell	NOUN
fnp-3790	43	24	,	,	PUNCT
fnp-3790	43	25	but	but	CCONJ
fnp-3790	43	26	a	a	DET
fnp-3790	43	27	very	very	ADV
fnp-3790	43	28	low	low	ADJ
fnp-3790	43	29	number	number	NOUN
fnp-3790	43	30	of	of	ADP
fnp-3790	43	31	b	b	NOUN
fnp-3790	43	32	-	-	PUNCT
fnp-3790	43	33	cells	cell	NOUN
fnp-3790	43	34	and	and	CCONJ
fnp-3790	43	35	plasma	plasma	NOUN
fnp-3790	43	36	cells	cell	NOUN
fnp-3790	43	37	.	.	PUNCT
fnp-3790	44	1	in	in	ADP
fnp-3790	44	2	comparison	comparison	NOUN
fnp-3790	44	3	to	to	ADP
fnp-3790	44	4	other	other	ADJ
fnp-3790	44	5	diseases	disease	NOUN
fnp-3790	44	6	,	,	PUNCT
fnp-3790	44	7	neuroinflammation	neuroinflammation	NOUN
fnp-3790	44	8	was	be	AUX
fnp-3790	44	9	more	more	ADV
fnp-3790	44	10	pronounced	pronounced	ADJ
fnp-3790	44	11	than	than	ADP
fnp-3790	44	12	in	in	ADP
fnp-3790	44	13	patients	patient	NOUN
fnp-3790	44	14	who	who	PRON
fnp-3790	44	15	died	die	VERB
fnp-3790	44	16	in	in	ADP
fnp-3790	44	17	intensive	intensive	ADJ
fnp-3790	44	18	care	care	NOUN
fnp-3790	44	19	units	unit	NOUN
fnp-3790	44	20	under	under	ADP
fnp-3790	44	21	respiratory	respiratory	ADJ
fnp-3790	44	22	distress	distress	NOUN
fnp-3790	44	23	only	only	ADV
fnp-3790	44	24	,	,	PUNCT
fnp-3790	44	25	but	but	CCONJ
fnp-3790	44	26	the	the	DET
fnp-3790	44	27	inflammatory	inflammatory	ADJ
fnp-3790	44	28	reaction	reaction	NOUN
fnp-3790	44	29	in	in	ADP
fnp-3790	44	30	patients	patient	NOUN
fnp-3790	44	31	with	with	ADP
fnp-3790	44	32	multiple	multiple	ADJ
fnp-3790	44	33	sclerosis	sclerosis	NOUN
fnp-3790	44	34	was	be	AUX
fnp-3790	44	35	much	much	ADV
fnp-3790	44	36	more	more	ADV
fnp-3790	44	37	severe	severe	ADJ
fnp-3790	44	38	.	.	PUNCT
fnp-3790	45	1	considering	consider	VERB
fnp-3790	45	2	the	the	DET
fnp-3790	45	3	immensely	immensely	ADV
fnp-3790	45	4	rich	rich	ADJ
fnp-3790	45	5	spectrum	spectrum	NOUN
fnp-3790	45	6	of	of	ADP
fnp-3790	45	7	immunological	immunological	ADJ
fnp-3790	45	8	details	detail	NOUN
fnp-3790	45	9	described	describe	VERB
fnp-3790	45	10	in	in	ADP
fnp-3790	45	11	this	this	DET
fnp-3790	45	12	study	study	NOUN
fnp-3790	45	13	,	,	PUNCT
fnp-3790	45	14	a	a	DET
fnp-3790	45	15	number	number	NOUN
fnp-3790	45	16	of	of	ADP
fnp-3790	45	17	conclusions	conclusion	NOUN
fnp-3790	45	18	have	have	AUX
fnp-3790	45	19	been	be	AUX
fnp-3790	45	20	reached	reach	VERB
fnp-3790	45	21	.	.	PUNCT
fnp-3790	46	1	there	there	PRON
fnp-3790	46	2	is	be	VERB
fnp-3790	46	3	apparent	apparent	ADJ
fnp-3790	46	4	evidence	evidence	NOUN
fnp-3790	46	5	for	for	ADP
fnp-3790	46	6	a	a	DET
fnp-3790	46	7	sars	sar	NOUN
fnp-3790	46	8	-	-	PUNCT
fnp-3790	46	9	cov-2	cov-2	NOUN
fnp-3790	46	10	infection	infection	NOUN
fnp-3790	46	11	in	in	ADP
fnp-3790	46	12	the	the	DET
fnp-3790	46	13	vessel	vessel	NOUN
fnp-3790	46	14	walls	wall	NOUN
fnp-3790	46	15	,	,	PUNCT
fnp-3790	46	16	in	in	ADP
fnp-3790	46	17	particular	particular	ADJ
fnp-3790	46	18	affecting	affect	VERB
fnp-3790	46	19	endothelial	endothelial	ADJ
fnp-3790	46	20	cells	cell	NOUN
fnp-3790	46	21	,	,	PUNCT
fnp-3790	46	22	and	and	CCONJ
fnp-3790	46	23	this	this	PRON
fnp-3790	46	24	is	be	AUX
fnp-3790	46	25	associated	associate	VERB
fnp-3790	46	26	with	with	ADP
fnp-3790	46	27	a	a	DET
fnp-3790	46	28	perivascular	perivascular	ADJ
fnp-3790	46	29	inflammatory	inflammatory	ADJ
fnp-3790	46	30	reaction	reaction	NOUN
fnp-3790	46	31	with	with	ADP
fnp-3790	46	32	blood	blood	NOUN
fnp-3790	46	33	brain	brain	NOUN
fnp-3790	46	34	barrier	barrier	NOUN
fnp-3790	46	35	damage	damage	NOUN
fnp-3790	46	36	,	,	PUNCT
fnp-3790	46	37	mainly	mainly	ADV
fnp-3790	46	38	composed	compose	VERB
fnp-3790	46	39	of	of	ADP
fnp-3790	46	40	cd8	cd8	PROPN
fnp-3790	46	41	+	+	PROPN
fnp-3790	46	42	t	t	PROPN
fnp-3790	46	43	-	-	PUNCT
fnp-3790	46	44	lymphocytes	lymphocyte	NOUN
fnp-3790	46	45	and	and	CCONJ
fnp-3790	46	46	recruited	recruit	VERB
fnp-3790	46	47	myeloid	myeloid	ADJ
fnp-3790	46	48	cells	cell	NOUN
fnp-3790	46	49	.	.	PUNCT
fnp-3790	47	1	however	however	ADV
fnp-3790	47	2	,	,	PUNCT
fnp-3790	47	3	in	in	ADP
fnp-3790	47	4	contrast	contrast	NOUN
fnp-3790	47	5	to	to	ADP
fnp-3790	47	6	other	other	ADJ
fnp-3790	47	7	previous	previous	ADJ
fnp-3790	47	8	studies	study	NOUN
fnp-3790	47	9	thrombotic	thrombotic	ADJ
fnp-3790	47	10	changes	change	NOUN
fnp-3790	47	11	in	in	ADP
fnp-3790	47	12	inflamed	inflamed	ADJ
fnp-3790	47	13	vessels	vessel	NOUN
fnp-3790	47	14	were	be	AUX
fnp-3790	47	15	absent	absent	ADJ
fnp-3790	47	16	.	.	PUNCT
fnp-3790	48	1	the	the	DET
fnp-3790	48	2	inflammatory	inflammatory	ADJ
fnp-3790	48	3	process	process	NOUN
fnp-3790	48	4	concurred	concur	VERB
fnp-3790	48	5	with	with	ADP
fnp-3790	48	6	global	global	ADJ
fnp-3790	48	7	microglia	microglia	ADJ
fnp-3790	48	8	activation	activation	NOUN
fnp-3790	48	9	and	and	CCONJ
fnp-3790	48	10	the	the	DET
fnp-3790	48	11	formation	formation	NOUN
fnp-3790	48	12	of	of	ADP
fnp-3790	48	13	microglia	microglia	ADJ
fnp-3790	48	14	nodules	nodule	NOUN
fnp-3790	48	15	.	.	PUNCT
fnp-3790	49	1	the	the	DET
fnp-3790	49	2	latter	latter	ADJ
fnp-3790	49	3	were	be	AUX
fnp-3790	49	4	the	the	DET
fnp-3790	49	5	sites	site	NOUN
fnp-3790	49	6	for	for	ADP
fnp-3790	49	7	most	most	ADJ
fnp-3790	49	8	intense	intense	ADJ
fnp-3790	49	9	microglia	microglia	ADJ
fnp-3790	49	10	activation	activation	NOUN
fnp-3790	49	11	and	and	CCONJ
fnp-3790	49	12	within	within	ADP
fnp-3790	49	13	the	the	DET
fnp-3790	49	14	nodules	nodule	NOUN
fnp-3790	49	15	cd8	cd8	PROPN
fnp-3790	49	16	+	+	PROPN
fnp-3790	49	17	t	t	PROPN
fnp-3790	49	18	-	-	PUNCT
fnp-3790	49	19	cells	cell	NOUN
fnp-3790	49	20	closely	closely	ADV
fnp-3790	49	21	interacted	interact	VERB
fnp-3790	49	22	with	with	ADP
fnp-3790	49	23	activated	activated	ADJ
fnp-3790	49	24	microglia	microglia	NOUN
fnp-3790	49	25	,	,	PUNCT
fnp-3790	49	26	possibly	possibly	ADV
fnp-3790	49	27	providing	provide	VERB
fnp-3790	49	28	pro	pro	ADJ
fnp-3790	49	29	-	-	ADJ
fnp-3790	49	30	inflammatory	inflammatory	ADJ
fnp-3790	49	31	as	as	ADV
fnp-3790	49	32	well	well	ADV
fnp-3790	49	33	as	as	ADP
fnp-3790	49	34	immunoregulatory	immunoregulatory	ADJ
fnp-3790	49	35	signals	signal	NOUN
fnp-3790	49	36	.	.	PUNCT
fnp-3790	50	1	whether	whether	SCONJ
fnp-3790	50	2	such	such	ADJ
fnp-3790	50	3	microglia	microglia	ADJ
fnp-3790	50	4	nodules	nodule	NOUN
fnp-3790	50	5	are	be	AUX
fnp-3790	50	6	a	a	DET
fnp-3790	50	7	secondary	secondary	ADJ
fnp-3790	50	8	phenomenon	phenomenon	NOUN
fnp-3790	50	9	of	of	ADP
fnp-3790	50	10	the	the	DET
fnp-3790	50	11	profound	profound	ADJ
fnp-3790	50	12	inflammatory	inflammatory	ADJ
fnp-3790	50	13	reaction	reaction	NOUN
fnp-3790	50	14	in	in	ADP
fnp-3790	50	15	the	the	DET
fnp-3790	50	16	tissue	tissue	NOUN
fnp-3790	50	17	or	or	CCONJ
fnp-3790	50	18	drive	drive	VERB
fnp-3790	50	19	the	the	DET
fnp-3790	50	20	inflammation	inflammation	NOUN
fnp-3790	50	21	through	through	ADP
fnp-3790	50	22	(	(	PUNCT
fnp-3790	50	23	virus	virus	NOUN
fnp-3790	50	24	)	)	PUNCT
fnp-3790	50	25	antigen	antigen	ADJ
fnp-3790	50	26	recognition	recognition	NOUN
fnp-3790	50	27	remains	remain	VERB
fnp-3790	50	28	unresolved	unresolved	ADJ
fnp-3790	50	29	.	.	PUNCT
fnp-3790	51	1	analysis	analysis	NOUN
fnp-3790	51	2	of	of	ADP
fnp-3790	51	3	virus	virus	NOUN
fnp-3790	51	4	antigen	antigen	NOUN
fnp-3790	51	5	expression	expression	NOUN
fnp-3790	51	6	did	do	AUX
fnp-3790	51	7	not	not	PART
fnp-3790	51	8	provide	provide	VERB
fnp-3790	51	9	evidence	evidence	NOUN
fnp-3790	51	10	for	for	ADP
fnp-3790	51	11	virus	virus	NOUN
fnp-3790	51	12	entry	entry	NOUN
fnp-3790	51	13	into	into	ADP
fnp-3790	51	14	the	the	DET
fnp-3790	51	15	brain	brain	NOUN
fnp-3790	51	16	through	through	ADP
fnp-3790	51	17	retrograde	retrograde	ADJ
fnp-3790	51	18	axonal	axonal	ADJ
fnp-3790	51	19	transport	transport	NOUN
fnp-3790	51	20	from	from	ADP
fnp-3790	51	21	mucosal	mucosal	NOUN
fnp-3790	51	22	sites	site	NOUN
fnp-3790	51	23	or	or	CCONJ
fnp-3790	51	24	through	through	ADP
fnp-3790	51	25	olfactory	olfactory	ADJ
fnp-3790	51	26	nerves	nerve	NOUN
fnp-3790	51	27	.	.	PUNCT
fnp-3790	52	1	despite	despite	SCONJ
fnp-3790	52	2	the	the	DET
fnp-3790	52	3	ground	ground	NOUN
fnp-3790	52	4	-	-	PUNCT
fnp-3790	52	5	breaking	break	VERB
fnp-3790	52	6	nature	nature	NOUN
fnp-3790	52	7	of	of	ADP
fnp-3790	52	8	this	this	DET
fnp-3790	52	9	study	study	NOUN
fnp-3790	52	10	,	,	PUNCT
fnp-3790	52	11	there	there	PRON
fnp-3790	52	12	are	be	VERB
fnp-3790	52	13	still	still	ADV
fnp-3790	52	14	a	a	DET
fnp-3790	52	15	number	number	NOUN
fnp-3790	52	16	of	of	ADP
fnp-3790	52	17	limitations	limitation	NOUN
fnp-3790	52	18	.	.	PUNCT
fnp-3790	53	1	the	the	DET
fnp-3790	53	2	major	major	ADJ
fnp-3790	53	3	open	open	ADJ
fnp-3790	53	4	question	question	NOUN
fnp-3790	53	5	relates	relate	VERB
fnp-3790	53	6	to	to	ADP
fnp-3790	53	7	the	the	DET
fnp-3790	53	8	mechanisms	mechanism	NOUN
fnp-3790	53	9	of	of	ADP
fnp-3790	53	10	microglia	microglia	ADJ
fnp-3790	53	11	activation	activation	NOUN
fnp-3790	53	12	.	.	PUNCT
fnp-3790	54	1	although	although	SCONJ
fnp-3790	54	2	the	the	DET
fnp-3790	54	3	authors	author	NOUN
fnp-3790	54	4	did	do	AUX
fnp-3790	54	5	not	not	PART
fnp-3790	54	6	find	find	VERB
fnp-3790	54	7	positive	positive	ADJ
fnp-3790	54	8	evidence	evidence	NOUN
fnp-3790	54	9	,	,	PUNCT
fnp-3790	54	10	a	a	DET
fnp-3790	54	11	potential	potential	ADJ
fnp-3790	54	12	role	role	NOUN
fnp-3790	54	13	of	of	ADP
fnp-3790	54	14	direct	direct	ADJ
fnp-3790	54	15	sars	sar	NOUN
fnp-3790	54	16	-	-	PUNCT
fnp-3790	54	17	cov-2	cov-2	PART
fnp-3790	54	18	infection	infection	NOUN
fnp-3790	54	19	in	in	ADP
fnp-3790	54	20	the	the	DET
fnp-3790	54	21	brain	brain	NOUN
fnp-3790	54	22	tissue	tissue	NOUN
fnp-3790	54	23	is	be	AUX
fnp-3790	54	24	not	not	PART
fnp-3790	54	25	completely	completely	ADV
fnp-3790	54	26	excluded	exclude	VERB
fnp-3790	54	27	.	.	PUNCT
fnp-3790	54	28	to	to	PART
fnp-3790	54	29	finally	finally	ADV
fnp-3790	54	30	prove	prove	VERB
fnp-3790	54	31	or	or	CCONJ
fnp-3790	54	32	disprove	disprove	VERB
fnp-3790	54	33	a	a	DET
fnp-3790	54	34	neuronal	neuronal	ADJ
fnp-3790	54	35	transport	transport	NOUN
fnp-3790	54	36	of	of	ADP
fnp-3790	54	37	virus	virus	NOUN
fnp-3790	54	38	into	into	ADP
fnp-3790	54	39	the	the	DET
fnp-3790	54	40	brain	brain	NOUN
fnp-3790	54	41	and	and	CCONJ
fnp-3790	54	42	its	its	PRON
fnp-3790	54	43	direct	direct	ADJ
fnp-3790	54	44	role	role	NOUN
fnp-3790	54	45	in	in	ADP
fnp-3790	54	46	microglia	microglia	ADJ
fnp-3790	54	47	activation	activation	NOUN
fnp-3790	54	48	and	and	CCONJ
fnp-3790	54	49	neurodegeneration	neurodegeneration	NOUN
fnp-3790	54	50	,	,	PUNCT
fnp-3790	54	51	the	the	DET
fnp-3790	54	52	analysis	analysis	NOUN
fnp-3790	54	53	of	of	ADP
fnp-3790	54	54	much	much	ADV
fnp-3790	54	55	earlier	early	ADJ
fnp-3790	54	56	stages	stage	NOUN
fnp-3790	54	57	in	in	ADP
fnp-3790	54	58	the	the	DET
fnp-3790	54	59	infectious	infectious	ADJ
fnp-3790	54	60	process	process	NOUN
fnp-3790	54	61	,	,	PUNCT
fnp-3790	54	62	disease	disease	NOUN
fnp-3790	54	63	stages	stage	NOUN
fnp-3790	54	64	which	which	PRON
fnp-3790	54	65	are	be	AUX
fnp-3790	54	66	rarely	rarely	ADV
fnp-3790	54	67	encountered	encounter	VERB
fnp-3790	54	68	in	in	ADP
fnp-3790	54	69	human	human	ADJ
fnp-3790	54	70	autopsies	autopsy	NOUN
fnp-3790	54	71	,	,	PUNCT
fnp-3790	54	72	may	may	AUX
fnp-3790	54	73	be	be	AUX
fnp-3790	54	74	required	require	VERB
fnp-3790	54	75	.	.	PUNCT
fnp-3790	55	1	similarly	similarly	ADV
fnp-3790	55	2	,	,	PUNCT
fnp-3790	55	3	a	a	DET
fnp-3790	55	4	final	final	ADJ
fnp-3790	55	5	view	view	NOUN
fnp-3790	55	6	on	on	ADP
fnp-3790	55	7	similarities	similarity	NOUN
fnp-3790	55	8	and	and	CCONJ
fnp-3790	55	9	differences	difference	NOUN
fnp-3790	55	10	of	of	ADP
fnp-3790	55	11	the	the	DET
fnp-3790	55	12	inflammatory	inflammatory	ADJ
fnp-3790	55	13	process	process	NOUN
fnp-3790	55	14	between	between	ADP
fnp-3790	55	15	covid-19	covid-19	PROPN
fnp-3790	55	16	and	and	CCONJ
fnp-3790	55	17	multiple	multiple	ADJ
fnp-3790	55	18	sclerosis	sclerosis	NOUN
fnp-3790	55	19	requires	require	VERB
fnp-3790	55	20	the	the	DET
fnp-3790	55	21	analysis	analysis	NOUN
fnp-3790	55	22	of	of	ADP
fnp-3790	55	23	much	much	ADV
fnp-3790	55	24	larger	large	ADJ
fnp-3790	55	25	numbers	number	NOUN
fnp-3790	55	26	of	of	ADP
fnp-3790	55	27	samples	sample	NOUN
fnp-3790	55	28	from	from	ADP
fnp-3790	55	29	different	different	ADJ
fnp-3790	55	30	disease	disease	NOUN
fnp-3790	55	31	and	and	CCONJ
fnp-3790	55	32	lesion	lesion	NOUN
fnp-3790	55	33	stages	stage	NOUN
fnp-3790	55	34	.	.	PUNCT
fnp-3790	56	1	finally	finally	ADV
fnp-3790	56	2	,	,	PUNCT
fnp-3790	56	3	there	there	PRON
fnp-3790	56	4	are	be	VERB
fnp-3790	56	5	still	still	ADV
fnp-3790	56	6	some	some	DET
fnp-3790	56	7	technical	technical	ADJ
fnp-3790	56	8	issues	issue	NOUN
fnp-3790	56	9	which	which	PRON
fnp-3790	56	10	have	have	VERB
fnp-3790	56	11	to	to	PART
fnp-3790	56	12	be	be	AUX
fnp-3790	56	13	resolved	resolve	VERB
fnp-3790	56	14	in	in	ADP
fnp-3790	56	15	the	the	DET
fnp-3790	56	16	future	future	NOUN
fnp-3790	56	17	.	.	PUNCT
fnp-3790	57	1	the	the	DET
fnp-3790	57	2	technology	technology	NOUN
fnp-3790	57	3	used	use	VERB
fnp-3790	57	4	here	here	ADV
fnp-3790	57	5	depicts	depict	VERB
fnp-3790	57	6	phenotypic	phenotypic	ADJ
fnp-3790	57	7	cell	cell	NOUN
fnp-3790	57	8	clusters	cluster	NOUN
fnp-3790	57	9	,	,	PUNCT
fnp-3790	57	10	but	but	CCONJ
fnp-3790	57	11	whether	whether	SCONJ
fnp-3790	57	12	these	these	DET
fnp-3790	57	13	separations	separation	NOUN
fnp-3790	57	14	are	be	AUX
fnp-3790	57	15	functionally	functionally	ADV
fnp-3790	57	16	meaningful	meaningful	ADJ
fnp-3790	57	17	has	have	VERB
fnp-3790	57	18	yet	yet	ADV
fnp-3790	57	19	to	to	PART
fnp-3790	57	20	be	be	AUX
fnp-3790	57	21	shown	show	VERB
fnp-3790	57	22	.	.	PUNCT
fnp-3790	58	1	furthermore	furthermore	ADV
fnp-3790	58	2	,	,	PUNCT
fnp-3790	58	3	when	when	SCONJ
fnp-3790	58	4	the	the	DET
fnp-3790	58	5	expression	expression	NOUN
fnp-3790	58	6	profiles	profile	NOUN
fnp-3790	58	7	of	of	ADP
fnp-3790	58	8	the	the	DET
fnp-3790	58	9	different	different	ADJ
fnp-3790	58	10	markers	marker	NOUN
fnp-3790	58	11	in	in	ADP
fnp-3790	58	12	imaging	image	VERB
fnp-3790	58	13	mass	mass	NOUN
fnp-3790	58	14	spectrometry	spectrometry	NOUN
fnp-3790	58	15	,	,	PUNCT
fnp-3790	58	16	as	as	SCONJ
fnp-3790	58	17	shown	show	VERB
fnp-3790	58	18	for	for	ADP
fnp-3790	58	19	instance	instance	NOUN
fnp-3790	58	20	in	in	ADP
fnp-3790	58	21	the	the	DET
fnp-3790	58	22	supplementary	supplementary	ADJ
fnp-3790	58	23	figure	figure	NOUN
fnp-3790	58	24	3b	3b	NOUN
fnp-3790	58	25	in	in	ADP
fnp-3790	58	26	this	this	DET
fnp-3790	58	27	study	study	NOUN
fnp-3790	58	28	,	,	PUNCT
fnp-3790	58	29	are	be	AUX
fnp-3790	58	30	compared	compare	VERB
fnp-3790	58	31	with	with	ADP
fnp-3790	58	32	the	the	DET
fnp-3790	58	33	experience	experience	NOUN
fnp-3790	58	34	obtained	obtain	VERB
fnp-3790	58	35	during	during	ADP
fnp-3790	58	36	the	the	DET
fnp-3790	58	37	last	last	ADJ
fnp-3790	58	38	decades	decade	NOUN
fnp-3790	58	39	with	with	ADP
fnp-3790	58	40	conventional	conventional	ADJ
fnp-3790	58	41	immunocytochemistry	immunocytochemistry	NOUN
fnp-3790	58	42	,	,	PUNCT
fnp-3790	58	43	there	there	PRON
fnp-3790	58	44	are	be	VERB
fnp-3790	58	45	some	some	DET
fnp-3790	58	46	obvious	obvious	ADJ
fnp-3790	58	47	discrepancies	discrepancy	NOUN
fnp-3790	58	48	,	,	PUNCT
fnp-3790	58	49	which	which	PRON
fnp-3790	58	50	raise	raise	VERB
fnp-3790	58	51	some	some	DET
fnp-3790	58	52	questions	question	NOUN
fnp-3790	58	53	regarding	regard	VERB
fnp-3790	58	54	specificity	specificity	NOUN
fnp-3790	58	55	controls	control	VERB
fnp-3790	58	56	for	for	ADP
fnp-3790	58	57	each	each	DET
fnp-3790	58	58	individual	individual	ADJ
fnp-3790	58	59	marker	marker	NOUN
fnp-3790	58	60	used	use	VERB
fnp-3790	58	61	in	in	ADP
fnp-3790	58	62	the	the	DET
fnp-3790	58	63	imaging	imaging	NOUN
fnp-3790	58	64	mass	mass	PROPN
fnp-3790	58	65	spectrometry	spectrometry	NOUN
fnp-3790	58	66	panel	panel	NOUN
fnp-3790	58	67	.	.	PUNCT
fnp-3790	59	1	selective	selective	ADJ
fnp-3790	59	2	vulnerability	vulnerability	NOUN
fnp-3790	59	3	of	of	ADP
fnp-3790	59	4	neuron	neuron	NOUN
fnp-3790	59	5	subpopulations	subpopulation	NOUN
fnp-3790	59	6	in	in	ADP
fnp-3790	59	7	inflammatory	inflammatory	ADJ
fnp-3790	59	8	or	or	CCONJ
fnp-3790	59	9	demyelinating	demyelinate	VERB
fnp-3790	59	10	conditions	condition	NOUN
fnp-3790	59	11	acute	acute	ADJ
fnp-3790	59	12	and	and	CCONJ
fnp-3790	59	13	partially	partially	ADV
fnp-3790	59	14	reversible	reversible	ADJ
fnp-3790	59	15	neurological	neurological	ADJ
fnp-3790	59	16	deficit	deficit	NOUN
fnp-3790	59	17	is	be	AUX
fnp-3790	59	18	a	a	DET
fnp-3790	59	19	common	common	ADJ
fnp-3790	59	20	feature	feature	NOUN
fnp-3790	59	21	of	of	ADP
fnp-3790	59	22	inflammatory	inflammatory	ADJ
fnp-3790	59	23	brain	brain	NOUN
fnp-3790	59	24	diseases	disease	NOUN
fnp-3790	59	25	.	.	PUNCT
fnp-3790	60	1	this	this	PRON
fnp-3790	60	2	can	can	AUX
fnp-3790	60	3	be	be	AUX
fnp-3790	60	4	mediated	mediate	VERB
fnp-3790	60	5	through	through	ADP
fnp-3790	60	6	disturbance	disturbance	NOUN
fnp-3790	60	7	of	of	ADP
fnp-3790	60	8	electrical	electrical	ADJ
fnp-3790	60	9	conduction	conduction	NOUN
fnp-3790	60	10	or	or	CCONJ
fnp-3790	60	11	through	through	ADP
fnp-3790	60	12	demyelination	demyelination	NOUN
fnp-3790	60	13	or	or	CCONJ
fnp-3790	60	14	synaptic	synaptic	ADJ
fnp-3790	60	15	loss	loss	NOUN
fnp-3790	60	16	,	,	PUNCT
fnp-3790	60	17	and	and	CCONJ
fnp-3790	60	18	can	can	AUX
fnp-3790	60	19	be	be	AUX
fnp-3790	60	20	compensated	compensate	VERB
fnp-3790	60	21	by	by	ADP
fnp-3790	60	22	remyelination	remyelination	NOUN
fnp-3790	60	23	or	or	CCONJ
fnp-3790	60	24	synaptic	synaptic	ADJ
fnp-3790	60	25	plasticity	plasticity	NOUN
fnp-3790	60	26	.	.	PUNCT
fnp-3790	61	1	in	in	ADP
fnp-3790	61	2	contrast	contrast	NOUN
fnp-3790	61	3	,	,	PUNCT
fnp-3790	61	4	neuronal	neuronal	ADJ
fnp-3790	61	5	damage	damage	NOUN
fnp-3790	61	6	and	and	CCONJ
fnp-3790	61	7	loss	loss	NOUN
fnp-3790	61	8	is	be	AUX
fnp-3790	61	9	the	the	DET
fnp-3790	61	10	prime	prime	ADJ
fnp-3790	61	11	substrate	substrate	NOUN
fnp-3790	61	12	of	of	ADP
fnp-3790	61	13	permanent	permanent	ADJ
fnp-3790	61	14	and	and	CCONJ
fnp-3790	61	15	irreversible	irreversible	ADJ
fnp-3790	61	16	neurological	neurological	ADJ
fnp-3790	61	17	deficit	deficit	NOUN
fnp-3790	61	18	.	.	PUNCT
fnp-3790	62	1	an	an	DET
fnp-3790	62	2	interesting	interesting	ADJ
fnp-3790	62	3	but	but	CCONJ
fnp-3790	62	4	controversial	controversial	ADJ
fnp-3790	62	5	issue	issue	NOUN
fnp-3790	62	6	is	be	AUX
fnp-3790	62	7	whether	whether	SCONJ
fnp-3790	62	8	there	there	PRON
fnp-3790	62	9	is	be	VERB
fnp-3790	62	10	a	a	DET
fnp-3790	62	11	selective	selective	ADJ
fnp-3790	62	12	vulnerability	vulnerability	NOUN
fnp-3790	62	13	of	of	ADP
fnp-3790	62	14	certain	certain	ADJ
fnp-3790	62	15	neuronal	neuronal	ADJ
fnp-3790	62	16	subpopulations	subpopulation	NOUN
fnp-3790	62	17	,	,	PUNCT
fnp-3790	62	18	and	and	CCONJ
fnp-3790	62	19	when	when	SCONJ
fnp-3790	62	20	this	this	PRON
fnp-3790	62	21	is	be	AUX
fnp-3790	62	22	the	the	DET
fnp-3790	62	23	case	case	NOUN
fnp-3790	62	24	,	,	PUNCT
fnp-3790	62	25	what	what	PRON
fnp-3790	62	26	its	its	PRON
fnp-3790	62	27	mechanisms	mechanism	NOUN
fnp-3790	62	28	and	and	CCONJ
fnp-3790	62	29	consequences	consequence	NOUN
fnp-3790	62	30	are	be	AUX
fnp-3790	62	31	.	.	PUNCT
fnp-3790	63	1	as	as	ADP
fnp-3790	63	2	an	an	DET
fnp-3790	63	3	example	example	NOUN
fnp-3790	63	4	,	,	PUNCT
fnp-3790	63	5	in	in	ADP
fnp-3790	63	6	cortical	cortical	ADJ
fnp-3790	63	7	lesions	lesion	NOUN
fnp-3790	63	8	in	in	ADP
fnp-3790	63	9	multiple	multiple	ADJ
fnp-3790	63	10	sclerosis	sclerosis	NOUN
fnp-3790	63	11	(	(	PUNCT
fnp-3790	63	12	ms	ms	NOUN
fnp-3790	63	13	)	)	PUNCT
fnp-3790	63	14	several	several	ADJ
fnp-3790	63	15	groups	group	NOUN
fnp-3790	63	16	have	have	AUX
fnp-3790	63	17	provided	provide	VERB
fnp-3790	63	18	evidence	evidence	NOUN
fnp-3790	63	19	that	that	SCONJ
fnp-3790	63	20	the	the	DET
fnp-3790	63	21	gabaergic	gabaergic	ADJ
fnp-3790	63	22	interneurons	interneuron	NOUN
fnp-3790	63	23	are	be	AUX
fnp-3790	63	24	prime	prime	ADJ
fnp-3790	63	25	targets	target	NOUN
fnp-3790	63	26	for	for	ADP
fnp-3790	63	27	neurodegeneration	neurodegeneration	NOUN
fnp-3790	63	28	(	(	PUNCT
fnp-3790	63	29	dutta	dutta	PROPN
fnp-3790	63	30	et	et	PROPN
fnp-3790	63	31	al	al	PROPN
fnp-3790	63	32	.	.	PROPN
fnp-3790	63	33	2006	2006	NUM
fnp-3790	63	34	,	,	PUNCT
fnp-3790	63	35	clements	clements	PROPN
fnp-3790	63	36	et	et	PROPN
fnp-3790	63	37	al	al	PROPN
fnp-3790	63	38	.	.	PROPN
fnp-3790	63	39	2008	2008	NUM
fnp-3790	63	40	)	)	PUNCT
fnp-3790	63	41	,	,	PUNCT
fnp-3790	63	42	while	while	SCONJ
fnp-3790	63	43	in	in	ADP
fnp-3790	63	44	another	another	DET
fnp-3790	63	45	study	study	NOUN
fnp-3790	63	46	a	a	DET
fnp-3790	63	47	predominant	predominant	ADJ
fnp-3790	63	48	degeneration	degeneration	NOUN
fnp-3790	63	49	of	of	ADP
fnp-3790	63	50	cux2	cux2	ADJ
fnp-3790	63	51	positive	positive	ADJ
fnp-3790	63	52	excitatory	excitatory	NOUN
fnp-3790	63	53	neurons	neuron	NOUN
fnp-3790	63	54	was	be	AUX
fnp-3790	63	55	observed	observe	VERB
fnp-3790	63	56	and	and	CCONJ
fnp-3790	63	57	gabaergic	gabaergic	ADJ
fnp-3790	63	58	interneurons	interneuron	NOUN
fnp-3790	63	59	were	be	AUX
fnp-3790	63	60	unaffected	unaffected	ADJ
fnp-3790	63	61	(	(	PUNCT
fnp-3790	63	62	schirmer	schirmer	PROPN
fnp-3790	63	63	et	et	PROPN
fnp-3790	63	64	al	al	PROPN
fnp-3790	63	65	.	.	PROPN
fnp-3790	63	66	2019	2019	NUM
fnp-3790	63	67	)	)	PUNCT
fnp-3790	63	68	.	.	PUNCT
fnp-3790	64	1	these	these	DET
fnp-3790	64	2	contradicting	contradict	VERB
fnp-3790	64	3	data	datum	NOUN
fnp-3790	64	4	need	need	VERB
fnp-3790	64	5	to	to	PART
fnp-3790	64	6	be	be	AUX
fnp-3790	64	7	resolved	resolve	VERB
fnp-3790	64	8	.	.	PUNCT
fnp-3790	65	1	two	two	NUM
fnp-3790	65	2	large	large	ADJ
fnp-3790	65	3	and	and	CCONJ
fnp-3790	65	4	very	very	ADV
fnp-3790	65	5	well	well	ADV
fnp-3790	65	6	-	-	PUNCT
fnp-3790	65	7	performed	perform	VERB
fnp-3790	65	8	studies	study	NOUN
fnp-3790	65	9	have	have	AUX
fnp-3790	65	10	re	re	VERB
fnp-3790	65	11	-	-	VERB
fnp-3790	65	12	addressed	address	VERB
fnp-3790	65	13	the	the	DET
fnp-3790	65	14	question	question	NOUN
fnp-3790	65	15	of	of	ADP
fnp-3790	65	16	selective	selective	ADJ
fnp-3790	65	17	vulnerability	vulnerability	NOUN
fnp-3790	65	18	of	of	ADP
fnp-3790	65	19	cortical	cortical	ADJ
fnp-3790	65	20	neurons	neuron	NOUN
fnp-3790	65	21	in	in	ADP
fnp-3790	65	22	inflammatory	inflammatory	ADJ
fnp-3790	65	23	demyelinating	demyelinate	VERB
fnp-3790	65	24	disease	disease	NOUN
fnp-3790	65	25	in	in	ADP
fnp-3790	65	26	2021	2021	NUM
fnp-3790	65	27	,	,	PUNCT
fnp-3790	65	28	and	and	CCONJ
fnp-3790	65	29	both	both	PRON
fnp-3790	65	30	came	come	VERB
fnp-3790	65	31	to	to	ADP
fnp-3790	65	32	the	the	DET
fnp-3790	65	33	conclusion	conclusion	NOUN
fnp-3790	65	34	that	that	SCONJ
fnp-3790	65	35	the	the	DET
fnp-3790	65	36	specific	specific	ADJ
fnp-3790	65	37	subpopulation	subpopulation	NOUN
fnp-3790	65	38	of	of	ADP
fnp-3790	65	39	gabaergic	gabaergic	ADJ
fnp-3790	65	40	parvalbumin	parvalbumin	NOUN
fnp-3790	65	41	-	-	PUNCT
fnp-3790	65	42	containing	contain	VERB
fnp-3790	65	43	inhibitory	inhibitory	ADJ
fnp-3790	65	44	interneurons	interneuron	NOUN
fnp-3790	65	45	is	be	AUX
fnp-3790	65	46	lost	lose	VERB
fnp-3790	65	47	preferentially	preferentially	ADV
fnp-3790	65	48	in	in	ADP
fnp-3790	65	49	the	the	DET
fnp-3790	65	50	ms	ms	PROPN
fnp-3790	65	51	cortex	cortex	NOUN
fnp-3790	65	52	(	(	PUNCT
fnp-3790	65	53	magliozzi	magliozzi	NOUN
fnp-3790	65	54	et	et	PROPN
fnp-3790	65	55	al	al	PROPN
fnp-3790	65	56	.	.	PROPN
fnp-3790	65	57	2021	2021	NUM
fnp-3790	65	58	,	,	PUNCT
fnp-3790	65	59	zoupi	zoupi	PROPN
fnp-3790	65	60	et	et	NOUN
fnp-3790	65	61	al	al	PROPN
fnp-3790	65	62	.	.	PROPN
fnp-3790	65	63	2021	2021	NUM
fnp-3790	65	64	)	)	PUNCT
fnp-3790	65	65	.	.	PUNCT
fnp-3790	66	1	this	this	PRON
fnp-3790	66	2	is	be	AUX
fnp-3790	66	3	in	in	ADP
fnp-3790	66	4	agreement	agreement	NOUN
fnp-3790	66	5	with	with	ADP
fnp-3790	66	6	previous	previous	ADJ
fnp-3790	66	7	human	human	ADJ
fnp-3790	66	8	and	and	CCONJ
fnp-3790	66	9	experimental	experimental	ADJ
fnp-3790	66	10	studies	study	NOUN
fnp-3790	66	11	,	,	PUNCT
fnp-3790	66	12	which	which	PRON
fnp-3790	66	13	also	also	ADV
fnp-3790	66	14	showed	show	VERB
fnp-3790	66	15	a	a	DET
fnp-3790	66	16	preferential	preferential	ADJ
fnp-3790	66	17	loss	loss	NOUN
fnp-3790	66	18	of	of	ADP
fnp-3790	66	19	parvalbumin	parvalbumin	ADJ
fnp-3790	66	20	positive	positive	ADJ
fnp-3790	66	21	interneurons	interneuron	NOUN
fnp-3790	66	22	in	in	ADP
fnp-3790	66	23	autoimmune	autoimmune	ADJ
fnp-3790	66	24	encephalomyelitis	encephalomyelitis	NOUN
fnp-3790	66	25	and	and	CCONJ
fnp-3790	66	26	in	in	ADP
fnp-3790	66	27	toxic	toxic	ADJ
fnp-3790	66	28	demyelination	demyelination	NOUN
fnp-3790	66	29	(	(	PUNCT
fnp-3790	66	30	falco	falco	PROPN
fnp-3790	66	31	et	et	PROPN
fnp-3790	66	32	al	al	PROPN
fnp-3790	66	33	.	.	PROPN
fnp-3790	66	34	2014	2014	NUM
fnp-3790	66	35	,	,	PUNCT
fnp-3790	66	36	lapato	lapato	VERB
fnp-3790	66	37	et	et	PROPN
fnp-3790	66	38	al	al	PROPN
fnp-3790	66	39	.	.	PROPN
fnp-3790	66	40	2017	2017	NUM
fnp-3790	66	41	)	)	PUNCT
fnp-3790	66	42	.	.	PUNCT
fnp-3790	67	1	importantly	importantly	ADV
fnp-3790	67	2	,	,	PUNCT
fnp-3790	67	3	the	the	DET
fnp-3790	67	4	loss	loss	NOUN
fnp-3790	67	5	of	of	ADP
fnp-3790	67	6	these	these	DET
fnp-3790	67	7	neurons	neuron	NOUN
fnp-3790	67	8	was	be	AUX
fnp-3790	67	9	associated	associate	VERB
fnp-3790	67	10	with	with	ADP
fnp-3790	67	11	a	a	DET
fnp-3790	67	12	significant	significant	ADJ
fnp-3790	67	13	and	and	CCONJ
fnp-3790	67	14	selective	selective	ADJ
fnp-3790	67	15	reduction	reduction	NOUN
fnp-3790	67	16	of	of	ADP
fnp-3790	67	17	gabaergic	gabaergic	ADJ
fnp-3790	67	18	presynaptic	presynaptic	ADJ
fnp-3790	67	19	terminals	terminal	NOUN
fnp-3790	67	20	in	in	ADP
fnp-3790	67	21	the	the	DET
fnp-3790	67	22	cortex	cortex	NOUN
fnp-3790	67	23	(	(	PUNCT
fnp-3790	67	24	zoupi	zoupi	X
fnp-3790	67	25	et	et	PROPN
fnp-3790	67	26	al	al	PROPN
fnp-3790	67	27	.	.	PROPN
fnp-3790	67	28	2021	2021	NUM
fnp-3790	67	29	)	)	PUNCT
fnp-3790	67	30	.	.	PUNCT
fnp-3790	68	1	in	in	ADP
fnp-3790	68	2	an	an	DET
fnp-3790	68	3	attempt	attempt	NOUN
fnp-3790	68	4	to	to	PART
fnp-3790	68	5	clarify	clarify	VERB
fnp-3790	68	6	the	the	DET
fnp-3790	68	7	underlying	underlie	VERB
fnp-3790	68	8	mechanisms	mechanism	NOUN
fnp-3790	68	9	,	,	PUNCT
fnp-3790	68	10	the	the	DET
fnp-3790	68	11	authors	author	NOUN
fnp-3790	68	12	also	also	ADV
fnp-3790	68	13	analyzed	analyze	VERB
fnp-3790	68	14	an	an	DET
fnp-3790	68	15	experimental	experimental	ADJ
fnp-3790	68	16	rodent	rodent	NOUN
fnp-3790	68	17	model	model	NOUN
fnp-3790	68	18	with	with	ADP
fnp-3790	68	19	focal	focal	ADJ
fnp-3790	68	20	primary	primary	ADJ
fnp-3790	68	21	cortical	cortical	ADJ
fnp-3790	68	22	demyelination	demyelination	NOUN
fnp-3790	68	23	,	,	PUNCT
fnp-3790	68	24	induced	induce	VERB
fnp-3790	68	25	by	by	ADP
fnp-3790	68	26	a	a	DET
fnp-3790	68	27	chronic	chronic	ADJ
fnp-3790	68	28	application	application	NOUN
fnp-3790	68	29	of	of	ADP
fnp-3790	68	30	a	a	DET
fnp-3790	68	31	lysolecithin	lysolecithin	NOUN
fnp-3790	68	32	-	-	PUNCT
fnp-3790	68	33	containing	contain	VERB
fnp-3790	68	34	hydrogel	hydrogel	NOUN
fnp-3790	68	35	.	.	PUNCT
fnp-3790	69	1	the	the	DET
fnp-3790	69	2	authors	author	NOUN
fnp-3790	69	3	conclude	conclude	VERB
fnp-3790	69	4	that	that	SCONJ
fnp-3790	69	5	demyelination	demyelination	NOUN
fnp-3790	69	6	triggers	trigger	VERB
fnp-3790	69	7	the	the	DET
fnp-3790	69	8	loss	loss	NOUN
fnp-3790	69	9	of	of	ADP
fnp-3790	69	10	these	these	DET
fnp-3790	69	11	particular	particular	ADJ
fnp-3790	69	12	neurons	neuron	NOUN
fnp-3790	69	13	,	,	PUNCT
fnp-3790	69	14	and	and	CCONJ
fnp-3790	69	15	this	this	PRON
fnp-3790	69	16	may	may	AUX
fnp-3790	69	17	be	be	AUX
fnp-3790	69	18	related	relate	VERB
fnp-3790	69	19	to	to	ADP
fnp-3790	69	20	their	their	PRON
fnp-3790	69	21	particular	particular	ADJ
fnp-3790	69	22	features	feature	NOUN
fnp-3790	69	23	of	of	ADP
fnp-3790	69	24	axonal	axonal	ADJ
fnp-3790	69	25	myelination	myelination	NOUN
fnp-3790	69	26	(	(	PUNCT
fnp-3790	69	27	zoupi	zoupi	X
fnp-3790	69	28	et	et	NOUN
fnp-3790	69	29	al	al	PROPN
fnp-3790	69	30	.	.	PROPN
fnp-3790	69	31	2021	2021	NUM
fnp-3790	69	32	)	)	PUNCT
fnp-3790	69	33	.	.	PUNCT
fnp-3790	70	1	in	in	ADP
fnp-3790	70	2	the	the	DET
fnp-3790	70	3	other	other	ADJ
fnp-3790	70	4	study	study	NOUN
fnp-3790	70	5	(	(	PUNCT
fnp-3790	70	6	magliozzi	magliozzi	NOUN
fnp-3790	70	7	et	et	PROPN
fnp-3790	70	8	al	al	PROPN
fnp-3790	70	9	.	.	PROPN
fnp-3790	70	10	2021	2021	NUM
fnp-3790	70	11	)	)	PUNCT
fnp-3790	71	1	it	it	PRON
fnp-3790	71	2	was	be	AUX
fnp-3790	71	3	shown	show	VERB
fnp-3790	71	4	that	that	SCONJ
fnp-3790	71	5	the	the	DET
fnp-3790	71	6	extent	extent	NOUN
fnp-3790	71	7	of	of	ADP
fnp-3790	71	8	loss	loss	NOUN
fnp-3790	71	9	of	of	ADP
fnp-3790	71	10	parvalbumin	parvalbumin	NOUN
fnp-3790	71	11	-	-	PUNCT
fnp-3790	71	12	containing	contain	VERB
fnp-3790	71	13	neurons	neuron	NOUN
fnp-3790	71	14	correlated	correlate	VERB
fnp-3790	71	15	with	with	ADP
fnp-3790	71	16	the	the	DET
fnp-3790	71	17	extent	extent	NOUN
fnp-3790	71	18	of	of	ADP
fnp-3790	71	19	meningeal	meningeal	ADJ
fnp-3790	71	20	inflammation	inflammation	NOUN
fnp-3790	71	21	.	.	PUNCT
fnp-3790	72	1	since	since	SCONJ
fnp-3790	72	2	meningeal	meningeal	ADJ
fnp-3790	72	3	inflammation	inflammation	NOUN
fnp-3790	72	4	also	also	ADV
fnp-3790	72	5	determines	determine	VERB
fnp-3790	72	6	the	the	DET
fnp-3790	72	7	extent	extent	NOUN
fnp-3790	72	8	of	of	ADP
fnp-3790	72	9	cortical	cortical	ADJ
fnp-3790	72	10	demyelination	demyelination	NOUN
fnp-3790	72	11	in	in	ADP
fnp-3790	72	12	ms	ms	ADJ
fnp-3790	72	13	lesions	lesion	NOUN
fnp-3790	72	14	,	,	PUNCT
fnp-3790	72	15	demyelination	demyelination	NOUN
fnp-3790	72	16	may	may	AUX
fnp-3790	72	17	be	be	AUX
fnp-3790	72	18	the	the	DET
fnp-3790	72	19	driving	drive	VERB
fnp-3790	72	20	force	force	NOUN
fnp-3790	72	21	of	of	ADP
fnp-3790	72	22	neurodegeneration	neurodegeneration	NOUN
fnp-3790	72	23	also	also	ADV
fnp-3790	72	24	in	in	ADP
fnp-3790	72	25	this	this	DET
fnp-3790	72	26	study	study	NOUN
fnp-3790	72	27	.	.	PUNCT
fnp-3790	73	1	the	the	DET
fnp-3790	73	2	observation	observation	NOUN
fnp-3790	73	3	that	that	SCONJ
fnp-3790	73	4	parvalbumin	parvalbumin	NOUN
fnp-3790	73	5	(	(	PUNCT
fnp-3790	73	6	pv	pv	NOUN
fnp-3790	73	7	)	)	PUNCT
fnp-3790	73	8	containing	contain	VERB
fnp-3790	73	9	interneurons	interneuron	NOUN
fnp-3790	73	10	are	be	AUX
fnp-3790	73	11	preferentially	preferentially	ADV
fnp-3790	73	12	destroyed	destroy	VERB
fnp-3790	73	13	in	in	ADP
fnp-3790	73	14	inflammatory	inflammatory	ADJ
fnp-3790	73	15	and/or	and/or	CCONJ
fnp-3790	73	16	demyelinating	demyelinate	VERB
fnp-3790	73	17	diseases	disease	NOUN
fnp-3790	73	18	has	have	VERB
fnp-3790	73	19	clinical	clinical	ADJ
fnp-3790	73	20	implications	implication	NOUN
fnp-3790	73	21	.	.	PUNCT
fnp-3790	74	1	parvalbumin	parvalbumin	PROPN
fnp-3790	74	2	is	be	AUX
fnp-3790	74	3	liberated	liberate	VERB
fnp-3790	74	4	during	during	ADP
fnp-3790	74	5	cell	cell	NOUN
fnp-3790	74	6	death	death	NOUN
fnp-3790	74	7	and	and	CCONJ
fnp-3790	74	8	reaches	reach	VERB
fnp-3790	74	9	the	the	DET
fnp-3790	74	10	cerebrospinal	cerebrospinal	ADJ
fnp-3790	74	11	fluid	fluid	NOUN
fnp-3790	74	12	,	,	PUNCT
fnp-3790	74	13	where	where	SCONJ
fnp-3790	74	14	it	it	PRON
fnp-3790	74	15	may	may	AUX
fnp-3790	74	16	serve	serve	VERB
fnp-3790	74	17	as	as	ADP
fnp-3790	74	18	a	a	DET
fnp-3790	74	19	paraclinical	paraclinical	ADJ
fnp-3790	74	20	marker	marker	NOUN
fnp-3790	74	21	for	for	ADP
fnp-3790	74	22	active	active	ADJ
fnp-3790	74	23	neurodegeneration	neurodegeneration	NOUN
fnp-3790	74	24	(	(	PUNCT
fnp-3790	75	1	magliozzi	magliozzi	NOUN
fnp-3790	75	2	et	et	PROPN
fnp-3790	75	3	al	al	PROPN
fnp-3790	75	4	.	.	PROPN
fnp-3790	75	5	2021	2021	NUM
fnp-3790	75	6	)	)	PUNCT
fnp-3790	75	7	.	.	PUNCT
fnp-3790	76	1	furthermore	furthermore	ADV
fnp-3790	76	2	,	,	PUNCT
fnp-3790	76	3	loss	loss	NOUN
fnp-3790	76	4	of	of	ADP
fnp-3790	76	5	gabaergic	gabaergic	ADJ
fnp-3790	76	6	interneurons	interneuron	NOUN
fnp-3790	76	7	in	in	ADP
fnp-3790	76	8	the	the	DET
fnp-3790	76	9	course	course	NOUN
fnp-3790	76	10	of	of	ADP
fnp-3790	76	11	inflammatory	inflammatory	ADJ
fnp-3790	76	12	demyelination	demyelination	NOUN
fnp-3790	76	13	results	result	NOUN
fnp-3790	76	14	in	in	ADP
fnp-3790	76	15	an	an	DET
fnp-3790	76	16	altered	alter	VERB
fnp-3790	76	17	excitatory	excitatory	NOUN
fnp-3790	76	18	/	/	SYM
fnp-3790	76	19	inhibitory	inhibitory	ADJ
fnp-3790	76	20	balance	balance	NOUN
fnp-3790	76	21	,	,	PUNCT
fnp-3790	76	22	clinically	clinically	ADV
fnp-3790	76	23	manifested	manifest	VERB
fnp-3790	76	24	by	by	ADP
fnp-3790	76	25	epileptic	epileptic	ADJ
fnp-3790	76	26	seizures	seizure	NOUN
fnp-3790	76	27	(	(	PUNCT
fnp-3790	76	28	potter	potter	PROPN
fnp-3790	76	29	et	et	PROPN
fnp-3790	76	30	al	al	PROPN
fnp-3790	76	31	.	.	PROPN
fnp-3790	76	32	2016	2016	NUM
fnp-3790	76	33	,	,	PUNCT
fnp-3790	76	34	lapato	lapato	VERB
fnp-3790	76	35	et	et	PROPN
fnp-3790	76	36	al	al	PROPN
fnp-3790	76	37	.	.	PROPN
fnp-3790	76	38	2017	2017	NUM
fnp-3790	76	39	)	)	PUNCT
fnp-3790	76	40	.	.	PUNCT
fnp-3790	77	1	thus	thus	ADV
fnp-3790	77	2	,	,	PUNCT
fnp-3790	77	3	the	the	DET
fnp-3790	77	4	selective	selective	ADJ
fnp-3790	77	5	vulnerability	vulnerability	NOUN
fnp-3790	77	6	of	of	ADP
fnp-3790	77	7	inhibitory	inhibitory	ADJ
fnp-3790	77	8	interneurons	interneuron	NOUN
fnp-3790	77	9	may	may	AUX
fnp-3790	77	10	be	be	AUX
fnp-3790	77	11	one	one	NUM
fnp-3790	77	12	of	of	ADP
fnp-3790	77	13	the	the	DET
fnp-3790	77	14	explanations	explanation	NOUN
fnp-3790	77	15	for	for	ADP
fnp-3790	77	16	the	the	DET
fnp-3790	77	17	occurrence	occurrence	NOUN
fnp-3790	77	18	of	of	ADP
fnp-3790	77	19	epileptic	epileptic	ADJ
fnp-3790	77	20	seizures	seizure	NOUN
fnp-3790	77	21	in	in	ADP
fnp-3790	77	22	multiple	multiple	ADJ
fnp-3790	77	23	sclerosis	sclerosis	NOUN
fnp-3790	77	24	and	and	CCONJ
fnp-3790	77	25	other	other	ADJ
fnp-3790	77	26	inflammatory	inflammatory	ADJ
fnp-3790	77	27	brain	brain	NOUN
fnp-3790	77	28	diseases	disease	NOUN
fnp-3790	77	29	(	(	PUNCT
fnp-3790	77	30	koch	koch	PROPN
fnp-3790	77	31	et	et	PROPN
fnp-3790	77	32	al	al	PROPN
fnp-3790	77	33	.	.	PROPN
fnp-3790	77	34	2008	2008	NUM
fnp-3790	77	35	,	,	PUNCT
fnp-3790	77	36	nicholas	nicholas	PROPN
fnp-3790	77	37	et	et	PROPN
fnp-3790	77	38	al	al	PROPN
fnp-3790	77	39	.	.	PROPN
fnp-3790	77	40	2016	2016	NUM
fnp-3790	77	41	,	,	PUNCT
fnp-3790	77	42	langenbruch	langenbruch	ADV
fnp-3790	77	43	et	et	PROPN
fnp-3790	77	44	al	al	PROPN
fnp-3790	77	45	.	.	PROPN
fnp-3790	77	46	2019	2019	NUM
fnp-3790	77	47	)	)	PUNCT
fnp-3790	77	48	.	.	PUNCT
fnp-3790	78	1	loss	loss	NOUN
fnp-3790	78	2	of	of	ADP
fnp-3790	78	3	gabaergic	gabaergic	ADJ
fnp-3790	78	4	interneurons	interneuron	NOUN
fnp-3790	78	5	involves	involve	VERB
fnp-3790	78	6	complement	complement	NOUN
fnp-3790	78	7	and	and	CCONJ
fnp-3790	78	8	results	result	NOUN
fnp-3790	78	9	in	in	ADP
fnp-3790	78	10	specific	specific	ADJ
fnp-3790	78	11	brain	brain	NOUN
fnp-3790	78	12	region	region	NOUN
fnp-3790	78	13	dependent	dependent	ADJ
fnp-3790	78	14	functional	functional	ADJ
fnp-3790	78	15	consequences	consequence	NOUN
fnp-3790	78	16	a	a	DET
fnp-3790	78	17	similar	similar	ADJ
fnp-3790	78	18	selective	selective	ADJ
fnp-3790	78	19	loss	loss	NOUN
fnp-3790	78	20	of	of	ADP
fnp-3790	78	21	gabaergic	gabaergic	ADJ
fnp-3790	78	22	interneurons	interneuron	NOUN
fnp-3790	78	23	was	be	AUX
fnp-3790	78	24	observed	observe	VERB
fnp-3790	78	25	in	in	ADP
fnp-3790	78	26	the	the	DET
fnp-3790	78	27	hippocampus	hippocampus	NOUN
fnp-3790	78	28	of	of	ADP
fnp-3790	78	29	multiple	multiple	ADJ
fnp-3790	78	30	sclerosis	sclerosis	NOUN
fnp-3790	78	31	patients	patient	NOUN
fnp-3790	78	32	,	,	PUNCT
fnp-3790	78	33	mainly	mainly	ADV
fnp-3790	78	34	affecting	affect	VERB
fnp-3790	78	35	the	the	DET
fnp-3790	78	36	ca2	ca2	PROPN
fnp-3790	78	37	subfield	subfield	PROPN
fnp-3790	78	38	.	.	PUNCT
fnp-3790	79	1	in	in	ADP
fnp-3790	79	2	line	line	NOUN
fnp-3790	79	3	with	with	ADP
fnp-3790	79	4	the	the	DET
fnp-3790	79	5	results	result	NOUN
fnp-3790	79	6	discussed	discuss	VERB
fnp-3790	79	7	above	above	ADP
fnp-3790	79	8	this	this	PRON
fnp-3790	79	9	was	be	AUX
fnp-3790	79	10	also	also	ADV
fnp-3790	79	11	associated	associate	VERB
fnp-3790	79	12	with	with	ADP
fnp-3790	79	13	an	an	DET
fnp-3790	79	14	even	even	ADV
fnp-3790	79	15	more	more	ADV
fnp-3790	79	16	prominent	prominent	ADJ
fnp-3790	79	17	loss	loss	NOUN
fnp-3790	79	18	of	of	ADP
fnp-3790	79	19	gabaergic	gabaergic	ADJ
fnp-3790	79	20	synaptic	synaptic	ADJ
fnp-3790	79	21	terminals	terminal	NOUN
fnp-3790	79	22	.	.	PUNCT
fnp-3790	80	1	since	since	SCONJ
fnp-3790	80	2	excitatory	excitatory	ADJ
fnp-3790	80	3	glutamatergic	glutamatergic	ADJ
fnp-3790	80	4	terminals	terminal	NOUN
fnp-3790	80	5	were	be	AUX
fnp-3790	80	6	unaffected	unaffected	ADJ
fnp-3790	80	7	,	,	PUNCT
fnp-3790	80	8	a	a	DET
fnp-3790	80	9	dysbalance	dysbalance	NOUN
fnp-3790	80	10	between	between	ADP
fnp-3790	80	11	excitatory	excitatory	NOUN
fnp-3790	80	12	and	and	CCONJ
fnp-3790	80	13	inhibitory	inhibitory	ADJ
fnp-3790	80	14	synaptic	synaptic	ADJ
fnp-3790	80	15	input	input	NOUN
fnp-3790	80	16	was	be	AUX
fnp-3790	80	17	noted	note	VERB
fnp-3790	80	18	(	(	PUNCT
fnp-3790	80	19	ramaglia	ramaglia	X
fnp-3790	80	20	et	et	PROPN
fnp-3790	80	21	al	al	PROPN
fnp-3790	80	22	.	.	PROPN
fnp-3790	80	23	2021	2021	NUM
fnp-3790	80	24	)	)	PUNCT
fnp-3790	80	25	.	.	PUNCT
fnp-3790	81	1	essentially	essentially	ADV
fnp-3790	81	2	similar	similar	ADJ
fnp-3790	81	3	findings	finding	NOUN
fnp-3790	81	4	were	be	AUX
fnp-3790	81	5	obtained	obtain	VERB
fnp-3790	81	6	in	in	ADP
fnp-3790	81	7	the	the	DET
fnp-3790	81	8	demyelinated	demyelinate	VERB
fnp-3790	81	9	hippocampus	hippocampus	NOUN
fnp-3790	81	10	in	in	ADP
fnp-3790	81	11	the	the	DET
fnp-3790	81	12	rodent	rodent	ADJ
fnp-3790	81	13	cuprizone	cuprizone	NOUN
fnp-3790	81	14	model	model	NOUN
fnp-3790	81	15	(	(	PUNCT
fnp-3790	81	16	ramaglia	ramaglia	X
fnp-3790	81	17	et	et	PROPN
fnp-3790	81	18	al	al	PROPN
fnp-3790	81	19	.	.	PROPN
fnp-3790	81	20	2021	2021	NUM
fnp-3790	81	21	)	)	PUNCT
fnp-3790	81	22	.	.	PUNCT
fnp-3790	82	1	this	this	PRON
fnp-3790	82	2	allowed	allow	VERB
fnp-3790	82	3	a	a	DET
fnp-3790	82	4	detailed	detailed	ADJ
fnp-3790	82	5	analysis	analysis	NOUN
fnp-3790	82	6	of	of	ADP
fnp-3790	82	7	neurobiological	neurobiological	ADJ
fnp-3790	82	8	mechanisms	mechanism	NOUN
fnp-3790	82	9	of	of	ADP
fnp-3790	82	10	neurodegeneration	neurodegeneration	NOUN
fnp-3790	82	11	and	and	CCONJ
fnp-3790	82	12	its	its	PRON
fnp-3790	82	13	functional	functional	ADJ
fnp-3790	82	14	consequences	consequence	NOUN
fnp-3790	82	15	.	.	PUNCT
fnp-3790	83	1	synaptic	synaptic	ADJ
fnp-3790	83	2	degeneration	degeneration	NOUN
fnp-3790	83	3	was	be	AUX
fnp-3790	83	4	associated	associate	VERB
fnp-3790	83	5	with	with	ADP
fnp-3790	83	6	profound	profound	ADJ
fnp-3790	83	7	precipitation	precipitation	NOUN
fnp-3790	83	8	of	of	ADP
fnp-3790	83	9	the	the	DET
fnp-3790	83	10	complement	complement	NOUN
fnp-3790	83	11	component	component	NOUN
fnp-3790	83	12	c1q	c1q	PROPN
fnp-3790	83	13	,	,	PUNCT
fnp-3790	83	14	which	which	PRON
fnp-3790	83	15	significantly	significantly	ADV
fnp-3790	83	16	correlated	correlate	VERB
fnp-3790	83	17	with	with	ADP
fnp-3790	83	18	synaptic	synaptic	ADJ
fnp-3790	83	19	pathology	pathology	NOUN
fnp-3790	83	20	and	and	CCONJ
fnp-3790	83	21	the	the	DET
fnp-3790	83	22	extent	extent	NOUN
fnp-3790	83	23	of	of	ADP
fnp-3790	83	24	demyelination	demyelination	NOUN
fnp-3790	83	25	,	,	PUNCT
fnp-3790	83	26	but	but	CCONJ
fnp-3790	83	27	was	be	AUX
fnp-3790	83	28	not	not	PART
fnp-3790	83	29	associated	associate	VERB
fnp-3790	83	30	with	with	ADP
fnp-3790	83	31	the	the	DET
fnp-3790	83	32	presence	presence	NOUN
fnp-3790	83	33	of	of	ADP
fnp-3790	83	34	pathogenic	pathogenic	ADJ
fnp-3790	83	35	autoantibodies	autoantibody	NOUN
fnp-3790	83	36	.	.	PUNCT
fnp-3790	84	1	a	a	DET
fnp-3790	84	2	key	key	ADJ
fnp-3790	84	3	role	role	NOUN
fnp-3790	84	4	of	of	ADP
fnp-3790	84	5	complement	complement	NOUN
fnp-3790	84	6	in	in	ADP
fnp-3790	84	7	synaptic	synaptic	ADJ
fnp-3790	84	8	plasticity	plasticity	NOUN
fnp-3790	84	9	and	and	CCONJ
fnp-3790	84	10	degeneration	degeneration	NOUN
fnp-3790	84	11	has	have	AUX
fnp-3790	84	12	been	be	AUX
fnp-3790	84	13	observed	observe	VERB
fnp-3790	84	14	in	in	ADP
fnp-3790	84	15	a	a	DET
fnp-3790	84	16	variety	variety	NOUN
fnp-3790	84	17	of	of	ADP
fnp-3790	84	18	studies	study	NOUN
fnp-3790	84	19	before	before	ADV
fnp-3790	84	20	(	(	PUNCT
fnp-3790	84	21	schartz	schartz	NOUN
fnp-3790	84	22	and	and	CCONJ
fnp-3790	84	23	tenner	tenner	ADV
fnp-3790	84	24	2020	2020	NUM
fnp-3790	84	25	)	)	PUNCT
fnp-3790	84	26	.	.	PUNCT
fnp-3790	85	1	early	early	ADJ
fnp-3790	85	2	complement	complement	NOUN
fnp-3790	85	3	components	component	NOUN
fnp-3790	85	4	,	,	PUNCT
fnp-3790	85	5	such	such	ADJ
fnp-3790	85	6	as	as	ADP
fnp-3790	85	7	c1q	c1q	PROPN
fnp-3790	85	8	or	or	CCONJ
fnp-3790	85	9	c3	c3	NOUN
fnp-3790	85	10	,	,	PUNCT
fnp-3790	85	11	are	be	AUX
fnp-3790	85	12	produced	produce	VERB
fnp-3790	85	13	in	in	ADP
fnp-3790	85	14	part	part	NOUN
fnp-3790	85	15	in	in	ADP
fnp-3790	85	16	neurons	neuron	NOUN
fnp-3790	85	17	and	and	CCONJ
fnp-3790	85	18	their	their	PRON
fnp-3790	85	19	production	production	NOUN
fnp-3790	85	20	is	be	AUX
fnp-3790	85	21	enhanced	enhance	VERB
fnp-3790	85	22	in	in	ADP
fnp-3790	85	23	conditions	condition	NOUN
fnp-3790	85	24	of	of	ADP
fnp-3790	85	25	neurodegeneration	neurodegeneration	NOUN
fnp-3790	85	26	.	.	PUNCT
fnp-3790	86	1	these	these	DET
fnp-3790	86	2	proteins	protein	NOUN
fnp-3790	86	3	are	be	AUX
fnp-3790	86	4	transported	transport	VERB
fnp-3790	86	5	in	in	ADP
fnp-3790	86	6	the	the	DET
fnp-3790	86	7	axons	axon	NOUN
fnp-3790	86	8	to	to	ADP
fnp-3790	86	9	the	the	DET
fnp-3790	86	10	terminals	terminal	NOUN
fnp-3790	86	11	and	and	CCONJ
fnp-3790	86	12	focally	focally	ADV
fnp-3790	86	13	accumulate	accumulate	NOUN
fnp-3790	86	14	at	at	ADP
fnp-3790	86	15	sites	site	NOUN
fnp-3790	86	16	of	of	ADP
fnp-3790	86	17	axonal	axonal	ADJ
fnp-3790	86	18	or	or	CCONJ
fnp-3790	86	19	synaptic	synaptic	ADJ
fnp-3790	86	20	damage	damage	NOUN
fnp-3790	86	21	(	(	PUNCT
fnp-3790	86	22	michailidou	michailidou	NOUN
fnp-3790	86	23	et	et	PROPN
fnp-3790	86	24	al	al	PROPN
fnp-3790	86	25	.	.	PROPN
fnp-3790	86	26	2016	2016	NUM
fnp-3790	86	27	)	)	PUNCT
fnp-3790	86	28	.	.	PUNCT
fnp-3790	87	1	their	their	PRON
fnp-3790	87	2	removal	removal	NOUN
fnp-3790	87	3	by	by	ADP
fnp-3790	87	4	microglia	microglia	NOUN
fnp-3790	87	5	is	be	AUX
fnp-3790	87	6	a	a	DET
fnp-3790	87	7	prerequisite	prerequisite	NOUN
fnp-3790	87	8	for	for	ADP
fnp-3790	87	9	synaptic	synaptic	ADJ
fnp-3790	87	10	plasticity	plasticity	NOUN
fnp-3790	87	11	and	and	CCONJ
fnp-3790	87	12	axonal	axonal	ADJ
fnp-3790	87	13	regeneration	regeneration	NOUN
fnp-3790	87	14	.	.	PUNCT
fnp-3790	88	1	in	in	ADP
fnp-3790	88	2	pathological	pathological	ADJ
fnp-3790	88	3	conditions	condition	NOUN
fnp-3790	88	4	this	this	DET
fnp-3790	88	5	mechanism	mechanism	NOUN
fnp-3790	88	6	is	be	AUX
fnp-3790	88	7	enhanced	enhance	VERB
fnp-3790	88	8	(	(	PUNCT
fnp-3790	88	9	michailidou	michailidou	NOUN
fnp-3790	88	10	et	et	PROPN
fnp-3790	88	11	al	al	PROPN
fnp-3790	88	12	.	.	PROPN
fnp-3790	88	13	2016	2016	NUM
fnp-3790	88	14	)	)	PUNCT
fnp-3790	88	15	and	and	CCONJ
fnp-3790	88	16	the	the	DET
fnp-3790	88	17	subsequent	subsequent	ADJ
fnp-3790	88	18	complement	complement	NOUN
fnp-3790	88	19	/	/	SYM
fnp-3790	88	20	microglia	microglia	NOUN
fnp-3790	88	21	interaction	interaction	NOUN
fnp-3790	88	22	may	may	AUX
fnp-3790	88	23	result	result	VERB
fnp-3790	88	24	in	in	ADP
fnp-3790	88	25	substantial	substantial	ADJ
fnp-3790	88	26	axonal	axonal	ADJ
fnp-3790	88	27	and	and	CCONJ
fnp-3790	88	28	synaptic	synaptic	ADJ
fnp-3790	88	29	loss	loss	NOUN
fnp-3790	88	30	,	,	PUNCT
fnp-3790	88	31	followed	follow	VERB
fnp-3790	88	32	by	by	ADP
fnp-3790	88	33	retrograde	retrograde	ADJ
fnp-3790	88	34	neuronal	neuronal	ADJ
fnp-3790	88	35	degeneration	degeneration	NOUN
fnp-3790	88	36	(	(	PUNCT
fnp-3790	88	37	schartz	schartz	NOUN
fnp-3790	88	38	and	and	CCONJ
fnp-3790	88	39	tenner	tenner	ADV
fnp-3790	88	40	2020	2020	NUM
fnp-3790	88	41	)	)	PUNCT
fnp-3790	88	42	.	.	PUNCT
fnp-3790	89	1	the	the	DET
fnp-3790	89	2	neurophysiological	neurophysiological	ADJ
fnp-3790	89	3	consequences	consequence	NOUN
fnp-3790	89	4	of	of	ADP
fnp-3790	89	5	the	the	DET
fnp-3790	89	6	loss	loss	NOUN
fnp-3790	89	7	of	of	ADP
fnp-3790	89	8	gabaergic	gabaergic	ADJ
fnp-3790	89	9	interneurons	interneuron	NOUN
fnp-3790	89	10	and	and	CCONJ
fnp-3790	89	11	synapses	synapsis	NOUN
fnp-3790	89	12	in	in	ADP
fnp-3790	89	13	the	the	DET
fnp-3790	89	14	ca2	ca2	PROPN
fnp-3790	89	15	region	region	NOUN
fnp-3790	89	16	was	be	AUX
fnp-3790	89	17	a	a	DET
fnp-3790	89	18	disturbance	disturbance	NOUN
fnp-3790	89	19	of	of	ADP
fnp-3790	89	20	the	the	DET
fnp-3790	89	21	excitatory	excitatory	ADJ
fnp-3790	89	22	/	/	SYM
fnp-3790	89	23	inhibitor	inhibitor	NOUN
fnp-3790	89	24	balance	balance	NOUN
fnp-3790	89	25	and	and	CCONJ
fnp-3790	89	26	a	a	DET
fnp-3790	89	27	loss	loss	NOUN
fnp-3790	89	28	of	of	ADP
fnp-3790	89	29	feed	feed	NOUN
fnp-3790	89	30	-	-	PUNCT
fnp-3790	89	31	forward	forward	NOUN
fnp-3790	89	32	inhibition	inhibition	NOUN
fnp-3790	89	33	of	of	ADP
fnp-3790	89	34	pyramidal	pyramidal	ADJ
fnp-3790	89	35	neurons	neuron	NOUN
fnp-3790	89	36	.	.	PUNCT
fnp-3790	90	1	in	in	ADP
fnp-3790	90	2	concomitant	concomitant	ADJ
fnp-3790	90	3	behavioral	behavioral	ADJ
fnp-3790	90	4	investigations	investigation	NOUN
fnp-3790	90	5	it	it	PRON
fnp-3790	90	6	turned	turn	VERB
fnp-3790	90	7	out	out	ADP
fnp-3790	90	8	that	that	SCONJ
fnp-3790	90	9	these	these	DET
fnp-3790	90	10	functional	functional	ADJ
fnp-3790	90	11	changes	change	NOUN
fnp-3790	90	12	were	be	AUX
fnp-3790	90	13	mainly	mainly	ADV
fnp-3790	90	14	reflected	reflect	VERB
fnp-3790	90	15	in	in	ADP
fnp-3790	90	16	a	a	DET
fnp-3790	90	17	disturbance	disturbance	NOUN
fnp-3790	90	18	of	of	ADP
fnp-3790	90	19	social	social	ADJ
fnp-3790	90	20	memory	memory	NOUN
fnp-3790	90	21	tasks	task	NOUN
fnp-3790	90	22	,	,	PUNCT
fnp-3790	90	23	which	which	PRON
fnp-3790	90	24	were	be	AUX
fnp-3790	90	25	not	not	PART
fnp-3790	90	26	accompanied	accompany	VERB
fnp-3790	90	27	by	by	ADP
fnp-3790	90	28	a	a	DET
fnp-3790	90	29	general	general	ADJ
fnp-3790	90	30	learning	learning	NOUN
fnp-3790	90	31	impairment	impairment	NOUN
fnp-3790	90	32	or	or	CCONJ
fnp-3790	90	33	by	by	ADP
fnp-3790	90	34	changes	change	NOUN
fnp-3790	90	35	of	of	ADP
fnp-3790	90	36	motor	motor	NOUN
fnp-3790	90	37	activities	activity	NOUN
fnp-3790	90	38	(	(	PUNCT
fnp-3790	90	39	ramaglia	ramaglia	X
fnp-3790	90	40	et	et	PROPN
fnp-3790	90	41	al	al	PROPN
fnp-3790	90	42	.	.	PROPN
fnp-3790	90	43	2021	2021	NUM
fnp-3790	90	44	)	)	PUNCT
fnp-3790	90	45	.	.	PUNCT
fnp-3790	91	1	in	in	ADP
fnp-3790	91	2	summary	summary	NOUN
fnp-3790	91	3	,	,	PUNCT
fnp-3790	91	4	this	this	DET
fnp-3790	91	5	study	study	NOUN
fnp-3790	91	6	,	,	PUNCT
fnp-3790	91	7	too	too	ADV
fnp-3790	91	8	,	,	PUNCT
fnp-3790	91	9	shows	show	VERB
fnp-3790	91	10	a	a	DET
fnp-3790	91	11	selective	selective	ADJ
fnp-3790	91	12	vulnerability	vulnerability	NOUN
fnp-3790	91	13	of	of	ADP
fnp-3790	91	14	gabaergic	gabaergic	ADJ
fnp-3790	91	15	interneurons	interneuron	NOUN
fnp-3790	91	16	in	in	ADP
fnp-3790	91	17	ms	ms	NOUN
fnp-3790	91	18	and	and	CCONJ
fnp-3790	91	19	cuprizone	cuprizone	NOUN
fnp-3790	91	20	lesions	lesion	NOUN
fnp-3790	91	21	and	and	CCONJ
fnp-3790	91	22	suggests	suggest	VERB
fnp-3790	91	23	that	that	SCONJ
fnp-3790	91	24	these	these	DET
fnp-3790	91	25	changes	change	NOUN
fnp-3790	91	26	are	be	AUX
fnp-3790	91	27	a	a	DET
fnp-3790	91	28	potential	potential	ADJ
fnp-3790	91	29	consequence	consequence	NOUN
fnp-3790	91	30	of	of	ADP
fnp-3790	91	31	demyelination	demyelination	NOUN
fnp-3790	91	32	.	.	PUNCT
fnp-3790	92	1	however	however	ADV
fnp-3790	92	2	,	,	PUNCT
fnp-3790	92	3	no	no	DET
fnp-3790	92	4	loss	loss	NOUN
fnp-3790	92	5	of	of	ADP
fnp-3790	92	6	pv	pv	NOUN
fnp-3790	92	7	-	-	PUNCT
fnp-3790	92	8	containing	contain	VERB
fnp-3790	92	9	gabaergic	gabaergic	ADJ
fnp-3790	92	10	interneurons	interneuron	NOUN
fnp-3790	92	11	has	have	AUX
fnp-3790	92	12	been	be	AUX
fnp-3790	92	13	seen	see	VERB
fnp-3790	92	14	in	in	ADP
fnp-3790	92	15	another	another	DET
fnp-3790	92	16	study	study	NOUN
fnp-3790	92	17	in	in	ADP
fnp-3790	92	18	hippocampal	hippocampal	ADJ
fnp-3790	92	19	ms	ms	PROPN
fnp-3790	92	20	lesions	lesion	NOUN
fnp-3790	92	21	despite	despite	SCONJ
fnp-3790	92	22	extensive	extensive	ADJ
fnp-3790	92	23	demyelination	demyelination	NOUN
fnp-3790	92	24	(	(	PUNCT
fnp-3790	92	25	kiljan	kiljan	NOUN
fnp-3790	92	26	et	et	PROPN
fnp-3790	92	27	al	al	PROPN
fnp-3790	92	28	.	.	PROPN
fnp-3790	92	29	2019	2019	NUM
fnp-3790	92	30	)	)	PUNCT
fnp-3790	92	31	,	,	PUNCT
fnp-3790	92	32	suggesting	suggest	VERB
fnp-3790	92	33	that	that	SCONJ
fnp-3790	92	34	demyelination	demyelination	NOUN
fnp-3790	92	35	alone	alone	ADV
fnp-3790	92	36	is	be	AUX
fnp-3790	92	37	unlikely	unlikely	ADJ
fnp-3790	92	38	to	to	PART
fnp-3790	92	39	be	be	AUX
fnp-3790	92	40	responsible	responsible	ADJ
fnp-3790	92	41	.	.	PUNCT
fnp-3790	93	1	a	a	DET
fnp-3790	93	2	similar	similar	ADJ
fnp-3790	93	3	preferential	preferential	ADJ
fnp-3790	93	4	loss	loss	NOUN
fnp-3790	93	5	of	of	ADP
fnp-3790	93	6	parvalbumin	parvalbumin	ADJ
fnp-3790	93	7	reactive	reactive	ADJ
fnp-3790	93	8	neurons	neuron	NOUN
fnp-3790	93	9	has	have	AUX
fnp-3790	93	10	also	also	ADV
fnp-3790	93	11	been	be	AUX
fnp-3790	93	12	seen	see	VERB
fnp-3790	93	13	in	in	ADP
fnp-3790	93	14	a	a	DET
fnp-3790	93	15	mouse	mouse	NOUN
fnp-3790	93	16	model	model	NOUN
fnp-3790	93	17	of	of	ADP
fnp-3790	93	18	autoimmune	autoimmune	ADJ
fnp-3790	93	19	encephalomyelitis	encephalomyelitis	NOUN
fnp-3790	93	20	,	,	PUNCT
fnp-3790	93	21	which	which	PRON
fnp-3790	93	22	is	be	AUX
fnp-3790	93	23	driven	drive	VERB
fnp-3790	93	24	by	by	ADP
fnp-3790	93	25	inflammation	inflammation	NOUN
fnp-3790	93	26	,	,	PUNCT
fnp-3790	93	27	but	but	CCONJ
fnp-3790	93	28	largely	largely	ADV
fnp-3790	93	29	lacks	lack	VERB
fnp-3790	93	30	primary	primary	ADJ
fnp-3790	93	31	demyelination	demyelination	NOUN
fnp-3790	93	32	in	in	ADP
fnp-3790	93	33	the	the	DET
fnp-3790	93	34	cortex	cortex	NOUN
fnp-3790	93	35	(	(	PUNCT
fnp-3790	93	36	falco	falco	PROPN
fnp-3790	93	37	et	et	PROPN
fnp-3790	93	38	al	al	PROPN
fnp-3790	93	39	.	.	PROPN
fnp-3790	93	40	2014	2014	NUM
fnp-3790	93	41	)	)	PUNCT
fnp-3790	93	42	.	.	PUNCT
fnp-3790	94	1	furthermore	furthermore	ADV
fnp-3790	94	2	,	,	PUNCT
fnp-3790	94	3	hypoxic	hypoxic	ADJ
fnp-3790	94	4	/	/	SYM
fnp-3790	94	5	ischemic	ischemic	ADJ
fnp-3790	94	6	damage	damage	NOUN
fnp-3790	94	7	is	be	AUX
fnp-3790	94	8	associated	associate	VERB
fnp-3790	94	9	with	with	ADP
fnp-3790	94	10	a	a	DET
fnp-3790	94	11	preferential	preferential	ADJ
fnp-3790	94	12	loss	loss	NOUN
fnp-3790	94	13	of	of	ADP
fnp-3790	94	14	pv	pv	NOUN
fnp-3790	94	15	-	-	PUNCT
fnp-3790	94	16	containing	contain	VERB
fnp-3790	94	17	gabaergic	gabaergic	ADJ
fnp-3790	94	18	interneurons	interneuron	NOUN
fnp-3790	94	19	(	(	PUNCT
fnp-3790	94	20	fowke	fowke	ADP
fnp-3790	94	21	et	et	PROPN
fnp-3790	94	22	al	al	PROPN
fnp-3790	94	23	.	.	PROPN
fnp-3790	94	24	2018	2018	NUM
fnp-3790	94	25	,	,	PUNCT
fnp-3790	94	26	stolp	stolp	PROPN
fnp-3790	94	27	et	et	PROPN
fnp-3790	94	28	al	al	PROPN
fnp-3790	94	29	.	.	PROPN
fnp-3790	94	30	2019	2019	NUM
fnp-3790	94	31	,	,	PUNCT
fnp-3790	94	32	vaes	vaes	PROPN
fnp-3790	94	33	et	et	PROPN
fnp-3790	94	34	al	al	PROPN
fnp-3790	94	35	.	.	PROPN
fnp-3790	94	36	2020	2020	NUM
fnp-3790	94	37	,	,	PUNCT
fnp-3790	94	38	povysheva	povysheva	VERB
fnp-3790	94	39	et	et	PROPN
fnp-3790	94	40	al	al	PROPN
fnp-3790	94	41	.	.	PROPN
fnp-3790	94	42	2019	2019	NUM
fnp-3790	94	43	)	)	PUNCT
fnp-3790	94	44	and	and	CCONJ
fnp-3790	94	45	a	a	DET
fnp-3790	94	46	similar	similar	ADJ
fnp-3790	94	47	selective	selective	ADJ
fnp-3790	94	48	vulnerability	vulnerability	NOUN
fnp-3790	94	49	has	have	AUX
fnp-3790	94	50	also	also	ADV
fnp-3790	94	51	been	be	AUX
fnp-3790	94	52	observed	observe	VERB
fnp-3790	94	53	in	in	ADP
fnp-3790	94	54	a	a	DET
fnp-3790	94	55	mouse	mouse	NOUN
fnp-3790	94	56	model	model	NOUN
fnp-3790	94	57	of	of	ADP
fnp-3790	94	58	alzheimer	alzheimer	PROPN
fnp-3790	94	59	’s	’s	PART
fnp-3790	94	60	disease	disease	NOUN
fnp-3790	94	61	(	(	PUNCT
fnp-3790	94	62	petrache	petrache	PROPN
fnp-3790	94	63	et	et	PROPN
fnp-3790	94	64	al	al	PROPN
fnp-3790	94	65	.	.	PROPN
fnp-3790	94	66	2019	2019	NUM
fnp-3790	94	67	)	)	PUNCT
fnp-3790	95	1	thus	thus	ADV
fnp-3790	95	2	,	,	PUNCT
fnp-3790	95	3	the	the	DET
fnp-3790	95	4	key	key	ADJ
fnp-3790	95	5	question	question	NOUN
fnp-3790	95	6	arises	arise	VERB
fnp-3790	95	7	whether	whether	SCONJ
fnp-3790	95	8	there	there	PRON
fnp-3790	95	9	are	be	VERB
fnp-3790	95	10	common	common	ADJ
fnp-3790	95	11	mechanisms	mechanism	NOUN
fnp-3790	95	12	of	of	ADP
fnp-3790	95	13	brain	brain	NOUN
fnp-3790	95	14	injury	injury	NOUN
fnp-3790	95	15	shared	share	VERB
fnp-3790	95	16	between	between	ADP
fnp-3790	95	17	these	these	DET
fnp-3790	95	18	different	different	ADJ
fnp-3790	95	19	conditions	condition	NOUN
fnp-3790	95	20	.	.	PUNCT
fnp-3790	96	1	all	all	PRON
fnp-3790	96	2	of	of	ADP
fnp-3790	96	3	these	these	DET
fnp-3790	96	4	conditions	condition	NOUN
fnp-3790	96	5	are	be	AUX
fnp-3790	96	6	associated	associate	VERB
fnp-3790	96	7	with	with	ADP
fnp-3790	96	8	microglia	microglia	ADJ
fnp-3790	96	9	activation	activation	NOUN
fnp-3790	96	10	,	,	PUNCT
fnp-3790	96	11	reflected	reflect	VERB
fnp-3790	96	12	by	by	ADP
fnp-3790	96	13	the	the	DET
fnp-3790	96	14	expression	expression	NOUN
fnp-3790	96	15	of	of	ADP
fnp-3790	96	16	nadph	nadph	ADJ
fnp-3790	96	17	oxidase	oxidase	NOUN
fnp-3790	96	18	in	in	ADP
fnp-3790	96	19	activated	activate	VERB
fnp-3790	96	20	microglia	microglia	NOUN
fnp-3790	96	21	(	(	PUNCT
fnp-3790	96	22	zrzavy	zrzavy	PROPN
fnp-3790	96	23	et	et	PROPN
fnp-3790	96	24	al	al	PROPN
fnp-3790	96	25	.	.	PROPN
fnp-3790	96	26	2017	2017	NUM
fnp-3790	96	27	,	,	PUNCT
fnp-3790	96	28	2018	2018	NUM
fnp-3790	96	29	)	)	PUNCT
fnp-3790	96	30	.	.	PUNCT
fnp-3790	97	1	the	the	DET
fnp-3790	97	2	beneficial	beneficial	ADJ
fnp-3790	97	3	effect	effect	NOUN
fnp-3790	97	4	of	of	ADP
fnp-3790	97	5	its	its	PRON
fnp-3790	97	6	pharmacological	pharmacological	ADJ
fnp-3790	97	7	blockade	blockade	NOUN
fnp-3790	97	8	indicates	indicate	VERB
fnp-3790	97	9	a	a	DET
fnp-3790	97	10	role	role	NOUN
fnp-3790	97	11	of	of	ADP
fnp-3790	97	12	oxidative	oxidative	ADJ
fnp-3790	97	13	injury	injury	NOUN
fnp-3790	97	14	in	in	ADP
fnp-3790	97	15	the	the	DET
fnp-3790	97	16	induction	induction	NOUN
fnp-3790	97	17	of	of	ADP
fnp-3790	97	18	neuronal	neuronal	ADJ
fnp-3790	97	19	damage	damage	NOUN
fnp-3790	97	20	(	(	PUNCT
fnp-3790	97	21	yuan	yuan	NOUN
fnp-3790	97	22	et	et	NOUN
fnp-3790	97	23	al	al	PROPN
fnp-3790	97	24	.	.	PROPN
fnp-3790	97	25	2015	2015	NUM
fnp-3790	97	26	)	)	PUNCT
fnp-3790	97	27	by	by	ADP
fnp-3790	97	28	mitochondrial	mitochondrial	ADJ
fnp-3790	97	29	injury	injury	NOUN
fnp-3790	97	30	and	and	CCONJ
fnp-3790	97	31	subsequent	subsequent	ADJ
fnp-3790	97	32	energy	energy	NOUN
fnp-3790	97	33	deficiency	deficiency	NOUN
fnp-3790	97	34	(	(	PUNCT
fnp-3790	97	35	mahad	mahad	PROPN
fnp-3790	97	36	et	et	PROPN
fnp-3790	97	37	al	al	PROPN
fnp-3790	97	38	.	.	PROPN
fnp-3790	97	39	2015	2015	NUM
fnp-3790	97	40	)	)	PUNCT
fnp-3790	97	41	.	.	PUNCT
fnp-3790	98	1	in	in	ADP
fnp-3790	98	2	such	such	DET
fnp-3790	98	3	a	a	DET
fnp-3790	98	4	state	state	NOUN
fnp-3790	98	5	of	of	ADP
fnp-3790	98	6	“	"	PUNCT
fnp-3790	98	7	virtual	virtual	ADJ
fnp-3790	98	8	hypoxia	hypoxia	NOUN
fnp-3790	98	9	”	"	PUNCT
fnp-3790	98	10	(	(	PUNCT
fnp-3790	98	11	dutta	dutta	NOUN
fnp-3790	98	12	et	et	PROPN
fnp-3790	98	13	al	al	PROPN
fnp-3790	98	14	.	.	PROPN
fnp-3790	98	15	2013	2013	NUM
fnp-3790	98	16	)	)	PUNCT
fnp-3790	98	17	additional	additional	ADJ
fnp-3790	98	18	demyelination	demyelination	NOUN
fnp-3790	98	19	amplifies	amplify	VERB
fnp-3790	98	20	damage	damage	NOUN
fnp-3790	98	21	due	due	ADP
fnp-3790	98	22	to	to	ADP
fnp-3790	98	23	the	the	DET
fnp-3790	98	24	increased	increase	VERB
fnp-3790	98	25	energy	energy	NOUN
fnp-3790	98	26	demand	demand	NOUN
fnp-3790	98	27	of	of	ADP
fnp-3790	98	28	denuded	denuded	ADJ
fnp-3790	98	29	axons	axon	NOUN
fnp-3790	98	30	.	.	PUNCT
fnp-3790	99	1	microglia	microglia	ADJ
fnp-3790	99	2	phenotype	phenotype	NOUN
fnp-3790	99	3	in	in	ADP
fnp-3790	99	4	relation	relation	NOUN
fnp-3790	99	5	to	to	ADP
fnp-3790	99	6	alzheimer	alzheimer	PROPN
fnp-3790	99	7	’s	’s	PART
fnp-3790	99	8	disease	disease	NOUN
fnp-3790	99	9	(	(	PUNCT
fnp-3790	99	10	ad	ad	NOUN
fnp-3790	99	11	)	)	PUNCT
fnp-3790	99	12	pathology	pathology	NOUN
fnp-3790	99	13	research	research	NOUN
fnp-3790	99	14	performed	perform	VERB
fnp-3790	99	15	during	during	ADP
fnp-3790	99	16	the	the	DET
fnp-3790	99	17	last	last	ADJ
fnp-3790	99	18	decade	decade	NOUN
fnp-3790	99	19	brought	bring	VERB
fnp-3790	99	20	microglia	microglia	ADV
fnp-3790	99	21	into	into	ADP
fnp-3790	99	22	a	a	DET
fnp-3790	99	23	central	central	ADJ
fnp-3790	99	24	position	position	NOUN
fnp-3790	99	25	in	in	ADP
fnp-3790	99	26	the	the	DET
fnp-3790	99	27	cascade	cascade	NOUN
fnp-3790	99	28	of	of	ADP
fnp-3790	99	29	events	event	NOUN
fnp-3790	99	30	triggering	trigger	VERB
fnp-3790	99	31	neurodegeneration	neurodegeneration	NOUN
fnp-3790	99	32	.	.	PUNCT
fnp-3790	100	1	in	in	ADP
fnp-3790	100	2	alzheimer	alzheimer	PROPN
fnp-3790	100	3	’s	’s	PART
fnp-3790	100	4	disease	disease	NOUN
fnp-3790	100	5	the	the	DET
fnp-3790	100	6	concept	concept	NOUN
fnp-3790	100	7	was	be	AUX
fnp-3790	100	8	originally	originally	ADV
fnp-3790	100	9	proposed	propose	VERB
fnp-3790	100	10	following	follow	VERB
fnp-3790	100	11	the	the	DET
fnp-3790	100	12	observation	observation	NOUN
fnp-3790	100	13	that	that	PRON
fnp-3790	100	14	activated	activate	VERB
fnp-3790	100	15	microglia	microglia	ADJ
fnp-3790	100	16	cumulate	cumulate	NOUN
fnp-3790	100	17	in	in	ADP
fnp-3790	100	18	amyloid	amyloid	NOUN
fnp-3790	100	19	plaques	plaque	NOUN
fnp-3790	100	20	(	(	PUNCT
fnp-3790	100	21	mcgeer	mcgeer	NOUN
fnp-3790	100	22	et	et	PROPN
fnp-3790	100	23	al	al	PROPN
fnp-3790	100	24	.	.	PROPN
fnp-3790	100	25	1988	1988	NUM
fnp-3790	100	26	)	)	PUNCT
fnp-3790	100	27	and	and	CCONJ
fnp-3790	100	28	that	that	SCONJ
fnp-3790	100	29	a	a	DET
fnp-3790	100	30	variety	variety	NOUN
fnp-3790	100	31	of	of	ADP
fnp-3790	100	32	different	different	ADJ
fnp-3790	100	33	pro	pro	ADJ
fnp-3790	100	34	-	-	ADJ
fnp-3790	100	35	inflammatory	inflammatory	ADJ
fnp-3790	100	36	cytokines	cytokine	NOUN
fnp-3790	100	37	and	and	CCONJ
fnp-3790	100	38	mediators	mediator	NOUN
fnp-3790	100	39	are	be	AUX
fnp-3790	100	40	expressed	express	VERB
fnp-3790	100	41	in	in	ADP
fnp-3790	100	42	the	the	DET
fnp-3790	100	43	ad	ad	NOUN
fnp-3790	100	44	cortex	cortex	NOUN
fnp-3790	100	45	(	(	PUNCT
fnp-3790	100	46	eikelenboom	eikelenboom	NOUN
fnp-3790	100	47	and	and	CCONJ
fnp-3790	100	48	stam	stam	VERB
fnp-3790	100	49	1982	1982	NUM
fnp-3790	100	50	,	,	PUNCT
fnp-3790	100	51	mcgeer	mcgeer	PROPN
fnp-3790	100	52	et	et	PROPN
fnp-3790	100	53	al	al	PROPN
fnp-3790	100	54	.	.	PROPN
fnp-3790	100	55	1988	1988	NUM
fnp-3790	100	56	,	,	PUNCT
fnp-3790	100	57	dickson	dickson	PROPN
fnp-3790	100	58	and	and	CCONJ
fnp-3790	100	59	rogers	roger	NOUN
fnp-3790	100	60	1992	1992	NUM
fnp-3790	100	61	)	)	PUNCT
fnp-3790	100	62	.	.	PUNCT
fnp-3790	101	1	more	more	ADV
fnp-3790	101	2	recently	recently	ADV
fnp-3790	101	3	,	,	PUNCT
fnp-3790	101	4	systematic	systematic	ADJ
fnp-3790	101	5	genome	genome	NOUN
fnp-3790	101	6	wide	wide	ADJ
fnp-3790	101	7	association	association	NOUN
fnp-3790	101	8	studies	study	NOUN
fnp-3790	101	9	(	(	PUNCT
fnp-3790	101	10	gwas	gwas	PROPN
fnp-3790	101	11	)	)	PUNCT
fnp-3790	101	12	identified	identify	VERB
fnp-3790	101	13	numerous	numerous	ADJ
fnp-3790	101	14	risk	risk	NOUN
fnp-3790	101	15	genes	gene	NOUN
fnp-3790	101	16	for	for	ADP
fnp-3790	101	17	ad	ad	NOUN
fnp-3790	101	18	susceptibility	susceptibility	NOUN
fnp-3790	101	19	,	,	PUNCT
fnp-3790	101	20	and	and	CCONJ
fnp-3790	101	21	many	many	ADJ
fnp-3790	101	22	of	of	ADP
fnp-3790	101	23	these	these	DET
fnp-3790	101	24	genes	gene	NOUN
fnp-3790	101	25	code	code	NOUN
fnp-3790	101	26	for	for	ADP
fnp-3790	101	27	molecules	molecule	NOUN
fnp-3790	101	28	involved	involve	VERB
fnp-3790	101	29	in	in	ADP
fnp-3790	101	30	microglia	microglia	ADJ
fnp-3790	101	31	function	function	NOUN
fnp-3790	101	32	(	(	PUNCT
fnp-3790	101	33	lambert	lambert	PROPN
fnp-3790	101	34	et	et	PROPN
fnp-3790	101	35	al	al	PROPN
fnp-3790	101	36	.	.	PROPN
fnp-3790	101	37	2013	2013	NUM
fnp-3790	101	38	,	,	PUNCT
fnp-3790	101	39	lewcock	lewcock	NOUN
fnp-3790	101	40	et	et	PROPN
fnp-3790	101	41	al	al	PROPN
fnp-3790	101	42	.	.	PROPN
fnp-3790	101	43	2020	2020	NUM
fnp-3790	101	44	)	)	PUNCT
fnp-3790	101	45	.	.	PUNCT
fnp-3790	102	1	these	these	DET
fnp-3790	102	2	results	result	NOUN
fnp-3790	102	3	encouraged	encourage	VERB
fnp-3790	102	4	new	new	ADJ
fnp-3790	102	5	studies	study	NOUN
fnp-3790	102	6	on	on	ADP
fnp-3790	102	7	the	the	DET
fnp-3790	102	8	phenotype	phenotype	NOUN
fnp-3790	102	9	of	of	ADP
fnp-3790	102	10	microglia	microglia	NOUN
fnp-3790	102	11	in	in	ADP
fnp-3790	102	12	alzheimer	alzheimer	PROPN
fnp-3790	102	13	’s	’s	PART
fnp-3790	102	14	disease	disease	NOUN
fnp-3790	102	15	using	use	VERB
fnp-3790	102	16	the	the	DET
fnp-3790	102	17	new	new	ADJ
fnp-3790	102	18	opportunities	opportunity	NOUN
fnp-3790	102	19	offered	offer	VERB
fnp-3790	102	20	by	by	ADP
fnp-3790	102	21	single	single	ADJ
fnp-3790	102	22	cell	cell	NOUN
fnp-3790	102	23	transcriptomics	transcriptomic	NOUN
fnp-3790	102	24	and	and	CCONJ
fnp-3790	102	25	proteomics	proteomic	NOUN
fnp-3790	102	26	(	(	PUNCT
fnp-3790	102	27	mathys	mathy	NOUN
fnp-3790	102	28	et	et	PROPN
fnp-3790	102	29	al	al	PROPN
fnp-3790	102	30	.	.	PROPN
fnp-3790	102	31	2019	2019	NUM
fnp-3790	102	32	,	,	PUNCT
fnp-3790	102	33	lewcock	lewcock	NOUN
fnp-3790	102	34	et	et	PROPN
fnp-3790	102	35	al	al	PROPN
fnp-3790	102	36	.	.	PROPN
fnp-3790	102	37	2020	2020	NUM
fnp-3790	102	38	)	)	PUNCT
fnp-3790	102	39	.	.	PUNCT
fnp-3790	103	1	this	this	PRON
fnp-3790	103	2	allowed	allow	VERB
fnp-3790	103	3	the	the	DET
fnp-3790	103	4	identification	identification	NOUN
fnp-3790	103	5	of	of	ADP
fnp-3790	103	6	a	a	DET
fnp-3790	103	7	disease	disease	NOUN
fnp-3790	103	8	-	-	PUNCT
fnp-3790	103	9	associated	associate	VERB
fnp-3790	103	10	microglia	microglia	ADJ
fnp-3790	103	11	phenotype	phenotype	NOUN
fnp-3790	103	12	(	(	PUNCT
fnp-3790	103	13	dam	dam	NOUN
fnp-3790	103	14	)	)	PUNCT
fnp-3790	103	15	,	,	PUNCT
fnp-3790	103	16	which	which	PRON
fnp-3790	103	17	was	be	AUX
fnp-3790	103	18	characterized	characterize	VERB
fnp-3790	103	19	by	by	ADP
fnp-3790	103	20	the	the	DET
fnp-3790	103	21	loss	loss	NOUN
fnp-3790	103	22	of	of	ADP
fnp-3790	103	23	homeostatic	homeostatic	ADJ
fnp-3790	103	24	phenotypic	phenotypic	ADJ
fnp-3790	103	25	markers	marker	NOUN
fnp-3790	103	26	and	and	CCONJ
fnp-3790	103	27	the	the	DET
fnp-3790	103	28	expression	expression	NOUN
fnp-3790	103	29	of	of	ADP
fnp-3790	103	30	a	a	DET
fnp-3790	103	31	large	large	ADJ
fnp-3790	103	32	array	array	NOUN
fnp-3790	103	33	of	of	ADP
fnp-3790	103	34	different	different	ADJ
fnp-3790	103	35	activation	activation	NOUN
fnp-3790	103	36	markers	marker	NOUN
fnp-3790	103	37	(	(	PUNCT
fnp-3790	103	38	figure	figure	NOUN
fnp-3790	103	39	1	1	NUM
fnp-3790	103	40	)	)	PUNCT
fnp-3790	103	41	.	.	PUNCT
fnp-3790	104	1	figure	figure	VERB
fnp-3790	104	2	1	1	NUM
fnp-3790	104	3	:	:	PUNCT
fnp-3790	104	4	microglia	microglia	ADJ
fnp-3790	104	5	activation	activation	NOUN
fnp-3790	104	6	in	in	ADP
fnp-3790	104	7	alzheimer	alzheimer	PROPN
fnp-3790	104	8	’s	’s	PART
fnp-3790	104	9	disease	disease	NOUN
fnp-3790	104	10	:	:	PUNCT
fnp-3790	104	11	microglia	microglia	NOUN
fnp-3790	104	12	in	in	ADP
fnp-3790	104	13	the	the	DET
fnp-3790	104	14	cortex	cortex	NOUN
fnp-3790	104	15	of	of	ADP
fnp-3790	104	16	ad	ad	NOUN
fnp-3790	104	17	patients	patient	NOUN
fnp-3790	104	18	are	be	AUX
fnp-3790	104	19	activated	activate	VERB
fnp-3790	104	20	within	within	ADP
fnp-3790	104	21	the	the	DET
fnp-3790	104	22	amyloid	amyloid	NOUN
fnp-3790	104	23	plaques	plaque	NOUN
fnp-3790	104	24	and	and	CCONJ
fnp-3790	104	25	also	also	ADV
fnp-3790	104	26	in	in	ADP
fnp-3790	104	27	surrounding	surround	VERB
fnp-3790	104	28	cortical	cortical	ADJ
fnp-3790	104	29	parenchyma	parenchyma	NOUN
fnp-3790	104	30	.	.	PUNCT
fnp-3790	105	1	within	within	ADP
fnp-3790	105	2	the	the	DET
fnp-3790	105	3	plaques	plaque	NOUN
fnp-3790	105	4	(	(	PUNCT
fnp-3790	105	5	labeled	label	VERB
fnp-3790	105	6	with	with	ADP
fnp-3790	105	7	*	*	PUNCT
fnp-3790	105	8	)	)	PUNCT
fnp-3790	105	9	the	the	DET
fnp-3790	105	10	activation	activation	NOUN
fnp-3790	105	11	is	be	AUX
fnp-3790	105	12	more	more	ADV
fnp-3790	105	13	advanced	advanced	ADJ
fnp-3790	105	14	showing	show	VERB
fnp-3790	105	15	an	an	DET
fnp-3790	105	16	ameboid	ameboid	ADJ
fnp-3790	105	17	microglia	microglia	ADJ
fnp-3790	105	18	phenotype	phenotype	NOUN
fnp-3790	105	19	and	and	CCONJ
fnp-3790	105	20	a	a	DET
fnp-3790	105	21	higher	high	ADJ
fnp-3790	105	22	expression	expression	NOUN
fnp-3790	105	23	of	of	ADP
fnp-3790	105	24	markers	marker	NOUN
fnp-3790	105	25	associated	associate	VERB
fnp-3790	105	26	with	with	ADP
fnp-3790	105	27	phagocytosis	phagocytosis	NOUN
fnp-3790	105	28	(	(	PUNCT
fnp-3790	105	29	cd68	cd68	PROPN
fnp-3790	105	30	)	)	PUNCT
fnp-3790	105	31	,	,	PUNCT
fnp-3790	105	32	antigen	antigen	ADJ
fnp-3790	105	33	presentation	presentation	NOUN
fnp-3790	105	34	(	(	PUNCT
fnp-3790	105	35	mhc	mhc	PROPN
fnp-3790	105	36	)	)	PUNCT
fnp-3790	105	37	,	,	PUNCT
fnp-3790	105	38	oxidative	oxidative	ADJ
fnp-3790	105	39	injury	injury	NOUN
fnp-3790	105	40	(	(	PUNCT
fnp-3790	105	41	nadph	nadph	ADJ
fnp-3790	105	42	oxidase	oxidase	NOUN
fnp-3790	105	43	and	and	CCONJ
fnp-3790	105	44	iron	iron	NOUN
fnp-3790	105	45	storage	storage	NOUN
fnp-3790	105	46	(	(	PUNCT
fnp-3790	105	47	ferritin	ferritin	ADJ
fnp-3790	105	48	,	,	PUNCT
fnp-3790	105	49	iron	iron	NOUN
fnp-3790	105	50	)	)	PUNCT
fnp-3790	105	51	)	)	PUNCT
fnp-3790	105	52	,	,	PUNCT
fnp-3790	105	53	and	and	CCONJ
fnp-3790	105	54	proteolysis	proteolysis	NOUN
fnp-3790	105	55	(	(	PUNCT
fnp-3790	105	56	tpp2	tpp2	PROPN
fnp-3790	105	57	)	)	PUNCT
fnp-3790	105	58	.	.	PUNCT
fnp-3790	106	1	a	a	DET
fnp-3790	106	2	key	key	ADJ
fnp-3790	106	3	step	step	NOUN
fnp-3790	106	4	in	in	ADP
fnp-3790	106	5	this	this	DET
fnp-3790	106	6	activation	activation	NOUN
fnp-3790	106	7	is	be	AUX
fnp-3790	106	8	the	the	DET
fnp-3790	106	9	induction	induction	NOUN
fnp-3790	106	10	of	of	ADP
fnp-3790	106	11	the	the	DET
fnp-3790	106	12	trem2	trem2	NOUN
fnp-3790	106	13	/	/	SYM
fnp-3790	106	14	apoe	apoe	ADJ
fnp-3790	106	15	pathway	pathway	NOUN
fnp-3790	106	16	,	,	PUNCT
fnp-3790	106	17	which	which	PRON
fnp-3790	106	18	occurs	occur	VERB
fnp-3790	106	19	in	in	ADP
fnp-3790	106	20	response	response	NOUN
fnp-3790	106	21	to	to	ADP
fnp-3790	106	22	programed	program	VERB
fnp-3790	106	23	neuronal	neuronal	ADJ
fnp-3790	106	24	cell	cell	NOUN
fnp-3790	106	25	death	death	NOUN
fnp-3790	106	26	(	(	PUNCT
fnp-3790	106	27	krasemann	krasemann	PROPN
fnp-3790	106	28	et	et	PROPN
fnp-3790	106	29	al	al	PROPN
fnp-3790	106	30	.	.	PROPN
fnp-3790	106	31	2017	2017	NUM
fnp-3790	106	32	)	)	PUNCT
fnp-3790	106	33	.	.	PUNCT
fnp-3790	107	1	a	a	DET
fnp-3790	107	2	variety	variety	NOUN
fnp-3790	107	3	of	of	ADP
fnp-3790	107	4	different	different	ADJ
fnp-3790	107	5	molecules	molecule	NOUN
fnp-3790	107	6	,	,	PUNCT
fnp-3790	107	7	identified	identify	VERB
fnp-3790	107	8	by	by	ADP
fnp-3790	107	9	gwas	gwas	PROPN
fnp-3790	107	10	in	in	ADP
fnp-3790	107	11	ad	ad	NOUN
fnp-3790	107	12	patients	patient	NOUN
fnp-3790	107	13	,	,	PUNCT
fnp-3790	107	14	are	be	AUX
fnp-3790	107	15	related	relate	VERB
fnp-3790	107	16	to	to	ADP
fnp-3790	107	17	this	this	DET
fnp-3790	107	18	pathway	pathway	NOUN
fnp-3790	107	19	,	,	PUNCT
fnp-3790	107	20	and	and	CCONJ
fnp-3790	107	21	loss	loss	NOUN
fnp-3790	107	22	of	of	ADP
fnp-3790	107	23	function	function	NOUN
fnp-3790	107	24	mutations	mutation	NOUN
fnp-3790	107	25	of	of	ADP
fnp-3790	107	26	trem2	trem2	NOUN
fnp-3790	107	27	are	be	AUX
fnp-3790	107	28	associated	associate	VERB
fnp-3790	107	29	with	with	ADP
fnp-3790	107	30	earlier	early	ADJ
fnp-3790	107	31	onset	onset	ADJ
fnp-3790	107	32	and	and	CCONJ
fnp-3790	107	33	more	more	ADV
fnp-3790	107	34	severe	severe	ADJ
fnp-3790	107	35	disease	disease	NOUN
fnp-3790	107	36	.	.	PUNCT
fnp-3790	108	1	functional	functional	ADJ
fnp-3790	108	2	studies	study	NOUN
fnp-3790	108	3	revealed	reveal	VERB
fnp-3790	108	4	that	that	SCONJ
fnp-3790	108	5	loss	loss	NOUN
fnp-3790	108	6	of	of	ADP
fnp-3790	108	7	trem2	trem2	NOUN
fnp-3790	108	8	function	function	NOUN
fnp-3790	108	9	arrests	arrest	NOUN
fnp-3790	108	10	microglia	microglia	NOUN
fnp-3790	108	11	in	in	ADP
fnp-3790	108	12	a	a	DET
fnp-3790	108	13	homeostatic	homeostatic	ADJ
fnp-3790	108	14	state	state	NOUN
fnp-3790	108	15	,	,	PUNCT
fnp-3790	108	16	reduces	reduce	VERB
fnp-3790	108	17	phagocytosis	phagocytosis	NOUN
fnp-3790	108	18	and	and	CCONJ
fnp-3790	108	19	inhibits	inhibit	VERB
fnp-3790	108	20	the	the	DET
fnp-3790	108	21	focal	focal	ADJ
fnp-3790	108	22	stabilization	stabilization	NOUN
fnp-3790	108	23	of	of	ADP
fnp-3790	108	24	aβ	aβ	DET
fnp-3790	108	25	deposits	deposit	NOUN
fnp-3790	108	26	(	(	PUNCT
fnp-3790	108	27	lewcock	lewcock	NOUN
fnp-3790	108	28	et	et	PROPN
fnp-3790	108	29	al	al	PROPN
fnp-3790	108	30	.	.	PROPN
fnp-3790	108	31	2020	2020	NUM
fnp-3790	108	32	)	)	PUNCT
fnp-3790	108	33	.	.	PUNCT
fnp-3790	109	1	all	all	DET
fnp-3790	109	2	these	these	DET
fnp-3790	109	3	data	datum	NOUN
fnp-3790	109	4	support	support	VERB
fnp-3790	109	5	the	the	DET
fnp-3790	109	6	view	view	NOUN
fnp-3790	109	7	that	that	PRON
fnp-3790	109	8	activated	activate	VERB
fnp-3790	109	9	microglia	microglia	NOUN
fnp-3790	109	10	within	within	ADP
fnp-3790	109	11	plaques	plaque	NOUN
fnp-3790	109	12	play	play	VERB
fnp-3790	109	13	a	a	DET
fnp-3790	109	14	neuroprotective	neuroprotective	ADJ
fnp-3790	109	15	role	role	NOUN
fnp-3790	109	16	by	by	ADP
fnp-3790	109	17	inhibiting	inhibit	VERB
fnp-3790	109	18	the	the	DET
fnp-3790	109	19	spread	spread	NOUN
fnp-3790	109	20	of	of	ADP
fnp-3790	109	21	soluble	soluble	ADJ
fnp-3790	109	22	aβ	aβ	NOUN
fnp-3790	109	23	oligomers	oligomer	NOUN
fnp-3790	109	24	.	.	PUNCT
fnp-3790	110	1	however	however	ADV
fnp-3790	110	2	,	,	PUNCT
fnp-3790	110	3	microglia	microglia	NOUN
fnp-3790	110	4	in	in	ADP
fnp-3790	110	5	the	the	DET
fnp-3790	110	6	ad	ad	NOUN
fnp-3790	110	7	cortex	cortex	NOUN
fnp-3790	110	8	are	be	AUX
fnp-3790	110	9	also	also	ADV
fnp-3790	110	10	activated	activate	VERB
fnp-3790	110	11	outside	outside	ADP
fnp-3790	110	12	of	of	ADP
fnp-3790	110	13	aβ	aβ	DET
fnp-3790	110	14	plaques	plaque	NOUN
fnp-3790	110	15	,	,	PUNCT
fnp-3790	110	16	where	where	SCONJ
fnp-3790	110	17	they	they	PRON
fnp-3790	110	18	are	be	AUX
fnp-3790	110	19	also	also	ADV
fnp-3790	110	20	associated	associate	VERB
fnp-3790	110	21	with	with	ADP
fnp-3790	110	22	degeneration	degeneration	NOUN
fnp-3790	110	23	and	and	CCONJ
fnp-3790	110	24	loss	loss	NOUN
fnp-3790	110	25	of	of	ADP
fnp-3790	110	26	neurons	neuron	NOUN
fnp-3790	110	27	and	and	CCONJ
fnp-3790	110	28	synapses	synapsis	NOUN
fnp-3790	110	29	.	.	PUNCT
fnp-3790	111	1	whether	whether	SCONJ
fnp-3790	111	2	these	these	DET
fnp-3790	111	3	microglia	microglia	ADJ
fnp-3790	111	4	cells	cell	NOUN
fnp-3790	111	5	have	have	AUX
fnp-3790	111	6	other	other	ADJ
fnp-3790	111	7	activation	activation	NOUN
fnp-3790	111	8	profiles	profile	NOUN
fnp-3790	111	9	compared	compare	VERB
fnp-3790	111	10	to	to	ADP
fnp-3790	111	11	the	the	DET
fnp-3790	111	12	plaque	plaque	NOUN
fnp-3790	111	13	-	-	PUNCT
fnp-3790	111	14	associated	associate	VERB
fnp-3790	111	15	microglia	microglia	NOUN
fnp-3790	111	16	has	have	AUX
fnp-3790	111	17	been	be	AUX
fnp-3790	111	18	addressed	address	VERB
fnp-3790	111	19	in	in	ADP
fnp-3790	111	20	a	a	DET
fnp-3790	111	21	recent	recent	ADJ
fnp-3790	111	22	systematic	systematic	ADJ
fnp-3790	111	23	study	study	NOUN
fnp-3790	111	24	using	use	VERB
fnp-3790	111	25	single	single	ADJ
fnp-3790	111	26	nuclei	nucleus	NOUN
fnp-3790	111	27	transcriptomics	transcriptomic	NOUN
fnp-3790	111	28	(	(	PUNCT
fnp-3790	111	29	gerrits	gerrit	NOUN
fnp-3790	111	30	et	et	PROPN
fnp-3790	111	31	al	al	PROPN
fnp-3790	111	32	.	.	PROPN
fnp-3790	111	33	2021	2021	NUM
fnp-3790	111	34	)	)	PUNCT
fnp-3790	111	35	.	.	PUNCT
fnp-3790	112	1	the	the	DET
fnp-3790	112	2	authors	author	NOUN
fnp-3790	112	3	confirmed	confirm	VERB
fnp-3790	112	4	the	the	DET
fnp-3790	112	5	phenotype	phenotype	NOUN
fnp-3790	112	6	of	of	ADP
fnp-3790	112	7	the	the	DET
fnp-3790	112	8	plaque	plaque	NOUN
fnp-3790	112	9	-	-	PUNCT
fnp-3790	112	10	associated	associate	VERB
fnp-3790	112	11	microglia	microglia	NOUN
fnp-3790	112	12	.	.	PUNCT
fnp-3790	113	1	in	in	ADP
fnp-3790	113	2	addition	addition	NOUN
fnp-3790	113	3	,	,	PUNCT
fnp-3790	113	4	however	however	ADV
fnp-3790	113	5	,	,	PUNCT
fnp-3790	113	6	they	they	PRON
fnp-3790	113	7	identified	identify	VERB
fnp-3790	113	8	several	several	ADJ
fnp-3790	113	9	new	new	ADJ
fnp-3790	113	10	phenotypic	phenotypic	ADJ
fnp-3790	113	11	microglia	microglia	ADJ
fnp-3790	113	12	clusters	cluster	NOUN
fnp-3790	113	13	,	,	PUNCT
fnp-3790	113	14	which	which	PRON
fnp-3790	113	15	were	be	AUX
fnp-3790	113	16	associated	associate	VERB
fnp-3790	113	17	with	with	ADP
fnp-3790	113	18	the	the	DET
fnp-3790	113	19	severity	severity	NOUN
fnp-3790	113	20	of	of	ADP
fnp-3790	113	21	cortical	cortical	ADJ
fnp-3790	113	22	tau	tau	NOUN
fnp-3790	113	23	-	-	PUNCT
fnp-3790	113	24	pathology	pathology	NOUN
fnp-3790	113	25	.	.	PUNCT
fnp-3790	114	1	this	this	PRON
fnp-3790	114	2	shows	show	VERB
fnp-3790	114	3	for	for	ADP
fnp-3790	114	4	the	the	DET
fnp-3790	114	5	first	first	ADJ
fnp-3790	114	6	time	time	NOUN
fnp-3790	114	7	that	that	SCONJ
fnp-3790	114	8	the	the	DET
fnp-3790	114	9	activation	activation	NOUN
fnp-3790	114	10	patterns	pattern	NOUN
fnp-3790	114	11	of	of	ADP
fnp-3790	114	12	microglia	microglia	NOUN
fnp-3790	114	13	are	be	AUX
fnp-3790	114	14	heterogeneous	heterogeneous	ADJ
fnp-3790	114	15	in	in	ADP
fnp-3790	114	16	the	the	DET
fnp-3790	114	17	ad	ad	NOUN
fnp-3790	114	18	cortex	cortex	NOUN
fnp-3790	114	19	in	in	ADP
fnp-3790	114	20	a	a	DET
fnp-3790	114	21	context	context	NOUN
fnp-3790	114	22	-	-	PUNCT
fnp-3790	114	23	dependent	dependent	ADJ
fnp-3790	114	24	manner	manner	NOUN
fnp-3790	114	25	.	.	PUNCT
fnp-3790	115	1	these	these	DET
fnp-3790	115	2	data	datum	NOUN
fnp-3790	115	3	indicate	indicate	VERB
fnp-3790	115	4	that	that	SCONJ
fnp-3790	115	5	tau	tau	PROPN
fnp-3790	115	6	-	-	PUNCT
fnp-3790	115	7	related	relate	VERB
fnp-3790	115	8	neurodegeneration	neurodegeneration	NOUN
fnp-3790	115	9	is	be	AUX
fnp-3790	115	10	triggered	trigger	VERB
fnp-3790	115	11	or	or	CCONJ
fnp-3790	115	12	associated	associate	VERB
fnp-3790	115	13	with	with	ADP
fnp-3790	115	14	microglia	microglia	ADJ
fnp-3790	115	15	activation	activation	NOUN
fnp-3790	115	16	steps	step	NOUN
fnp-3790	115	17	,	,	PUNCT
fnp-3790	115	18	which	which	PRON
fnp-3790	115	19	differ	differ	VERB
fnp-3790	115	20	from	from	ADP
fnp-3790	115	21	those	those	PRON
fnp-3790	115	22	responsible	responsible	ADJ
fnp-3790	115	23	for	for	ADP
fnp-3790	115	24	their	their	PRON
fnp-3790	115	25	protective	protective	ADJ
fnp-3790	115	26	role	role	NOUN
fnp-3790	115	27	in	in	ADP
fnp-3790	115	28	plaques	plaque	NOUN
fnp-3790	115	29	.	.	PUNCT
fnp-3790	116	1	only	only	ADV
fnp-3790	116	2	a	a	DET
fnp-3790	116	3	minority	minority	NOUN
fnp-3790	116	4	of	of	ADP
fnp-3790	116	5	the	the	DET
fnp-3790	116	6	molecules	molecule	NOUN
fnp-3790	116	7	identified	identify	VERB
fnp-3790	116	8	in	in	ADP
fnp-3790	116	9	these	these	DET
fnp-3790	116	10	neurodegeneration	neurodegeneration	NOUN
fnp-3790	116	11	-	-	PUNCT
fnp-3790	116	12	associated	associate	VERB
fnp-3790	116	13	clusters	cluster	NOUN
fnp-3790	116	14	are	be	AUX
fnp-3790	116	15	so	so	ADV
fnp-3790	116	16	far	far	ADV
fnp-3790	116	17	functionally	functionally	ADV
fnp-3790	116	18	characterized	characterize	VERB
fnp-3790	116	19	,	,	PUNCT
fnp-3790	116	20	some	some	PRON
fnp-3790	116	21	of	of	ADP
fnp-3790	116	22	them	they	PRON
fnp-3790	116	23	,	,	PUNCT
fnp-3790	116	24	however	however	ADV
fnp-3790	116	25	,	,	PUNCT
fnp-3790	116	26	seem	seem	VERB
fnp-3790	116	27	to	to	PART
fnp-3790	116	28	be	be	AUX
fnp-3790	116	29	related	relate	VERB
fnp-3790	116	30	to	to	ADP
fnp-3790	116	31	mechanisms	mechanism	NOUN
fnp-3790	116	32	of	of	ADP
fnp-3790	116	33	tissue	tissue	NOUN
fnp-3790	116	34	plasticity	plasticity	NOUN
fnp-3790	116	35	and	and	CCONJ
fnp-3790	116	36	repair	repair	NOUN
fnp-3790	116	37	.	.	PUNCT
fnp-3790	117	1	thus	thus	ADV
fnp-3790	117	2	,	,	PUNCT
fnp-3790	117	3	the	the	DET
fnp-3790	117	4	final	final	ADJ
fnp-3790	117	5	role	role	NOUN
fnp-3790	117	6	of	of	ADP
fnp-3790	117	7	this	this	DET
fnp-3790	117	8	new	new	ADJ
fnp-3790	117	9	neurodegeneration	neurodegeneration	NOUN
fnp-3790	117	10	-	-	PUNCT
fnp-3790	117	11	associated	associate	VERB
fnp-3790	117	12	microglia	microglia	ADJ
fnp-3790	117	13	phenotype	phenotype	NOUN
fnp-3790	117	14	is	be	AUX
fnp-3790	117	15	currently	currently	ADV
fnp-3790	117	16	unresolved	unresolved	ADJ
fnp-3790	117	17	.	.	PUNCT
fnp-3790	118	1	despite	despite	SCONJ
fnp-3790	118	2	the	the	DET
fnp-3790	118	3	highly	highly	ADV
fnp-3790	118	4	innovative	innovative	ADJ
fnp-3790	118	5	approach	approach	NOUN
fnp-3790	118	6	of	of	ADP
fnp-3790	118	7	recent	recent	ADJ
fnp-3790	118	8	studies	study	NOUN
fnp-3790	118	9	using	use	VERB
fnp-3790	118	10	single	single	ADJ
fnp-3790	118	11	cell	cell	NOUN
fnp-3790	118	12	transcriptomics	transcriptomic	NOUN
fnp-3790	118	13	and	and	CCONJ
fnp-3790	118	14	proteomics	proteomic	NOUN
fnp-3790	118	15	,	,	PUNCT
fnp-3790	118	16	such	such	ADJ
fnp-3790	118	17	studies	study	NOUN
fnp-3790	118	18	have	have	VERB
fnp-3790	118	19	major	major	ADJ
fnp-3790	118	20	limitations	limitation	NOUN
fnp-3790	118	21	.	.	PUNCT
fnp-3790	119	1	they	they	PRON
fnp-3790	119	2	identify	identify	VERB
fnp-3790	119	3	a	a	DET
fnp-3790	119	4	large	large	ADJ
fnp-3790	119	5	battery	battery	NOUN
fnp-3790	119	6	of	of	ADP
fnp-3790	119	7	cluster	cluster	NOUN
fnp-3790	119	8	-	-	PUNCT
fnp-3790	119	9	associated	associate	VERB
fnp-3790	119	10	molecules	molecule	NOUN
fnp-3790	119	11	,	,	PUNCT
fnp-3790	119	12	but	but	CCONJ
fnp-3790	119	13	only	only	ADV
fnp-3790	119	14	a	a	DET
fnp-3790	119	15	small	small	ADJ
fnp-3790	119	16	fraction	fraction	NOUN
fnp-3790	119	17	of	of	ADP
fnp-3790	119	18	them	they	PRON
fnp-3790	119	19	is	be	AUX
fnp-3790	119	20	functionally	functionally	ADV
fnp-3790	119	21	defined	define	VERB
fnp-3790	119	22	at	at	ADP
fnp-3790	119	23	the	the	DET
fnp-3790	119	24	present	present	ADJ
fnp-3790	119	25	time	time	NOUN
fnp-3790	119	26	.	.	PUNCT
fnp-3790	120	1	their	their	PRON
fnp-3790	120	2	functional	functional	ADJ
fnp-3790	120	3	characterization	characterization	NOUN
fnp-3790	120	4	has	have	VERB
fnp-3790	120	5	to	to	PART
fnp-3790	120	6	be	be	AUX
fnp-3790	120	7	performed	perform	VERB
fnp-3790	120	8	in	in	ADP
fnp-3790	120	9	experimental	experimental	ADJ
fnp-3790	120	10	models	model	NOUN
fnp-3790	120	11	,	,	PUNCT
fnp-3790	120	12	but	but	CCONJ
fnp-3790	120	13	this	this	DET
fnp-3790	120	14	approach	approach	NOUN
fnp-3790	120	15	has	have	VERB
fnp-3790	120	16	limitations	limitation	NOUN
fnp-3790	120	17	.	.	PUNCT
fnp-3790	121	1	although	although	SCONJ
fnp-3790	121	2	basic	basic	ADJ
fnp-3790	121	3	activation	activation	NOUN
fnp-3790	121	4	steps	step	NOUN
fnp-3790	121	5	of	of	ADP
fnp-3790	121	6	microglia	microglia	NOUN
fnp-3790	121	7	are	be	AUX
fnp-3790	121	8	similar	similar	ADJ
fnp-3790	121	9	between	between	ADP
fnp-3790	121	10	different	different	ADJ
fnp-3790	121	11	species	specie	NOUN
fnp-3790	121	12	,	,	PUNCT
fnp-3790	121	13	there	there	PRON
fnp-3790	121	14	are	be	VERB
fnp-3790	121	15	major	major	ADJ
fnp-3790	121	16	differences	difference	NOUN
fnp-3790	121	17	in	in	ADP
fnp-3790	121	18	the	the	DET
fnp-3790	121	19	molecular	molecular	ADJ
fnp-3790	121	20	phenotypes	phenotype	NOUN
fnp-3790	121	21	of	of	ADP
fnp-3790	121	22	activated	activate	VERB
fnp-3790	121	23	microglia	microglia	NOUN
fnp-3790	121	24	between	between	ADP
fnp-3790	121	25	rodents	rodent	NOUN
fnp-3790	121	26	and	and	CCONJ
fnp-3790	121	27	humans	human	NOUN
fnp-3790	121	28	(	(	PUNCT
fnp-3790	121	29	wimmer	wimmer	PROPN
fnp-3790	121	30	et	et	PROPN
fnp-3790	121	31	al	al	PROPN
fnp-3790	121	32	.	.	PROPN
fnp-3790	121	33	2018	2018	NUM
fnp-3790	121	34	)	)	PUNCT
fnp-3790	121	35	,	,	PUNCT
fnp-3790	121	36	and	and	CCONJ
fnp-3790	121	37	further	further	ADJ
fnp-3790	121	38	differences	difference	NOUN
fnp-3790	121	39	in	in	ADP
fnp-3790	121	40	their	their	PRON
fnp-3790	121	41	patterns	pattern	NOUN
fnp-3790	121	42	of	of	ADP
fnp-3790	121	43	activation	activation	NOUN
fnp-3790	121	44	are	be	AUX
fnp-3790	121	45	seen	see	VERB
fnp-3790	121	46	in	in	ADP
fnp-3790	121	47	human	human	ADJ
fnp-3790	121	48	disease	disease	NOUN
fnp-3790	121	49	in	in	ADP
fnp-3790	121	50	comparison	comparison	NOUN
fnp-3790	121	51	to	to	ADP
fnp-3790	121	52	those	those	PRON
fnp-3790	121	53	in	in	ADP
fnp-3790	121	54	ad	ad	NOUN
fnp-3790	121	55	models	model	NOUN
fnp-3790	121	56	(	(	PUNCT
fnp-3790	121	57	sobue	sobue	PROPN
fnp-3790	121	58	et	et	PROPN
fnp-3790	121	59	al	al	PROPN
fnp-3790	121	60	.	.	PROPN
fnp-3790	121	61	2021	2021	NUM
fnp-3790	121	62	)	)	PUNCT
fnp-3790	121	63	.	.	PUNCT
fnp-3790	122	1	another	another	DET
fnp-3790	122	2	problem	problem	NOUN
fnp-3790	122	3	is	be	AUX
fnp-3790	122	4	related	relate	VERB
fnp-3790	122	5	to	to	ADP
fnp-3790	122	6	the	the	DET
fnp-3790	122	7	annotation	annotation	NOUN
fnp-3790	122	8	of	of	ADP
fnp-3790	122	9	specific	specific	ADJ
fnp-3790	122	10	molecules	molecule	NOUN
fnp-3790	122	11	to	to	ADP
fnp-3790	122	12	specific	specific	ADJ
fnp-3790	122	13	cell	cell	NOUN
fnp-3790	122	14	types	type	NOUN
fnp-3790	122	15	.	.	PUNCT
fnp-3790	123	1	as	as	ADP
fnp-3790	123	2	an	an	DET
fnp-3790	123	3	example	example	NOUN
fnp-3790	123	4	,	,	PUNCT
fnp-3790	123	5	molecules	molecule	NOUN
fnp-3790	123	6	of	of	ADP
fnp-3790	123	7	the	the	DET
fnp-3790	123	8	nadph	nadph	ADJ
fnp-3790	123	9	oxidase	oxidase	NOUN
fnp-3790	123	10	complex	complex	NOUN
fnp-3790	123	11	,	,	PUNCT
fnp-3790	123	12	which	which	PRON
fnp-3790	123	13	are	be	AUX
fnp-3790	123	14	prominently	prominently	ADV
fnp-3790	123	15	expressed	express	VERB
fnp-3790	123	16	in	in	ADP
fnp-3790	123	17	human	human	ADJ
fnp-3790	123	18	microglia	microglia	NOUN
fnp-3790	123	19	and	and	CCONJ
fnp-3790	123	20	are	be	AUX
fnp-3790	123	21	clearly	clearly	ADV
fnp-3790	123	22	associated	associate	VERB
fnp-3790	123	23	with	with	ADP
fnp-3790	123	24	oxidative	oxidative	ADJ
fnp-3790	123	25	injury	injury	NOUN
fnp-3790	123	26	in	in	ADP
fnp-3790	123	27	a	a	DET
fnp-3790	123	28	variety	variety	NOUN
fnp-3790	123	29	of	of	ADP
fnp-3790	123	30	different	different	ADJ
fnp-3790	123	31	diseases	disease	NOUN
fnp-3790	123	32	(	(	PUNCT
fnp-3790	123	33	fischer	fischer	PROPN
fnp-3790	123	34	et	et	PROPN
fnp-3790	123	35	al	al	PROPN
fnp-3790	123	36	.	.	PROPN
fnp-3790	123	37	2012	2012	NUM
fnp-3790	123	38	)	)	PUNCT
fnp-3790	123	39	,	,	PUNCT
fnp-3790	123	40	are	be	AUX
fnp-3790	123	41	surprisingly	surprisingly	ADV
fnp-3790	123	42	absent	absent	ADJ
fnp-3790	123	43	from	from	ADP
fnp-3790	123	44	the	the	DET
fnp-3790	123	45	microglia	microglia	ADJ
fnp-3790	123	46	activation	activation	NOUN
fnp-3790	123	47	list	list	NOUN
fnp-3790	123	48	in	in	ADP
fnp-3790	123	49	recent	recent	ADJ
fnp-3790	123	50	single	single	ADJ
fnp-3790	123	51	cells	cell	NOUN
fnp-3790	123	52	transcriptomic	transcriptomic	ADJ
fnp-3790	123	53	studies	study	NOUN
fnp-3790	123	54	.	.	PUNCT
fnp-3790	124	1	why	why	SCONJ
fnp-3790	124	2	this	this	PRON
fnp-3790	124	3	is	be	AUX
fnp-3790	124	4	the	the	DET
fnp-3790	124	5	case	case	NOUN
fnp-3790	124	6	is	be	AUX
fnp-3790	124	7	not	not	PART
fnp-3790	124	8	clear	clear	ADJ
fnp-3790	124	9	.	.	PUNCT
fnp-3790	125	1	it	it	PRON
fnp-3790	125	2	may	may	AUX
fnp-3790	125	3	be	be	AUX
fnp-3790	125	4	that	that	SCONJ
fnp-3790	125	5	these	these	DET
fnp-3790	125	6	molecules	molecule	NOUN
fnp-3790	125	7	are	be	AUX
fnp-3790	125	8	not	not	PART
fnp-3790	125	9	included	include	VERB
fnp-3790	125	10	in	in	ADP
fnp-3790	125	11	the	the	DET
fnp-3790	125	12	list	list	NOUN
fnp-3790	125	13	of	of	ADP
fnp-3790	125	14	microglia	microglia	ADJ
fnp-3790	125	15	genes	gene	NOUN
fnp-3790	125	16	,	,	PUNCT
fnp-3790	125	17	since	since	SCONJ
fnp-3790	125	18	they	they	PRON
fnp-3790	125	19	are	be	AUX
fnp-3790	125	20	prominently	prominently	ADV
fnp-3790	125	21	expressed	express	VERB
fnp-3790	125	22	in	in	ADP
fnp-3790	125	23	granulocytes	granulocyte	NOUN
fnp-3790	125	24	and	and	CCONJ
fnp-3790	125	25	thus	thus	ADV
fnp-3790	125	26	annotated	annotate	VERB
fnp-3790	125	27	as	as	ADP
fnp-3790	125	28	granulocyte	granulocyte	ADJ
fnp-3790	125	29	markers	marker	NOUN
fnp-3790	125	30	.	.	PUNCT
fnp-3790	126	1	the	the	DET
fnp-3790	126	2	other	other	ADJ
fnp-3790	126	3	possibility	possibility	NOUN
fnp-3790	126	4	is	be	AUX
fnp-3790	126	5	that	that	SCONJ
fnp-3790	126	6	they	they	PRON
fnp-3790	126	7	are	be	AUX
fnp-3790	126	8	not	not	PART
fnp-3790	126	9	included	include	VERB
fnp-3790	126	10	,	,	PUNCT
fnp-3790	126	11	since	since	SCONJ
fnp-3790	126	12	the	the	DET
fnp-3790	126	13	gene	gene	NOUN
fnp-3790	126	14	lists	list	NOUN
fnp-3790	126	15	have	have	AUX
fnp-3790	126	16	originally	originally	ADV
fnp-3790	126	17	been	be	AUX
fnp-3790	126	18	defined	define	VERB
fnp-3790	126	19	in	in	ADP
fnp-3790	126	20	mouse	mouse	NOUN
fnp-3790	126	21	models	model	NOUN
fnp-3790	126	22	,	,	PUNCT
fnp-3790	126	23	and	and	CCONJ
fnp-3790	126	24	nadph	nadph	ADJ
fnp-3790	126	25	oxidase	oxidase	NOUN
fnp-3790	126	26	,	,	PUNCT
fnp-3790	126	27	in	in	ADP
fnp-3790	126	28	contrast	contrast	NOUN
fnp-3790	126	29	to	to	ADP
fnp-3790	126	30	humans	human	NOUN
fnp-3790	126	31	,	,	PUNCT
fnp-3790	126	32	is	be	AUX
fnp-3790	126	33	not	not	PART
fnp-3790	126	34	prominently	prominently	ADV
fnp-3790	126	35	expressed	express	VERB
fnp-3790	126	36	in	in	ADP
fnp-3790	126	37	mouse	mouse	NOUN
fnp-3790	126	38	microglia	microglia	NOUN
fnp-3790	126	39	.	.	PUNCT
fnp-3790	127	1	protective	protective	ADJ
fnp-3790	127	2	or	or	CCONJ
fnp-3790	127	3	detrimental	detrimental	ADJ
fnp-3790	127	4	action	action	NOUN
fnp-3790	127	5	of	of	ADP
fnp-3790	127	6	microglia	microglia	NOUN
fnp-3790	127	7	in	in	ADP
fnp-3790	127	8	alzheimer	alzheimer	PROPN
fnp-3790	127	9	’s	’s	PART
fnp-3790	127	10	disease	disease	NOUN
fnp-3790	127	11	:	:	PUNCT
fnp-3790	127	12	context	context	NOUN
fnp-3790	127	13	or	or	CCONJ
fnp-3790	127	14	lesion	lesion	NOUN
fnp-3790	127	15	stage	stage	NOUN
fnp-3790	127	16	dependent	dependent	ADJ
fnp-3790	127	17	?	?	PUNCT
fnp-3790	128	1	as	as	SCONJ
fnp-3790	128	2	discussed	discuss	VERB
fnp-3790	128	3	above	above	ADV
fnp-3790	128	4	,	,	PUNCT
fnp-3790	128	5	heterogeneous	heterogeneous	ADJ
fnp-3790	128	6	clusters	cluster	NOUN
fnp-3790	128	7	of	of	ADP
fnp-3790	128	8	activated	activate	VERB
fnp-3790	128	9	microglia	microglia	NOUN
fnp-3790	128	10	are	be	AUX
fnp-3790	128	11	prominent	prominent	ADJ
fnp-3790	128	12	in	in	ADP
fnp-3790	128	13	the	the	DET
fnp-3790	128	14	ad	ad	NOUN
fnp-3790	128	15	cortex	cortex	NOUN
fnp-3790	128	16	and	and	CCONJ
fnp-3790	128	17	they	they	PRON
fnp-3790	128	18	are	be	AUX
fnp-3790	128	19	associated	associate	VERB
fnp-3790	128	20	with	with	ADP
fnp-3790	128	21	deposits	deposit	NOUN
fnp-3790	128	22	of	of	ADP
fnp-3790	128	23	aβ	aβ	PRON
fnp-3790	128	24	in	in	ADP
fnp-3790	128	25	the	the	DET
fnp-3790	128	26	plaques	plaque	NOUN
fnp-3790	128	27	(	(	PUNCT
fnp-3790	128	28	lewcock	lewcock	NOUN
fnp-3790	128	29	et	et	PROPN
fnp-3790	128	30	al	al	PROPN
fnp-3790	128	31	.	.	PROPN
fnp-3790	128	32	2020	2020	NUM
fnp-3790	128	33	)	)	PUNCT
fnp-3790	128	34	.	.	PUNCT
fnp-3790	129	1	whether	whether	SCONJ
fnp-3790	129	2	activated	activate	VERB
fnp-3790	129	3	microglia	microglia	NOUN
fnp-3790	129	4	promote	promote	NOUN
fnp-3790	129	5	or	or	CCONJ
fnp-3790	129	6	ameliorate	ameliorate	VERB
fnp-3790	129	7	disease	disease	NOUN
fnp-3790	129	8	is	be	AUX
fnp-3790	129	9	unclear	unclear	ADJ
fnp-3790	129	10	and	and	CCONJ
fnp-3790	129	11	can	can	AUX
fnp-3790	129	12	only	only	ADV
fnp-3790	129	13	partly	partly	ADV
fnp-3790	129	14	be	be	AUX
fnp-3790	129	15	addressed	address	VERB
fnp-3790	129	16	in	in	ADP
fnp-3790	129	17	humans	human	NOUN
fnp-3790	129	18	.	.	PUNCT
fnp-3790	130	1	the	the	DET
fnp-3790	130	2	identification	identification	NOUN
fnp-3790	130	3	of	of	ADP
fnp-3790	130	4	trem2	trem2	NOUN
fnp-3790	130	5	loss	loss	NOUN
fnp-3790	130	6	of	of	ADP
fnp-3790	130	7	function	function	NOUN
fnp-3790	130	8	mutations	mutation	NOUN
fnp-3790	130	9	as	as	ADP
fnp-3790	130	10	risk	risk	NOUN
fnp-3790	130	11	genes	gene	NOUN
fnp-3790	130	12	in	in	ADP
fnp-3790	130	13	ad	ad	NOUN
fnp-3790	130	14	suggests	suggest	VERB
fnp-3790	130	15	that	that	SCONJ
fnp-3790	130	16	microglia	microglia	ADJ
fnp-3790	130	17	activation	activation	NOUN
fnp-3790	130	18	is	be	AUX
fnp-3790	130	19	protective	protective	ADJ
fnp-3790	130	20	by	by	ADP
fnp-3790	130	21	inhibiting	inhibit	VERB
fnp-3790	130	22	aβ	aβ	PRON
fnp-3790	130	23	spread	spread	VERB
fnp-3790	130	24	into	into	ADP
fnp-3790	130	25	the	the	DET
fnp-3790	130	26	cortical	cortical	ADJ
fnp-3790	130	27	parenchyma	parenchyma	NOUN
fnp-3790	130	28	.	.	PUNCT
fnp-3790	131	1	however	however	ADV
fnp-3790	131	2	,	,	PUNCT
fnp-3790	131	3	experimental	experimental	ADJ
fnp-3790	131	4	models	model	NOUN
fnp-3790	131	5	suggest	suggest	VERB
fnp-3790	131	6	a	a	DET
fnp-3790	131	7	more	more	ADV
fnp-3790	131	8	complex	complex	ADJ
fnp-3790	131	9	role	role	NOUN
fnp-3790	131	10	of	of	ADP
fnp-3790	131	11	microglia	microglia	NOUN
fnp-3790	131	12	.	.	PUNCT
fnp-3790	132	1	thus	thus	ADV
fnp-3790	132	2	,	,	PUNCT
fnp-3790	132	3	microglia	microglia	ADJ
fnp-3790	132	4	depletion	depletion	NOUN
fnp-3790	132	5	before	before	ADP
fnp-3790	132	6	the	the	DET
fnp-3790	132	7	onset	onset	NOUN
fnp-3790	132	8	of	of	ADP
fnp-3790	132	9	amyloid	amyloid	NOUN
fnp-3790	132	10	deposition	deposition	NOUN
fnp-3790	132	11	in	in	ADP
fnp-3790	132	12	ad	ad	NOUN
fnp-3790	132	13	mouse	mouse	NOUN
fnp-3790	132	14	models	model	NOUN
fnp-3790	132	15	reduces	reduce	VERB
fnp-3790	132	16	plaque	plaque	NOUN
fnp-3790	132	17	formation	formation	NOUN
fnp-3790	132	18	,	,	PUNCT
fnp-3790	132	19	possibly	possibly	ADV
fnp-3790	132	20	by	by	ADP
fnp-3790	132	21	inhibiting	inhibit	VERB
fnp-3790	132	22	synapse	synapse	NOUN
fnp-3790	132	23	degeneration	degeneration	NOUN
fnp-3790	132	24	,	,	PUNCT
fnp-3790	132	25	the	the	DET
fnp-3790	132	26	liberation	liberation	NOUN
fnp-3790	132	27	of	of	ADP
fnp-3790	132	28	amyloid	amyloid	NOUN
fnp-3790	132	29	precursor	precursor	NOUN
fnp-3790	132	30	protein	protein	NOUN
fnp-3790	132	31	(	(	PUNCT
fnp-3790	132	32	app	app	NOUN
fnp-3790	132	33	)	)	PUNCT
fnp-3790	132	34	and	and	CCONJ
fnp-3790	132	35	its	its	PRON
fnp-3790	132	36	cleavage	cleavage	NOUN
fnp-3790	132	37	into	into	ADP
fnp-3790	132	38	aβ	aβ	NOUN
fnp-3790	132	39	fragments	fragment	NOUN
fnp-3790	132	40	in	in	ADP
fnp-3790	132	41	the	the	DET
fnp-3790	132	42	course	course	NOUN
fnp-3790	132	43	of	of	ADP
fnp-3790	132	44	synapse	synapse	NOUN
fnp-3790	132	45	degeneration	degeneration	NOUN
fnp-3790	132	46	(	(	PUNCT
fnp-3790	132	47	delizannis	delizannis	PROPN
fnp-3790	132	48	et	et	PROPN
fnp-3790	132	49	al	al	PROPN
fnp-3790	132	50	.	.	PROPN
fnp-3790	132	51	2021	2021	NUM
fnp-3790	132	52	)	)	PUNCT
fnp-3790	132	53	.	.	PUNCT
fnp-3790	133	1	in	in	ADP
fnp-3790	133	2	addition	addition	NOUN
fnp-3790	133	3	,	,	PUNCT
fnp-3790	133	4	microglia	microglia	NOUN
fnp-3790	133	5	seem	seem	VERB
fnp-3790	133	6	to	to	PART
fnp-3790	133	7	play	play	VERB
fnp-3790	133	8	a	a	DET
fnp-3790	133	9	fundamentally	fundamentally	ADV
fnp-3790	133	10	different	different	ADJ
fnp-3790	133	11	role	role	NOUN
fnp-3790	133	12	in	in	ADP
fnp-3790	133	13	neurodegeneration	neurodegeneration	NOUN
fnp-3790	133	14	in	in	ADP
fnp-3790	133	15	the	the	DET
fnp-3790	133	16	ad	ad	NOUN
fnp-3790	133	17	brain	brain	NOUN
fnp-3790	133	18	.	.	PUNCT
fnp-3790	134	1	this	this	PRON
fnp-3790	134	2	was	be	AUX
fnp-3790	134	3	recently	recently	ADV
fnp-3790	134	4	observed	observe	VERB
fnp-3790	134	5	in	in	ADP
fnp-3790	134	6	transgenic	transgenic	NOUN
fnp-3790	134	7	mice	mouse	NOUN
fnp-3790	134	8	expressing	express	VERB
fnp-3790	134	9	familial	familial	ADJ
fnp-3790	134	10	alzheimer	alzheimer	NOUN
fnp-3790	134	11	’s	’s	PART
fnp-3790	134	12	disease	disease	NOUN
fnp-3790	134	13	and	and	CCONJ
fnp-3790	134	14	human	human	PROPN
fnp-3790	134	15	tau	tau	PROPN
fnp-3790	134	16	mutations	mutation	NOUN
fnp-3790	134	17	(	(	PUNCT
fnp-3790	134	18	5xfad	5xfad	NUM
fnp-3790	134	19	/	/	SYM
fnp-3790	134	20	ps19	ps19	PROPN
fnp-3790	134	21	mice	mouse	NOUN
fnp-3790	134	22	)	)	PUNCT
fnp-3790	134	23	,	,	PUNCT
fnp-3790	134	24	in	in	ADP
fnp-3790	134	25	which	which	PRON
fnp-3790	134	26	tau	tau	PROPN
fnp-3790	134	27	tangles	tangle	NOUN
fnp-3790	134	28	were	be	AUX
fnp-3790	134	29	precipitated	precipitate	VERB
fnp-3790	134	30	by	by	ADP
fnp-3790	134	31	stereotactic	stereotactic	ADJ
fnp-3790	134	32	seed	seed	NOUN
fnp-3790	134	33	injections	injection	NOUN
fnp-3790	134	34	of	of	ADP
fnp-3790	134	35	synthetic	synthetic	ADJ
fnp-3790	134	36	preformed	preformed	ADJ
fnp-3790	134	37	tau	tau	PROPN
fnp-3790	134	38	fibrils	fibril	VERB
fnp-3790	134	39	into	into	ADP
fnp-3790	134	40	the	the	DET
fnp-3790	134	41	hippocampus	hippocampus	NOUN
fnp-3790	134	42	(	(	PUNCT
fnp-3790	134	43	lodder	lodder	X
fnp-3790	134	44	et	et	PROPN
fnp-3790	134	45	al	al	PROPN
fnp-3790	134	46	.	.	PROPN
fnp-3790	134	47	2021	2021	NUM
fnp-3790	134	48	)	)	PUNCT
fnp-3790	134	49	.	.	PUNCT
fnp-3790	135	1	these	these	DET
fnp-3790	135	2	animals	animal	NOUN
fnp-3790	135	3	developed	develop	VERB
fnp-3790	135	4	severe	severe	ADJ
fnp-3790	135	5	aβ	aβ	NOUN
fnp-3790	135	6	plaque	plaque	NOUN
fnp-3790	135	7	pathology	pathology	NOUN
fnp-3790	135	8	in	in	ADP
fnp-3790	135	9	addition	addition	NOUN
fnp-3790	135	10	to	to	ADP
fnp-3790	135	11	profound	profound	VERB
fnp-3790	135	12	tau	tau	PROPN
fnp-3790	135	13	-	-	PUNCT
fnp-3790	135	14	tangle	tangle	NOUN
fnp-3790	135	15	pathology	pathology	NOUN
fnp-3790	135	16	in	in	ADP
fnp-3790	135	17	the	the	DET
fnp-3790	135	18	hippocampus	hippocampus	NOUN
fnp-3790	135	19	and	and	CCONJ
fnp-3790	135	20	cerebral	cerebral	ADJ
fnp-3790	135	21	cortex	cortex	NOUN
fnp-3790	135	22	,	,	PUNCT
fnp-3790	135	23	and	and	CCONJ
fnp-3790	135	24	both	both	DET
fnp-3790	135	25	pathologies	pathology	NOUN
fnp-3790	135	26	were	be	AUX
fnp-3790	135	27	associated	associate	VERB
fnp-3790	135	28	with	with	ADP
fnp-3790	135	29	a	a	DET
fnp-3790	135	30	disease	disease	NOUN
fnp-3790	135	31	-	-	PUNCT
fnp-3790	135	32	associated	associate	VERB
fnp-3790	135	33	microglia	microglia	ADJ
fnp-3790	135	34	phenotype	phenotype	NOUN
fnp-3790	135	35	(	(	PUNCT
fnp-3790	135	36	dam	dam	NOUN
fnp-3790	135	37	)	)	PUNCT
fnp-3790	135	38	.	.	PUNCT
fnp-3790	136	1	microglia	microglia	NOUN
fnp-3790	136	2	in	in	ADP
fnp-3790	136	3	the	the	DET
fnp-3790	136	4	central	central	ADJ
fnp-3790	136	5	nervous	nervous	ADJ
fnp-3790	136	6	system	system	NOUN
fnp-3790	136	7	can	can	AUX
fnp-3790	136	8	be	be	AUX
fnp-3790	136	9	depleted	deplete	VERB
fnp-3790	136	10	by	by	ADP
fnp-3790	136	11	chronic	chronic	ADJ
fnp-3790	136	12	treatment	treatment	NOUN
fnp-3790	136	13	of	of	ADP
fnp-3790	136	14	the	the	DET
fnp-3790	136	15	animals	animal	NOUN
fnp-3790	136	16	with	with	ADP
fnp-3790	136	17	plx	plx	PROPN
fnp-3790	136	18	3397	3397	NUM
fnp-3790	136	19	,	,	PUNCT
fnp-3790	136	20	a	a	DET
fnp-3790	136	21	drug	drug	NOUN
fnp-3790	136	22	which	which	PRON
fnp-3790	136	23	selectively	selectively	ADV
fnp-3790	136	24	inhibits	inhibit	VERB
fnp-3790	136	25	the	the	DET
fnp-3790	136	26	colony	colony	NOUN
fnp-3790	136	27	stimulating	stimulate	VERB
fnp-3790	136	28	factor	factor	NOUN
fnp-3790	136	29	1	1	NUM
fnp-3790	136	30	receptor	receptor	NOUN
fnp-3790	136	31	(	(	PUNCT
fnp-3790	136	32	csf1r	csf1r	NOUN
fnp-3790	136	33	)	)	PUNCT
fnp-3790	136	34	.	.	PUNCT
fnp-3790	137	1	interestingly	interestingly	ADV
fnp-3790	137	2	,	,	PUNCT
fnp-3790	137	3	this	this	DET
fnp-3790	137	4	treatment	treatment	NOUN
fnp-3790	137	5	had	have	VERB
fnp-3790	137	6	a	a	DET
fnp-3790	137	7	differential	differential	ADJ
fnp-3790	137	8	effect	effect	NOUN
fnp-3790	137	9	on	on	ADP
fnp-3790	137	10	plaque	plaque	NOUN
fnp-3790	137	11	or	or	CCONJ
fnp-3790	137	12	tangle	tangle	NOUN
fnp-3790	137	13	-	-	PUNCT
fnp-3790	137	14	associated	associate	VERB
fnp-3790	137	15	microglia	microglia	NOUN
fnp-3790	137	16	.	.	PUNCT
fnp-3790	138	1	while	while	SCONJ
fnp-3790	138	2	the	the	DET
fnp-3790	138	3	diffuse	diffuse	ADJ
fnp-3790	138	4	microglia	microglia	ADJ
fnp-3790	138	5	infiltration	infiltration	NOUN
fnp-3790	138	6	,	,	PUNCT
fnp-3790	138	7	which	which	PRON
fnp-3790	138	8	was	be	AUX
fnp-3790	138	9	associated	associate	VERB
fnp-3790	138	10	with	with	ADP
fnp-3790	138	11	tau	tau	PROPN
fnp-3790	138	12	-	-	PUNCT
fnp-3790	138	13	pathology	pathology	PROPN
fnp-3790	138	14	,	,	PUNCT
fnp-3790	138	15	was	be	AUX
fnp-3790	138	16	completely	completely	ADV
fnp-3790	138	17	eliminated	eliminate	VERB
fnp-3790	138	18	,	,	PUNCT
fnp-3790	138	19	the	the	DET
fnp-3790	138	20	plaque	plaque	NOUN
fnp-3790	138	21	-	-	PUNCT
fnp-3790	138	22	associated	associate	VERB
fnp-3790	138	23	activated	activate	VERB
fnp-3790	138	24	microglia	microglia	NOUN
fnp-3790	138	25	was	be	AUX
fnp-3790	138	26	unaffected	unaffected	ADJ
fnp-3790	138	27	.	.	PUNCT
fnp-3790	139	1	this	this	DET
fnp-3790	139	2	selective	selective	ADJ
fnp-3790	139	3	elimination	elimination	NOUN
fnp-3790	139	4	of	of	ADP
fnp-3790	139	5	diffuse	diffuse	ADJ
fnp-3790	139	6	microglia	microglia	NOUN
fnp-3790	139	7	in	in	ADP
fnp-3790	139	8	the	the	DET
fnp-3790	139	9	cortical	cortical	ADJ
fnp-3790	139	10	parenchyma	parenchyma	NOUN
fnp-3790	139	11	resulted	result	VERB
fnp-3790	139	12	in	in	ADP
fnp-3790	139	13	a	a	DET
fnp-3790	139	14	significant	significant	ADJ
fnp-3790	139	15	attenuation	attenuation	NOUN
fnp-3790	139	16	of	of	ADP
fnp-3790	139	17	the	the	DET
fnp-3790	139	18	propagation	propagation	NOUN
fnp-3790	139	19	of	of	ADP
fnp-3790	139	20	tau	tau	PROPN
fnp-3790	139	21	-	-	PUNCT
fnp-3790	139	22	pathology	pathology	NOUN
fnp-3790	139	23	and	and	CCONJ
fnp-3790	139	24	neurodegeneration	neurodegeneration	NOUN
fnp-3790	139	25	.	.	PUNCT
fnp-3790	140	1	from	from	ADP
fnp-3790	140	2	all	all	DET
fnp-3790	140	3	these	these	DET
fnp-3790	140	4	data	datum	NOUN
fnp-3790	140	5	one	one	PRON
fnp-3790	140	6	can	can	AUX
fnp-3790	140	7	conclude	conclude	VERB
fnp-3790	140	8	that	that	DET
fnp-3790	140	9	microglia	microglia	NOUN
fnp-3790	140	10	in	in	ADP
fnp-3790	140	11	the	the	DET
fnp-3790	140	12	ad	ad	NOUN
fnp-3790	140	13	brain	brain	NOUN
fnp-3790	140	14	exert	exert	VERB
fnp-3790	140	15	different	different	ADJ
fnp-3790	140	16	functions	function	NOUN
fnp-3790	140	17	,	,	PUNCT
fnp-3790	140	18	depending	depend	VERB
fnp-3790	140	19	upon	upon	SCONJ
fnp-3790	140	20	the	the	DET
fnp-3790	140	21	stage	stage	NOUN
fnp-3790	140	22	of	of	ADP
fnp-3790	140	23	the	the	DET
fnp-3790	140	24	cortical	cortical	ADJ
fnp-3790	140	25	lesions	lesion	NOUN
fnp-3790	140	26	and	and	CCONJ
fnp-3790	140	27	the	the	DET
fnp-3790	140	28	nature	nature	NOUN
fnp-3790	140	29	of	of	ADP
fnp-3790	140	30	the	the	DET
fnp-3790	140	31	damage	damage	NOUN
fnp-3790	140	32	.	.	PUNCT
fnp-3790	141	1	the	the	DET
fnp-3790	141	2	initial	initial	ADJ
fnp-3790	141	3	stage	stage	NOUN
fnp-3790	141	4	of	of	ADP
fnp-3790	141	5	aβ	aβ	PRON
fnp-3790	141	6	plaque	plaque	NOUN
fnp-3790	141	7	formation	formation	NOUN
fnp-3790	141	8	is	be	AUX
fnp-3790	141	9	propagated	propagate	VERB
fnp-3790	141	10	,	,	PUNCT
fnp-3790	141	11	but	but	CCONJ
fnp-3790	141	12	the	the	DET
fnp-3790	141	13	spread	spread	NOUN
fnp-3790	141	14	of	of	ADP
fnp-3790	141	15	mature	mature	ADJ
fnp-3790	141	16	plaques	plaque	NOUN
fnp-3790	141	17	into	into	ADP
fnp-3790	141	18	the	the	DET
fnp-3790	141	19	surrounding	surround	VERB
fnp-3790	141	20	tissue	tissue	NOUN
fnp-3790	141	21	is	be	AUX
fnp-3790	141	22	ameliorated	ameliorate	VERB
fnp-3790	141	23	by	by	ADP
fnp-3790	141	24	activated	activated	ADJ
fnp-3790	141	25	microglia	microglia	NOUN
fnp-3790	141	26	.	.	PUNCT
fnp-3790	142	1	when	when	SCONJ
fnp-3790	142	2	there	there	PRON
fnp-3790	142	3	is	be	VERB
fnp-3790	142	4	a	a	DET
fnp-3790	142	5	predisposition	predisposition	NOUN
fnp-3790	142	6	for	for	ADP
fnp-3790	142	7	tau	tau	PROPN
fnp-3790	142	8	phosphorylation	phosphorylation	NOUN
fnp-3790	142	9	,	,	PUNCT
fnp-3790	142	10	aβ	aβ	DET
fnp-3790	142	11	deposition	deposition	NOUN
fnp-3790	142	12	propagates	propagate	VERB
fnp-3790	142	13	tau	tau	NOUN
fnp-3790	142	14	-	-	PUNCT
fnp-3790	142	15	tangles	tangle	NOUN
fnp-3790	142	16	,	,	PUNCT
fnp-3790	142	17	and	and	CCONJ
fnp-3790	142	18	this	this	DET
fnp-3790	142	19	process	process	NOUN
fnp-3790	142	20	is	be	AUX
fnp-3790	142	21	further	far	ADV
fnp-3790	142	22	enhanced	enhance	VERB
fnp-3790	142	23	by	by	ADP
fnp-3790	142	24	activated	activated	ADJ
fnp-3790	142	25	microglia	microglia	NOUN
fnp-3790	142	26	.	.	PUNCT
fnp-3790	143	1	this	this	DET
fnp-3790	143	2	heterogenous	heterogenous	ADJ
fnp-3790	143	3	scenario	scenario	NOUN
fnp-3790	143	4	of	of	ADP
fnp-3790	143	5	microglia	microglia	ADJ
fnp-3790	143	6	function	function	NOUN
fnp-3790	143	7	in	in	ADP
fnp-3790	143	8	ad	ad	NOUN
fnp-3790	143	9	pathogenesis	pathogenesis	NOUN
fnp-3790	143	10	is	be	AUX
fnp-3790	143	11	a	a	DET
fnp-3790	143	12	challenge	challenge	NOUN
fnp-3790	143	13	for	for	ADP
fnp-3790	143	14	the	the	DET
fnp-3790	143	15	development	development	NOUN
fnp-3790	143	16	of	of	ADP
fnp-3790	143	17	anti	anti	ADJ
fnp-3790	143	18	-	-	ADJ
fnp-3790	143	19	inflammatory	inflammatory	ADJ
fnp-3790	143	20	treatment	treatment	NOUN
fnp-3790	143	21	strategies	strategy	NOUN
fnp-3790	143	22	.	.	PUNCT
fnp-3790	144	1	iron	iron	NOUN
fnp-3790	144	2	and	and	CCONJ
fnp-3790	144	3	microglia	microglia	NOUN
fnp-3790	144	4	in	in	ADP
fnp-3790	144	5	alzheimer	alzheimer	PROPN
fnp-3790	144	6	’s	’s	PART
fnp-3790	144	7	disease	disease	NOUN
fnp-3790	144	8	microglia	microglia	ADJ
fnp-3790	144	9	activation	activation	NOUN
fnp-3790	144	10	is	be	AUX
fnp-3790	144	11	seen	see	VERB
fnp-3790	144	12	in	in	ADP
fnp-3790	144	13	human	human	ADJ
fnp-3790	144	14	ad	ad	NOUN
fnp-3790	144	15	as	as	ADV
fnp-3790	144	16	well	well	ADV
fnp-3790	144	17	as	as	ADP
fnp-3790	144	18	in	in	ADP
fnp-3790	144	19	mouse	mouse	NOUN
fnp-3790	144	20	ad	ad	NOUN
fnp-3790	144	21	models	model	NOUN
fnp-3790	144	22	and	and	CCONJ
fnp-3790	144	23	their	their	PRON
fnp-3790	144	24	basic	basic	ADJ
fnp-3790	144	25	activation	activation	NOUN
fnp-3790	144	26	pattern	pattern	NOUN
fnp-3790	144	27	is	be	AUX
fnp-3790	144	28	similar	similar	ADJ
fnp-3790	144	29	,	,	PUNCT
fnp-3790	144	30	but	but	CCONJ
fnp-3790	144	31	not	not	PART
fnp-3790	144	32	identical	identical	ADJ
fnp-3790	144	33	between	between	ADP
fnp-3790	144	34	these	these	DET
fnp-3790	144	35	two	two	NUM
fnp-3790	144	36	conditions	condition	NOUN
fnp-3790	144	37	(	(	PUNCT
fnp-3790	144	38	krasemann	krasemann	PROPN
fnp-3790	144	39	et	et	PROPN
fnp-3790	144	40	al	al	PROPN
fnp-3790	144	41	.	.	PROPN
fnp-3790	144	42	2017	2017	NUM
fnp-3790	144	43	,	,	PUNCT
fnp-3790	144	44	keren	keren	PROPN
fnp-3790	144	45	-	-	PUNCT
fnp-3790	144	46	shaul	shaul	PROPN
fnp-3790	144	47	et	et	PROPN
fnp-3790	144	48	al	al	PROPN
fnp-3790	144	49	.	.	PROPN
fnp-3790	144	50	2017	2017	NUM
fnp-3790	144	51	,	,	PUNCT
fnp-3790	144	52	mathys	mathy	NOUN
fnp-3790	144	53	et	et	NOUN
fnp-3790	144	54	al	al	PROPN
fnp-3790	144	55	.	.	PROPN
fnp-3790	144	56	2019	2019	NUM
fnp-3790	144	57	)	)	PUNCT
fnp-3790	144	58	.	.	PUNCT
fnp-3790	145	1	most	most	ADV
fnp-3790	145	2	importantly	importantly	ADV
fnp-3790	145	3	,	,	PUNCT
fnp-3790	145	4	most	most	ADJ
fnp-3790	145	5	rodent	rodent	ADJ
fnp-3790	145	6	models	model	NOUN
fnp-3790	145	7	of	of	ADP
fnp-3790	145	8	ad	ad	NOUN
fnp-3790	145	9	differ	differ	VERB
fnp-3790	145	10	from	from	ADP
fnp-3790	145	11	human	human	ADJ
fnp-3790	145	12	disease	disease	NOUN
fnp-3790	145	13	in	in	ADP
fnp-3790	145	14	the	the	DET
fnp-3790	145	15	absence	absence	NOUN
fnp-3790	145	16	or	or	CCONJ
fnp-3790	145	17	the	the	DET
fnp-3790	145	18	extent	extent	NOUN
fnp-3790	145	19	of	of	ADP
fnp-3790	145	20	neurodegeneration	neurodegeneration	NOUN
fnp-3790	145	21	.	.	PUNCT
fnp-3790	146	1	one	one	NUM
fnp-3790	146	2	difference	difference	NOUN
fnp-3790	146	3	between	between	ADP
fnp-3790	146	4	human	human	ADJ
fnp-3790	146	5	and	and	CCONJ
fnp-3790	146	6	rodent	rodent	ADJ
fnp-3790	146	7	neuropathology	neuropathology	NOUN
fnp-3790	146	8	is	be	AUX
fnp-3790	146	9	the	the	DET
fnp-3790	146	10	age	age	NOUN
fnp-3790	146	11	-	-	PUNCT
fnp-3790	146	12	related	relate	VERB
fnp-3790	146	13	accumulation	accumulation	NOUN
fnp-3790	146	14	of	of	ADP
fnp-3790	146	15	iron	iron	NOUN
fnp-3790	146	16	in	in	ADP
fnp-3790	146	17	the	the	DET
fnp-3790	146	18	brain	brain	NOUN
fnp-3790	146	19	(	(	PUNCT
fnp-3790	146	20	connor	connor	PROPN
fnp-3790	146	21	et	et	PROPN
fnp-3790	146	22	al	al	PROPN
fnp-3790	146	23	.	.	PROPN
fnp-3790	146	24	1992	1992	NUM
fnp-3790	146	25	,	,	PUNCT
fnp-3790	146	26	hametner	hametner	PROPN
fnp-3790	146	27	et	et	PROPN
fnp-3790	146	28	al	al	PROPN
fnp-3790	146	29	.	.	PROPN
fnp-3790	146	30	2013	2013	NUM
fnp-3790	146	31	)	)	PUNCT
fnp-3790	146	32	,	,	PUNCT
fnp-3790	146	33	which	which	PRON
fnp-3790	146	34	is	be	AUX
fnp-3790	146	35	largely	largely	ADV
fnp-3790	146	36	absent	absent	ADJ
fnp-3790	146	37	in	in	ADP
fnp-3790	146	38	rodents	rodent	NOUN
fnp-3790	146	39	,	,	PUNCT
fnp-3790	146	40	at	at	ADP
fnp-3790	146	41	least	least	ADJ
fnp-3790	146	42	at	at	ADP
fnp-3790	146	43	ages	age	NOUN
fnp-3790	146	44	of	of	ADP
fnp-3790	146	45	the	the	DET
fnp-3790	146	46	animals	animal	NOUN
fnp-3790	146	47	generally	generally	ADV
fnp-3790	146	48	investigated	investigate	VERB
fnp-3790	146	49	in	in	ADP
fnp-3790	146	50	ad	ad	NOUN
fnp-3790	146	51	models	model	NOUN
fnp-3790	146	52	.	.	PUNCT
fnp-3790	147	1	iron	iron	NOUN
fnp-3790	147	2	accumulation	accumulation	NOUN
fnp-3790	147	3	in	in	ADP
fnp-3790	147	4	human	human	ADJ
fnp-3790	147	5	microglia	microglia	NOUN
fnp-3790	147	6	is	be	AUX
fnp-3790	147	7	increased	increase	VERB
fnp-3790	147	8	in	in	ADP
fnp-3790	147	9	neurodegenerative	neurodegenerative	ADJ
fnp-3790	147	10	diseases	disease	NOUN
fnp-3790	147	11	,	,	PUNCT
fnp-3790	147	12	and	and	CCONJ
fnp-3790	147	13	it	it	PRON
fnp-3790	147	14	is	be	AUX
fnp-3790	147	15	associated	associate	VERB
fnp-3790	147	16	with	with	ADP
fnp-3790	147	17	a	a	DET
fnp-3790	147	18	pro	pro	ADJ
fnp-3790	147	19	-	-	ADJ
fnp-3790	147	20	inflammatory	inflammatory	ADJ
fnp-3790	147	21	activation	activation	NOUN
fnp-3790	147	22	of	of	ADP
fnp-3790	147	23	the	the	DET
fnp-3790	147	24	cells	cell	NOUN
fnp-3790	147	25	(	(	PUNCT
fnp-3790	147	26	mehta	mehta	PROPN
fnp-3790	147	27	et	et	PROPN
fnp-3790	147	28	al	al	PROPN
fnp-3790	147	29	.	.	PROPN
fnp-3790	147	30	2013	2013	NUM
fnp-3790	147	31	,	,	PUNCT
fnp-3790	147	32	hametner	hametner	X
fnp-3790	147	33	et	et	PROPN
fnp-3790	147	34	al	al	PROPN
fnp-3790	147	35	.	.	PROPN
fnp-3790	147	36	2013	2013	NUM
fnp-3790	147	37	,	,	PUNCT
fnp-3790	147	38	van	van	PROPN
fnp-3790	147	39	duijn	duijn	PROPN
fnp-3790	147	40	et	et	PROPN
fnp-3790	147	41	al	al	PROPN
fnp-3790	147	42	.	.	PROPN
fnp-3790	147	43	2017	2017	NUM
fnp-3790	147	44	)	)	PUNCT
fnp-3790	147	45	,	,	PUNCT
fnp-3790	147	46	possibly	possibly	ADV
fnp-3790	147	47	related	relate	VERB
fnp-3790	147	48	to	to	ADP
fnp-3790	147	49	its	its	PRON
fnp-3790	147	50	pro	pro	ADJ
fnp-3790	147	51	-	-	ADJ
fnp-3790	147	52	oxidative	oxidative	ADJ
fnp-3790	147	53	function	function	NOUN
fnp-3790	147	54	.	.	PUNCT
fnp-3790	148	1	furthermore	furthermore	ADV
fnp-3790	148	2	,	,	PUNCT
fnp-3790	148	3	the	the	DET
fnp-3790	148	4	phenotype	phenotype	NOUN
fnp-3790	148	5	of	of	ADP
fnp-3790	148	6	dystrophic	dystrophic	ADJ
fnp-3790	148	7	microglia	microglia	NOUN
fnp-3790	148	8	,	,	PUNCT
fnp-3790	148	9	present	present	ADJ
fnp-3790	148	10	in	in	ADP
fnp-3790	148	11	human	human	ADJ
fnp-3790	148	12	ad	ad	NOUN
fnp-3790	148	13	but	but	CCONJ
fnp-3790	148	14	largely	largely	ADV
fnp-3790	148	15	absent	absent	ADJ
fnp-3790	148	16	in	in	ADP
fnp-3790	148	17	rodent	rodent	ADJ
fnp-3790	148	18	models	model	NOUN
fnp-3790	148	19	,	,	PUNCT
fnp-3790	148	20	is	be	AUX
fnp-3790	148	21	restricted	restrict	VERB
fnp-3790	148	22	to	to	PART
fnp-3790	148	23	iron	iron	VERB
fnp-3790	148	24	and	and	CCONJ
fnp-3790	148	25	ferritin	ferritin	ADV
fnp-3790	148	26	-	-	PUNCT
fnp-3790	148	27	loaded	load	VERB
fnp-3790	148	28	cells	cell	NOUN
fnp-3790	148	29	(	(	PUNCT
fnp-3790	148	30	lopes	lope	NOUN
fnp-3790	148	31	et	et	PROPN
fnp-3790	148	32	al	al	PROPN
fnp-3790	148	33	.	.	PROPN
fnp-3790	148	34	2008	2008	NUM
fnp-3790	148	35	,	,	PUNCT
fnp-3790	148	36	hametner	hametner	PROPN
fnp-3790	148	37	et	et	PROPN
fnp-3790	148	38	al	al	PROPN
fnp-3790	148	39	.	.	PROPN
fnp-3790	148	40	2013	2013	NUM
fnp-3790	148	41	;	;	PUNCT
fnp-3790	148	42	figure	figure	NOUN
fnp-3790	148	43	2	2	NUM
fnp-3790	148	44	)	)	PUNCT
fnp-3790	148	45	.	.	PUNCT
fnp-3790	149	1	figure	figure	VERB
fnp-3790	149	2	2	2	NUM
fnp-3790	149	3	:	:	PUNCT
fnp-3790	149	4	iron	iron	NOUN
fnp-3790	149	5	accumulation	accumulation	NOUN
fnp-3790	149	6	and	and	CCONJ
fnp-3790	149	7	microglia	microglia	ADJ
fnp-3790	149	8	senescence	senescence	NOUN
fnp-3790	149	9	:	:	PUNCT
fnp-3790	149	10	microglia	microglia	ADJ
fnp-3790	149	11	,	,	PUNCT
fnp-3790	149	12	identified	identify	VERB
fnp-3790	149	13	with	with	ADP
fnp-3790	149	14	the	the	DET
fnp-3790	149	15	panmicroglia	panmicroglia	PROPN
fnp-3790	149	16	marker	marker	NOUN
fnp-3790	149	17	iba1	iba1	PROPN
fnp-3790	149	18	in	in	ADP
fnp-3790	149	19	the	the	DET
fnp-3790	149	20	cortex	cortex	NOUN
fnp-3790	149	21	of	of	ADP
fnp-3790	149	22	ad	ad	NOUN
fnp-3790	149	23	patients	patient	NOUN
fnp-3790	149	24	may	may	AUX
fnp-3790	149	25	display	display	VERB
fnp-3790	149	26	a	a	DET
fnp-3790	149	27	homeostatic	homeostatic	ADJ
fnp-3790	149	28	phenotype	phenotype	NOUN
fnp-3790	149	29	,	,	PUNCT
fnp-3790	149	30	expressing	express	VERB
fnp-3790	149	31	p2ry12	p2ry12	PROPN
fnp-3790	149	32	and	and	CCONJ
fnp-3790	149	33	showing	show	VERB
fnp-3790	149	34	a	a	DET
fnp-3790	149	35	normal	normal	ADJ
fnp-3790	149	36	ramification	ramification	NOUN
fnp-3790	149	37	of	of	ADP
fnp-3790	149	38	their	their	PRON
fnp-3790	149	39	cell	cell	NOUN
fnp-3790	149	40	processes	process	NOUN
fnp-3790	149	41	.	.	PUNCT
fnp-3790	150	1	another	another	DET
fnp-3790	150	2	fraction	fraction	NOUN
fnp-3790	150	3	of	of	ADP
fnp-3790	150	4	microglia	microglia	NOUN
fnp-3790	150	5	contains	contain	VERB
fnp-3790	150	6	high	high	ADJ
fnp-3790	150	7	levels	level	NOUN
fnp-3790	150	8	of	of	ADP
fnp-3790	150	9	iron	iron	NOUN
fnp-3790	150	10	stored	store	VERB
fnp-3790	150	11	together	together	ADV
fnp-3790	150	12	with	with	ADP
fnp-3790	150	13	ferritin	ferritin	ADJ
fnp-3790	150	14	.	.	PUNCT
fnp-3790	151	1	these	these	DET
fnp-3790	151	2	cells	cell	NOUN
fnp-3790	151	3	frequently	frequently	ADV
fnp-3790	151	4	show	show	VERB
fnp-3790	151	5	a	a	DET
fnp-3790	151	6	dystrophic	dystrophic	ADJ
fnp-3790	151	7	phenotype	phenotype	NOUN
fnp-3790	151	8	with	with	ADP
fnp-3790	151	9	loss	loss	NOUN
fnp-3790	151	10	and	and	CCONJ
fnp-3790	151	11	clumping	clumping	NOUN
fnp-3790	151	12	of	of	ADP
fnp-3790	151	13	cell	cell	NOUN
fnp-3790	151	14	processes	process	NOUN
fnp-3790	151	15	.	.	PUNCT
fnp-3790	152	1	the	the	DET
fnp-3790	152	2	insert	insert	NOUN
fnp-3790	152	3	in	in	ADP
fnp-3790	152	4	the	the	DET
fnp-3790	152	5	iron	iron	NOUN
fnp-3790	152	6	figure	figure	NOUN
fnp-3790	152	7	shows	shows	AUX
fnp-3790	152	8	double	double	ADJ
fnp-3790	152	9	staining	stain	VERB
fnp-3790	152	10	for	for	ADP
fnp-3790	152	11	iron	iron	NOUN
fnp-3790	152	12	(	(	PUNCT
fnp-3790	152	13	brown	brown	NOUN
fnp-3790	152	14	)	)	PUNCT
fnp-3790	152	15	and	and	CCONJ
fnp-3790	152	16	the	the	DET
fnp-3790	152	17	microglia	microglia	ADJ
fnp-3790	152	18	/	/	SYM
fnp-3790	152	19	macrophage	macrophage	NOUN
fnp-3790	152	20	marker	marker	NOUN
fnp-3790	152	21	cd68	cd68	PROPN
fnp-3790	152	22	(	(	PUNCT
fnp-3790	152	23	blue	blue	PROPN
fnp-3790	152	24	)	)	PUNCT
fnp-3790	152	25	.	.	PUNCT
fnp-3790	153	1	an	an	DET
fnp-3790	153	2	important	important	ADJ
fnp-3790	153	3	missing	missing	ADJ
fnp-3790	153	4	piece	piece	NOUN
fnp-3790	153	5	of	of	ADP
fnp-3790	153	6	knowledge	knowledge	NOUN
fnp-3790	153	7	was	be	AUX
fnp-3790	153	8	a	a	DET
fnp-3790	153	9	detailed	detailed	ADJ
fnp-3790	153	10	phenotypic	phenotypic	ADJ
fnp-3790	153	11	and	and	CCONJ
fnp-3790	153	12	functional	functional	ADJ
fnp-3790	153	13	characterization	characterization	NOUN
fnp-3790	153	14	of	of	ADP
fnp-3790	153	15	different	different	ADJ
fnp-3790	153	16	microglia	microglia	ADJ
fnp-3790	153	17	populations	population	NOUN
fnp-3790	153	18	in	in	ADP
fnp-3790	153	19	the	the	DET
fnp-3790	153	20	ad	ad	NOUN
fnp-3790	153	21	brain	brain	NOUN
fnp-3790	153	22	in	in	ADP
fnp-3790	153	23	relation	relation	NOUN
fnp-3790	153	24	to	to	ADP
fnp-3790	153	25	their	their	PRON
fnp-3790	153	26	iron	iron	NOUN
fnp-3790	153	27	content	content	NOUN
fnp-3790	153	28	.	.	PUNCT
fnp-3790	154	1	this	this	DET
fnp-3790	154	2	information	information	NOUN
fnp-3790	154	3	is	be	AUX
fnp-3790	154	4	now	now	ADV
fnp-3790	154	5	provided	provide	VERB
fnp-3790	154	6	by	by	ADP
fnp-3790	154	7	a	a	DET
fnp-3790	154	8	recent	recent	ADJ
fnp-3790	154	9	study	study	NOUN
fnp-3790	154	10	,	,	PUNCT
fnp-3790	154	11	describing	describe	VERB
fnp-3790	154	12	the	the	DET
fnp-3790	154	13	microglia	microglia	ADJ
fnp-3790	154	14	activation	activation	NOUN
fnp-3790	154	15	profile	profile	NOUN
fnp-3790	154	16	in	in	ADP
fnp-3790	154	17	the	the	DET
fnp-3790	154	18	cortex	cortex	NOUN
fnp-3790	154	19	of	of	ADP
fnp-3790	154	20	ad	ad	NOUN
fnp-3790	154	21	patients	patient	NOUN
fnp-3790	154	22	using	use	VERB
fnp-3790	154	23	multispectral	multispectral	ADJ
fnp-3790	154	24	immunofluorescence	immunofluorescence	NOUN
fnp-3790	154	25	(	(	PUNCT
fnp-3790	154	26	kenkhuis	kenkhuis	PROPN
fnp-3790	154	27	et	et	PROPN
fnp-3790	154	28	al	al	PROPN
fnp-3790	154	29	.	.	PROPN
fnp-3790	154	30	2021	2021	NUM
fnp-3790	154	31	)	)	PUNCT
fnp-3790	154	32	.	.	PUNCT
fnp-3790	155	1	as	as	SCONJ
fnp-3790	155	2	described	describe	VERB
fnp-3790	155	3	before	before	ADV
fnp-3790	155	4	,	,	PUNCT
fnp-3790	155	5	the	the	DET
fnp-3790	155	6	study	study	NOUN
fnp-3790	155	7	confirmed	confirm	VERB
fnp-3790	155	8	the	the	DET
fnp-3790	155	9	increased	increase	VERB
fnp-3790	155	10	microglia	microglia	ADJ
fnp-3790	155	11	infiltration	infiltration	NOUN
fnp-3790	155	12	and	and	CCONJ
fnp-3790	155	13	activation	activation	NOUN
fnp-3790	155	14	in	in	ADP
fnp-3790	155	15	the	the	DET
fnp-3790	155	16	ad	ad	NOUN
fnp-3790	155	17	cortex	cortex	NOUN
fnp-3790	155	18	,	,	PUNCT
fnp-3790	155	19	the	the	DET
fnp-3790	155	20	association	association	NOUN
fnp-3790	155	21	of	of	ADP
fnp-3790	155	22	activated	activate	VERB
fnp-3790	155	23	microglia	microglia	NOUN
fnp-3790	155	24	with	with	ADP
fnp-3790	155	25	aβ	aβ	NOUN
fnp-3790	155	26	-	-	PUNCT
fnp-3790	155	27	plaques	plaque	NOUN
fnp-3790	155	28	and	and	CCONJ
fnp-3790	155	29	the	the	DET
fnp-3790	155	30	ferritin	ferritin	ADJ
fnp-3790	155	31	and	and	CCONJ
fnp-3790	155	32	iron	iron	NOUN
fnp-3790	155	33	accumulation	accumulation	NOUN
fnp-3790	155	34	in	in	ADP
fnp-3790	155	35	the	the	DET
fnp-3790	155	36	microglia	microglia	ADJ
fnp-3790	155	37	cytoplasm	cytoplasm	NOUN
fnp-3790	155	38	.	.	PUNCT
fnp-3790	156	1	fine	fine	ADJ
fnp-3790	156	2	mapping	mapping	NOUN
fnp-3790	156	3	of	of	ADP
fnp-3790	156	4	microglia	microglia	NOUN
fnp-3790	156	5	was	be	AUX
fnp-3790	156	6	performed	perform	VERB
fnp-3790	156	7	by	by	ADP
fnp-3790	156	8	cluster	cluster	NOUN
fnp-3790	156	9	analysis	analysis	NOUN
fnp-3790	156	10	.	.	PUNCT
fnp-3790	157	1	this	this	PRON
fnp-3790	157	2	revealed	reveal	VERB
fnp-3790	157	3	microglia	microglia	ADJ
fnp-3790	157	4	clusters	cluster	NOUN
fnp-3790	157	5	,	,	PUNCT
fnp-3790	157	6	which	which	PRON
fnp-3790	157	7	were	be	AUX
fnp-3790	157	8	mainly	mainly	ADV
fnp-3790	157	9	associated	associate	VERB
fnp-3790	157	10	with	with	ADP
fnp-3790	157	11	ad	ad	NOUN
fnp-3790	157	12	lesions	lesion	NOUN
fnp-3790	157	13	,	,	PUNCT
fnp-3790	157	14	and	and	CCONJ
fnp-3790	157	15	these	these	DET
fnp-3790	157	16	clusters	cluster	NOUN
fnp-3790	157	17	had	have	VERB
fnp-3790	157	18	in	in	ADP
fnp-3790	157	19	common	common	ADJ
fnp-3790	157	20	the	the	DET
fnp-3790	157	21	high	high	ADJ
fnp-3790	157	22	ferritin	ferritin	ADJ
fnp-3790	157	23	content	content	NOUN
fnp-3790	157	24	and	and	CCONJ
fnp-3790	157	25	the	the	DET
fnp-3790	157	26	downregulation	downregulation	NOUN
fnp-3790	157	27	of	of	ADP
fnp-3790	157	28	various	various	ADJ
fnp-3790	157	29	markers	marker	NOUN
fnp-3790	157	30	of	of	ADP
fnp-3790	157	31	the	the	DET
fnp-3790	157	32	homeostatic	homeostatic	ADJ
fnp-3790	157	33	microglia	microglia	ADJ
fnp-3790	157	34	phenotype	phenotype	NOUN
fnp-3790	157	35	.	.	PUNCT
fnp-3790	158	1	the	the	DET
fnp-3790	158	2	high	high	ADJ
fnp-3790	158	3	ferritin	ferritin	ADJ
fnp-3790	158	4	content	content	NOUN
fnp-3790	158	5	was	be	AUX
fnp-3790	158	6	associated	associate	VERB
fnp-3790	158	7	with	with	ADP
fnp-3790	158	8	a	a	DET
fnp-3790	158	9	phenotypic	phenotypic	ADJ
fnp-3790	158	10	change	change	NOUN
fnp-3790	158	11	of	of	ADP
fnp-3790	158	12	the	the	DET
fnp-3790	158	13	cells	cell	NOUN
fnp-3790	158	14	towards	towards	ADP
fnp-3790	158	15	dystrophic	dystrophic	ADJ
fnp-3790	158	16	microglia	microglia	NOUN
fnp-3790	158	17	.	.	PUNCT
fnp-3790	159	1	in	in	ADP
fnp-3790	159	2	contrast	contrast	NOUN
fnp-3790	159	3	,	,	PUNCT
fnp-3790	159	4	microglia	microglia	NOUN
fnp-3790	159	5	in	in	ADP
fnp-3790	159	6	the	the	DET
fnp-3790	159	7	surrounding	surround	VERB
fnp-3790	159	8	normal	normal	ADJ
fnp-3790	159	9	-	-	PUNCT
fnp-3790	159	10	appearing	appear	VERB
fnp-3790	159	11	brain	brain	NOUN
fnp-3790	159	12	tissue	tissue	NOUN
fnp-3790	159	13	were	be	AUX
fnp-3790	159	14	grouped	group	VERB
fnp-3790	159	15	in	in	ADP
fnp-3790	159	16	clusters	cluster	NOUN
fnp-3790	159	17	with	with	ADP
fnp-3790	159	18	high	high	ADJ
fnp-3790	159	19	or	or	CCONJ
fnp-3790	159	20	variable	variable	ADJ
fnp-3790	159	21	expression	expression	NOUN
fnp-3790	159	22	of	of	ADP
fnp-3790	159	23	homeostatic	homeostatic	ADJ
fnp-3790	159	24	markers	marker	NOUN
fnp-3790	159	25	and	and	CCONJ
fnp-3790	159	26	low	low	ADJ
fnp-3790	159	27	expression	expression	NOUN
fnp-3790	159	28	of	of	ADP
fnp-3790	159	29	ferritin	ferritin	NOUN
fnp-3790	159	30	.	.	PUNCT
fnp-3790	160	1	thus	thus	ADV
fnp-3790	160	2	,	,	PUNCT
fnp-3790	160	3	this	this	DET
fnp-3790	160	4	study	study	NOUN
fnp-3790	160	5	identifies	identify	VERB
fnp-3790	160	6	disease	disease	NOUN
fnp-3790	160	7	-	-	PUNCT
fnp-3790	160	8	associated	associate	VERB
fnp-3790	160	9	microglia	microglia	NOUN
fnp-3790	160	10	through	through	ADP
fnp-3790	160	11	their	their	PRON
fnp-3790	160	12	iron	iron	NOUN
fnp-3790	160	13	and	and	CCONJ
fnp-3790	160	14	ferritin	ferritin	ADJ
fnp-3790	160	15	content	content	NOUN
fnp-3790	160	16	.	.	PUNCT
fnp-3790	161	1	this	this	PRON
fnp-3790	161	2	was	be	AUX
fnp-3790	161	3	also	also	ADV
fnp-3790	161	4	reflected	reflect	VERB
fnp-3790	161	5	by	by	ADP
fnp-3790	161	6	the	the	DET
fnp-3790	161	7	association	association	NOUN
fnp-3790	161	8	of	of	ADP
fnp-3790	161	9	this	this	DET
fnp-3790	161	10	microglia	microglia	ADJ
fnp-3790	161	11	phenotype	phenotype	NOUN
fnp-3790	161	12	with	with	ADP
fnp-3790	161	13	disease	disease	NOUN
fnp-3790	161	14	severity	severity	NOUN
fnp-3790	161	15	,	,	PUNCT
fnp-3790	161	16	apo	apo	PROPN
fnp-3790	161	17	-	-	PUNCT
fnp-3790	161	18	e	e	NOUN
fnp-3790	161	19	genotype	genotype	NOUN
fnp-3790	161	20	and	and	CCONJ
fnp-3790	161	21	the	the	DET
fnp-3790	161	22	accumulation	accumulation	NOUN
fnp-3790	161	23	of	of	ADP
fnp-3790	161	24	aβ	aβ	ADP
fnp-3790	161	25	plaques	plaque	NOUN
fnp-3790	161	26	and	and	CCONJ
fnp-3790	161	27	neurofibrillary	neurofibrillary	ADJ
fnp-3790	161	28	tangles	tangle	NOUN
fnp-3790	161	29	in	in	ADP
fnp-3790	161	30	the	the	DET
fnp-3790	161	31	brain	brain	NOUN
fnp-3790	161	32	.	.	PUNCT
fnp-3790	162	1	the	the	DET
fnp-3790	162	2	major	major	ADJ
fnp-3790	162	3	limitation	limitation	NOUN
fnp-3790	162	4	of	of	ADP
fnp-3790	162	5	this	this	DET
fnp-3790	162	6	study	study	NOUN
fnp-3790	162	7	is	be	AUX
fnp-3790	162	8	the	the	DET
fnp-3790	162	9	selection	selection	NOUN
fnp-3790	162	10	of	of	ADP
fnp-3790	162	11	ad	ad	NOUN
fnp-3790	162	12	cases	case	NOUN
fnp-3790	162	13	,	,	PUNCT
fnp-3790	162	14	which	which	PRON
fnp-3790	162	15	is	be	AUX
fnp-3790	162	16	dominated	dominate	VERB
fnp-3790	162	17	by	by	ADP
fnp-3790	162	18	patients	patient	NOUN
fnp-3790	162	19	at	at	ADP
fnp-3790	162	20	later	later	ADJ
fnp-3790	162	21	disease	disease	NOUN
fnp-3790	162	22	stage	stage	NOUN
fnp-3790	162	23	(	(	PUNCT
fnp-3790	162	24	braak	braak	NOUN
fnp-3790	162	25	stage	stage	VERB
fnp-3790	162	26	v	v	PROPN
fnp-3790	162	27	to	to	ADP
fnp-3790	162	28	vi	vi	NUM
fnp-3790	162	29	)	)	PUNCT
fnp-3790	162	30	.	.	PUNCT
fnp-3790	163	1	thus	thus	ADV
fnp-3790	163	2	,	,	PUNCT
fnp-3790	163	3	it	it	PRON
fnp-3790	163	4	remains	remain	VERB
fnp-3790	163	5	unclear	unclear	ADJ
fnp-3790	163	6	whether	whether	SCONJ
fnp-3790	163	7	iron	iron	NOUN
fnp-3790	163	8	accumulation	accumulation	NOUN
fnp-3790	163	9	and	and	CCONJ
fnp-3790	163	10	its	its	PRON
fnp-3790	163	11	binding	binding	NOUN
fnp-3790	163	12	to	to	PART
fnp-3790	163	13	ferritin	ferritin	VERB
fnp-3790	163	14	is	be	AUX
fnp-3790	163	15	a	a	DET
fnp-3790	163	16	secondary	secondary	ADJ
fnp-3790	163	17	phenomenon	phenomenon	NOUN
fnp-3790	163	18	in	in	ADP
fnp-3790	163	19	the	the	DET
fnp-3790	163	20	formation	formation	NOUN
fnp-3790	163	21	of	of	ADP
fnp-3790	163	22	aβ	aβ	DET
fnp-3790	163	23	plaques	plaque	NOUN
fnp-3790	163	24	.	.	PUNCT
fnp-3790	164	1	thus	thus	ADV
fnp-3790	164	2	,	,	PUNCT
fnp-3790	164	3	iron	iron	NOUN
fnp-3790	164	4	uptake	uptake	NOUN
fnp-3790	164	5	in	in	ADP
fnp-3790	164	6	microglia	microglia	NOUN
fnp-3790	164	7	at	at	ADP
fnp-3790	164	8	the	the	DET
fnp-3790	164	9	expense	expense	NOUN
fnp-3790	164	10	of	of	ADP
fnp-3790	164	11	microglia	microglia	ADJ
fnp-3790	164	12	dystrophy	dystrophy	NOUN
fnp-3790	164	13	may	may	AUX
fnp-3790	164	14	reflect	reflect	VERB
fnp-3790	164	15	removal	removal	NOUN
fnp-3790	164	16	of	of	ADP
fnp-3790	164	17	free	free	ADJ
fnp-3790	164	18	iron	iron	NOUN
fnp-3790	164	19	from	from	ADP
fnp-3790	164	20	the	the	DET
fnp-3790	164	21	extracellular	extracellular	ADJ
fnp-3790	164	22	space	space	NOUN
fnp-3790	164	23	in	in	ADP
fnp-3790	164	24	an	an	DET
fnp-3790	164	25	attempt	attempt	NOUN
fnp-3790	164	26	to	to	PART
fnp-3790	164	27	ameliorate	ameliorate	VERB
fnp-3790	164	28	oxidative	oxidative	ADJ
fnp-3790	164	29	injury	injury	NOUN
fnp-3790	164	30	.	.	PUNCT
fnp-3790	165	1	however	however	ADV
fnp-3790	165	2	,	,	PUNCT
fnp-3790	165	3	iron	iron	NOUN
fnp-3790	165	4	in	in	ADP
fnp-3790	165	5	microglia	microglia	NOUN
fnp-3790	165	6	may	may	AUX
fnp-3790	165	7	activate	activate	VERB
fnp-3790	165	8	microglia	microglia	NOUN
fnp-3790	165	9	in	in	ADP
fnp-3790	165	10	a	a	DET
fnp-3790	165	11	pro	pro	ADJ
fnp-3790	165	12	-	-	ADJ
fnp-3790	165	13	inflammatory	inflammatory	ADJ
fnp-3790	165	14	manner	manner	NOUN
fnp-3790	165	15	,	,	PUNCT
fnp-3790	165	16	which	which	PRON
fnp-3790	165	17	contributes	contribute	VERB
fnp-3790	165	18	to	to	PART
fnp-3790	165	19	oxidative	oxidative	ADJ
fnp-3790	165	20	damage	damage	NOUN
fnp-3790	165	21	in	in	ADP
fnp-3790	165	22	the	the	DET
fnp-3790	165	23	lesions	lesion	NOUN
fnp-3790	165	24	.	.	PUNCT
fnp-3790	166	1	the	the	DET
fnp-3790	166	2	iron	iron	NOUN
fnp-3790	166	3	content	content	NOUN
fnp-3790	166	4	in	in	ADP
fnp-3790	166	5	the	the	DET
fnp-3790	166	6	brain	brain	NOUN
fnp-3790	166	7	can	can	AUX
fnp-3790	166	8	be	be	AUX
fnp-3790	166	9	visualized	visualize	VERB
fnp-3790	166	10	and	and	CCONJ
fnp-3790	166	11	quantified	quantify	VERB
fnp-3790	166	12	in	in	ADP
fnp-3790	166	13	magnetic	magnetic	ADJ
fnp-3790	166	14	resonance	resonance	NOUN
fnp-3790	166	15	imaging	imaging	NOUN
fnp-3790	166	16	(	(	PUNCT
fnp-3790	166	17	mri	mri	NOUN
fnp-3790	166	18	)	)	PUNCT
fnp-3790	166	19	,	,	PUNCT
fnp-3790	166	20	using	use	VERB
fnp-3790	166	21	specific	specific	ADJ
fnp-3790	166	22	sequences	sequence	NOUN
fnp-3790	166	23	such	such	ADJ
fnp-3790	166	24	as	as	ADP
fnp-3790	166	25	r2	r2	PROPN
fnp-3790	166	26	*	*	PUNCT
fnp-3790	166	27	or	or	CCONJ
fnp-3790	166	28	quantitative	quantitative	ADJ
fnp-3790	166	29	susceptibility	susceptibility	NOUN
fnp-3790	166	30	mapping	mapping	NOUN
fnp-3790	166	31	(	(	PUNCT
fnp-3790	166	32	qsm	qsm	PROPN
fnp-3790	166	33	)	)	PUNCT
fnp-3790	166	34	(	(	PUNCT
fnp-3790	166	35	bulk	bulk	NOUN
fnp-3790	166	36	et	et	PROPN
fnp-3790	166	37	al	al	PROPN
fnp-3790	166	38	.	.	PROPN
fnp-3790	166	39	2018	2018	NUM
fnp-3790	166	40	)	)	PUNCT
fnp-3790	166	41	.	.	PUNCT
fnp-3790	167	1	using	use	VERB
fnp-3790	167	2	this	this	DET
fnp-3790	167	3	technology	technology	NOUN
fnp-3790	167	4	,	,	PUNCT
fnp-3790	167	5	the	the	DET
fnp-3790	167	6	authors	author	NOUN
fnp-3790	167	7	also	also	ADV
fnp-3790	167	8	showed	show	VERB
fnp-3790	167	9	that	that	SCONJ
fnp-3790	167	10	the	the	DET
fnp-3790	167	11	increased	increase	VERB
fnp-3790	167	12	iron	iron	NOUN
fnp-3790	167	13	content	content	NOUN
fnp-3790	167	14	in	in	ADP
fnp-3790	167	15	the	the	DET
fnp-3790	167	16	sections	section	NOUN
fnp-3790	167	17	is	be	AUX
fnp-3790	167	18	also	also	ADV
fnp-3790	167	19	correlated	correlate	VERB
fnp-3790	167	20	with	with	ADP
fnp-3790	167	21	an	an	DET
fnp-3790	167	22	increased	increase	VERB
fnp-3790	167	23	mri	mri	NOUN
fnp-3790	167	24	signal	signal	NOUN
fnp-3790	167	25	(	(	PUNCT
fnp-3790	167	26	kenkhuis	kenkhuis	PROPN
fnp-3790	167	27	et	et	PROPN
fnp-3790	167	28	al	al	PROPN
fnp-3790	167	29	.	.	PROPN
fnp-3790	167	30	2021	2021	NUM
fnp-3790	167	31	)	)	PUNCT
fnp-3790	167	32	.	.	PUNCT
fnp-3790	168	1	dynamics	dynamic	NOUN
fnp-3790	168	2	of	of	ADP
fnp-3790	168	3	chronic	chronic	ADJ
fnp-3790	168	4	microglia	microglia	ADJ
fnp-3790	168	5	-	-	PUNCT
fnp-3790	168	6	associated	associate	VERB
fnp-3790	168	7	neurodegeneration	neurodegeneration	NOUN
fnp-3790	168	8	the	the	DET
fnp-3790	168	9	possibility	possibility	NOUN
fnp-3790	168	10	to	to	PART
fnp-3790	168	11	detect	detect	VERB
fnp-3790	168	12	accumulation	accumulation	NOUN
fnp-3790	168	13	of	of	ADP
fnp-3790	168	14	iron	iron	NOUN
fnp-3790	168	15	-	-	PUNCT
fnp-3790	168	16	loaded	load	VERB
fnp-3790	168	17	microglia	microglia	NOUN
fnp-3790	168	18	in	in	ADP
fnp-3790	168	19	vivo	vivo	NOUN
fnp-3790	168	20	by	by	ADP
fnp-3790	168	21	magnetic	magnetic	ADJ
fnp-3790	168	22	resonance	resonance	NOUN
fnp-3790	168	23	imaging	imaging	NOUN
fnp-3790	168	24	offers	offer	VERB
fnp-3790	168	25	a	a	DET
fnp-3790	168	26	very	very	ADV
fnp-3790	168	27	attractive	attractive	ADJ
fnp-3790	168	28	tool	tool	NOUN
fnp-3790	168	29	to	to	PART
fnp-3790	168	30	monitor	monitor	VERB
fnp-3790	168	31	the	the	DET
fnp-3790	168	32	dynamics	dynamic	NOUN
fnp-3790	168	33	of	of	ADP
fnp-3790	168	34	active	active	ADJ
fnp-3790	168	35	lesions	lesion	NOUN
fnp-3790	168	36	and	and	CCONJ
fnp-3790	168	37	neurodegeneration	neurodegeneration	NOUN
fnp-3790	168	38	in	in	ADP
fnp-3790	168	39	human	human	ADJ
fnp-3790	168	40	disease	disease	NOUN
fnp-3790	168	41	.	.	PUNCT
fnp-3790	169	1	this	this	PRON
fnp-3790	169	2	is	be	AUX
fnp-3790	169	3	exemplified	exemplify	VERB
fnp-3790	169	4	in	in	ADP
fnp-3790	169	5	multiple	multiple	ADJ
fnp-3790	169	6	sclerosis	sclerosis	NOUN
fnp-3790	169	7	,	,	PUNCT
fnp-3790	169	8	where	where	SCONJ
fnp-3790	169	9	the	the	DET
fnp-3790	169	10	presence	presence	NOUN
fnp-3790	169	11	of	of	ADP
fnp-3790	169	12	an	an	DET
fnp-3790	169	13	iron	iron	NOUN
fnp-3790	169	14	rim	rim	NOUN
fnp-3790	169	15	around	around	ADP
fnp-3790	169	16	the	the	DET
fnp-3790	169	17	lesion	lesion	NOUN
fnp-3790	169	18	identifies	identify	VERB
fnp-3790	169	19	it	it	PRON
fnp-3790	169	20	as	as	ADP
fnp-3790	169	21	chronic	chronic	ADJ
fnp-3790	169	22	active	active	ADJ
fnp-3790	169	23	(	(	PUNCT
fnp-3790	169	24	bagnato	bagnato	PROPN
fnp-3790	169	25	et	et	PROPN
fnp-3790	169	26	al	al	PROPN
fnp-3790	169	27	.	.	PROPN
fnp-3790	169	28	2011	2011	NUM
fnp-3790	169	29	,	,	PUNCT
fnp-3790	169	30	mehta	mehta	PROPN
fnp-3790	169	31	et	et	PROPN
fnp-3790	169	32	al	al	PROPN
fnp-3790	169	33	.	.	PROPN
fnp-3790	169	34	2013	2013	NUM
fnp-3790	169	35	,	,	PUNCT
fnp-3790	169	36	hametner	hametner	X
fnp-3790	169	37	et	et	PROPN
fnp-3790	169	38	al	al	PROPN
fnp-3790	169	39	.	.	PROPN
fnp-3790	169	40	2013	2013	NUM
fnp-3790	169	41	;	;	PUNCT
fnp-3790	169	42	figure	figure	NOUN
fnp-3790	169	43	3	3	NUM
fnp-3790	169	44	)	)	PUNCT
fnp-3790	169	45	.	.	PUNCT
fnp-3790	170	1	furthermore	furthermore	ADV
fnp-3790	170	2	,	,	PUNCT
fnp-3790	170	3	such	such	ADJ
fnp-3790	170	4	lesions	lesion	NOUN
fnp-3790	170	5	show	show	VERB
fnp-3790	170	6	more	more	ADV
fnp-3790	170	7	pronounced	pronounced	ADJ
fnp-3790	170	8	tissue	tissue	NOUN
fnp-3790	170	9	damage	damage	NOUN
fnp-3790	170	10	and	and	CCONJ
fnp-3790	170	11	neurodegeneration	neurodegeneration	NOUN
fnp-3790	170	12	in	in	ADP
fnp-3790	170	13	comparison	comparison	NOUN
fnp-3790	170	14	to	to	ADP
fnp-3790	170	15	those	those	PRON
fnp-3790	170	16	lacking	lack	VERB
fnp-3790	170	17	an	an	DET
fnp-3790	170	18	iron	iron	NOUN
fnp-3790	170	19	ring	ring	NOUN
fnp-3790	170	20	,	,	PUNCT
fnp-3790	170	21	and	and	CCONJ
fnp-3790	170	22	the	the	DET
fnp-3790	170	23	presence	presence	NOUN
fnp-3790	170	24	of	of	ADP
fnp-3790	170	25	such	such	ADJ
fnp-3790	170	26	lesions	lesion	NOUN
fnp-3790	170	27	is	be	AUX
fnp-3790	170	28	associated	associate	VERB
fnp-3790	170	29	with	with	ADP
fnp-3790	170	30	an	an	DET
fnp-3790	170	31	aggressive	aggressive	ADJ
fnp-3790	170	32	clinical	clinical	ADJ
fnp-3790	170	33	disease	disease	NOUN
fnp-3790	170	34	course	course	NOUN
fnp-3790	170	35	(	(	PUNCT
fnp-3790	170	36	absinta	absinta	PROPN
fnp-3790	170	37	et	et	PROPN
fnp-3790	170	38	al	al	PROPN
fnp-3790	170	39	.	.	PROPN
fnp-3790	170	40	2016	2016	NUM
fnp-3790	170	41	,	,	PUNCT
fnp-3790	170	42	weber	weber	PROPN
fnp-3790	170	43	et	et	PROPN
fnp-3790	170	44	al	al	PROPN
fnp-3790	170	45	.	.	PROPN
fnp-3790	170	46	2021	2021	NUM
fnp-3790	170	47	)	)	PUNCT
fnp-3790	170	48	.	.	PUNCT
fnp-3790	171	1	pathological	pathological	ADJ
fnp-3790	171	2	data	datum	NOUN
fnp-3790	171	3	on	on	ADP
fnp-3790	171	4	the	the	DET
fnp-3790	171	5	distribution	distribution	NOUN
fnp-3790	171	6	of	of	ADP
fnp-3790	171	7	tissue	tissue	NOUN
fnp-3790	171	8	degradation	degradation	NOUN
fnp-3790	171	9	products	product	NOUN
fnp-3790	171	10	in	in	ADP
fnp-3790	171	11	such	such	ADJ
fnp-3790	171	12	iron	iron	NOUN
fnp-3790	171	13	lesions	lesion	NOUN
fnp-3790	171	14	suggested	suggest	VERB
fnp-3790	171	15	that	that	SCONJ
fnp-3790	171	16	they	they	PRON
fnp-3790	171	17	expand	expand	VERB
fnp-3790	171	18	very	very	ADV
fnp-3790	171	19	slowly	slowly	ADV
fnp-3790	171	20	,	,	PUNCT
fnp-3790	171	21	but	but	CCONJ
fnp-3790	171	22	the	the	DET
fnp-3790	171	23	time	time	NOUN
fnp-3790	171	24	course	course	NOUN
fnp-3790	171	25	of	of	ADP
fnp-3790	171	26	their	their	PRON
fnp-3790	171	27	dynamic	dynamic	ADJ
fnp-3790	171	28	evolution	evolution	NOUN
fnp-3790	171	29	was	be	AUX
fnp-3790	171	30	unknown	unknown	ADJ
fnp-3790	171	31	.	.	PUNCT
fnp-3790	172	1	this	this	PRON
fnp-3790	172	2	has	have	AUX
fnp-3790	172	3	changed	change	VERB
fnp-3790	172	4	when	when	SCONJ
fnp-3790	172	5	prospective	prospective	ADJ
fnp-3790	172	6	longitudinal	longitudinal	ADJ
fnp-3790	172	7	mri	mri	NOUN
fnp-3790	172	8	studies	study	NOUN
fnp-3790	172	9	using	use	VERB
fnp-3790	172	10	iron	iron	NOUN
fnp-3790	172	11	sensitive	sensitive	ADJ
fnp-3790	172	12	sequences	sequence	NOUN
fnp-3790	172	13	were	be	AUX
fnp-3790	172	14	performed	perform	VERB
fnp-3790	172	15	,	,	PUNCT
fnp-3790	172	16	which	which	PRON
fnp-3790	172	17	provide	provide	VERB
fnp-3790	172	18	data	datum	NOUN
fnp-3790	172	19	on	on	ADP
fnp-3790	172	20	dynamic	dynamic	ADJ
fnp-3790	172	21	changes	change	NOUN
fnp-3790	172	22	in	in	ADP
fnp-3790	172	23	ms	ms	ADJ
fnp-3790	172	24	lesions	lesion	NOUN
fnp-3790	172	25	over	over	ADP
fnp-3790	172	26	a	a	DET
fnp-3790	172	27	time	time	NOUN
fnp-3790	172	28	period	period	NOUN
fnp-3790	172	29	of	of	ADP
fnp-3790	172	30	up	up	ADP
fnp-3790	172	31	to	to	PART
fnp-3790	172	32	7	7	NUM
fnp-3790	172	33	years	year	NOUN
fnp-3790	172	34	(	(	PUNCT
fnp-3790	172	35	dal	dal	NOUN
fnp-3790	172	36	bianco	bianco	PROPN
fnp-3790	172	37	et	et	PROPN
fnp-3790	172	38	al	al	PROPN
fnp-3790	172	39	.	.	PROPN
fnp-3790	172	40	2017	2017	NUM
fnp-3790	172	41	,	,	PUNCT
fnp-3790	172	42	2021	2021	NUM
fnp-3790	172	43	)	)	PUNCT
fnp-3790	172	44	.	.	PUNCT
fnp-3790	173	1	brain	brain	NOUN
fnp-3790	173	2	lesions	lesion	NOUN
fnp-3790	173	3	without	without	ADP
fnp-3790	173	4	an	an	DET
fnp-3790	173	5	iron	iron	NOUN
fnp-3790	173	6	rim	rim	NOUN
fnp-3790	173	7	shrank	shrink	VERB
fnp-3790	173	8	during	during	ADP
fnp-3790	173	9	the	the	DET
fnp-3790	173	10	first	first	ADJ
fnp-3790	173	11	3	3	NUM
fnp-3790	173	12	years	year	NOUN
fnp-3790	173	13	and	and	CCONJ
fnp-3790	173	14	then	then	ADV
fnp-3790	173	15	their	their	PRON
fnp-3790	173	16	volume	volume	NOUN
fnp-3790	173	17	stabilized	stabilize	VERB
fnp-3790	173	18	.	.	PUNCT
fnp-3790	174	1	in	in	ADP
fnp-3790	174	2	contrast	contrast	NOUN
fnp-3790	174	3	,	,	PUNCT
fnp-3790	174	4	iron	iron	NOUN
fnp-3790	174	5	ring	ring	NOUN
fnp-3790	174	6	lesions	lesion	NOUN
fnp-3790	174	7	slowly	slowly	ADV
fnp-3790	174	8	expanded	expand	VERB
fnp-3790	174	9	over	over	ADP
fnp-3790	174	10	3	3	NUM
fnp-3790	174	11	to	to	PART
fnp-3790	174	12	5	5	NUM
fnp-3790	174	13	years	year	NOUN
fnp-3790	174	14	,	,	PUNCT
fnp-3790	174	15	before	before	SCONJ
fnp-3790	174	16	their	their	PRON
fnp-3790	174	17	size	size	NOUN
fnp-3790	174	18	stabilized	stabilize	VERB
fnp-3790	174	19	.	.	PUNCT
fnp-3790	175	1	these	these	DET
fnp-3790	175	2	data	datum	NOUN
fnp-3790	175	3	indicate	indicate	VERB
fnp-3790	175	4	that	that	SCONJ
fnp-3790	175	5	chronic	chronic	ADJ
fnp-3790	175	6	neurodegeneration	neurodegeneration	NOUN
fnp-3790	175	7	in	in	ADP
fnp-3790	175	8	progressive	progressive	ADJ
fnp-3790	175	9	multiple	multiple	ADJ
fnp-3790	175	10	sclerosis	sclerosis	NOUN
fnp-3790	175	11	is	be	AUX
fnp-3790	175	12	a	a	DET
fnp-3790	175	13	very	very	ADV
fnp-3790	175	14	slow	slow	ADJ
fnp-3790	175	15	process	process	NOUN
fnp-3790	175	16	,	,	PUNCT
fnp-3790	175	17	gradually	gradually	ADV
fnp-3790	175	18	developing	develop	VERB
fnp-3790	175	19	over	over	ADP
fnp-3790	175	20	years	year	NOUN
fnp-3790	175	21	,	,	PUNCT
fnp-3790	175	22	while	while	SCONJ
fnp-3790	175	23	demyelination	demyelination	NOUN
fnp-3790	175	24	and	and	CCONJ
fnp-3790	175	25	neurodegeneration	neurodegeneration	NOUN
fnp-3790	175	26	in	in	ADP
fnp-3790	175	27	acute	acute	ADJ
fnp-3790	175	28	relapses	relapse	NOUN
fnp-3790	175	29	develop	develop	VERB
fnp-3790	175	30	within	within	ADP
fnp-3790	175	31	weeks	week	NOUN
fnp-3790	175	32	.	.	PUNCT
fnp-3790	176	1	figure	figure	VERB
fnp-3790	176	2	3	3	NUM
fnp-3790	176	3	:	:	PUNCT
fnp-3790	176	4	slowly	slowly	ADV
fnp-3790	176	5	expanding	expand	VERB
fnp-3790	176	6	iron	iron	NOUN
fnp-3790	176	7	ring	ring	NOUN
fnp-3790	176	8	lesions	lesion	NOUN
fnp-3790	176	9	in	in	ADP
fnp-3790	176	10	the	the	DET
fnp-3790	176	11	ms	ms	PROPN
fnp-3790	176	12	brain	brain	NOUN
fnp-3790	176	13	can	can	AUX
fnp-3790	176	14	be	be	AUX
fnp-3790	176	15	visualized	visualize	VERB
fnp-3790	176	16	on	on	ADP
fnp-3790	176	17	mri	mri	NOUN
fnp-3790	176	18	with	with	ADP
fnp-3790	176	19	iron	iron	NOUN
fnp-3790	176	20	sensitive	sensitive	ADJ
fnp-3790	176	21	imaging	imaging	NOUN
fnp-3790	176	22	sequences	sequence	NOUN
fnp-3790	176	23	.	.	PUNCT
fnp-3790	177	1	the	the	DET
fnp-3790	177	2	typical	typical	ADJ
fnp-3790	177	3	presentation	presentation	NOUN
fnp-3790	177	4	of	of	ADP
fnp-3790	177	5	such	such	ADJ
fnp-3790	177	6	lesions	lesion	NOUN
fnp-3790	177	7	reveals	reveal	VERB
fnp-3790	177	8	high	high	ADJ
fnp-3790	177	9	iron	iron	NOUN
fnp-3790	177	10	signal	signal	NOUN
fnp-3790	177	11	in	in	ADP
fnp-3790	177	12	one	one	NUM
fnp-3790	177	13	or	or	CCONJ
fnp-3790	177	14	several	several	ADJ
fnp-3790	177	15	central	central	ADJ
fnp-3790	177	16	veins	vein	NOUN
fnp-3790	177	17	and	and	CCONJ
fnp-3790	177	18	in	in	ADP
fnp-3790	177	19	a	a	DET
fnp-3790	177	20	rim	rim	NOUN
fnp-3790	177	21	at	at	ADP
fnp-3790	177	22	the	the	DET
fnp-3790	177	23	lesion	lesion	NOUN
fnp-3790	177	24	edge	edge	NOUN
fnp-3790	177	25	,	,	PUNCT
fnp-3790	177	26	reflecting	reflect	VERB
fnp-3790	177	27	iron	iron	NOUN
fnp-3790	177	28	-	-	PUNCT
fnp-3790	177	29	containing	contain	VERB
fnp-3790	177	30	activated	activate	VERB
fnp-3790	177	31	microglia	microglia	NOUN
fnp-3790	177	32	.	.	PUNCT
fnp-3790	178	1	the	the	DET
fnp-3790	178	2	iron	iron	NOUN
fnp-3790	178	3	rim	rim	NOUN
fnp-3790	178	4	(	(	PUNCT
fnp-3790	178	5	r	r	NOUN
fnp-3790	178	6	)	)	PUNCT
fnp-3790	178	7	demarcates	demarcate	VERB
fnp-3790	178	8	the	the	DET
fnp-3790	178	9	demyelinated	demyelinated	ADJ
fnp-3790	178	10	plaque	plaque	NOUN
fnp-3790	178	11	(	(	PUNCT
fnp-3790	178	12	pl	pl	NOUN
fnp-3790	178	13	)	)	PUNCT
fnp-3790	178	14	;	;	PUNCT
fnp-3790	178	15	the	the	DET
fnp-3790	178	16	abnormal	abnormal	ADJ
fnp-3790	178	17	mri	mri	NOUN
fnp-3790	178	18	signal	signal	NOUN
fnp-3790	178	19	around	around	ADP
fnp-3790	178	20	the	the	DET
fnp-3790	178	21	iron	iron	NOUN
fnp-3790	178	22	rim	rim	NOUN
fnp-3790	178	23	is	be	AUX
fnp-3790	178	24	due	due	ADJ
fnp-3790	178	25	to	to	ADP
fnp-3790	178	26	wallerian	wallerian	ADJ
fnp-3790	178	27	degeneration	degeneration	NOUN
fnp-3790	178	28	(	(	PUNCT
fnp-3790	178	29	wd	wd	PROPN
fnp-3790	178	30	)	)	PUNCT
fnp-3790	178	31	.	.	PUNCT
fnp-3790	179	1	direct	direct	ADJ
fnp-3790	179	2	neuropathological	neuropathological	ADJ
fnp-3790	179	3	analysis	analysis	NOUN
fnp-3790	179	4	of	of	ADP
fnp-3790	179	5	mri	mri	NOUN
fnp-3790	179	6	scanned	scan	VERB
fnp-3790	179	7	tissue	tissue	NOUN
fnp-3790	179	8	blocks	block	NOUN
fnp-3790	179	9	showed	show	VERB
fnp-3790	179	10	that	that	SCONJ
fnp-3790	179	11	the	the	DET
fnp-3790	179	12	iron	iron	NOUN
fnp-3790	179	13	ring	ring	NOUN
fnp-3790	179	14	seen	see	VERB
fnp-3790	179	15	in	in	ADP
fnp-3790	179	16	mri	mri	NOUN
fnp-3790	179	17	always	always	ADV
fnp-3790	179	18	reflects	reflect	VERB
fnp-3790	179	19	the	the	DET
fnp-3790	179	20	iron	iron	NOUN
fnp-3790	179	21	-	-	PUNCT
fnp-3790	179	22	loaded	load	VERB
fnp-3790	179	23	microglia	microglia	NOUN
fnp-3790	179	24	at	at	ADP
fnp-3790	179	25	the	the	DET
fnp-3790	179	26	edge	edge	NOUN
fnp-3790	179	27	of	of	ADP
fnp-3790	179	28	active	active	ADJ
fnp-3790	179	29	plaques	plaque	NOUN
fnp-3790	179	30	,	,	PUNCT
fnp-3790	179	31	while	while	SCONJ
fnp-3790	179	32	the	the	DET
fnp-3790	179	33	t2	t2	NOUN
fnp-3790	179	34	signal	signal	NOUN
fnp-3790	179	35	of	of	ADP
fnp-3790	179	36	the	the	DET
fnp-3790	179	37	lesions	lesion	NOUN
fnp-3790	179	38	gradually	gradually	ADV
fnp-3790	179	39	expands	expand	VERB
fnp-3790	179	40	outside	outside	ADP
fnp-3790	179	41	the	the	DET
fnp-3790	179	42	ring	ring	NOUN
fnp-3790	179	43	(	(	PUNCT
fnp-3790	179	44	dal	dal	NOUN
fnp-3790	179	45	bianco	bianco	PROPN
fnp-3790	179	46	et	et	PROPN
fnp-3790	179	47	al	al	PROPN
fnp-3790	179	48	.	.	PROPN
fnp-3790	179	49	2017	2017	NUM
fnp-3790	179	50	,	,	PUNCT
fnp-3790	179	51	2021	2021	NUM
fnp-3790	179	52	)	)	PUNCT
fnp-3790	179	53	.	.	PUNCT
fnp-3790	180	1	these	these	DET
fnp-3790	180	2	lesion	lesion	NOUN
fnp-3790	180	3	changes	change	NOUN
fnp-3790	180	4	reflect	reflect	VERB
fnp-3790	180	5	an	an	DET
fnp-3790	180	6	expanding	expand	VERB
fnp-3790	180	7	halo	halo	NOUN
fnp-3790	180	8	of	of	ADP
fnp-3790	180	9	secondary	secondary	ADJ
fnp-3790	180	10	wallerian	wallerian	NOUN
fnp-3790	180	11	degeneration	degeneration	NOUN
fnp-3790	180	12	around	around	ADP
fnp-3790	180	13	a	a	DET
fnp-3790	180	14	destructive	destructive	ADJ
fnp-3790	180	15	lesion	lesion	NOUN
fnp-3790	180	16	(	(	PUNCT
fnp-3790	180	17	figure	figure	NOUN
fnp-3790	180	18	3	3	NUM
fnp-3790	180	19	)	)	PUNCT
fnp-3790	180	20	.	.	PUNCT
fnp-3790	181	1	thus	thus	ADV
fnp-3790	181	2	,	,	PUNCT
fnp-3790	181	3	the	the	DET
fnp-3790	181	4	quantitative	quantitative	ADJ
fnp-3790	181	5	lesion	lesion	NOUN
fnp-3790	181	6	load	load	NOUN
fnp-3790	181	7	,	,	PUNCT
fnp-3790	181	8	determined	determine	VERB
fnp-3790	181	9	on	on	ADP
fnp-3790	181	10	mri	mri	NOUN
fnp-3790	181	11	,	,	PUNCT
fnp-3790	181	12	not	not	PART
fnp-3790	181	13	necessarily	necessarily	ADV
fnp-3790	181	14	indicated	indicate	VERB
fnp-3790	181	15	lesion	lesion	NOUN
fnp-3790	181	16	load	load	NOUN
fnp-3790	181	17	,	,	PUNCT
fnp-3790	181	18	but	but	CCONJ
fnp-3790	181	19	also	also	ADV
fnp-3790	181	20	wallerian	wallerian	ADJ
fnp-3790	181	21	degeneration	degeneration	NOUN
fnp-3790	181	22	in	in	ADP
fnp-3790	181	23	the	the	DET
fnp-3790	181	24	normal	normal	ADJ
fnp-3790	181	25	appearing	appearing	ADJ
fnp-3790	181	26	white	white	ADJ
fnp-3790	181	27	matter	matter	NOUN
fnp-3790	181	28	.	.	PUNCT
fnp-3790	182	1	all	all	DET
fnp-3790	182	2	these	these	DET
fnp-3790	182	3	data	datum	NOUN
fnp-3790	182	4	highlight	highlight	VERB
fnp-3790	182	5	the	the	DET
fnp-3790	182	6	importance	importance	NOUN
fnp-3790	182	7	of	of	ADP
fnp-3790	182	8	studies	study	NOUN
fnp-3790	182	9	,	,	PUNCT
fnp-3790	182	10	directly	directly	ADV
fnp-3790	182	11	correlating	correlate	VERB
fnp-3790	182	12	mri	mri	NOUN
fnp-3790	182	13	changes	change	NOUN
fnp-3790	182	14	with	with	ADP
fnp-3790	182	15	neuropathology	neuropathology	NOUN
fnp-3790	182	16	and	and	CCONJ
fnp-3790	182	17	integrating	integrate	VERB
fnp-3790	182	18	this	this	DET
fnp-3790	182	19	information	information	NOUN
fnp-3790	182	20	into	into	ADP
fnp-3790	182	21	long	long	ADJ
fnp-3790	182	22	term	term	NOUN
fnp-3790	182	23	longitudinal	longitudinal	ADJ
fnp-3790	182	24	prospective	prospective	ADJ
fnp-3790	182	25	studies	study	NOUN
fnp-3790	182	26	.	.	PUNCT
fnp-3790	183	1	it	it	PRON
fnp-3790	183	2	is	be	AUX
fnp-3790	183	3	expected	expect	VERB
fnp-3790	183	4	that	that	SCONJ
fnp-3790	183	5	a	a	DET
fnp-3790	183	6	similar	similar	ADJ
fnp-3790	183	7	approach	approach	NOUN
fnp-3790	183	8	will	will	AUX
fnp-3790	183	9	also	also	ADV
fnp-3790	183	10	provide	provide	VERB
fnp-3790	183	11	significant	significant	ADJ
fnp-3790	183	12	new	new	ADJ
fnp-3790	183	13	information	information	NOUN
fnp-3790	183	14	for	for	ADP
fnp-3790	183	15	age	age	NOUN
fnp-3790	183	16	-	-	PUNCT
fnp-3790	183	17	related	relate	VERB
fnp-3790	183	18	neurodegenerative	neurodegenerative	ADJ
fnp-3790	183	19	diseases	disease	NOUN
fnp-3790	183	20	.	.	PUNCT
fnp-3790	184	1	is	be	AUX
fnp-3790	184	2	there	there	PRON
fnp-3790	184	3	evidence	evidence	NOUN
fnp-3790	184	4	for	for	ADP
fnp-3790	184	5	involvement	involvement	NOUN
fnp-3790	184	6	of	of	ADP
fnp-3790	184	7	t	t	PROPN
fnp-3790	184	8	-	-	PUNCT
fnp-3790	184	9	cells	cell	NOUN
fnp-3790	184	10	in	in	ADP
fnp-3790	184	11	neurodegenerative	neurodegenerative	ADJ
fnp-3790	184	12	disease	disease	NOUN
fnp-3790	184	13	?	?	PUNCT
fnp-3790	185	1	neuropathological	neuropathological	ADJ
fnp-3790	185	2	studies	study	NOUN
fnp-3790	185	3	have	have	AUX
fnp-3790	185	4	provided	provide	VERB
fnp-3790	185	5	evidence	evidence	NOUN
fnp-3790	185	6	that	that	SCONJ
fnp-3790	185	7	cells	cell	NOUN
fnp-3790	185	8	of	of	ADP
fnp-3790	185	9	the	the	DET
fnp-3790	185	10	adaptive	adaptive	ADJ
fnp-3790	185	11	immune	immune	ADJ
fnp-3790	185	12	system	system	NOUN
fnp-3790	185	13	infiltrate	infiltrate	VERB
fnp-3790	185	14	the	the	DET
fnp-3790	185	15	brain	brain	NOUN
fnp-3790	185	16	,	,	PUNCT
fnp-3790	185	17	in	in	ADP
fnp-3790	185	18	particular	particular	ADJ
fnp-3790	185	19	at	at	ADP
fnp-3790	185	20	sites	site	NOUN
fnp-3790	185	21	of	of	ADP
fnp-3790	185	22	ongoing	ongoing	ADJ
fnp-3790	185	23	neurodegeneration	neurodegeneration	NOUN
fnp-3790	185	24	in	in	ADP
fnp-3790	185	25	diseases	disease	NOUN
fnp-3790	185	26	such	such	ADJ
fnp-3790	185	27	as	as	ADP
fnp-3790	185	28	alzheimer	alzheimer	PROPN
fnp-3790	185	29	’s	’s	PART
fnp-3790	185	30	disease	disease	NOUN
fnp-3790	185	31	or	or	CCONJ
fnp-3790	185	32	parkinson	parkinson	NOUN
fnp-3790	185	33	’s	’s	PART
fnp-3790	185	34	disease	disease	NOUN
fnp-3790	185	35	(	(	PUNCT
fnp-3790	185	36	togo	togo	PROPN
fnp-3790	185	37	et	et	PROPN
fnp-3790	185	38	al	al	PROPN
fnp-3790	185	39	.	.	PROPN
fnp-3790	185	40	2002	2002	NUM
fnp-3790	185	41	,	,	PUNCT
fnp-3790	185	42	brochard	brochard	NOUN
fnp-3790	185	43	et	et	PROPN
fnp-3790	185	44	al	al	PROPN
fnp-3790	185	45	.	.	PROPN
fnp-3790	185	46	2009	2009	NUM
fnp-3790	185	47	,	,	PUNCT
fnp-3790	185	48	evans	evans	PROPN
fnp-3790	185	49	et	et	PROPN
fnp-3790	185	50	al	al	PROPN
fnp-3790	185	51	.	.	PROPN
fnp-3790	185	52	2019	2019	NUM
fnp-3790	185	53	)	)	PUNCT
fnp-3790	185	54	.	.	PUNCT
fnp-3790	186	1	these	these	DET
fnp-3790	186	2	cells	cell	NOUN
fnp-3790	186	3	are	be	AUX
fnp-3790	186	4	mainly	mainly	ADV
fnp-3790	186	5	t	t	NOUN
fnp-3790	186	6	-	-	PUNCT
fnp-3790	186	7	cells	cell	NOUN
fnp-3790	186	8	,	,	PUNCT
fnp-3790	186	9	including	include	VERB
fnp-3790	186	10	mhc	mhc	PROPN
fnp-3790	186	11	class	class	PROPN
fnp-3790	186	12	ii	ii	PROPN
fnp-3790	186	13	restricted	restrict	VERB
fnp-3790	186	14	cd4	cd4	PROPN
fnp-3790	186	15	+	+	PROPN
fnp-3790	186	16	and	and	CCONJ
fnp-3790	186	17	mhc	mhc	PROPN
fnp-3790	186	18	class	class	NOUN
fnp-3790	186	19	i	i	PRON
fnp-3790	186	20	restricted	restrict	VERB
fnp-3790	186	21	cd8	cd8	PROPN
fnp-3790	186	22	+	+	PROPN
fnp-3790	186	23	cells	cell	NOUN
fnp-3790	186	24	.	.	PUNCT
fnp-3790	187	1	the	the	DET
fnp-3790	187	2	key	key	ADJ
fnp-3790	187	3	question	question	NOUN
fnp-3790	187	4	,	,	PUNCT
fnp-3790	187	5	which	which	PRON
fnp-3790	187	6	is	be	AUX
fnp-3790	187	7	currently	currently	ADV
fnp-3790	187	8	unresolved	unresolved	ADJ
fnp-3790	187	9	,	,	PUNCT
fnp-3790	187	10	is	be	AUX
fnp-3790	187	11	whether	whether	SCONJ
fnp-3790	187	12	these	these	DET
fnp-3790	187	13	cells	cell	NOUN
fnp-3790	187	14	actively	actively	ADV
fnp-3790	187	15	contribute	contribute	VERB
fnp-3790	187	16	to	to	ADP
fnp-3790	187	17	tissue	tissue	NOUN
fnp-3790	187	18	injury	injury	NOUN
fnp-3790	187	19	,	,	PUNCT
fnp-3790	187	20	are	be	AUX
fnp-3790	187	21	neuroprotective	neuroprotective	ADJ
fnp-3790	187	22	or	or	CCONJ
fnp-3790	187	23	are	be	AUX
fnp-3790	187	24	just	just	ADV
fnp-3790	187	25	passively	passively	ADV
fnp-3790	187	26	recruited	recruit	VERB
fnp-3790	187	27	bystanders	bystander	NOUN
fnp-3790	187	28	.	.	PUNCT
fnp-3790	188	1	this	this	DET
fnp-3790	188	2	question	question	NOUN
fnp-3790	188	3	has	have	AUX
fnp-3790	188	4	recently	recently	ADV
fnp-3790	188	5	been	be	AUX
fnp-3790	188	6	addressed	address	VERB
fnp-3790	188	7	in	in	ADP
fnp-3790	188	8	an	an	DET
fnp-3790	188	9	experimental	experimental	ADJ
fnp-3790	188	10	model	model	NOUN
fnp-3790	188	11	of	of	ADP
fnp-3790	188	12	parkinson	parkinson	NOUN
fnp-3790	188	13	’s	’s	PART
fnp-3790	188	14	disease	disease	NOUN
fnp-3790	188	15	,	,	PUNCT
fnp-3790	188	16	induced	induce	VERB
fnp-3790	188	17	by	by	ADP
fnp-3790	188	18	local	local	ADJ
fnp-3790	188	19	injection	injection	NOUN
fnp-3790	188	20	of	of	ADP
fnp-3790	188	21	an	an	DET
fnp-3790	188	22	adeno	adeno	NOUN
fnp-3790	188	23	-	-	PUNCT
fnp-3790	188	24	associated	associate	VERB
fnp-3790	188	25	virus	virus	NOUN
fnp-3790	188	26	vector	vector	NOUN
fnp-3790	188	27	,	,	PUNCT
fnp-3790	188	28	inducing	induce	VERB
fnp-3790	188	29	the	the	DET
fnp-3790	188	30	over	over	NOUN
fnp-3790	188	31	-	-	PUNCT
fnp-3790	188	32	expression	expression	NOUN
fnp-3790	188	33	of	of	ADP
fnp-3790	188	34	α	α	NOUN
fnp-3790	188	35	-	-	PUNCT
fnp-3790	188	36	synuclein	synuclein	NOUN
fnp-3790	188	37	in	in	ADP
fnp-3790	188	38	the	the	DET
fnp-3790	188	39	substantia	substantia	NOUN
fnp-3790	188	40	nigra	nigra	NOUN
fnp-3790	188	41	of	of	ADP
fnp-3790	188	42	mice	mouse	NOUN
fnp-3790	188	43	(	(	PUNCT
fnp-3790	188	44	williams	williams	PROPN
fnp-3790	188	45	et	et	PROPN
fnp-3790	188	46	al	al	PROPN
fnp-3790	188	47	.	.	PROPN
fnp-3790	188	48	2021	2021	NUM
fnp-3790	188	49	)	)	PUNCT
fnp-3790	188	50	.	.	PUNCT
fnp-3790	189	1	in	in	ADP
fnp-3790	189	2	this	this	DET
fnp-3790	189	3	model	model	NOUN
fnp-3790	189	4	cd4	cd4	PROPN
fnp-3790	189	5	+	+	PROPN
fnp-3790	189	6	and	and	CCONJ
fnp-3790	189	7	cd8	cd8	PROPN
fnp-3790	189	8	+	+	PROPN
fnp-3790	189	9	t	t	PROPN
fnp-3790	189	10	-	-	PUNCT
fnp-3790	189	11	cells	cell	NOUN
fnp-3790	189	12	infiltrate	infiltrate	VERB
fnp-3790	189	13	the	the	DET
fnp-3790	189	14	midbrain	midbrain	NOUN
fnp-3790	189	15	,	,	PUNCT
fnp-3790	189	16	and	and	CCONJ
fnp-3790	189	17	this	this	PRON
fnp-3790	189	18	is	be	AUX
fnp-3790	189	19	associated	associate	VERB
fnp-3790	189	20	with	with	ADP
fnp-3790	189	21	activation	activation	NOUN
fnp-3790	189	22	of	of	ADP
fnp-3790	189	23	myeloid	myeloid	ADJ
fnp-3790	189	24	cells	cell	NOUN
fnp-3790	189	25	,	,	PUNCT
fnp-3790	189	26	including	include	VERB
fnp-3790	189	27	microglia	microglia	NOUN
fnp-3790	189	28	,	,	PUNCT
fnp-3790	189	29	and	and	CCONJ
fnp-3790	189	30	the	the	DET
fnp-3790	189	31	degeneration	degeneration	NOUN
fnp-3790	189	32	and	and	CCONJ
fnp-3790	189	33	loss	loss	NOUN
fnp-3790	189	34	of	of	ADP
fnp-3790	189	35	tyrosine	tyrosine	NOUN
fnp-3790	189	36	hydroxylase	hydroxylase	VERB
fnp-3790	189	37	positive	positive	ADJ
fnp-3790	189	38	nigral	nigral	ADJ
fnp-3790	189	39	neurons	neuron	NOUN
fnp-3790	189	40	.	.	PUNCT
fnp-3790	190	1	the	the	DET
fnp-3790	190	2	t	t	PROPN
fnp-3790	190	3	-	-	PUNCT
fnp-3790	190	4	cell	cell	NOUN
fnp-3790	190	5	infiltrates	infiltrate	NOUN
fnp-3790	190	6	are	be	AUX
fnp-3790	190	7	associated	associate	VERB
fnp-3790	190	8	with	with	ADP
fnp-3790	190	9	the	the	DET
fnp-3790	190	10	local	local	ADJ
fnp-3790	190	11	expression	expression	NOUN
fnp-3790	190	12	of	of	ADP
fnp-3790	190	13	pro	pro	ADJ
fnp-3790	190	14	-	-	ADJ
fnp-3790	190	15	inflammatory	inflammatory	ADJ
fnp-3790	190	16	and	and	CCONJ
fnp-3790	190	17	in	in	ADP
fnp-3790	190	18	part	part	NOUN
fnp-3790	190	19	also	also	ADV
fnp-3790	190	20	regulatory	regulatory	ADJ
fnp-3790	190	21	cytokines	cytokine	NOUN
fnp-3790	190	22	.	.	PUNCT
fnp-3790	191	1	most	most	ADV
fnp-3790	191	2	importantly	importantly	ADV
fnp-3790	191	3	,	,	PUNCT
fnp-3790	191	4	t	t	NOUN
fnp-3790	191	5	-	-	PUNCT
fnp-3790	191	6	cell	cell	NOUN
fnp-3790	191	7	receptor	receptor	NOUN
fnp-3790	191	8	or	or	CCONJ
fnp-3790	191	9	cd4	cd4	PROPN
fnp-3790	191	10	deficient	deficient	ADJ
fnp-3790	191	11	mice	mouse	NOUN
fnp-3790	191	12	revealed	reveal	VERB
fnp-3790	191	13	a	a	DET
fnp-3790	191	14	reduced	reduced	ADJ
fnp-3790	191	15	activation	activation	NOUN
fnp-3790	191	16	of	of	ADP
fnp-3790	191	17	immune	immune	ADJ
fnp-3790	191	18	effector	effector	NOUN
fnp-3790	191	19	cells	cell	NOUN
fnp-3790	191	20	and	and	CCONJ
fnp-3790	191	21	also	also	ADV
fnp-3790	191	22	an	an	DET
fnp-3790	191	23	ameliorated	ameliorate	VERB
fnp-3790	191	24	neurodegeneration	neurodegeneration	NOUN
fnp-3790	191	25	in	in	ADP
fnp-3790	191	26	the	the	DET
fnp-3790	191	27	substantia	substantia	NOUN
fnp-3790	191	28	nigra	nigra	NOUN
fnp-3790	191	29	.	.	PUNCT
fnp-3790	192	1	this	this	DET
fnp-3790	192	2	study	study	NOUN
fnp-3790	192	3	thus	thus	ADV
fnp-3790	192	4	provides	provide	VERB
fnp-3790	192	5	evidence	evidence	NOUN
fnp-3790	192	6	that	that	SCONJ
fnp-3790	192	7	adaptive	adaptive	ADJ
fnp-3790	192	8	immune	immune	ADJ
fnp-3790	192	9	reactions	reaction	NOUN
fnp-3790	192	10	,	,	PUNCT
fnp-3790	192	11	mainly	mainly	ADV
fnp-3790	192	12	mediated	mediate	VERB
fnp-3790	192	13	by	by	ADP
fnp-3790	192	14	mhc	mhc	PROPN
fnp-3790	192	15	class	class	PROPN
fnp-3790	192	16	ii	ii	PROPN
fnp-3790	192	17	restricted	restrict	VERB
fnp-3790	192	18	cd4	cd4	PROPN
fnp-3790	192	19	+	+	PROPN
fnp-3790	192	20	t	t	PROPN
fnp-3790	192	21	-	-	PUNCT
fnp-3790	192	22	cells	cell	NOUN
fnp-3790	192	23	,	,	PUNCT
fnp-3790	192	24	contribute	contribute	VERB
fnp-3790	192	25	to	to	ADP
fnp-3790	192	26	the	the	DET
fnp-3790	192	27	propagation	propagation	NOUN
fnp-3790	192	28	of	of	ADP
fnp-3790	192	29	neurodegeneration	neurodegeneration	NOUN
fnp-3790	192	30	in	in	ADP
fnp-3790	192	31	this	this	DET
fnp-3790	192	32	model	model	NOUN
fnp-3790	192	33	.	.	PUNCT
fnp-3790	193	1	the	the	DET
fnp-3790	193	2	results	result	NOUN
fnp-3790	193	3	support	support	VERB
fnp-3790	193	4	the	the	DET
fnp-3790	193	5	view	view	NOUN
fnp-3790	193	6	that	that	SCONJ
fnp-3790	193	7	attempts	attempt	VERB
fnp-3790	193	8	to	to	PART
fnp-3790	193	9	therapeutically	therapeutically	ADV
fnp-3790	193	10	modulate	modulate	VERB
fnp-3790	193	11	the	the	DET
fnp-3790	193	12	t	t	NOUN
fnp-3790	193	13	-	-	PUNCT
fnp-3790	193	14	cell	cell	NOUN
fnp-3790	193	15	immune	immune	ADJ
fnp-3790	193	16	response	response	NOUN
fnp-3790	193	17	(	(	PUNCT
fnp-3790	193	18	weiner	weiner	NOUN
fnp-3790	193	19	et	et	PROPN
fnp-3790	193	20	al	al	PROPN
fnp-3790	193	21	.	.	PROPN
fnp-3790	193	22	2011	2011	NUM
fnp-3790	193	23	,	,	PUNCT
fnp-3790	193	24	mayo	mayo	NOUN
fnp-3790	193	25	et	et	PROPN
fnp-3790	193	26	al	al	PROPN
fnp-3790	193	27	.	.	PROPN
fnp-3790	193	28	2016	2016	NUM
fnp-3790	193	29	)	)	PUNCT
fnp-3790	193	30	could	could	AUX
fnp-3790	193	31	be	be	AUX
fnp-3790	193	32	effective	effective	ADJ
fnp-3790	193	33	.	.	PUNCT
fnp-3790	194	1	direct	direct	ADJ
fnp-3790	194	2	support	support	NOUN
fnp-3790	194	3	is	be	AUX
fnp-3790	194	4	provided	provide	VERB
fnp-3790	194	5	by	by	ADP
fnp-3790	194	6	the	the	DET
fnp-3790	194	7	observation	observation	NOUN
fnp-3790	194	8	that	that	SCONJ
fnp-3790	194	9	fingolimod	fingolimod	NOUN
fnp-3790	194	10	,	,	PUNCT
fnp-3790	194	11	a	a	DET
fnp-3790	194	12	drug	drug	NOUN
fnp-3790	194	13	which	which	PRON
fnp-3790	194	14	reduces	reduce	VERB
fnp-3790	194	15	the	the	DET
fnp-3790	194	16	infiltration	infiltration	NOUN
fnp-3790	194	17	of	of	ADP
fnp-3790	194	18	immune	immune	ADJ
fnp-3790	194	19	cells	cell	NOUN
fnp-3790	194	20	into	into	ADP
fnp-3790	194	21	the	the	DET
fnp-3790	194	22	central	central	ADJ
fnp-3790	194	23	nervous	nervous	ADJ
fnp-3790	194	24	system	system	NOUN
fnp-3790	194	25	and	and	CCONJ
fnp-3790	194	26	is	be	AUX
fnp-3790	194	27	effective	effective	ADJ
fnp-3790	194	28	in	in	ADP
fnp-3790	194	29	the	the	DET
fnp-3790	194	30	treatment	treatment	NOUN
fnp-3790	194	31	of	of	ADP
fnp-3790	194	32	multiple	multiple	ADJ
fnp-3790	194	33	sclerosis	sclerosis	NOUN
fnp-3790	194	34	patients	patient	NOUN
fnp-3790	194	35	,	,	PUNCT
fnp-3790	194	36	ameliorates	ameliorate	VERB
fnp-3790	194	37	disease	disease	NOUN
fnp-3790	194	38	in	in	ADP
fnp-3790	194	39	the	the	DET
fnp-3790	194	40	respective	respective	ADJ
fnp-3790	194	41	parkinson	parkinson	NOUN
fnp-3790	194	42	’s	’s	PART
fnp-3790	194	43	disease	disease	NOUN
fnp-3790	194	44	model	model	NOUN
fnp-3790	194	45	(	(	PUNCT
fnp-3790	194	46	williams	williams	PROPN
fnp-3790	194	47	et	et	PROPN
fnp-3790	194	48	al	al	PROPN
fnp-3790	194	49	.	.	PROPN
fnp-3790	194	50	2021	2021	NUM
fnp-3790	194	51	)	)	PUNCT
fnp-3790	194	52	.	.	PUNCT
fnp-3790	195	1	despite	despite	SCONJ
fnp-3790	195	2	these	these	DET
fnp-3790	195	3	findings	finding	NOUN
fnp-3790	195	4	,	,	PUNCT
fnp-3790	195	5	which	which	PRON
fnp-3790	195	6	suggest	suggest	VERB
fnp-3790	195	7	a	a	DET
fnp-3790	195	8	pathogenic	pathogenic	ADJ
fnp-3790	195	9	role	role	NOUN
fnp-3790	195	10	of	of	ADP
fnp-3790	195	11	t	t	PROPN
fnp-3790	195	12	-	-	PUNCT
fnp-3790	195	13	cells	cell	NOUN
fnp-3790	195	14	in	in	ADP
fnp-3790	195	15	parkinson	parkinson	NOUN
fnp-3790	195	16	’s	’s	PART
fnp-3790	195	17	disease	disease	NOUN
fnp-3790	195	18	and	and	CCONJ
fnp-3790	195	19	other	other	ADJ
fnp-3790	195	20	neurodegenerative	neurodegenerative	ADJ
fnp-3790	195	21	diseases	disease	NOUN
fnp-3790	195	22	,	,	PUNCT
fnp-3790	195	23	it	it	PRON
fnp-3790	195	24	remains	remain	VERB
fnp-3790	195	25	unresolved	unresolved	ADJ
fnp-3790	195	26	whether	whether	SCONJ
fnp-3790	195	27	this	this	PRON
fnp-3790	195	28	is	be	AUX
fnp-3790	195	29	mediated	mediate	VERB
fnp-3790	195	30	by	by	ADP
fnp-3790	195	31	autoimmunity	autoimmunity	NOUN
fnp-3790	195	32	.	.	PUNCT
fnp-3790	196	1	no	no	DET
fnp-3790	196	2	proof	proof	NOUN
fnp-3790	196	3	is	be	AUX
fnp-3790	196	4	provided	provide	VERB
fnp-3790	196	5	that	that	SCONJ
fnp-3790	196	6	the	the	DET
fnp-3790	196	7	t	t	NOUN
fnp-3790	196	8	-	-	PUNCT
fnp-3790	196	9	cell	cell	NOUN
fnp-3790	196	10	immune	immune	ADJ
fnp-3790	196	11	reaction	reaction	NOUN
fnp-3790	196	12	is	be	AUX
fnp-3790	196	13	directed	direct	VERB
fnp-3790	196	14	against	against	ADP
fnp-3790	196	15	a	a	DET
fnp-3790	196	16	specific	specific	ADJ
fnp-3790	196	17	autoantigen	autoantigen	NOUN
fnp-3790	196	18	,	,	PUNCT
fnp-3790	196	19	such	such	ADJ
fnp-3790	196	20	as	as	ADP
fnp-3790	196	21	for	for	ADP
fnp-3790	196	22	instance	instance	NOUN
fnp-3790	196	23	α	α	NOUN
fnp-3790	196	24	-	-	NOUN
fnp-3790	196	25	synuclein	synuclein	NOUN
fnp-3790	196	26	(	(	PUNCT
fnp-3790	196	27	williams	williams	PROPN
fnp-3790	196	28	et	et	PROPN
fnp-3790	196	29	al	al	PROPN
fnp-3790	196	30	.	.	PROPN
fnp-3790	196	31	2021	2021	NUM
fnp-3790	196	32	)	)	PUNCT
fnp-3790	196	33	.	.	PUNCT
fnp-3790	197	1	thus	thus	ADV
fnp-3790	197	2	,	,	PUNCT
fnp-3790	197	3	local	local	ADJ
fnp-3790	197	4	overexpression	overexpression	NOUN
fnp-3790	197	5	of	of	ADP
fnp-3790	197	6	α	α	NOUN
fnp-3790	197	7	-	-	PUNCT
fnp-3790	197	8	synuclein	synuclein	NOUN
fnp-3790	197	9	may	may	AUX
fnp-3790	197	10	attract	attract	VERB
fnp-3790	197	11	non	non	ADJ
fnp-3790	197	12	-	-	ADJ
fnp-3790	197	13	specifically	specifically	ADV
fnp-3790	197	14	t	t	NOUN
fnp-3790	197	15	-	-	PUNCT
fnp-3790	197	16	cells	cell	NOUN
fnp-3790	197	17	into	into	ADP
fnp-3790	197	18	the	the	DET
fnp-3790	197	19	brain	brain	NOUN
fnp-3790	197	20	.	.	PUNCT
fnp-3790	198	1	since	since	SCONJ
fnp-3790	198	2	the	the	DET
fnp-3790	198	3	normal	normal	ADJ
fnp-3790	198	4	immune	immune	ADJ
fnp-3790	198	5	repertoire	repertoire	NOUN
fnp-3790	198	6	contains	contain	VERB
fnp-3790	198	7	t	t	NOUN
fnp-3790	198	8	-	-	PUNCT
fnp-3790	198	9	cells	cell	NOUN
fnp-3790	198	10	against	against	ADP
fnp-3790	198	11	a	a	DET
fnp-3790	198	12	variety	variety	NOUN
fnp-3790	198	13	of	of	ADP
fnp-3790	198	14	different	different	ADJ
fnp-3790	198	15	brain	brain	NOUN
fnp-3790	198	16	auto	auto	NOUN
fnp-3790	198	17	-	-	PUNCT
fnp-3790	198	18	antigens	antigen	NOUN
fnp-3790	198	19	(	(	PUNCT
fnp-3790	198	20	wekerle	wekerle	PROPN
fnp-3790	198	21	et	et	PROPN
fnp-3790	198	22	al	al	PROPN
fnp-3790	198	23	.	.	PROPN
fnp-3790	198	24	1996	1996	NUM
fnp-3790	198	25	)	)	PUNCT
fnp-3790	198	26	,	,	PUNCT
fnp-3790	198	27	their	their	PRON
fnp-3790	198	28	activation	activation	NOUN
fnp-3790	198	29	in	in	ADP
fnp-3790	198	30	the	the	DET
fnp-3790	198	31	lesions	lesion	NOUN
fnp-3790	198	32	may	may	AUX
fnp-3790	198	33	just	just	ADV
fnp-3790	198	34	represent	represent	VERB
fnp-3790	198	35	a	a	DET
fnp-3790	198	36	non	non	ADJ
fnp-3790	198	37	-	-	ADJ
fnp-3790	198	38	specific	specific	ADJ
fnp-3790	198	39	consequence	consequence	NOUN
fnp-3790	198	40	of	of	ADP
fnp-3790	198	41	the	the	DET
fnp-3790	198	42	inflammatory	inflammatory	ADJ
fnp-3790	198	43	response	response	NOUN
fnp-3790	198	44	.	.	PUNCT
fnp-3790	199	1	also	also	ADV
fnp-3790	199	2	,	,	PUNCT
fnp-3790	199	3	the	the	DET
fnp-3790	199	4	mechanism	mechanism	NOUN
fnp-3790	199	5	of	of	ADP
fnp-3790	199	6	damage	damage	NOUN
fnp-3790	199	7	of	of	ADP
fnp-3790	199	8	neurons	neuron	NOUN
fnp-3790	199	9	in	in	ADP
fnp-3790	199	10	the	the	DET
fnp-3790	199	11	substantia	substantia	NOUN
fnp-3790	199	12	nigra	nigra	PROPN
fnp-3790	199	13	remains	remain	VERB
fnp-3790	199	14	unresolved	unresolved	ADJ
fnp-3790	199	15	.	.	PUNCT
fnp-3790	200	1	involvement	involvement	NOUN
fnp-3790	200	2	of	of	ADP
fnp-3790	200	3	microglia	microglia	NOUN
fnp-3790	200	4	and	and	CCONJ
fnp-3790	200	5	macrophages	macrophage	NOUN
fnp-3790	200	6	,	,	PUNCT
fnp-3790	200	7	which	which	PRON
fnp-3790	200	8	are	be	AUX
fnp-3790	200	9	activated	activate	VERB
fnp-3790	200	10	by	by	ADP
fnp-3790	200	11	the	the	DET
fnp-3790	200	12	t	t	PROPN
fnp-3790	200	13	-	-	PUNCT
fnp-3790	200	14	cell	cell	NOUN
fnp-3790	200	15	mediated	mediate	VERB
fnp-3790	200	16	immune	immune	ADJ
fnp-3790	200	17	response	response	NOUN
fnp-3790	200	18	,	,	PUNCT
fnp-3790	200	19	is	be	AUX
fnp-3790	200	20	likely	likely	ADJ
fnp-3790	200	21	to	to	PART
fnp-3790	200	22	amplify	amplify	VERB
fnp-3790	200	23	neurodegeneration	neurodegeneration	NOUN
fnp-3790	200	24	,	,	PUNCT
fnp-3790	200	25	but	but	CCONJ
fnp-3790	200	26	innate	innate	ADJ
fnp-3790	200	27	immunity	immunity	NOUN
fnp-3790	200	28	alone	alone	ADV
fnp-3790	200	29	will	will	AUX
fnp-3790	200	30	not	not	PART
fnp-3790	200	31	specifically	specifically	ADV
fnp-3790	200	32	and	and	CCONJ
fnp-3790	200	33	selectively	selectively	ADV
fnp-3790	200	34	target	target	VERB
fnp-3790	200	35	dopaminergic	dopaminergic	ADJ
fnp-3790	200	36	neurons	neuron	NOUN
fnp-3790	200	37	(	(	PUNCT
fnp-3790	200	38	lassmann	lassmann	NOUN
fnp-3790	200	39	and	and	CCONJ
fnp-3790	200	40	van	van	PROPN
fnp-3790	200	41	horssen	horssen	PROPN
fnp-3790	200	42	2011	2011	NUM
fnp-3790	200	43	)	)	PUNCT
fnp-3790	200	44	.	.	PUNCT
fnp-3790	201	1	finally	finally	ADV
fnp-3790	201	2	,	,	PUNCT
fnp-3790	201	3	the	the	DET
fnp-3790	201	4	amelioration	amelioration	NOUN
fnp-3790	201	5	of	of	ADP
fnp-3790	201	6	neuronal	neuronal	ADJ
fnp-3790	201	7	damage	damage	NOUN
fnp-3790	201	8	in	in	ADP
fnp-3790	201	9	animals	animal	NOUN
fnp-3790	201	10	treated	treat	VERB
fnp-3790	201	11	with	with	ADP
fnp-3790	201	12	fingolimod	fingolimod	NOUN
fnp-3790	201	13	does	do	AUX
fnp-3790	201	14	not	not	PART
fnp-3790	201	15	necessarily	necessarily	ADV
fnp-3790	201	16	prove	prove	VERB
fnp-3790	201	17	immune	immune	ADJ
fnp-3790	201	18	mediated	mediate	VERB
fnp-3790	201	19	damage	damage	NOUN
fnp-3790	201	20	,	,	PUNCT
fnp-3790	201	21	since	since	SCONJ
fnp-3790	201	22	the	the	DET
fnp-3790	201	23	modulation	modulation	NOUN
fnp-3790	201	24	of	of	ADP
fnp-3790	201	25	sphingosine	sphingosine	NOUN
fnp-3790	201	26	1	1	NUM
fnp-3790	201	27	phosphate	phosphate	NOUN
fnp-3790	201	28	receptors	receptor	NOUN
fnp-3790	201	29	may	may	AUX
fnp-3790	201	30	also	also	ADV
fnp-3790	201	31	have	have	VERB
fnp-3790	201	32	direct	direct	ADJ
fnp-3790	201	33	neuroprotective	neuroprotective	ADJ
fnp-3790	201	34	effects	effect	NOUN
fnp-3790	201	35	(	(	PUNCT
fnp-3790	201	36	colombo	colombo	NOUN
fnp-3790	201	37	and	and	CCONJ
fnp-3790	201	38	farina	farina	PROPN
fnp-3790	201	39	2022	2022	NUM
fnp-3790	201	40	)	)	PUNCT
fnp-3790	201	41	.	.	PUNCT
fnp-3790	202	1	thus	thus	ADV
fnp-3790	202	2	,	,	PUNCT
fnp-3790	202	3	the	the	DET
fnp-3790	202	4	study	study	NOUN
fnp-3790	202	5	by	by	ADP
fnp-3790	202	6	williams	williams	PROPN
fnp-3790	202	7	et	et	PROPN
fnp-3790	202	8	al	al	PROPN
fnp-3790	202	9	.	.	PROPN
fnp-3790	203	1	(	(	PUNCT
fnp-3790	203	2	2021	2021	NUM
fnp-3790	203	3	)	)	PUNCT
fnp-3790	203	4	supports	support	VERB
fnp-3790	203	5	a	a	DET
fnp-3790	203	6	possible	possible	ADJ
fnp-3790	203	7	involvement	involvement	NOUN
fnp-3790	203	8	of	of	ADP
fnp-3790	203	9	t	t	PROPN
fnp-3790	203	10	-	-	PUNCT
fnp-3790	203	11	cell	cell	NOUN
fnp-3790	203	12	mediated	mediate	VERB
fnp-3790	203	13	mechanisms	mechanism	NOUN
fnp-3790	203	14	in	in	ADP
fnp-3790	203	15	neurodegeneration	neurodegeneration	NOUN
fnp-3790	203	16	in	in	ADP
fnp-3790	203	17	parkinson	parkinson	NOUN
fnp-3790	203	18	’s	’s	PART
fnp-3790	203	19	disease	disease	NOUN
fnp-3790	203	20	,	,	PUNCT
fnp-3790	203	21	but	but	CCONJ
fnp-3790	203	22	further	further	ADJ
fnp-3790	203	23	research	research	NOUN
fnp-3790	203	24	is	be	AUX
fnp-3790	203	25	necessary	necessary	ADJ
fnp-3790	203	26	to	to	PART
fnp-3790	203	27	clarify	clarify	VERB
fnp-3790	203	28	the	the	DET
fnp-3790	203	29	underlying	underlie	VERB
fnp-3790	203	30	mechanisms	mechanism	NOUN
fnp-3790	203	31	.	.	PUNCT
fnp-3790	204	1	the	the	DET
fnp-3790	204	2	local	local	ADJ
fnp-3790	204	3	inflammatory	inflammatory	ADJ
fnp-3790	204	4	response	response	NOUN
fnp-3790	204	5	in	in	ADP
fnp-3790	204	6	gliomas	glioma	NOUN
fnp-3790	204	7	:	:	PUNCT
fnp-3790	204	8	good	good	ADJ
fnp-3790	204	9	or	or	CCONJ
fnp-3790	204	10	bad	bad	ADJ
fnp-3790	204	11	or	or	CCONJ
fnp-3790	204	12	irrelevant	irrelevant	ADJ
fnp-3790	204	13	?	?	PUNCT
fnp-3790	205	1	it	it	PRON
fnp-3790	205	2	is	be	AUX
fnp-3790	205	3	generally	generally	ADV
fnp-3790	205	4	accepted	accept	VERB
fnp-3790	205	5	that	that	SCONJ
fnp-3790	205	6	local	local	ADJ
fnp-3790	205	7	inflammation	inflammation	NOUN
fnp-3790	205	8	is	be	AUX
fnp-3790	205	9	present	present	ADJ
fnp-3790	205	10	in	in	ADP
fnp-3790	205	11	the	the	DET
fnp-3790	205	12	malignant	malignant	ADJ
fnp-3790	205	13	gliomas	glioma	NOUN
fnp-3790	205	14	,	,	PUNCT
fnp-3790	205	15	but	but	CCONJ
fnp-3790	205	16	it	it	PRON
fnp-3790	205	17	is	be	AUX
fnp-3790	205	18	largely	largely	ADV
fnp-3790	205	19	unresolved	unresolved	ADJ
fnp-3790	205	20	whether	whether	SCONJ
fnp-3790	205	21	this	this	PRON
fnp-3790	205	22	is	be	AUX
fnp-3790	205	23	beneficial	beneficial	ADJ
fnp-3790	205	24	or	or	CCONJ
fnp-3790	205	25	detrimental	detrimental	ADJ
fnp-3790	205	26	for	for	ADP
fnp-3790	205	27	the	the	DET
fnp-3790	205	28	patients	patient	NOUN
fnp-3790	205	29	(	(	PUNCT
fnp-3790	205	30	jack	jack	PROPN
fnp-3790	205	31	and	and	CCONJ
fnp-3790	205	32	lu	lu	PROPN
fnp-3790	205	33	2015	2015	NUM
fnp-3790	205	34	)	)	PUNCT
fnp-3790	205	35	.	.	PUNCT
fnp-3790	206	1	overall	overall	ADV
fnp-3790	206	2	,	,	PUNCT
fnp-3790	206	3	there	there	PRON
fnp-3790	206	4	is	be	VERB
fnp-3790	206	5	an	an	DET
fnp-3790	206	6	immunosuppressive	immunosuppressive	ADJ
fnp-3790	206	7	environment	environment	NOUN
fnp-3790	206	8	within	within	ADP
fnp-3790	206	9	gliomas	glioma	NOUN
fnp-3790	206	10	due	due	ADP
fnp-3790	206	11	to	to	ADP
fnp-3790	206	12	the	the	DET
fnp-3790	206	13	production	production	NOUN
fnp-3790	206	14	of	of	ADP
fnp-3790	206	15	anti	anti	ADJ
fnp-3790	206	16	-	-	ADJ
fnp-3790	206	17	inflammatory	inflammatory	ADJ
fnp-3790	206	18	cytokines	cytokine	NOUN
fnp-3790	206	19	,	,	PUNCT
fnp-3790	206	20	such	such	ADJ
fnp-3790	206	21	as	as	ADP
fnp-3790	206	22	transforming	transform	VERB
fnp-3790	206	23	growth	growth	NOUN
fnp-3790	206	24	factor	factor	NOUN
fnp-3790	206	25	β	β	X
fnp-3790	206	26	(	(	PUNCT
fnp-3790	206	27	tgf	tgf	PROPN
fnp-3790	206	28	-	-	PUNCT
fnp-3790	206	29	β	β	NOUN
fnp-3790	206	30	)	)	PUNCT
fnp-3790	206	31	in	in	ADP
fnp-3790	206	32	the	the	DET
fnp-3790	206	33	tumor	tumor	NOUN
fnp-3790	206	34	cells	cell	NOUN
fnp-3790	206	35	(	(	PUNCT
fnp-3790	206	36	binnewies	binnewie	NOUN
fnp-3790	206	37	et	et	PROPN
fnp-3790	206	38	al	al	PROPN
fnp-3790	206	39	.	.	PROPN
fnp-3790	206	40	2018	2018	NUM
fnp-3790	206	41	,	,	PUNCT
fnp-3790	206	42	brown	brown	PROPN
fnp-3790	206	43	et	et	PROPN
fnp-3790	206	44	al	al	PROPN
fnp-3790	206	45	.	.	PROPN
fnp-3790	206	46	2018	2018	NUM
fnp-3790	206	47	)	)	PUNCT
fnp-3790	206	48	.	.	PUNCT
fnp-3790	207	1	the	the	DET
fnp-3790	207	2	extent	extent	NOUN
fnp-3790	207	3	of	of	ADP
fnp-3790	207	4	tgf	tgf	PROPN
fnp-3790	207	5	-	-	PUNCT
fnp-3790	207	6	β	β	NOUN
fnp-3790	207	7	expression	expression	NOUN
fnp-3790	207	8	is	be	AUX
fnp-3790	207	9	,	,	PUNCT
fnp-3790	207	10	however	however	ADV
fnp-3790	207	11	,	,	PUNCT
fnp-3790	207	12	variable	variable	NOUN
fnp-3790	207	13	between	between	ADP
fnp-3790	207	14	patients	patient	NOUN
fnp-3790	207	15	and	and	CCONJ
fnp-3790	207	16	one	one	PRON
fnp-3790	207	17	expects	expect	VERB
fnp-3790	207	18	that	that	SCONJ
fnp-3790	207	19	lower	low	ADJ
fnp-3790	207	20	levels	level	NOUN
fnp-3790	207	21	of	of	ADP
fnp-3790	207	22	immunosuppression	immunosuppression	NOUN
fnp-3790	207	23	is	be	AUX
fnp-3790	207	24	associated	associate	VERB
fnp-3790	207	25	with	with	ADP
fnp-3790	207	26	inflammation	inflammation	NOUN
fnp-3790	207	27	,	,	PUNCT
fnp-3790	207	28	immune	immune	ADJ
fnp-3790	207	29	attack	attack	NOUN
fnp-3790	207	30	of	of	ADP
fnp-3790	207	31	tumor	tumor	NOUN
fnp-3790	207	32	cells	cell	NOUN
fnp-3790	207	33	and	and	CCONJ
fnp-3790	207	34	good	good	ADJ
fnp-3790	207	35	clinical	clinical	ADJ
fnp-3790	207	36	prognosis	prognosis	NOUN
fnp-3790	207	37	in	in	ADP
fnp-3790	207	38	patients	patient	NOUN
fnp-3790	207	39	.	.	PUNCT
fnp-3790	208	1	alternatively	alternatively	ADV
fnp-3790	208	2	,	,	PUNCT
fnp-3790	208	3	high	high	ADJ
fnp-3790	208	4	density	density	NOUN
fnp-3790	208	5	of	of	ADP
fnp-3790	208	6	inflammatory	inflammatory	ADJ
fnp-3790	208	7	cells	cell	NOUN
fnp-3790	208	8	within	within	ADP
fnp-3790	208	9	the	the	DET
fnp-3790	208	10	tumor	tumor	NOUN
fnp-3790	208	11	may	may	AUX
fnp-3790	208	12	be	be	AUX
fnp-3790	208	13	secondary	secondary	ADJ
fnp-3790	208	14	to	to	ADP
fnp-3790	208	15	more	more	ADV
fnp-3790	208	16	aggressive	aggressive	ADJ
fnp-3790	208	17	tissue	tissue	NOUN
fnp-3790	208	18	damage	damage	NOUN
fnp-3790	208	19	and	and	CCONJ
fnp-3790	208	20	associated	associate	VERB
fnp-3790	208	21	with	with	ADP
fnp-3790	208	22	a	a	DET
fnp-3790	208	23	less	less	ADV
fnp-3790	208	24	favorable	favorable	ADJ
fnp-3790	208	25	prognosis	prognosis	NOUN
fnp-3790	208	26	.	.	PUNCT
fnp-3790	209	1	in	in	ADP
fnp-3790	209	2	addition	addition	NOUN
fnp-3790	209	3	,	,	PUNCT
fnp-3790	209	4	the	the	DET
fnp-3790	209	5	inflammatory	inflammatory	ADJ
fnp-3790	209	6	response	response	NOUN
fnp-3790	209	7	itself	itself	PRON
fnp-3790	209	8	may	may	AUX
fnp-3790	209	9	be	be	AUX
fnp-3790	209	10	dominated	dominate	VERB
fnp-3790	209	11	by	by	ADP
fnp-3790	209	12	pro	pro	ADJ
fnp-3790	209	13	-	-	ADJ
fnp-3790	209	14	inflammatory	inflammatory	ADJ
fnp-3790	209	15	activated	activate	VERB
fnp-3790	209	16	cytotoxic	cytotoxic	ADJ
fnp-3790	209	17	effector	effector	NOUN
fnp-3790	209	18	cells	cell	NOUN
fnp-3790	209	19	or	or	CCONJ
fnp-3790	209	20	by	by	ADP
fnp-3790	209	21	regulatory	regulatory	ADJ
fnp-3790	209	22	t	t	PROPN
fnp-3790	209	23	-	-	PUNCT
fnp-3790	209	24	cells	cell	NOUN
fnp-3790	209	25	and	and	CCONJ
fnp-3790	209	26	myeloid	myeloid	NOUN
fnp-3790	209	27	-	-	PUNCT
fnp-3790	209	28	derived	derive	VERB
fnp-3790	209	29	suppressor	suppressor	NOUN
fnp-3790	209	30	cells	cell	NOUN
fnp-3790	209	31	,	,	PUNCT
fnp-3790	209	32	and	and	CCONJ
fnp-3790	209	33	this	this	PRON
fnp-3790	209	34	,	,	PUNCT
fnp-3790	209	35	too	too	ADV
fnp-3790	209	36	,	,	PUNCT
fnp-3790	209	37	may	may	AUX
fnp-3790	209	38	influence	influence	VERB
fnp-3790	209	39	tumor	tumor	NOUN
fnp-3790	209	40	progression	progression	NOUN
fnp-3790	209	41	and	and	CCONJ
fnp-3790	209	42	functional	functional	ADJ
fnp-3790	209	43	outcome	outcome	NOUN
fnp-3790	209	44	(	(	PUNCT
fnp-3790	209	45	kmiecik	kmiecik	X
fnp-3790	209	46	et	et	PROPN
fnp-3790	209	47	al	al	PROPN
fnp-3790	209	48	.	.	PROPN
fnp-3790	209	49	2013	2013	NUM
fnp-3790	209	50	,	,	PUNCT
fnp-3790	209	51	2014	2014	NUM
fnp-3790	209	52	,	,	PUNCT
fnp-3790	209	53	gabriely	gabriely	ADV
fnp-3790	209	54	et	et	VERB
fnp-3790	209	55	al	al	PROPN
fnp-3790	209	56	.	.	PROPN
fnp-3790	209	57	2017	2017	NUM
fnp-3790	209	58	)	)	PUNCT
fnp-3790	209	59	.	.	PUNCT
fnp-3790	210	1	several	several	ADJ
fnp-3790	210	2	studies	study	NOUN
fnp-3790	210	3	have	have	AUX
fnp-3790	210	4	so	so	ADV
fnp-3790	210	5	far	far	ADV
fnp-3790	210	6	analyzed	analyze	VERB
fnp-3790	210	7	the	the	DET
fnp-3790	210	8	phenotype	phenotype	NOUN
fnp-3790	210	9	of	of	ADP
fnp-3790	210	10	tumor	tumor	NOUN
fnp-3790	210	11	-	-	PUNCT
fnp-3790	210	12	infiltrating	infiltrate	VERB
fnp-3790	210	13	inflammatory	inflammatory	ADJ
fnp-3790	210	14	cells	cell	NOUN
fnp-3790	210	15	and	and	CCONJ
fnp-3790	210	16	its	its	PRON
fnp-3790	210	17	relation	relation	NOUN
fnp-3790	210	18	to	to	ADP
fnp-3790	210	19	clinical	clinical	ADJ
fnp-3790	210	20	outcome	outcome	NOUN
fnp-3790	210	21	,	,	PUNCT
fnp-3790	210	22	but	but	CCONJ
fnp-3790	210	23	the	the	DET
fnp-3790	210	24	results	result	NOUN
fnp-3790	210	25	are	be	AUX
fnp-3790	210	26	variable	variable	ADJ
fnp-3790	210	27	and	and	CCONJ
fnp-3790	210	28	in	in	ADP
fnp-3790	210	29	part	part	NOUN
fnp-3790	210	30	contradictory	contradictory	ADJ
fnp-3790	210	31	(	(	PUNCT
fnp-3790	210	32	charles	charles	PROPN
fnp-3790	210	33	et	et	PROPN
fnp-3790	210	34	al	al	PROPN
fnp-3790	210	35	.	.	PROPN
fnp-3790	210	36	2012	2012	NUM
fnp-3790	210	37	,	,	PUNCT
fnp-3790	210	38	szulzewsky	szulzewsky	PROPN
fnp-3790	210	39	et	et	PROPN
fnp-3790	210	40	al	al	PROPN
fnp-3790	210	41	.	.	PROPN
fnp-3790	210	42	2015	2015	NUM
fnp-3790	210	43	,	,	PUNCT
fnp-3790	210	44	orrego	orrego	NOUN
fnp-3790	210	45	et	et	NOUN
fnp-3790	210	46	al	al	PROPN
fnp-3790	210	47	.	.	PROPN
fnp-3790	210	48	2018	2018	NUM
fnp-3790	210	49	,	,	PUNCT
fnp-3790	210	50	martinez	martinez	PROPN
fnp-3790	210	51	et	et	PROPN
fnp-3790	210	52	al	al	PROPN
fnp-3790	210	53	.	.	PROPN
fnp-3790	210	54	2009	2009	NUM
fnp-3790	210	55	,	,	PUNCT
fnp-3790	210	56	zhang	zhang	PROPN
fnp-3790	210	57	et	et	PROPN
fnp-3790	210	58	al	al	PROPN
fnp-3790	210	59	.	.	PROPN
fnp-3790	210	60	2019	2019	NUM
fnp-3790	210	61	)	)	PUNCT
fnp-3790	210	62	.	.	PUNCT
fnp-3790	211	1	this	this	PRON
fnp-3790	211	2	is	be	AUX
fnp-3790	211	3	mainly	mainly	ADV
fnp-3790	211	4	due	due	ADJ
fnp-3790	211	5	to	to	ADP
fnp-3790	211	6	the	the	DET
fnp-3790	211	7	fact	fact	NOUN
fnp-3790	211	8	that	that	SCONJ
fnp-3790	211	9	the	the	DET
fnp-3790	211	10	studies	study	NOUN
fnp-3790	211	11	were	be	AUX
fnp-3790	211	12	performed	perform	VERB
fnp-3790	211	13	by	by	ADP
fnp-3790	211	14	immunocytochemistry	immunocytochemistry	NOUN
fnp-3790	211	15	,	,	PUNCT
fnp-3790	211	16	which	which	PRON
fnp-3790	211	17	does	do	AUX
fnp-3790	211	18	not	not	PART
fnp-3790	211	19	allow	allow	VERB
fnp-3790	211	20	the	the	DET
fnp-3790	211	21	simultaneous	simultaneous	ADJ
fnp-3790	211	22	analysis	analysis	NOUN
fnp-3790	211	23	of	of	ADP
fnp-3790	211	24	a	a	DET
fnp-3790	211	25	large	large	ADJ
fnp-3790	211	26	spectrum	spectrum	NOUN
fnp-3790	211	27	of	of	ADP
fnp-3790	211	28	different	different	ADJ
fnp-3790	211	29	immune	immune	ADJ
fnp-3790	211	30	cells	cell	NOUN
fnp-3790	211	31	.	.	PUNCT
fnp-3790	212	1	this	this	DET
fnp-3790	212	2	problem	problem	NOUN
fnp-3790	212	3	was	be	AUX
fnp-3790	212	4	addressed	address	VERB
fnp-3790	212	5	in	in	ADP
fnp-3790	212	6	a	a	DET
fnp-3790	212	7	recent	recent	ADJ
fnp-3790	212	8	study	study	NOUN
fnp-3790	212	9	by	by	ADP
fnp-3790	212	10	applying	apply	VERB
fnp-3790	212	11	flow	flow	NOUN
fnp-3790	212	12	cytometry	cytometry	NOUN
fnp-3790	212	13	of	of	ADP
fnp-3790	212	14	dissociated	dissociate	VERB
fnp-3790	212	15	cells	cell	NOUN
fnp-3790	212	16	from	from	ADP
fnp-3790	212	17	a	a	DET
fnp-3790	212	18	large	large	ADJ
fnp-3790	212	19	number	number	NOUN
fnp-3790	212	20	of	of	ADP
fnp-3790	212	21	biopsy	biopsy	NOUN
fnp-3790	212	22	samples	sample	NOUN
fnp-3790	212	23	from	from	ADP
fnp-3790	212	24	carefully	carefully	ADV
fnp-3790	212	25	characterized	characterize	VERB
fnp-3790	212	26	glioblastoma	glioblastoma	NOUN
fnp-3790	212	27	patients	patient	NOUN
fnp-3790	212	28	(	(	PUNCT
fnp-3790	212	29	gonzales	gonzale	NOUN
fnp-3790	212	30	-	-	PUNCT
fnp-3790	212	31	tablas	tabla	NOUN
fnp-3790	212	32	pimenta	pimenta	PROPN
fnp-3790	212	33	et	et	PROPN
fnp-3790	212	34	al	al	PROPN
fnp-3790	212	35	.	.	PROPN
fnp-3790	212	36	2021	2021	NUM
fnp-3790	212	37	)	)	PUNCT
fnp-3790	212	38	.	.	PUNCT
fnp-3790	213	1	by	by	ADP
fnp-3790	213	2	using	use	VERB
fnp-3790	213	3	novel	novel	ADJ
fnp-3790	213	4	state	state	NOUN
fnp-3790	213	5	-	-	PUNCT
fnp-3790	213	6	of	of	ADP
fnp-3790	213	7	-	-	PUNCT
fnp-3790	213	8	the	the	DET
fnp-3790	213	9	-	-	PUNCT
fnp-3790	213	10	art	art	NOUN
fnp-3790	213	11	techniques	technique	NOUN
fnp-3790	213	12	of	of	ADP
fnp-3790	213	13	multi	multi	ADJ
fnp-3790	213	14	-	-	ADJ
fnp-3790	213	15	antibody	antibody	ADJ
fnp-3790	213	16	and	and	CCONJ
fnp-3790	213	17	multi	multi	ADJ
fnp-3790	213	18	-	-	ADJ
fnp-3790	213	19	color	color	ADJ
fnp-3790	213	20	labeling	labeling	NOUN
fnp-3790	213	21	,	,	PUNCT
fnp-3790	213	22	a	a	DET
fnp-3790	213	23	simultaneous	simultaneous	ADJ
fnp-3790	213	24	quantitative	quantitative	ADJ
fnp-3790	213	25	evaluation	evaluation	NOUN
fnp-3790	213	26	of	of	ADP
fnp-3790	213	27	all	all	DET
fnp-3790	213	28	different	different	ADJ
fnp-3790	213	29	leukocyte	leukocyte	NOUN
fnp-3790	213	30	populations	population	NOUN
fnp-3790	213	31	was	be	AUX
fnp-3790	213	32	possible	possible	ADJ
fnp-3790	213	33	.	.	PUNCT
fnp-3790	214	1	as	as	SCONJ
fnp-3790	214	2	shown	show	VERB
fnp-3790	214	3	before	before	ADV
fnp-3790	214	4	,	,	PUNCT
fnp-3790	214	5	the	the	DET
fnp-3790	214	6	study	study	NOUN
fnp-3790	214	7	revealed	reveal	VERB
fnp-3790	214	8	that	that	SCONJ
fnp-3790	214	9	on	on	ADP
fnp-3790	214	10	average	average	ADJ
fnp-3790	214	11	only	only	ADV
fnp-3790	214	12	a	a	DET
fnp-3790	214	13	quarter	quarter	NOUN
fnp-3790	214	14	of	of	ADP
fnp-3790	214	15	the	the	DET
fnp-3790	214	16	total	total	ADJ
fnp-3790	214	17	cell	cell	NOUN
fnp-3790	214	18	population	population	NOUN
fnp-3790	214	19	were	be	AUX
fnp-3790	214	20	cd45	cd45	PROPN
fnp-3790	214	21	+	+	CCONJ
fnp-3790	214	22	immune	immune	ADJ
fnp-3790	214	23	cells	cell	NOUN
fnp-3790	214	24	,	,	PUNCT
fnp-3790	214	25	two	two	NUM
fnp-3790	214	26	thirds	third	NOUN
fnp-3790	214	27	of	of	ADP
fnp-3790	214	28	them	they	PRON
fnp-3790	214	29	being	be	AUX
fnp-3790	214	30	tumor	tumor	NOUN
fnp-3790	214	31	-	-	PUNCT
fnp-3790	214	32	associated	associate	VERB
fnp-3790	214	33	macrophages	macrophage	NOUN
fnp-3790	214	34	of	of	ADP
fnp-3790	214	35	hematogenous	hematogenous	ADJ
fnp-3790	214	36	or	or	CCONJ
fnp-3790	214	37	microglia	microglia	ADJ
fnp-3790	214	38	origin	origin	NOUN
fnp-3790	214	39	and	and	CCONJ
fnp-3790	214	40	granulocytes	granulocyte	NOUN
fnp-3790	214	41	.	.	PUNCT
fnp-3790	215	1	the	the	DET
fnp-3790	215	2	lymphocyte	lymphocyte	ADJ
fnp-3790	215	3	population	population	NOUN
fnp-3790	215	4	mainly	mainly	ADV
fnp-3790	215	5	consisted	consist	VERB
fnp-3790	215	6	of	of	ADP
fnp-3790	215	7	mhc	mhc	PROPN
fnp-3790	215	8	class	class	NOUN
fnp-3790	215	9	i	i	PRON
fnp-3790	215	10	restricted	restrict	VERB
fnp-3790	215	11	cd8	cd8	PROPN
fnp-3790	215	12	+	+	PROPN
fnp-3790	215	13	and	and	CCONJ
fnp-3790	215	14	mhc	mhc	PROPN
fnp-3790	215	15	class	class	PROPN
fnp-3790	215	16	ii	ii	PROPN
fnp-3790	215	17	restricted	restrict	VERB
fnp-3790	215	18	cd4	cd4	PROPN
fnp-3790	215	19	+	+	PROPN
fnp-3790	215	20	t	t	PROPN
fnp-3790	215	21	-	-	PUNCT
fnp-3790	215	22	cells	cell	NOUN
fnp-3790	215	23	.	.	PUNCT
fnp-3790	216	1	the	the	DET
fnp-3790	216	2	infiltration	infiltration	NOUN
fnp-3790	216	3	by	by	ADP
fnp-3790	216	4	regulatory	regulatory	ADJ
fnp-3790	216	5	t	t	PROPN
fnp-3790	216	6	-	-	PUNCT
fnp-3790	216	7	cells	cell	NOUN
fnp-3790	216	8	,	,	PUNCT
fnp-3790	216	9	b	b	X
fnp-3790	216	10	-	-	PUNCT
fnp-3790	216	11	lymphocytes	lymphocytes	ADJ
fnp-3790	216	12	and	and	CCONJ
fnp-3790	216	13	natural	natural	ADJ
fnp-3790	216	14	killer	killer	NOUN
fnp-3790	216	15	cells	cell	NOUN
fnp-3790	216	16	(	(	PUNCT
fnp-3790	216	17	nk	nk	PROPN
fnp-3790	216	18	cells	cell	NOUN
fnp-3790	216	19	)	)	PUNCT
fnp-3790	216	20	was	be	AUX
fnp-3790	216	21	very	very	ADV
fnp-3790	216	22	low	low	ADJ
fnp-3790	216	23	.	.	PUNCT
fnp-3790	217	1	immunosuppressive	immunosuppressive	ADJ
fnp-3790	217	2	cytokines	cytokine	NOUN
fnp-3790	217	3	,	,	PUNCT
fnp-3790	217	4	such	such	ADJ
fnp-3790	217	5	as	as	ADP
fnp-3790	217	6	tgf	tgf	PROPN
fnp-3790	217	7	-	-	PUNCT
fnp-3790	217	8	β	β	PROPN
fnp-3790	217	9	and	and	CCONJ
fnp-3790	217	10	interleukin	interleukin	NOUN
fnp-3790	217	11	10	10	NUM
fnp-3790	217	12	(	(	PUNCT
fnp-3790	217	13	il10	il10	PROPN
fnp-3790	217	14	)	)	PUNCT
fnp-3790	217	15	were	be	AUX
fnp-3790	217	16	mainly	mainly	ADV
fnp-3790	217	17	seen	see	VERB
fnp-3790	217	18	within	within	ADP
fnp-3790	217	19	tumor	tumor	NOUN
fnp-3790	217	20	cells	cell	NOUN
fnp-3790	217	21	and	and	CCONJ
fnp-3790	217	22	in	in	ADP
fnp-3790	217	23	low	low	ADJ
fnp-3790	217	24	incidence	incidence	NOUN
fnp-3790	217	25	in	in	ADP
fnp-3790	217	26	myeloid	myeloid	ADJ
fnp-3790	217	27	derived	derive	VERB
fnp-3790	217	28	suppressor	suppressor	NOUN
fnp-3790	217	29	cells	cell	NOUN
fnp-3790	217	30	.	.	PUNCT
fnp-3790	218	1	the	the	DET
fnp-3790	218	2	broad	broad	ADJ
fnp-3790	218	3	spectrum	spectrum	NOUN
fnp-3790	218	4	of	of	ADP
fnp-3790	218	5	markers	marker	NOUN
fnp-3790	218	6	used	use	VERB
fnp-3790	218	7	simultaneously	simultaneously	ADV
fnp-3790	218	8	in	in	ADP
fnp-3790	218	9	this	this	DET
fnp-3790	218	10	study	study	NOUN
fnp-3790	218	11	allowed	allow	VERB
fnp-3790	218	12	to	to	PART
fnp-3790	218	13	define	define	VERB
fnp-3790	218	14	three	three	NUM
fnp-3790	218	15	patient	patient	ADJ
fnp-3790	218	16	clusters	cluster	NOUN
fnp-3790	218	17	with	with	ADP
fnp-3790	218	18	distinct	distinct	ADJ
fnp-3790	218	19	immune	immune	ADJ
fnp-3790	218	20	infiltration	infiltration	NOUN
fnp-3790	218	21	.	.	PUNCT
fnp-3790	219	1	in	in	ADP
fnp-3790	219	2	the	the	DET
fnp-3790	219	3	first	first	ADJ
fnp-3790	219	4	,	,	PUNCT
fnp-3790	219	5	immune	immune	ADJ
fnp-3790	219	6	cell	cell	NOUN
fnp-3790	219	7	infiltration	infiltration	NOUN
fnp-3790	219	8	was	be	AUX
fnp-3790	219	9	sparse	sparse	ADJ
fnp-3790	219	10	and	and	CCONJ
fnp-3790	219	11	dominated	dominate	VERB
fnp-3790	219	12	by	by	ADP
fnp-3790	219	13	tumor	tumor	NOUN
fnp-3790	219	14	-	-	PUNCT
fnp-3790	219	15	associated	associate	VERB
fnp-3790	219	16	macrophages	macrophage	NOUN
fnp-3790	219	17	.	.	PUNCT
fnp-3790	220	1	in	in	ADP
fnp-3790	220	2	the	the	DET
fnp-3790	220	3	second	second	NOUN
fnp-3790	220	4	,	,	PUNCT
fnp-3790	220	5	the	the	DET
fnp-3790	220	6	tissue	tissue	NOUN
fnp-3790	220	7	infiltration	infiltration	NOUN
fnp-3790	220	8	was	be	AUX
fnp-3790	220	9	profound	profound	ADJ
fnp-3790	220	10	,	,	PUNCT
fnp-3790	220	11	but	but	CCONJ
fnp-3790	220	12	consisted	consist	VERB
fnp-3790	220	13	mainly	mainly	ADV
fnp-3790	220	14	of	of	ADP
fnp-3790	220	15	myeloid	myeloid	ADJ
fnp-3790	220	16	cells	cell	NOUN
fnp-3790	220	17	with	with	ADP
fnp-3790	220	18	little	little	ADJ
fnp-3790	220	19	contribution	contribution	NOUN
fnp-3790	220	20	of	of	ADP
fnp-3790	220	21	lymphocytes	lymphocyte	NOUN
fnp-3790	220	22	.	.	PUNCT
fnp-3790	221	1	in	in	ADP
fnp-3790	221	2	the	the	DET
fnp-3790	221	3	third	third	NOUN
fnp-3790	221	4	,	,	PUNCT
fnp-3790	221	5	the	the	DET
fnp-3790	221	6	immune	immune	ADJ
fnp-3790	221	7	infiltration	infiltration	NOUN
fnp-3790	221	8	,	,	PUNCT
fnp-3790	221	9	too	too	ADV
fnp-3790	221	10	,	,	PUNCT
fnp-3790	221	11	was	be	AUX
fnp-3790	221	12	high	high	ADV
fnp-3790	221	13	containing	contain	VERB
fnp-3790	221	14	high	high	ADJ
fnp-3790	221	15	amounts	amount	NOUN
fnp-3790	221	16	of	of	ADP
fnp-3790	221	17	tumor	tumor	NOUN
fnp-3790	221	18	-	-	PUNCT
fnp-3790	221	19	associated	associate	VERB
fnp-3790	221	20	macrophages	macrophage	NOUN
fnp-3790	221	21	,	,	PUNCT
fnp-3790	221	22	granulocytes	granulocyte	NOUN
fnp-3790	221	23	and	and	CCONJ
fnp-3790	221	24	t	t	NOUN
fnp-3790	221	25	-	-	PUNCT
fnp-3790	221	26	lymphocytes	lymphocyte	NOUN
fnp-3790	221	27	.	.	PUNCT
fnp-3790	222	1	the	the	DET
fnp-3790	222	2	latter	latter	ADJ
fnp-3790	222	3	patient	patient	ADJ
fnp-3790	222	4	cohort	cohort	NOUN
fnp-3790	222	5	showed	show	VERB
fnp-3790	222	6	a	a	DET
fnp-3790	222	7	significantly	significantly	ADV
fnp-3790	222	8	worse	bad	ADJ
fnp-3790	222	9	clinical	clinical	ADJ
fnp-3790	222	10	prognosis	prognosis	NOUN
fnp-3790	222	11	compared	compare	VERB
fnp-3790	222	12	to	to	ADP
fnp-3790	222	13	the	the	DET
fnp-3790	222	14	other	other	ADJ
fnp-3790	222	15	groups	group	NOUN
fnp-3790	222	16	.	.	PUNCT
fnp-3790	223	1	this	this	DET
fnp-3790	223	2	study	study	NOUN
fnp-3790	223	3	represents	represent	VERB
fnp-3790	223	4	an	an	DET
fnp-3790	223	5	important	important	ADJ
fnp-3790	223	6	first	first	ADJ
fnp-3790	223	7	step	step	NOUN
fnp-3790	223	8	for	for	ADP
fnp-3790	223	9	a	a	DET
fnp-3790	223	10	comprehensive	comprehensive	ADJ
fnp-3790	223	11	characterization	characterization	NOUN
fnp-3790	223	12	of	of	ADP
fnp-3790	223	13	the	the	DET
fnp-3790	223	14	local	local	ADJ
fnp-3790	223	15	immune	immune	ADJ
fnp-3790	223	16	response	response	NOUN
fnp-3790	223	17	in	in	ADP
fnp-3790	223	18	gliomas	glioma	NOUN
fnp-3790	223	19	in	in	ADP
fnp-3790	223	20	correlation	correlation	NOUN
fnp-3790	223	21	to	to	ADP
fnp-3790	223	22	clinical	clinical	ADJ
fnp-3790	223	23	prognosis	prognosis	NOUN
fnp-3790	223	24	and	and	CCONJ
fnp-3790	223	25	tumor	tumor	NOUN
fnp-3790	223	26	genotype	genotype	NOUN
fnp-3790	223	27	.	.	PUNCT
fnp-3790	224	1	this	this	DET
fnp-3790	224	2	approach	approach	NOUN
fnp-3790	224	3	will	will	AUX
fnp-3790	224	4	also	also	ADV
fnp-3790	224	5	be	be	AUX
fnp-3790	224	6	essential	essential	ADJ
fnp-3790	224	7	to	to	PART
fnp-3790	224	8	interpret	interpret	VERB
fnp-3790	224	9	the	the	DET
fnp-3790	224	10	effects	effect	NOUN
fnp-3790	224	11	of	of	ADP
fnp-3790	224	12	new	new	ADJ
fnp-3790	224	13	immunotherapies	immunotherapy	NOUN
fnp-3790	224	14	in	in	ADP
fnp-3790	224	15	gliomas	glioma	NOUN
fnp-3790	224	16	.	.	PUNCT
fnp-3790	225	1	conclusions	conclusion	NOUN
fnp-3790	225	2	mechanisms	mechanism	NOUN
fnp-3790	225	3	of	of	ADP
fnp-3790	225	4	adaptive	adaptive	ADJ
fnp-3790	225	5	and	and	CCONJ
fnp-3790	225	6	innate	innate	ADJ
fnp-3790	225	7	immunity	immunity	NOUN
fnp-3790	225	8	appear	appear	VERB
fnp-3790	225	9	to	to	PART
fnp-3790	225	10	be	be	AUX
fnp-3790	225	11	involved	involve	VERB
fnp-3790	225	12	in	in	ADP
fnp-3790	225	13	the	the	DET
fnp-3790	225	14	propagation	propagation	NOUN
fnp-3790	225	15	of	of	ADP
fnp-3790	225	16	neurodegeneration	neurodegeneration	NOUN
fnp-3790	225	17	in	in	ADP
fnp-3790	225	18	many	many	ADJ
fnp-3790	225	19	different	different	ADJ
fnp-3790	225	20	diseases	disease	NOUN
fnp-3790	225	21	,	,	PUNCT
fnp-3790	225	22	including	include	VERB
fnp-3790	225	23	inflammatory	inflammatory	ADJ
fnp-3790	225	24	conditions	condition	NOUN
fnp-3790	225	25	such	such	ADJ
fnp-3790	225	26	as	as	ADP
fnp-3790	225	27	multiple	multiple	ADJ
fnp-3790	225	28	sclerosis	sclerosis	NOUN
fnp-3790	225	29	or	or	CCONJ
fnp-3790	225	30	classical	classical	ADJ
fnp-3790	225	31	neurodegenerative	neurodegenerative	ADJ
fnp-3790	225	32	disorders	disorder	NOUN
fnp-3790	225	33	.	.	PUNCT
fnp-3790	226	1	these	these	DET
fnp-3790	226	2	mechanisms	mechanism	NOUN
fnp-3790	226	3	can	can	AUX
fnp-3790	226	4	now	now	ADV
fnp-3790	226	5	be	be	AUX
fnp-3790	226	6	studied	study	VERB
fnp-3790	226	7	in	in	ADP
fnp-3790	226	8	a	a	DET
fnp-3790	226	9	holistic	holistic	ADJ
fnp-3790	226	10	approach	approach	NOUN
fnp-3790	226	11	with	with	ADP
fnp-3790	226	12	modern	modern	ADJ
fnp-3790	226	13	technologies	technology	NOUN
fnp-3790	226	14	of	of	ADP
fnp-3790	226	15	single	single	ADJ
fnp-3790	226	16	cell	cell	NOUN
fnp-3790	226	17	transcriptomics	transcriptomic	NOUN
fnp-3790	226	18	and	and	CCONJ
fnp-3790	226	19	proteomics	proteomic	NOUN
fnp-3790	226	20	.	.	PUNCT
fnp-3790	227	1	microglia	microglia	NOUN
fnp-3790	227	2	plays	play	VERB
fnp-3790	227	3	a	a	DET
fnp-3790	227	4	central	central	ADJ
fnp-3790	227	5	role	role	NOUN
fnp-3790	227	6	.	.	PUNCT
fnp-3790	228	1	depending	depend	VERB
fnp-3790	228	2	upon	upon	SCONJ
fnp-3790	228	3	the	the	DET
fnp-3790	228	4	type	type	NOUN
fnp-3790	228	5	and	and	CCONJ
fnp-3790	228	6	stage	stage	NOUN
fnp-3790	228	7	of	of	ADP
fnp-3790	228	8	their	their	PRON
fnp-3790	228	9	activation	activation	NOUN
fnp-3790	228	10	they	they	PRON
fnp-3790	228	11	have	have	VERB
fnp-3790	228	12	beneficial	beneficial	ADJ
fnp-3790	228	13	or	or	CCONJ
fnp-3790	228	14	detrimental	detrimental	ADJ
fnp-3790	228	15	roles	role	NOUN
fnp-3790	228	16	.	.	PUNCT
fnp-3790	229	1	the	the	DET
fnp-3790	229	2	effects	effect	NOUN
fnp-3790	229	3	are	be	AUX
fnp-3790	229	4	in	in	ADP
fnp-3790	229	5	part	part	NOUN
fnp-3790	229	6	reproduced	reproduce	VERB
fnp-3790	229	7	in	in	ADP
fnp-3790	229	8	experimental	experimental	ADJ
fnp-3790	229	9	animal	animal	NOUN
fnp-3790	229	10	models	model	NOUN
fnp-3790	229	11	,	,	PUNCT
fnp-3790	229	12	but	but	CCONJ
fnp-3790	229	13	there	there	PRON
fnp-3790	229	14	are	be	VERB
fnp-3790	229	15	major	major	ADJ
fnp-3790	229	16	differences	difference	NOUN
fnp-3790	229	17	in	in	ADP
fnp-3790	229	18	microglia	microglia	ADJ
fnp-3790	229	19	function	function	NOUN
fnp-3790	229	20	between	between	ADP
fnp-3790	229	21	humans	human	NOUN
fnp-3790	229	22	and	and	CCONJ
fnp-3790	229	23	rodents	rodent	NOUN
fnp-3790	229	24	.	.	PUNCT
fnp-3790	230	1	importantly	importantly	ADV
fnp-3790	230	2	,	,	PUNCT
fnp-3790	230	3	microglia	microglia	ADJ
fnp-3790	230	4	-	-	PUNCT
fnp-3790	230	5	associated	associate	VERB
fnp-3790	230	6	neuronal	neuronal	ADJ
fnp-3790	230	7	damage	damage	NOUN
fnp-3790	230	8	results	result	NOUN
fnp-3790	230	9	in	in	ADP
fnp-3790	230	10	a	a	DET
fnp-3790	230	11	preferential	preferential	ADJ
fnp-3790	230	12	vulnerability	vulnerability	NOUN
fnp-3790	230	13	of	of	ADP
fnp-3790	230	14	gabaergic	gabaergic	ADJ
fnp-3790	230	15	interneurons	interneuron	NOUN
fnp-3790	230	16	,	,	PUNCT
fnp-3790	230	17	which	which	PRON
fnp-3790	230	18	results	result	VERB
fnp-3790	230	19	in	in	ADP
fnp-3790	230	20	an	an	DET
fnp-3790	230	21	altered	alter	VERB
fnp-3790	230	22	excitatory	excitatory	NOUN
fnp-3790	230	23	/	/	SYM
fnp-3790	230	24	inhibitory	inhibitory	ADJ
fnp-3790	230	25	balance	balance	NOUN
fnp-3790	230	26	and	and	CCONJ
fnp-3790	230	27	this	this	PRON
fnp-3790	230	28	may	may	AUX
fnp-3790	230	29	in	in	ADP
fnp-3790	230	30	part	part	NOUN
fnp-3790	230	31	explain	explain	VERB
fnp-3790	230	32	the	the	DET
fnp-3790	230	33	association	association	NOUN
fnp-3790	230	34	of	of	ADP
fnp-3790	230	35	brain	brain	NOUN
fnp-3790	230	36	inflammation	inflammation	NOUN
fnp-3790	230	37	with	with	ADP
fnp-3790	230	38	seizures	seizure	NOUN
fnp-3790	230	39	.	.	PUNCT
fnp-3790	231	1	references	reference	NOUN
fnp-3790	231	2	absinta	absinta	PROPN
fnp-3790	231	3	m	m	PROPN
fnp-3790	231	4	,	,	PUNCT
fnp-3790	231	5	sati	sati	PROPN
fnp-3790	231	6	p	p	PROPN
fnp-3790	231	7	,	,	PUNCT
fnp-3790	231	8	schindler	schindler	PROPN
fnp-3790	231	9	m	m	PROPN
fnp-3790	231	10	,	,	PUNCT
fnp-3790	231	11	leibovitch	leibovitch	VERB
fnp-3790	231	12	ec	ec	PROPN
fnp-3790	231	13	,	,	PUNCT
fnp-3790	231	14	ohayon	ohayon	PROPN
fnp-3790	231	15	j	j	PROPN
fnp-3790	231	16	,	,	PUNCT
fnp-3790	231	17	wu	wu	PROPN
fnp-3790	231	18	t	t	PROPN
fnp-3790	231	19	,	,	PUNCT
fnp-3790	231	20	meani	meani	X
fnp-3790	231	21	a	a	PROPN
fnp-3790	231	22	,	,	PUNCT
fnp-3790	231	23	filippi	filippi	PROPN
fnp-3790	231	24	m	m	PROPN
fnp-3790	231	25	,	,	PUNCT
fnp-3790	231	26	jacobson	jacobson	PROPN
fnp-3790	231	27	s	s	PROPN
fnp-3790	231	28	,	,	PUNCT
fnp-3790	231	29	cortese	cortese	PROPN
fnp-3790	231	30	ic	ic	PROPN
fnp-3790	231	31	,	,	PUNCT
fnp-3790	231	32	reich	reich	PROPN
fnp-3790	231	33	ds	ds	PROPN
fnp-3790	231	34	.	.	PROPN
fnp-3790	231	35	persistent	persistent	ADJ
fnp-3790	231	36	7	7	NUM
fnp-3790	231	37	-	-	PUNCT
fnp-3790	231	38	tesla	tesla	NOUN
fnp-3790	231	39	phase	phase	NOUN
fnp-3790	231	40	rim	rim	NOUN
fnp-3790	231	41	predicts	predict	VERB
fnp-3790	231	42	poor	poor	ADJ
fnp-3790	231	43	outcome	outcome	NOUN
fnp-3790	231	44	in	in	ADP
fnp-3790	231	45	new	new	ADJ
fnp-3790	231	46	multiple	multiple	ADJ
fnp-3790	231	47	sclerosis	sclerosis	NOUN
fnp-3790	231	48	patient	patient	NOUN
fnp-3790	231	49	lesions	lesion	NOUN
fnp-3790	231	50	.	.	PUNCT
fnp-3790	232	1	j	j	PROPN
fnp-3790	232	2	clin	clin	PROPN
fnp-3790	232	3	invest	invest	PROPN
fnp-3790	232	4	.	.	PUNCT
fnp-3790	233	1	2016;126:2597	2016;126:2597	NUM
fnp-3790	233	2	-	-	SYM
fnp-3790	233	3	2609	2609	NUM
fnp-3790	233	4	.	.	PUNCT
fnp-3790	234	1	https://doi.org/10.1172/jci86198	https://doi.org/10.1172/jci86198	PROPN
fnp-3790	234	2	epub	epub	PROPN
fnp-3790	234	3	2016	2016	NUM
fnp-3790	234	4	jun	jun	PROPN
fnp-3790	234	5	6	6	NUM
fnp-3790	234	6	.	.	PUNCT
fnp-3790	235	1	pmid	pmid	NOUN
fnp-3790	235	2	:	:	PUNCT
fnp-3790	235	3	27270171	27270171	NUM
fnp-3790	235	4	;	;	PUNCT
fnp-3790	235	5	pmcid	pmcid	NOUN
fnp-3790	235	6	:	:	PUNCT
fnp-3790	235	7	pmc4922708	pmc4922708	NOUN
fnp-3790	235	8	.	.	PUNCT
fnp-3790	236	1	al	al	PROPN
fnp-3790	236	2	-	-	PUNCT
fnp-3790	236	3	sarraj	sarraj	VERB
fnp-3790	236	4	s	s	PROPN
fnp-3790	236	5	,	,	PUNCT
fnp-3790	236	6	troakes	troake	VERB
fnp-3790	236	7	c	c	PROPN
fnp-3790	236	8	,	,	PUNCT
fnp-3790	236	9	hanley	hanley	PROPN
fnp-3790	236	10	b	b	PROPN
fnp-3790	236	11	,	,	PUNCT
fnp-3790	236	12	osborn	osborn	PROPN
fnp-3790	236	13	m	m	PROPN
fnp-3790	236	14	,	,	PUNCT
fnp-3790	236	15	richardson	richardson	PROPN
fnp-3790	236	16	mp	mp	PROPN
fnp-3790	236	17	,	,	PUNCT
fnp-3790	236	18	hotopf	hotopf	NOUN
fnp-3790	236	19	m	m	PROPN
fnp-3790	236	20	,	,	PUNCT
fnp-3790	236	21	bullmore	bullmore	NOUN
fnp-3790	236	22	e	e	NOUN
fnp-3790	236	23	,	,	PUNCT
fnp-3790	236	24	everall	everall	NOUN
fnp-3790	236	25	ip	ip	NOUN
fnp-3790	236	26	.	.	PUNCT
fnp-3790	237	1	invited	invite	VERB
fnp-3790	237	2	review	review	NOUN
fnp-3790	237	3	:	:	PUNCT
fnp-3790	237	4	the	the	DET
fnp-3790	237	5	spectrum	spectrum	NOUN
fnp-3790	237	6	of	of	ADP
fnp-3790	237	7	neuropathology	neuropathology	NOUN
fnp-3790	237	8	in	in	ADP
fnp-3790	237	9	covid-19	covid-19	PROPN
fnp-3790	237	10	.	.	PUNCT
fnp-3790	237	11	neuropathol	neuropathol	PROPN
fnp-3790	237	12	appl	appl	PROPN
fnp-3790	237	13	neurobiol	neurobiol	PROPN
fnp-3790	237	14	.	.	PUNCT
fnp-3790	238	1	2021;47:3	2021;47:3	NUM
fnp-3790	238	2	-	-	SYM
fnp-3790	238	3	16	16	NUM
fnp-3790	238	4	.	.	PUNCT
fnp-3790	239	1	https://doi.org/10.1111/nan.12667	https://doi.org/10.1111/nan.12667	PROPN
fnp-3790	239	2	epub	epub	PROPN
fnp-3790	239	3	2020	2020	NUM
fnp-3790	239	4	oct	oct	PROPN
fnp-3790	239	5	20	20	NUM
fnp-3790	239	6	.	.	PUNCT
fnp-3790	240	1	pmid	pmid	NOUN
fnp-3790	240	2	:	:	PUNCT
fnp-3790	240	3	32935873	32935873	NUM
fnp-3790	240	4	.	.	PUNCT
fnp-3790	241	1	bagnato	bagnato	PROPN
fnp-3790	241	2	f	f	PROPN
fnp-3790	241	3	,	,	PUNCT
fnp-3790	241	4	hametner	hametner	PROPN
fnp-3790	241	5	s	s	PART
fnp-3790	241	6	,	,	PUNCT
fnp-3790	241	7	yao	yao	PROPN
fnp-3790	241	8	b	b	NUM
fnp-3790	241	9	,	,	PUNCT
fnp-3790	241	10	van	van	PROPN
fnp-3790	241	11	gelderen	gelderen	PROPN
fnp-3790	241	12	p	p	X
fnp-3790	241	13	,	,	PUNCT
fnp-3790	241	14	merkle	merkle	NOUN
fnp-3790	241	15	h	h	NOUN
fnp-3790	241	16	,	,	PUNCT
fnp-3790	241	17	cantor	cantor	PROPN
fnp-3790	241	18	fk	fk	PROPN
fnp-3790	241	19	,	,	PUNCT
fnp-3790	241	20	lassmann	lassmann	PROPN
fnp-3790	241	21	h	h	PROPN
fnp-3790	241	22	,	,	PUNCT
fnp-3790	241	23	duyn	duyn	PROPN
fnp-3790	241	24	jh	jh	PROPN
fnp-3790	241	25	.	.	PUNCT
fnp-3790	242	1	tracking	track	VERB
fnp-3790	242	2	iron	iron	NOUN
fnp-3790	242	3	in	in	ADP
fnp-3790	242	4	multiple	multiple	ADJ
fnp-3790	242	5	sclerosis	sclerosis	NOUN
fnp-3790	242	6	:	:	PUNCT
fnp-3790	242	7	a	a	DET
fnp-3790	242	8	combined	combine	VERB
fnp-3790	242	9	imaging	imaging	NOUN
fnp-3790	242	10	and	and	CCONJ
fnp-3790	242	11	histopathological	histopathological	ADJ
fnp-3790	242	12	study	study	NOUN
fnp-3790	242	13	at	at	ADP
fnp-3790	242	14	7	7	NUM
fnp-3790	242	15	tesla	tesla	NOUN
fnp-3790	242	16	.	.	PUNCT
fnp-3790	243	1	brain	brain	NOUN
fnp-3790	243	2	.	.	PUNCT
fnp-3790	244	1	2011;134:3602	2011;134:3602	NUM
fnp-3790	244	2	-	-	SYM
fnp-3790	244	3	3615	3615	NUM
fnp-3790	244	4	.	.	PUNCT
fnp-3790	245	1	https://doi.org/10.1093/brain/awr278	https://doi.org/10.1093/brain/awr278	ADJ
fnp-3790	245	2	pmid	pmid	NOUN
fnp-3790	245	3	:	:	PUNCT
fnp-3790	245	4	22171355	22171355	NUM
fnp-3790	245	5	;	;	PUNCT
fnp-3790	245	6	pmcid	pmcid	ADJ
fnp-3790	245	7	:	:	PUNCT
fnp-3790	245	8	pmc3235560	pmc3235560	ADJ
fnp-3790	245	9	.	.	PUNCT
fnp-3790	246	1	baig	baig	PROPN
fnp-3790	246	2	am	be	AUX
fnp-3790	246	3	.	.	PUNCT
fnp-3790	247	1	chronic	chronic	ADJ
fnp-3790	247	2	long	long	ADJ
fnp-3790	247	3	-	-	PUNCT
fnp-3790	247	4	covid	covid	NOUN
fnp-3790	247	5	syndrome	syndrome	PROPN
fnp-3790	247	6	:	:	PUNCT
fnp-3790	247	7	a	a	DET
fnp-3790	247	8	protracted	protract	VERB
fnp-3790	247	9	covid-19	covid-19	PROPN
fnp-3790	247	10	illness	illness	NOUN
fnp-3790	247	11	with	with	ADP
fnp-3790	247	12	neurological	neurological	ADJ
fnp-3790	247	13	dysfunctions	dysfunction	NOUN
fnp-3790	247	14	.	.	PUNCT
fnp-3790	248	1	cns	cns	PROPN
fnp-3790	248	2	neurosci	neurosci	PROPN
fnp-3790	248	3	ther	ther	ADV
fnp-3790	248	4	.	.	PUNCT
fnp-3790	249	1	2021;27:1433	2021;27:1433	NUM
fnp-3790	249	2	-	-	SYM
fnp-3790	249	3	1436	1436	NUM
fnp-3790	249	4	.	.	PUNCT
fnp-3790	250	1	https://doi.org/10.1111/cns.13737	https://doi.org/10.1111/cns.13737	PROPN
fnp-3790	250	2	epub	epub	PROPN
fnp-3790	250	3	2021	2021	NUM
fnp-3790	250	4	oct	oct	NOUN
fnp-3790	250	5	9	9	NUM
fnp-3790	250	6	.	.	PUNCT
fnp-3790	251	1	pmid	pmid	NOUN
fnp-3790	251	2	:	:	PUNCT
fnp-3790	251	3	34626096	34626096	NUM
fnp-3790	251	4	;	;	PUNCT
fnp-3790	251	5	pmcid	pmcid	ADJ
fnp-3790	251	6	:	:	PUNCT
fnp-3790	251	7	pmc8611765	pmc8611765	PROPN
fnp-3790	251	8	.	.	PUNCT
fnp-3790	252	1	binnewies	binnewies	PROPN
fnp-3790	252	2	m	m	PROPN
fnp-3790	252	3	,	,	PUNCT
fnp-3790	252	4	roberts	roberts	PROPN
fnp-3790	252	5	ew	ew	PROPN
fnp-3790	252	6	,	,	PUNCT
fnp-3790	252	7	kersten	kersten	VERB
fnp-3790	252	8	k	k	PROPN
fnp-3790	252	9	,	,	PUNCT
fnp-3790	252	10	chan	chan	PROPN
fnp-3790	252	11	v	v	PROPN
fnp-3790	252	12	,	,	PUNCT
fnp-3790	252	13	fearon	fearon	PROPN
fnp-3790	252	14	df	df	PROPN
fnp-3790	252	15	,	,	PUNCT
fnp-3790	252	16	merad	merad	PROPN
fnp-3790	252	17	m	m	PROPN
fnp-3790	252	18	,	,	PUNCT
fnp-3790	252	19	coussens	coussen	VERB
fnp-3790	252	20	lm	lm	PROPN
fnp-3790	252	21	,	,	PUNCT
fnp-3790	252	22	gabrilovich	gabrilovich	NOUN
fnp-3790	252	23	di	di	NOUN
fnp-3790	252	24	,	,	PUNCT
fnp-3790	252	25	ostrand	ostrand	PROPN
fnp-3790	252	26	-	-	PUNCT
fnp-3790	252	27	rosenberg	rosenberg	PROPN
fnp-3790	252	28	s	s	PROPN
fnp-3790	252	29	,	,	PUNCT
fnp-3790	252	30	hedrick	hedrick	PROPN
fnp-3790	252	31	cc	cc	PROPN
fnp-3790	252	32	,	,	PUNCT
fnp-3790	252	33	vonderheide	vonderheide	PROPN
fnp-3790	252	34	rh	rh	PROPN
fnp-3790	252	35	,	,	PUNCT
fnp-3790	252	36	pittet	pittet	NOUN
fnp-3790	252	37	mj	mj	PROPN
fnp-3790	252	38	,	,	PUNCT
fnp-3790	252	39	jain	jain	PROPN
fnp-3790	252	40	rk	rk	PROPN
fnp-3790	252	41	,	,	PUNCT
fnp-3790	252	42	zou	zou	PROPN
fnp-3790	252	43	w	w	PROPN
fnp-3790	252	44	,	,	PUNCT
fnp-3790	252	45	howcroft	howcroft	PROPN
fnp-3790	252	46	tk	tk	PROPN
fnp-3790	252	47	,	,	PUNCT
fnp-3790	252	48	woodhouse	woodhouse	PROPN
fnp-3790	252	49	ec	ec	PROPN
fnp-3790	252	50	,	,	PUNCT
fnp-3790	252	51	weinberg	weinberg	PROPN
fnp-3790	252	52	ra	ra	PROPN
fnp-3790	252	53	,	,	PUNCT
fnp-3790	252	54	krummel	krummel	PROPN
fnp-3790	252	55	,	,	PUNCT
fnp-3790	252	56	mf	mf	X
fnp-3790	252	57	.	.	PROPN
fnp-3790	252	58	understanding	understand	VERB
fnp-3790	252	59	the	the	DET
fnp-3790	252	60	tumor	tumor	NOUN
fnp-3790	252	61	immune	immune	ADJ
fnp-3790	252	62	microenvironment	microenvironment	NOUN
fnp-3790	252	63	(	(	PUNCT
fnp-3790	252	64	time	time	NOUN
fnp-3790	252	65	)	)	PUNCT
fnp-3790	252	66	for	for	ADP
fnp-3790	252	67	effective	effective	ADJ
fnp-3790	252	68	therapy	therapy	NOUN
fnp-3790	252	69	.	.	PUNCT
fnp-3790	253	1	nat	nat	PROPN
fnp-3790	253	2	med	med	PROPN
fnp-3790	253	3	.	.	PUNCT
fnp-3790	254	1	2018;24:541–550	2018;24:541–550	PROPN
fnp-3790	254	2	.	.	PUNCT
fnp-3790	255	1	https://doi.org/10.1038/s41591-018-0014-x	https://doi.org/10.1038/s41591-018-0014-x	PROPN
fnp-3790	255	2	epub	epub	PROPN
fnp-3790	255	3	2018	2018	NUM
fnp-3790	255	4	apr	apr	PROPN
fnp-3790	255	5	23	23	NUM
fnp-3790	255	6	.	.	PUNCT
fnp-3790	256	1	pmid	pmid	NOUN
fnp-3790	256	2	:	:	PUNCT
fnp-3790	256	3	29686425	29686425	NUM
fnp-3790	256	4	;	;	PUNCT
fnp-3790	256	5	pmcid	pmcid	NOUN
fnp-3790	256	6	:	:	PUNCT
fnp-3790	256	7	pmc5998822	pmc5998822	PROPN
fnp-3790	256	8	brochard	brochard	PROPN
fnp-3790	256	9	v	v	NOUN
fnp-3790	256	10	,	,	PUNCT
fnp-3790	256	11	combadière	combadière	PROPN
fnp-3790	256	12	b	b	NUM
fnp-3790	256	13	,	,	PUNCT
fnp-3790	256	14	prigent	prigent	NOUN
fnp-3790	256	15	a	a	PRON
fnp-3790	256	16	,	,	PUNCT
fnp-3790	256	17	laouar	laouar	NOUN
fnp-3790	256	18	y	y	PROPN
fnp-3790	256	19	,	,	PUNCT
fnp-3790	256	20	perrin	perrin	NOUN
fnp-3790	256	21	a	a	PRON
fnp-3790	256	22	,	,	PUNCT
fnp-3790	256	23	beray	beray	NOUN
fnp-3790	256	24	-	-	PUNCT
fnp-3790	256	25	berthat	berthat	PROPN
fnp-3790	256	26	v	v	PROPN
fnp-3790	256	27	,	,	PUNCT
fnp-3790	256	28	bonduelle	bonduelle	NOUN
fnp-3790	256	29	o	o	NOUN
fnp-3790	256	30	,	,	PUNCT
fnp-3790	256	31	alvarez	alvarez	PROPN
fnp-3790	256	32	-	-	PUNCT
fnp-3790	256	33	fischer	fischer	PROPN
fnp-3790	256	34	d	d	PROPN
fnp-3790	256	35	,	,	PUNCT
fnp-3790	256	36	callebert	callebert	PROPN
fnp-3790	256	37	j	j	PROPN
fnp-3790	256	38	,	,	PUNCT
fnp-3790	256	39	launay	launay	PROPN
fnp-3790	256	40	jm	jm	PROPN
fnp-3790	256	41	,	,	PUNCT
fnp-3790	256	42	duyckaerts	duyckaerts	PROPN
fnp-3790	256	43	c	c	PROPN
fnp-3790	256	44	,	,	PUNCT
fnp-3790	256	45	flavell	flavell	PROPN
fnp-3790	256	46	ra	ra	PROPN
fnp-3790	256	47	,	,	PUNCT
fnp-3790	256	48	hirsch	hirsch	PROPN
fnp-3790	256	49	ec	ec	PROPN
fnp-3790	256	50	,	,	PUNCT
fnp-3790	256	51	hunot	hunot	PROPN
fnp-3790	256	52	s.	s.	PROPN
fnp-3790	256	53	infiltration	infiltration	NOUN
fnp-3790	256	54	of	of	ADP
fnp-3790	256	55	cd4	cd4	PROPN
fnp-3790	256	56	+	+	PROPN
fnp-3790	256	57	lymphocytes	lymphocyte	NOUN
fnp-3790	256	58	into	into	ADP
fnp-3790	256	59	the	the	DET
fnp-3790	256	60	brain	brain	NOUN
fnp-3790	256	61	contributes	contribute	VERB
fnp-3790	256	62	to	to	ADP
fnp-3790	256	63	neurodegeneration	neurodegeneration	NOUN
fnp-3790	256	64	in	in	ADP
fnp-3790	256	65	a	a	DET
fnp-3790	256	66	mouse	mouse	NOUN
fnp-3790	256	67	model	model	NOUN
fnp-3790	256	68	of	of	ADP
fnp-3790	256	69	parkinson	parkinson	NOUN
fnp-3790	256	70	disease	disease	NOUN
fnp-3790	256	71	.	.	PUNCT
fnp-3790	257	1	j	j	PROPN
fnp-3790	257	2	clin	clin	PROPN
fnp-3790	257	3	invest	invest	PROPN
fnp-3790	257	4	.	.	PUNCT
fnp-3790	258	1	2009;119:182	2009;119:182	NUM
fnp-3790	258	2	-	-	SYM
fnp-3790	258	3	192	192	NUM
fnp-3790	258	4	.	.	PUNCT
fnp-3790	259	1	https://doi.org/10.1172/jci36470	https://doi.org/10.1172/jci36470	PROPN
fnp-3790	259	2	epub	epub	NOUN
fnp-3790	259	3	2008	2008	NUM
fnp-3790	259	4	dec	dec	PROPN
fnp-3790	259	5	22	22	NUM
fnp-3790	259	6	.	.	PUNCT
fnp-3790	260	1	pmid	pmid	NOUN
fnp-3790	260	2	:	:	PUNCT
fnp-3790	260	3	19104149	19104149	NUM
fnp-3790	260	4	;	;	PUNCT
fnp-3790	260	5	pmcid	pmcid	ADJ
fnp-3790	260	6	:	:	PUNCT
fnp-3790	260	7	pmc2613467	pmc2613467	ADJ
fnp-3790	260	8	.	.	PUNCT
fnp-3790	260	9	brown	brown	PROPN
fnp-3790	260	10	nf	nf	PROPN
fnp-3790	260	11	,	,	PUNCT
fnp-3790	260	12	carter	carter	PROPN
fnp-3790	260	13	tj	tj	PROPN
fnp-3790	260	14	,	,	PUNCT
fnp-3790	260	15	ottaviani	ottaviani	PROPN
fnp-3790	260	16	d	d	NOUN
fnp-3790	260	17	,	,	PUNCT
fnp-3790	260	18	mulholland	mulholland	PROPN
fnp-3790	260	19	p.	p.	NOUN
fnp-3790	260	20	harnessing	harness	VERB
fnp-3790	260	21	the	the	DET
fnp-3790	260	22	immune	immune	ADJ
fnp-3790	260	23	system	system	NOUN
fnp-3790	260	24	in	in	ADP
fnp-3790	260	25	glioblastoma	glioblastoma	NOUN
fnp-3790	260	26	.	.	PUNCT
fnp-3790	261	1	br	br	PROPN
fnp-3790	261	2	j	j	PROPN
fnp-3790	261	3	cancer	cancer	NOUN
fnp-3790	261	4	.	.	PUNCT
fnp-3790	262	1	2018;119:1171–1181	2018;119:1171–1181	X
fnp-3790	262	2	.	.	PUNCT
fnp-3790	263	1	https://doi.org/10.1038/s41416-018-0258-8	https://doi.org/10.1038/s41416-018-0258-8	PROPN
fnp-3790	263	2	pmid	pmid	PROPN
fnp-3790	263	3	:	:	PUNCT
fnp-3790	263	4	30393372	30393372	NUM
fnp-3790	263	5	;	;	PUNCT
fnp-3790	263	6	pmcid	pmcid	NOUN
fnp-3790	263	7	:	:	PUNCT
fnp-3790	263	8	pmc6251037	pmc6251037	NOUN
fnp-3790	263	9	.	.	PUNCT
fnp-3790	264	1	bulk	bulk	NOUN
fnp-3790	264	2	m	m	PROPN
fnp-3790	264	3	,	,	PUNCT
fnp-3790	264	4	kenkhuis	kenkhuis	PROPN
fnp-3790	264	5	b	b	PROPN
fnp-3790	264	6	,	,	PUNCT
fnp-3790	264	7	van	van	PROPN
fnp-3790	264	8	der	der	PROPN
fnp-3790	264	9	graaf	graaf	PROPN
fnp-3790	264	10	lm	lm	PROPN
fnp-3790	264	11	,	,	PUNCT
fnp-3790	264	12	goeman	goeman	PROPN
fnp-3790	264	13	jj	jj	PROPN
fnp-3790	264	14	,	,	PUNCT
fnp-3790	264	15	natté	natté	NOUN
fnp-3790	264	16	r	r	NOUN
fnp-3790	264	17	,	,	PUNCT
fnp-3790	264	18	van	van	PROPN
fnp-3790	264	19	der	der	PROPN
fnp-3790	264	20	weerd	weerd	PROPN
fnp-3790	264	21	l.postmortem	l.postmortem	AUX
fnp-3790	265	1	t2*weighted	t2*weighte	VERB
fnp-3790	265	2	mri	mri	NOUN
fnp-3790	265	3	imaging	imaging	NOUN
fnp-3790	265	4	of	of	ADP
fnp-3790	265	5	cortical	cortical	ADJ
fnp-3790	265	6	iron	iron	NOUN
fnp-3790	265	7	reflects	reflect	VERB
fnp-3790	265	8	severity	severity	NOUN
fnp-3790	265	9	of	of	ADP
fnp-3790	265	10	alzheimer	alzheimer	PROPN
fnp-3790	265	11	’s	’s	PART
fnp-3790	265	12	disease	disease	NOUN
fnp-3790	265	13	.	.	PUNCT
fnp-3790	266	1	j	j	PROPN
fnp-3790	266	2	alzheimers	alzheimers	PROPN
fnp-3790	266	3	dis	dis	PROPN
fnp-3790	266	4	.	.	PUNCT
fnp-3790	267	1	2018;65:1125–1137	2018;65:1125–1137	NUM
fnp-3790	267	2	.	.	PUNCT
fnp-3790	268	1	https://doi.org/10.3233/jad-180317	https://doi.org/10.3233/jad-180317	ADJ
fnp-3790	268	2	pmid	pmid	NOUN
fnp-3790	268	3	:	:	PUNCT
fnp-3790	268	4	30103327	30103327	NUM
fnp-3790	268	5	;	;	PUNCT
fnp-3790	268	6	pmcid	pmcid	ADJ
fnp-3790	268	7	:	:	PUNCT
fnp-3790	268	8	pmc6218127	pmc6218127	NOUN
fnp-3790	268	9	.	.	PUNCT
fnp-3790	269	1	butowt	butowt	NOUN
fnp-3790	269	2	r	r	PROPN
fnp-3790	269	3	,	,	PUNCT
fnp-3790	269	4	meunier	meunier	NOUN
fnp-3790	269	5	n	n	CCONJ
fnp-3790	269	6	,	,	PUNCT
fnp-3790	269	7	bryche	bryche	PROPN
fnp-3790	269	8	b	b	NUM
fnp-3790	269	9	,	,	PUNCT
fnp-3790	269	10	von	von	PROPN
fnp-3790	269	11	bartheld	bartheld	PROPN
fnp-3790	269	12	cs	cs	PROPN
fnp-3790	269	13	.	.	PROPN
fnp-3790	270	1	the	the	DET
fnp-3790	270	2	olfactory	olfactory	NOUN
fnp-3790	270	3	nerve	nerve	NOUN
fnp-3790	270	4	is	be	AUX
fnp-3790	270	5	not	not	PART
fnp-3790	270	6	a	a	DET
fnp-3790	270	7	likely	likely	ADJ
fnp-3790	270	8	route	route	NOUN
fnp-3790	270	9	to	to	ADP
fnp-3790	270	10	brain	brain	NOUN
fnp-3790	270	11	infection	infection	NOUN
fnp-3790	270	12	in	in	ADP
fnp-3790	270	13	covid-19	covid-19	PROPN
fnp-3790	270	14	:	:	PUNCT
fnp-3790	270	15	a	a	DET
fnp-3790	270	16	critical	critical	ADJ
fnp-3790	270	17	review	review	NOUN
fnp-3790	270	18	of	of	ADP
fnp-3790	270	19	data	datum	NOUN
fnp-3790	270	20	from	from	ADP
fnp-3790	270	21	humans	human	NOUN
fnp-3790	270	22	and	and	CCONJ
fnp-3790	270	23	animal	animal	NOUN
fnp-3790	270	24	models	model	NOUN
fnp-3790	270	25	.	.	PUNCT
fnp-3790	271	1	acta	acta	PROPN
fnp-3790	271	2	neuropathol	neuropathol	PROPN
fnp-3790	271	3	.	.	PUNCT
fnp-3790	272	1	2021;141:809	2021;141:809	X
fnp-3790	272	2	-	-	PUNCT
fnp-3790	272	3	822	822	NUM
fnp-3790	272	4	.	.	PUNCT
fnp-3790	273	1	https://doi.org/10.1007/s00401-021-02314-2	https://doi.org/10.1007/s00401-021-02314-2	PROPN
fnp-3790	273	2	epub	epub	NOUN
fnp-3790	273	3	2021	2021	NUM
fnp-3790	273	4	apr	apr	NOUN
fnp-3790	273	5	26	26	NUM
fnp-3790	273	6	.	.	PUNCT
fnp-3790	274	1	pmid	pmid	NOUN
fnp-3790	274	2	:	:	PUNCT
fnp-3790	274	3	33903954	33903954	NUM
fnp-3790	274	4	;	;	PUNCT
fnp-3790	274	5	pmcid	pmcid	ADJ
fnp-3790	274	6	:	:	PUNCT
fnp-3790	274	7	pmc8075028	pmc8075028	ADJ
fnp-3790	274	8	.	.	PUNCT
fnp-3790	275	1	charles	charles	PROPN
fnp-3790	275	2	na	na	PROPN
fnp-3790	275	3	,	,	PUNCT
fnp-3790	275	4	holland	holland	PROPN
fnp-3790	275	5	ec	ec	PROPN
fnp-3790	275	6	,	,	PUNCT
fnp-3790	275	7	gilbertson	gilbertson	NOUN
fnp-3790	275	8	r	r	NOUN
fnp-3790	275	9	,	,	PUNCT
fnp-3790	275	10	glass	glass	NOUN
fnp-3790	275	11	r	r	NOUN
fnp-3790	275	12	,	,	PUNCT
fnp-3790	275	13	kettenmann	kettenmann	PROPN
fnp-3790	275	14	h.	h.	PROPN
fnp-3790	276	1	the	the	DET
fnp-3790	276	2	brain	brain	NOUN
fnp-3790	276	3	tumor	tumor	NOUN
fnp-3790	276	4	microenvironment	microenvironment	NOUN
fnp-3790	276	5	.	.	PUNCT
fnp-3790	277	1	glia	glia	PROPN
fnp-3790	277	2	.	.	PUNCT
fnp-3790	278	1	2012;60:502	2012;60:502	NUM
fnp-3790	278	2	-	-	SYM
fnp-3790	278	3	514	514	NUM
fnp-3790	278	4	.	.	PUNCT
fnp-3790	279	1	https://doi.org/10.1002/glia.21264	https://doi.org/10.1002/glia.21264	PROPN
fnp-3790	279	2	pmid	pmid	NOUN
fnp-3790	279	3	:	:	PUNCT
fnp-3790	279	4	22379614	22379614	NUM
fnp-3790	279	5	.	.	PUNCT
fnp-3790	280	1	clements	clements	PROPN
fnp-3790	280	2	rj	rj	PROPN
fnp-3790	280	3	,	,	PUNCT
fnp-3790	280	4	mcdonough	mcdonough	PROPN
fnp-3790	280	5	j	j	PROPN
fnp-3790	280	6	,	,	PUNCT
fnp-3790	280	7	freeman	freeman	PROPN
fnp-3790	280	8	ej	ej	PROPN
fnp-3790	280	9	.	.	PUNCT
fnp-3790	280	10	distribution	distribution	NOUN
fnp-3790	280	11	of	of	ADP
fnp-3790	280	12	parvalbumin	parvalbumin	NOUN
fnp-3790	280	13	and	and	CCONJ
fnp-3790	280	14	calretinin	calretinin	VERB
fnp-3790	280	15	immunoreactive	immunoreactive	ADJ
fnp-3790	280	16	interneurons	interneuron	NOUN
fnp-3790	280	17	in	in	ADP
fnp-3790	280	18	motor	motor	NOUN
fnp-3790	280	19	cortex	cortex	NOUN
fnp-3790	280	20	from	from	ADP
fnp-3790	280	21	multiple	multiple	ADJ
fnp-3790	280	22	sclerosis	sclerosis	NOUN
fnp-3790	280	23	post	post	ADJ
fnp-3790	280	24	-	-	ADJ
fnp-3790	280	25	mortem	mortem	ADJ
fnp-3790	280	26	tissue	tissue	NOUN
fnp-3790	280	27	.	.	PUNCT
fnp-3790	281	1	exp	exp	NOUN
fnp-3790	281	2	brain	brain	NOUN
fnp-3790	281	3	res	re	NOUN
fnp-3790	281	4	.	.	PUNCT
fnp-3790	281	5	2008;187:459	2008;187:459	NUM
fnp-3790	281	6	-	-	SYM
fnp-3790	281	7	465	465	NUM
fnp-3790	281	8	.	.	PUNCT
fnp-3790	282	1	https://doi.org/10.1007/s00221-008-1317-9	https://doi.org/10.1007/s00221-008-1317-9	VERB
fnp-3790	282	2	epub	epub	NOUN
fnp-3790	282	3	2008	2008	NUM
fnp-3790	282	4	feb	feb	NOUN
fnp-3790	282	5	23	23	NUM
fnp-3790	282	6	.	.	PUNCT
fnp-3790	283	1	pmid	pmid	NOUN
fnp-3790	283	2	:	:	PUNCT
fnp-3790	283	3	18297277	18297277	NUM
fnp-3790	283	4	.	.	PUNCT
fnp-3790	284	1	colombo	colombo	PROPN
fnp-3790	284	2	e	e	PROPN
fnp-3790	284	3	,	,	PUNCT
fnp-3790	284	4	farina	farina	PROPN
fnp-3790	284	5	c.	c.	PROPN
fnp-3790	284	6	lessons	lesson	NOUN
fnp-3790	284	7	from	from	ADP
fnp-3790	284	8	s1p	s1p	ADJ
fnp-3790	284	9	receptor	receptor	NOUN
fnp-3790	284	10	targeting	target	VERB
fnp-3790	284	11	in	in	ADP
fnp-3790	284	12	multiple	multiple	ADJ
fnp-3790	284	13	sclerosis	sclerosis	NOUN
fnp-3790	284	14	.	.	PUNCT
fnp-3790	285	1	pharmacol	pharmacol	VERB
fnp-3790	285	2	ther	ther	ADV
fnp-3790	285	3	.	.	PUNCT
fnp-3790	286	1	2022;230:107971	2022;230:107971	X
fnp-3790	286	2	.	.	PUNCT
fnp-3790	287	1	https://doi.org/10.1016/j.pharmthera.2021.107971	https://doi.org/10.1016/j.pharmthera.2021.107971	ADJ
fnp-3790	287	2	epub	epub	NOUN
fnp-3790	287	3	2021	2021	NUM
fnp-3790	287	4	aug	aug	PROPN
fnp-3790	287	5	25	25	NUM
fnp-3790	287	6	.	.	PUNCT
fnp-3790	288	1	pmid	pmid	NOUN
fnp-3790	288	2	:	:	PUNCT
fnp-3790	288	3	34450231	34450231	NUM
fnp-3790	288	4	.	.	PUNCT
fnp-3790	289	1	connor	connor	PROPN
fnp-3790	289	2	jr	jr	PROPN
fnp-3790	289	3	,	,	PUNCT
fnp-3790	289	4	menzies	menzies	PROPN
fnp-3790	289	5	sl	sl	PROPN
fnp-3790	289	6	,	,	PUNCT
fnp-3790	289	7	st	st	PROPN
fnp-3790	289	8	.	.	PROPN
fnp-3790	289	9	martin	martin	PROPN
fnp-3790	289	10	sm	sm	PROPN
fnp-3790	289	11	,	,	PUNCT
fnp-3790	289	12	mufson	mufson	NOUN
fnp-3790	289	13	ej	ej	PROPN
fnp-3790	289	14	.	.	PUNCT
fnp-3790	290	1	a	a	DET
fnp-3790	290	2	histochemical	histochemical	ADJ
fnp-3790	290	3	study	study	NOUN
fnp-3790	290	4	of	of	ADP
fnp-3790	290	5	iron	iron	NOUN
fnp-3790	290	6	,	,	PUNCT
fnp-3790	290	7	transferrin	transferrin	NOUN
fnp-3790	290	8	,	,	PUNCT
fnp-3790	290	9	and	and	CCONJ
fnp-3790	290	10	ferritin	ferritin	ADJ
fnp-3790	290	11	in	in	ADP
fnp-3790	290	12	alzheimer	alzheimer	PROPN
fnp-3790	290	13	’s	’s	PART
fnp-3790	290	14	diseased	diseased	ADJ
fnp-3790	290	15	brains	brain	NOUN
fnp-3790	290	16	.	.	PUNCT
fnp-3790	291	1	j	j	PROPN
fnp-3790	291	2	neurosci	neurosci	PROPN
fnp-3790	291	3	res	re	NOUN
fnp-3790	291	4	.	.	PUNCT
fnp-3790	292	1	1992;31:75–83	1992;31:75–83	NUM
fnp-3790	292	2	.	.	PUNCT
fnp-3790	293	1	https://doi.org/10.1002/jnr.490310111	https://doi.org/10.1002/jnr.490310111	PROPN
fnp-3790	293	2	pmid	pmid	PROPN
fnp-3790	293	3	:	:	PUNCT
fnp-3790	293	4	1613823	1613823	NUM
fnp-3790	293	5	.	.	PUNCT
fnp-3790	294	1	dal	dal	NOUN
fnp-3790	294	2	-	-	PUNCT
fnp-3790	294	3	bianco	bianco	PROPN
fnp-3790	294	4	a	a	PRON
fnp-3790	294	5	,	,	PUNCT
fnp-3790	294	6	grabner	grabner	NOUN
fnp-3790	294	7	g	g	NOUN
fnp-3790	294	8	,	,	PUNCT
fnp-3790	294	9	kronnerwetter	kronnerwetter	NOUN
fnp-3790	294	10	c	c	NOUN
fnp-3790	294	11	,	,	PUNCT
fnp-3790	294	12	weber	weber	PROPN
fnp-3790	294	13	m	m	PROPN
fnp-3790	294	14	,	,	PUNCT
fnp-3790	294	15	höftberger	höftberger	ADJ
fnp-3790	294	16	r	r	NOUN
fnp-3790	294	17	,	,	PUNCT
fnp-3790	294	18	berger	berger	PROPN
fnp-3790	294	19	t	t	PROPN
fnp-3790	294	20	,	,	PUNCT
fnp-3790	294	21	auff	auff	PROPN
fnp-3790	294	22	e	e	NOUN
fnp-3790	294	23	,	,	PUNCT
fnp-3790	294	24	leutmezer	leutmezer	NOUN
fnp-3790	294	25	f	f	PROPN
fnp-3790	294	26	,	,	PUNCT
fnp-3790	294	27	trattnig	trattnig	NOUN
fnp-3790	294	28	s	s	PART
fnp-3790	294	29	,	,	PUNCT
fnp-3790	294	30	lassmann	lassmann	PROPN
fnp-3790	294	31	h	h	NOUN
fnp-3790	294	32	,	,	PUNCT
fnp-3790	294	33	bagnato	bagnato	PROPN
fnp-3790	294	34	f	f	PROPN
fnp-3790	294	35	,	,	PUNCT
fnp-3790	294	36	hametner	hametner	PROPN
fnp-3790	294	37	s.	s.	PROPN
fnp-3790	294	38	slow	slow	ADJ
fnp-3790	294	39	expansion	expansion	NOUN
fnp-3790	294	40	of	of	ADP
fnp-3790	294	41	multiple	multiple	ADJ
fnp-3790	294	42	sclerosis	sclerosis	NOUN
fnp-3790	294	43	iron	iron	NOUN
fnp-3790	294	44	rim	rim	NOUN
fnp-3790	294	45	lesions	lesion	NOUN
fnp-3790	294	46	:	:	PUNCT
fnp-3790	294	47	pathology	pathology	NOUN
fnp-3790	294	48	and	and	CCONJ
fnp-3790	294	49	7	7	NUM
fnp-3790	294	50	t	t	NOUN
fnp-3790	294	51	magnetic	magnetic	ADJ
fnp-3790	294	52	resonance	resonance	NOUN
fnp-3790	294	53	imaging	imaging	NOUN
fnp-3790	294	54	.	.	PUNCT
fnp-3790	295	1	acta	acta	PROPN
fnp-3790	295	2	neuropathol	neuropathol	PROPN
fnp-3790	295	3	.	.	PUNCT
fnp-3790	296	1	2017;133:25	2017;133:25	NUM
fnp-3790	296	2	-	-	SYM
fnp-3790	296	3	42	42	NUM
fnp-3790	296	4	.	.	PUNCT
fnp-3790	297	1	https://doi.org/10.1007/s00401-016-1636-z	https://doi.org/10.1007/s00401-016-1636-z	NOUN
fnp-3790	297	2	epub	epub	PROPN
fnp-3790	297	3	2016	2016	NUM
fnp-3790	297	4	oct	oct	NOUN
fnp-3790	297	5	27	27	NUM
fnp-3790	297	6	.	.	PUNCT
fnp-3790	298	1	pmid	pmid	NOUN
fnp-3790	298	2	:	:	PUNCT
fnp-3790	298	3	27796537	27796537	NUM
fnp-3790	298	4	;	;	PUNCT
fnp-3790	298	5	pmcid	pmcid	ADJ
fnp-3790	298	6	:	:	PUNCT
fnp-3790	298	7	pmc5209400	pmc5209400	NOUN
fnp-3790	298	8	.	.	PUNCT
fnp-3790	299	1	dal	dal	PROPN
fnp-3790	299	2	-	-	PUNCT
fnp-3790	299	3	bianco	bianco	PROPN
fnp-3790	299	4	a	a	PRON
fnp-3790	299	5	,	,	PUNCT
fnp-3790	299	6	grabner	grabner	NOUN
fnp-3790	299	7	g	g	NOUN
fnp-3790	299	8	,	,	PUNCT
fnp-3790	299	9	kronnerwetter	kronnerwetter	NOUN
fnp-3790	299	10	c	c	NOUN
fnp-3790	299	11	,	,	PUNCT
fnp-3790	299	12	weber	weber	PROPN
fnp-3790	299	13	m	m	PROPN
fnp-3790	299	14	,	,	PUNCT
fnp-3790	299	15	kornek	kornek	PROPN
fnp-3790	299	16	b	b	NOUN
fnp-3790	299	17	,	,	PUNCT
fnp-3790	299	18	kasprian	kasprian	NOUN
fnp-3790	299	19	g	g	PROPN
fnp-3790	299	20	,	,	PUNCT
fnp-3790	299	21	berger	berger	PROPN
fnp-3790	299	22	t	t	PROPN
fnp-3790	299	23	,	,	PUNCT
fnp-3790	299	24	leutmezer	leutmezer	NOUN
fnp-3790	299	25	f	f	PROPN
fnp-3790	299	26	,	,	PUNCT
fnp-3790	299	27	rommer	rommer	NOUN
fnp-3790	299	28	ps	ps	PROPN
fnp-3790	299	29	,	,	PUNCT
fnp-3790	299	30	trattnig	trattnig	NOUN
fnp-3790	299	31	s	s	PART
fnp-3790	299	32	,	,	PUNCT
fnp-3790	299	33	lassmann	lassmann	PROPN
fnp-3790	299	34	h	h	NOUN
fnp-3790	299	35	,	,	PUNCT
fnp-3790	299	36	hametner	hametner	PROPN
fnp-3790	299	37	s.	s.	PROPN
fnp-3790	299	38	long	long	ADJ
fnp-3790	299	39	-	-	PUNCT
fnp-3790	299	40	term	term	NOUN
fnp-3790	299	41	evolution	evolution	NOUN
fnp-3790	299	42	of	of	ADP
fnp-3790	299	43	multiple	multiple	ADJ
fnp-3790	299	44	sclerosis	sclerosis	NOUN
fnp-3790	299	45	iron	iron	NOUN
fnp-3790	299	46	rim	rim	NOUN
fnp-3790	299	47	lesions	lesion	NOUN
fnp-3790	299	48	in	in	ADP
fnp-3790	299	49	7	7	NUM
fnp-3790	299	50	t	t	NOUN
fnp-3790	299	51	mri	mri	NOUN
fnp-3790	299	52	.	.	PUNCT
fnp-3790	300	1	brain	brain	NOUN
fnp-3790	300	2	.	.	PUNCT
fnp-3790	301	1	2021;144:833	2021;144:833	NUM
fnp-3790	301	2	-	-	SYM
fnp-3790	301	3	847	847	NUM
fnp-3790	301	4	.	.	PUNCT
fnp-3790	301	5	https://doi.org/10.1093/brain/awaa436	https://doi.org/10.1093/brain/awaa436	X
fnp-3790	302	1	pmid	pmid	NOUN
fnp-3790	302	2	:	:	PUNCT
fnp-3790	302	3	33484118	33484118	NUM
fnp-3790	302	4	.	.	PUNCT
fnp-3790	303	1	delizannis	delizannis	PROPN
fnp-3790	303	2	at	at	ADP
fnp-3790	303	3	,	,	PUNCT
fnp-3790	303	4	nonneman	nonneman	PROPN
fnp-3790	303	5	a	a	NOUN
fnp-3790	303	6	,	,	PUNCT
fnp-3790	303	7	tsering	tsere	VERB
fnp-3790	303	8	w	w	NOUN
fnp-3790	303	9	,	,	PUNCT
fnp-3790	303	10	de	de	PROPN
fnp-3790	303	11	bondt	bondt	PROPN
fnp-3790	303	12	a	a	PROPN
fnp-3790	303	13	,	,	PUNCT
fnp-3790	303	14	van	van	PROPN
fnp-3790	303	15	den	den	PROPN
fnp-3790	303	16	wyngaert	wyngaert	PROPN
fnp-3790	304	1	i	i	PROPN
fnp-3790	304	2	,	,	PUNCT
fnp-3790	304	3	zhang	zhang	PROPN
fnp-3790	304	4	b	b	PROPN
fnp-3790	304	5	,	,	PUNCT
fnp-3790	304	6	meymand	meymand	NOUN
fnp-3790	304	7	e	e	NOUN
fnp-3790	304	8	,	,	PUNCT
fnp-3790	304	9	olufemi	olufemi	ADJ
fnp-3790	304	10	mf	mf	PROPN
fnp-3790	304	11	,	,	PUNCT
fnp-3790	304	12	koivula	koivula	NOUN
fnp-3790	304	13	p	p	NOUN
fnp-3790	304	14	,	,	PUNCT
fnp-3790	304	15	maimaiti	maimaiti	PROPN
fnp-3790	304	16	s	s	PROPN
fnp-3790	304	17	,	,	PUNCT
fnp-3790	304	18	trojanowski	trojanowski	PROPN
fnp-3790	304	19	jq	jq	PROPN
fnp-3790	304	20	,	,	PUNCT
fnp-3790	304	21	lee	lee	PROPN
fnp-3790	304	22	vm	vm	PROPN
fnp-3790	304	23	,	,	PUNCT
fnp-3790	304	24	brunden	brunden	ADJ
fnp-3790	304	25	kr	kr	PROPN
fnp-3790	304	26	.	.	PUNCT
fnp-3790	304	27	effects	effect	NOUN
fnp-3790	304	28	of	of	ADP
fnp-3790	304	29	microglial	microglial	ADJ
fnp-3790	304	30	depletion	depletion	NOUN
fnp-3790	304	31	and	and	CCONJ
fnp-3790	304	32	trem2	trem2	NOUN
fnp-3790	304	33	deficiency	deficiency	NOUN
fnp-3790	304	34	on	on	ADP
fnp-3790	304	35	aβ	aβ	DET
fnp-3790	304	36	plaque	plaque	NOUN
fnp-3790	304	37	burden	burden	NOUN
fnp-3790	304	38	and	and	CCONJ
fnp-3790	304	39	neuritic	neuritic	ADJ
fnp-3790	304	40	plaque	plaque	NOUN
fnp-3790	304	41	tau	tau	PROPN
fnp-3790	304	42	pathology	pathology	NOUN
fnp-3790	304	43	in	in	ADP
fnp-3790	304	44	5xfad	5xfad	NUM
fnp-3790	304	45	mice	mouse	NOUN
fnp-3790	304	46	.	.	PUNCT
fnp-3790	305	1	acta	acta	PROPN
fnp-3790	305	2	neuropathol	neuropathol	PROPN
fnp-3790	305	3	commun	commun	PROPN
fnp-3790	305	4	.	.	PUNCT
fnp-3790	306	1	2021;9:150	2021;9:150	X
fnp-3790	306	2	.	.	PUNCT
fnp-3790	307	1	https://doi.org/10.1186/s40478-021-01251-1	https://doi.org/10.1186/s40478-021-01251-1	NUM
fnp-3790	308	1	pmid	pmid	NOUN
fnp-3790	308	2	:	:	PUNCT
fnp-3790	308	3	34503586	34503586	NUM
fnp-3790	308	4	;	;	PUNCT
fnp-3790	308	5	pmcid	pmcid	PROPN
fnp-3790	308	6	:	:	PUNCT
fnp-3790	308	7	pmc8428059	pmc8428059	PROPN
fnp-3790	308	8	.	.	PUNCT
fnp-3790	309	1	dickson	dickson	PROPN
fnp-3790	309	2	dw	dw	PROPN
fnp-3790	309	3	,	,	PUNCT
fnp-3790	309	4	rogers	rogers	PROPN
fnp-3790	309	5	j.	j.	PROPN
fnp-3790	309	6	neuroimmunology	neuroimmunology	PROPN
fnp-3790	309	7	of	of	ADP
fnp-3790	309	8	alzheimer	alzheimer	PROPN
fnp-3790	309	9	's	's	PART
fnp-3790	309	10	disease	disease	NOUN
fnp-3790	309	11	:	:	PUNCT
fnp-3790	309	12	a	a	DET
fnp-3790	309	13	conference	conference	NOUN
fnp-3790	309	14	report	report	NOUN
fnp-3790	309	15	.	.	PUNCT
fnp-3790	310	1	neurobiol	neurobiol	PROPN
fnp-3790	310	2	aging	aging	NOUN
fnp-3790	310	3	.	.	PUNCT
fnp-3790	311	1	1992;13:793	1992;13:793	NUM
fnp-3790	311	2	-	-	SYM
fnp-3790	311	3	798	798	NUM
fnp-3790	311	4	.	.	PUNCT
fnp-3790	312	1	https://doi.org/10.1016/0197-4580(92)90104-6	https://doi.org/10.1016/0197-4580(92)90104-6	PROPN
fnp-3790	313	1	pmid	pmid	NOUN
fnp-3790	313	2	:	:	PUNCT
fnp-3790	313	3	1491745	1491745	NUM
fnp-3790	313	4	.	.	PUNCT
fnp-3790	314	1	dutta	dutta	PROPN
fnp-3790	314	2	r	r	PROPN
fnp-3790	314	3	,	,	PUNCT
fnp-3790	314	4	chomyk	chomyk	PROPN
fnp-3790	314	5	am	am	PROPN
fnp-3790	314	6	,	,	PUNCT
fnp-3790	314	7	chang	chang	PROPN
fnp-3790	314	8	a	a	PROPN
fnp-3790	314	9	,	,	PUNCT
fnp-3790	314	10	ribaudo	ribaudo	PROPN
fnp-3790	314	11	mv	mv	PROPN
fnp-3790	314	12	,	,	PUNCT
fnp-3790	314	13	deckard	deckard	PROPN
fnp-3790	314	14	sa	sa	PROPN
fnp-3790	314	15	,	,	PUNCT
fnp-3790	314	16	doud	doud	PROPN
fnp-3790	314	17	mk	mk	PROPN
fnp-3790	314	18	,	,	PUNCT
fnp-3790	314	19	edberg	edberg	PROPN
fnp-3790	314	20	dd	dd	PROPN
fnp-3790	314	21	,	,	PUNCT
fnp-3790	314	22	bai	bai	PROPN
fnp-3790	314	23	b	b	PROPN
fnp-3790	314	24	,	,	PUNCT
fnp-3790	314	25	li	li	PROPN
fnp-3790	314	26	m	m	PROPN
fnp-3790	314	27	,	,	PUNCT
fnp-3790	314	28	baranzini	baranzini	PROPN
fnp-3790	314	29	se	se	PROPN
fnp-3790	314	30	,	,	PUNCT
fnp-3790	314	31	fox	fox	PROPN
fnp-3790	314	32	rj	rj	PROPN
fnp-3790	314	33	,	,	PUNCT
fnp-3790	314	34	staugaitis	staugaitis	PROPN
fnp-3790	314	35	sm	sm	PROPN
fnp-3790	314	36	,	,	PUNCT
fnp-3790	314	37	macklin	macklin	PROPN
fnp-3790	314	38	wb	wb	PROPN
fnp-3790	314	39	,	,	PUNCT
fnp-3790	314	40	trapp	trapp	PROPN
fnp-3790	314	41	bd	bd	PROPN
fnp-3790	314	42	.	.	PROPN
fnp-3790	314	43	hippocampal	hippocampal	ADJ
fnp-3790	314	44	demyelination	demyelination	NOUN
fnp-3790	314	45	and	and	CCONJ
fnp-3790	314	46	memory	memory	NOUN
fnp-3790	314	47	dysfunction	dysfunction	NOUN
fnp-3790	314	48	are	be	AUX
fnp-3790	314	49	associated	associate	VERB
fnp-3790	314	50	with	with	ADP
fnp-3790	314	51	increased	increase	VERB
fnp-3790	314	52	levels	level	NOUN
fnp-3790	314	53	of	of	ADP
fnp-3790	314	54	the	the	DET
fnp-3790	314	55	neuronal	neuronal	PROPN
fnp-3790	314	56	microrna	microrna	PROPN
fnp-3790	314	57	mir-124	mir-124	NOUN
fnp-3790	314	58	and	and	CCONJ
fnp-3790	314	59	reduced	reduce	VERB
fnp-3790	314	60	ampa	ampa	NOUN
fnp-3790	314	61	receptors	receptor	NOUN
fnp-3790	314	62	.	.	PUNCT
fnp-3790	315	1	ann	ann	PROPN
fnp-3790	315	2	neurol	neurol	PROPN
fnp-3790	315	3	.	.	PUNCT
fnp-3790	316	1	2013;73:637	2013;73:637	ADV
fnp-3790	316	2	-	-	SYM
fnp-3790	316	3	645	645	NUM
fnp-3790	316	4	.	.	PUNCT
fnp-3790	317	1	https://doi.org/10.1002/ana.23860	https://doi.org/10.1002/ana.23860	PROPN
fnp-3790	317	2	epub	epub	PROPN
fnp-3790	317	3	2013	2013	NUM
fnp-3790	317	4	apr	apr	NOUN
fnp-3790	317	5	17	17	NUM
fnp-3790	317	6	.	.	PUNCT
fnp-3790	318	1	pmid	pmid	NOUN
fnp-3790	318	2	:	:	PUNCT
fnp-3790	318	3	23595422	23595422	NUM
fnp-3790	318	4	;	;	PUNCT
fnp-3790	318	5	pmcid	pmcid	NOUN
fnp-3790	318	6	:	:	PUNCT
fnp-3790	318	7	pmc3679350	pmc3679350	PROPN
fnp-3790	318	8	.	.	PUNCT
fnp-3790	319	1	dutta	dutta	PROPN
fnp-3790	319	2	r	r	PROPN
fnp-3790	319	3	,	,	PUNCT
fnp-3790	319	4	mcdonough	mcdonough	PROPN
fnp-3790	319	5	j	j	PROPN
fnp-3790	319	6	,	,	PUNCT
fnp-3790	319	7	yin	yin	PROPN
fnp-3790	319	8	x	x	PROPN
fnp-3790	319	9	,	,	PUNCT
fnp-3790	319	10	peterson	peterson	PROPN
fnp-3790	319	11	j	j	PROPN
fnp-3790	319	12	,	,	PUNCT
fnp-3790	319	13	chang	chang	PROPN
fnp-3790	319	14	a	a	PROPN
fnp-3790	319	15	,	,	PUNCT
fnp-3790	319	16	torres	torre	VERB
fnp-3790	319	17	t	t	PROPN
fnp-3790	319	18	,	,	PUNCT
fnp-3790	319	19	gudz	gudz	PROPN
fnp-3790	319	20	t	t	PROPN
fnp-3790	319	21	,	,	PUNCT
fnp-3790	319	22	macklin	macklin	PROPN
fnp-3790	319	23	wb	wb	PROPN
fnp-3790	319	24	,	,	PUNCT
fnp-3790	319	25	lewis	lewis	PROPN
fnp-3790	319	26	da	da	PROPN
fnp-3790	319	27	,	,	PUNCT
fnp-3790	319	28	fox	fox	PROPN
fnp-3790	319	29	rj	rj	PROPN
fnp-3790	319	30	,	,	PUNCT
fnp-3790	319	31	rudick	rudick	VERB
fnp-3790	319	32	r	r	NOUN
fnp-3790	319	33	,	,	PUNCT
fnp-3790	319	34	mirnics	mirnic	NOUN
fnp-3790	319	35	k	k	PROPN
fnp-3790	319	36	,	,	PUNCT
fnp-3790	319	37	trapp	trapp	PROPN
fnp-3790	319	38	bd	bd	PROPN
fnp-3790	319	39	.	.	PROPN
fnp-3790	319	40	mitochondrial	mitochondrial	ADJ
fnp-3790	319	41	dysfunction	dysfunction	NOUN
fnp-3790	319	42	as	as	ADP
fnp-3790	319	43	a	a	DET
fnp-3790	319	44	cause	cause	NOUN
fnp-3790	319	45	of	of	ADP
fnp-3790	319	46	axonal	axonal	ADJ
fnp-3790	319	47	degeneration	degeneration	NOUN
fnp-3790	319	48	in	in	ADP
fnp-3790	319	49	multiple	multiple	ADJ
fnp-3790	319	50	sclerosis	sclerosis	NOUN
fnp-3790	319	51	patients	patient	NOUN
fnp-3790	319	52	.	.	PUNCT
fnp-3790	320	1	ann	ann	PROPN
fnp-3790	320	2	neurol	neurol	PROPN
fnp-3790	320	3	.	.	PUNCT
fnp-3790	321	1	2006;59:478	2006;59:478	X
fnp-3790	321	2	-	-	SYM
fnp-3790	321	3	489	489	NUM
fnp-3790	321	4	.	.	PUNCT
fnp-3790	322	1	https://doi.org/10.1002/ana.20736	https://doi.org/10.1002/ana.20736	PROPN
fnp-3790	322	2	pmid	pmid	PROPN
fnp-3790	322	3	:	:	PUNCT
fnp-3790	322	4	16392116	16392116	NUM
fnp-3790	322	5	.	.	PUNCT
fnp-3790	323	1	eikelenboom	eikelenboom	NOUN
fnp-3790	323	2	p	p	NOUN
fnp-3790	323	3	,	,	PUNCT
fnp-3790	323	4	stam	stam	VERB
fnp-3790	323	5	fc	fc	PROPN
fnp-3790	323	6	.	.	PUNCT
fnp-3790	324	1	immunoglobulins	immunoglobulin	NOUN
fnp-3790	324	2	and	and	CCONJ
fnp-3790	324	3	complement	complement	NOUN
fnp-3790	324	4	factors	factor	NOUN
fnp-3790	324	5	in	in	ADP
fnp-3790	324	6	senile	senile	ADJ
fnp-3790	324	7	plaques	plaque	NOUN
fnp-3790	324	8	.	.	PUNCT
fnp-3790	325	1	an	an	DET
fnp-3790	325	2	immunoperoxidase	immunoperoxidase	NOUN
fnp-3790	325	3	study	study	NOUN
fnp-3790	325	4	.	.	PUNCT
fnp-3790	326	1	acta	acta	PROPN
fnp-3790	326	2	neuropathol	neuropathol	PROPN
fnp-3790	326	3	.	.	PUNCT
fnp-3790	327	1	1982;57:239	1982;57:239	NUM
fnp-3790	327	2	-	-	SYM
fnp-3790	327	3	242	242	NUM
fnp-3790	327	4	.	.	PUNCT
fnp-3790	328	1	https://doi.org/10.1007/bf00685397	https://doi.org/10.1007/bf00685397	ADP
fnp-3790	329	1	pmid	pmid	NOUN
fnp-3790	329	2	:	:	PUNCT
fnp-3790	329	3	6812382	6812382	NUM
fnp-3790	329	4	.	.	PUNCT
fnp-3790	330	1	espiritu	espiritu	PROPN
fnp-3790	330	2	ai	ai	PROPN
fnp-3790	330	3	,	,	PUNCT
fnp-3790	330	4	sy	sy	PROPN
fnp-3790	330	5	mcc	mcc	NOUN
fnp-3790	330	6	,	,	PUNCT
fnp-3790	330	7	anlacan	anlacan	PROPN
fnp-3790	330	8	vmm	vmm	PROPN
fnp-3790	330	9	,	,	PUNCT
fnp-3790	330	10	jamora	jamora	PROPN
fnp-3790	330	11	rdg	rdg	PROPN
fnp-3790	330	12	;	;	PUNCT
fnp-3790	330	13	philippine	philippine	ADJ
fnp-3790	330	14	corona	corona	PROPN
fnp-3790	330	15	study	study	NOUN
fnp-3790	330	16	group	group	NOUN
fnp-3790	330	17	investigators	investigator	NOUN
fnp-3790	330	18	.	.	PUNCT
fnp-3790	331	1	covid-19	covid-19	PROPN
fnp-3790	331	2	outcomes	outcome	NOUN
fnp-3790	331	3	of	of	ADP
fnp-3790	331	4	10,881	10,881	NUM
fnp-3790	331	5	patients	patient	NOUN
fnp-3790	331	6	:	:	PUNCT
fnp-3790	331	7	retrospective	retrospective	ADJ
fnp-3790	331	8	study	study	NOUN
fnp-3790	331	9	of	of	ADP
fnp-3790	331	10	neurological	neurological	ADJ
fnp-3790	331	11	symptoms	symptom	NOUN
fnp-3790	331	12	and	and	CCONJ
fnp-3790	331	13	associated	associated	ADJ
fnp-3790	331	14	manifestations	manifestation	NOUN
fnp-3790	331	15	(	(	PUNCT
fnp-3790	331	16	philippine	philippine	ADJ
fnp-3790	331	17	corona	corona	NOUN
fnp-3790	331	18	study	study	PROPN
fnp-3790	331	19	)	)	PUNCT
fnp-3790	331	20	.	.	PUNCT
fnp-3790	332	1	j	j	PROPN
fnp-3790	332	2	neural	neural	ADJ
fnp-3790	332	3	transm	transm	PROPN
fnp-3790	332	4	(	(	PUNCT
fnp-3790	332	5	vienna	vienna	PROPN
fnp-3790	332	6	)	)	PUNCT
fnp-3790	332	7	.	.	PUNCT
fnp-3790	333	1	2021;128:1687	2021;128:1687	NUM
fnp-3790	333	2	-	-	PUNCT
fnp-3790	333	3	1703	1703	NUM
fnp-3790	333	4	.	.	PUNCT
fnp-3790	334	1	https://doi.org/10.1007/s00702-021-02400-5	https://doi.org/10.1007/s00702-021-02400-5	NUM
fnp-3790	334	2	epub	epub	VERB
fnp-3790	334	3	2021	2021	NUM
fnp-3790	334	4	aug	aug	PROPN
fnp-3790	334	5	27	27	NUM
fnp-3790	334	6	.	.	PUNCT
fnp-3790	335	1	pmid	pmid	NOUN
fnp-3790	335	2	:	:	PUNCT
fnp-3790	335	3	34448930	34448930	NUM
fnp-3790	335	4	;	;	PUNCT
fnp-3790	335	5	pmcid	pmcid	ADJ
fnp-3790	335	6	:	:	PUNCT
fnp-3790	335	7	pmc8391861	pmc8391861	PROPN
fnp-3790	335	8	.	.	PUNCT
fnp-3790	336	1	evans	evans	PROPN
fnp-3790	336	2	fl	fl	PROPN
fnp-3790	336	3	,	,	PUNCT
fnp-3790	336	4	dittmer	dittmer	PROPN
fnp-3790	336	5	m	m	PROPN
fnp-3790	336	6	,	,	PUNCT
fnp-3790	336	7	de	de	X
fnp-3790	336	8	la	la	X
fnp-3790	336	9	fuente	fuente	PROPN
fnp-3790	336	10	ag	ag	PROPN
fnp-3790	336	11	,	,	PUNCT
fnp-3790	336	12	fitzgerald	fitzgerald	PROPN
fnp-3790	336	13	dc	dc	PROPN
fnp-3790	336	14	.	.	PUNCT
fnp-3790	337	1	protective	protective	ADJ
fnp-3790	337	2	and	and	CCONJ
fnp-3790	337	3	regenerative	regenerative	ADJ
fnp-3790	337	4	roles	role	NOUN
fnp-3790	337	5	of	of	ADP
fnp-3790	337	6	t	t	NOUN
fnp-3790	337	7	cells	cell	NOUN
fnp-3790	337	8	in	in	ADP
fnp-3790	337	9	central	central	ADJ
fnp-3790	337	10	nervous	nervous	ADJ
fnp-3790	337	11	system	system	NOUN
fnp-3790	337	12	disorders	disorder	NOUN
fnp-3790	337	13	.	.	PUNCT
fnp-3790	338	1	front	front	ADJ
fnp-3790	338	2	immunol	immunol	NOUN
fnp-3790	338	3	.	.	PUNCT
fnp-3790	339	1	2019;10:2171	2019;10:2171	NUM
fnp-3790	339	2	.	.	PUNCT
fnp-3790	340	1	https://doi.org/10.3389/fimmu.2019.02171	https://doi.org/10.3389/fimmu.2019.02171	PROPN
fnp-3790	340	2	pmid	pmid	NOUN
fnp-3790	340	3	:	:	PUNCT
fnp-3790	340	4	31572381	31572381	NUM
fnp-3790	340	5	;	;	PUNCT
fnp-3790	340	6	pmcid	pmcid	ADJ
fnp-3790	340	7	:	:	PUNCT
fnp-3790	340	8	pmc6751344	pmc6751344	NOUN
fnp-3790	340	9	.	.	PUNCT
fnp-3790	341	1	fabbri	fabbri	NOUN
fnp-3790	341	2	vp	vp	PROPN
fnp-3790	341	3	,	,	PUNCT
fnp-3790	341	4	foschini	foschini	PROPN
fnp-3790	341	5	mp	mp	PROPN
fnp-3790	341	6	,	,	PUNCT
fnp-3790	341	7	lazzarotto	lazzarotto	ADJ
fnp-3790	341	8	t	t	PROPN
fnp-3790	341	9	,	,	PUNCT
fnp-3790	341	10	gabrielli	gabrielli	PROPN
fnp-3790	341	11	l	l	PROPN
fnp-3790	341	12	,	,	PUNCT
fnp-3790	341	13	cenacchi	cenacchi	PROPN
fnp-3790	341	14	g	g	PROPN
fnp-3790	341	15	,	,	PUNCT
fnp-3790	341	16	gallo	gallo	PROPN
fnp-3790	341	17	c	c	NOUN
fnp-3790	341	18	,	,	PUNCT
fnp-3790	341	19	aspide	aspide	ADJ
fnp-3790	341	20	r	r	NOUN
fnp-3790	341	21	,	,	PUNCT
fnp-3790	341	22	frascaroli	frascaroli	NOUN
fnp-3790	341	23	g	g	PROPN
fnp-3790	341	24	,	,	PUNCT
fnp-3790	341	25	cortelli	cortelli	PROPN
fnp-3790	341	26	p	p	X
fnp-3790	341	27	,	,	PUNCT
fnp-3790	341	28	riefolo	riefolo	PROPN
fnp-3790	341	29	m	m	PROPN
fnp-3790	341	30	,	,	PUNCT
fnp-3790	341	31	giannini	giannini	PROPN
fnp-3790	341	32	c	c	PROPN
fnp-3790	341	33	,	,	PUNCT
fnp-3790	341	34	d'errico	d'errico	PROPN
fnp-3790	341	35	a.	a.	NOUN
fnp-3790	341	36	brain	brain	PROPN
fnp-3790	341	37	ischemic	ischemic	ADJ
fnp-3790	341	38	injury	injury	NOUN
fnp-3790	341	39	in	in	ADP
fnp-3790	341	40	covid-19	covid-19	PROPN
fnp-3790	341	41	-	-	PUNCT
fnp-3790	341	42	infected	infect	VERB
fnp-3790	341	43	patients	patient	NOUN
fnp-3790	341	44	:	:	PUNCT
fnp-3790	341	45	a	a	DET
fnp-3790	341	46	series	series	NOUN
fnp-3790	341	47	of	of	ADP
fnp-3790	341	48	10	10	NUM
fnp-3790	341	49	post	post	ADJ
fnp-3790	341	50	-	-	ADJ
fnp-3790	341	51	mortem	mortem	ADJ
fnp-3790	341	52	cases	case	NOUN
fnp-3790	341	53	.	.	PUNCT
fnp-3790	342	1	brain	brain	NOUN
fnp-3790	342	2	pathol	pathol	NOUN
fnp-3790	342	3	.	.	PUNCT
fnp-3790	343	1	2021;31:205	2021;31:205	X
fnp-3790	343	2	-	-	SYM
fnp-3790	343	3	210	210	NUM
fnp-3790	343	4	.	.	PUNCT
fnp-3790	344	1	https://doi.org/10.1111/bpa.12901	https://doi.org/10.1111/bpa.12901	PROPN
fnp-3790	344	2	epub	epub	PROPN
fnp-3790	344	3	2020	2020	NUM
fnp-3790	344	4	nov	nov	PROPN
fnp-3790	344	5	2	2	NUM
fnp-3790	344	6	.	.	PUNCT
fnp-3790	344	7	pmid	pmid	NOUN
fnp-3790	344	8	:	:	PUNCT
fnp-3790	344	9	33002281	33002281	NUM
fnp-3790	344	10	;	;	PUNCT
fnp-3790	344	11	pmcid	pmcid	NOUN
fnp-3790	344	12	:	:	PUNCT
fnp-3790	344	13	pmc7536900	pmc7536900	ADV
fnp-3790	344	14	.	.	PUNCT
fnp-3790	345	1	falco	falco	PROPN
fnp-3790	345	2	a	a	PROPN
fnp-3790	345	3	,	,	PUNCT
fnp-3790	345	4	pennucci	pennucci	PROPN
fnp-3790	345	5	r	r	PROPN
fnp-3790	345	6	,	,	PUNCT
fnp-3790	345	7	brambilla	brambilla	NOUN
fnp-3790	345	8	e	e	NOUN
fnp-3790	345	9	,	,	PUNCT
fnp-3790	345	10	de	de	PROPN
fnp-3790	345	11	curtis	curtis	PROPN
fnp-3790	345	12	i.	i.	PROPN
fnp-3790	345	13	reduction	reduction	NOUN
fnp-3790	345	14	in	in	ADP
fnp-3790	345	15	parvalbumin	parvalbumin	ADJ
fnp-3790	345	16	-	-	PUNCT
fnp-3790	345	17	positive	positive	ADJ
fnp-3790	345	18	interneurons	interneuron	NOUN
fnp-3790	345	19	and	and	CCONJ
fnp-3790	345	20	inhibitory	inhibitory	ADJ
fnp-3790	345	21	input	input	NOUN
fnp-3790	345	22	in	in	ADP
fnp-3790	345	23	the	the	DET
fnp-3790	345	24	cortex	cortex	NOUN
fnp-3790	345	25	of	of	ADP
fnp-3790	345	26	mice	mouse	NOUN
fnp-3790	345	27	with	with	ADP
fnp-3790	345	28	experimental	experimental	ADJ
fnp-3790	345	29	autoimmune	autoimmune	ADJ
fnp-3790	345	30	encephalomyelitis	encephalomyelitis	NOUN
fnp-3790	345	31	.	.	PUNCT
fnp-3790	346	1	exp	exp	NOUN
fnp-3790	346	2	brain	brain	NOUN
fnp-3790	346	3	res	re	NOUN
fnp-3790	346	4	.	.	PUNCT
fnp-3790	347	1	2014;232:2439	2014;232:2439	NUM
fnp-3790	347	2	-	-	SYM
fnp-3790	347	3	2449	2449	NUM
fnp-3790	347	4	.	.	PUNCT
fnp-3790	348	1	https://doi.org/10.1007/s00221-014-3944-7	https://doi.org/10.1007/s00221-014-3944-7	NUM
fnp-3790	348	2	epub	epub	NOUN
fnp-3790	348	3	2014	2014	NUM
fnp-3790	348	4	apr	apr	NOUN
fnp-3790	348	5	26	26	NUM
fnp-3790	348	6	.	.	PUNCT
fnp-3790	349	1	pmid	pmid	NOUN
fnp-3790	349	2	:	:	PUNCT
fnp-3790	349	3	24770856	24770856	NUM
fnp-3790	349	4	;	;	PUNCT
fnp-3790	349	5	pmcid	pmcid	ADJ
fnp-3790	349	6	:	:	PUNCT
fnp-3790	349	7	pmc4055863	pmc4055863	PROPN
fnp-3790	349	8	.	.	PUNCT
fnp-3790	350	1	fischer	fischer	PROPN
fnp-3790	350	2	mt	mt	PROPN
fnp-3790	350	3	,	,	PUNCT
fnp-3790	350	4	sharma	sharma	PROPN
fnp-3790	350	5	r	r	PROPN
fnp-3790	350	6	,	,	PUNCT
fnp-3790	350	7	lim	lim	PROPN
fnp-3790	350	8	jl	jl	PROPN
fnp-3790	350	9	,	,	PUNCT
fnp-3790	350	10	haider	haider	PROPN
fnp-3790	350	11	l	l	PROPN
fnp-3790	350	12	,	,	PUNCT
fnp-3790	350	13	frischer	frischer	ADJ
fnp-3790	350	14	jm	jm	PROPN
fnp-3790	350	15	,	,	PUNCT
fnp-3790	350	16	drexhage	drexhage	PROPN
fnp-3790	350	17	j	j	PROPN
fnp-3790	350	18	,	,	PUNCT
fnp-3790	350	19	mahad	mahad	PROPN
fnp-3790	351	1	d	d	PROPN
fnp-3790	351	2	,	,	PUNCT
fnp-3790	351	3	bradl	bradl	NOUN
fnp-3790	351	4	m	m	PROPN
fnp-3790	351	5	,	,	PUNCT
fnp-3790	351	6	van	van	PROPN
fnp-3790	351	7	horssen	horssen	PROPN
fnp-3790	351	8	j	j	PROPN
fnp-3790	351	9	,	,	PUNCT
fnp-3790	351	10	lassmann	lassmann	PROPN
fnp-3790	351	11	h.	h.	PROPN
fnp-3790	351	12	nadph	nadph	ADJ
fnp-3790	351	13	oxidase	oxidase	NOUN
fnp-3790	351	14	expression	expression	NOUN
fnp-3790	351	15	in	in	ADP
fnp-3790	351	16	active	active	ADJ
fnp-3790	351	17	multiple	multiple	ADJ
fnp-3790	351	18	sclerosis	sclerosis	NOUN
fnp-3790	351	19	lesions	lesion	NOUN
fnp-3790	351	20	in	in	ADP
fnp-3790	351	21	relation	relation	NOUN
fnp-3790	351	22	to	to	PART
fnp-3790	351	23	oxidative	oxidative	VERB
fnp-3790	351	24	tissue	tissue	NOUN
fnp-3790	351	25	damage	damage	NOUN
fnp-3790	351	26	and	and	CCONJ
fnp-3790	351	27	mitochondrial	mitochondrial	ADJ
fnp-3790	351	28	injury	injury	NOUN
fnp-3790	351	29	.	.	PUNCT
fnp-3790	352	1	brain	brain	NOUN
fnp-3790	352	2	.	.	PUNCT
fnp-3790	353	1	2012;135:886	2012;135:886	NUM
fnp-3790	353	2	-	-	SYM
fnp-3790	353	3	899	899	NUM
fnp-3790	353	4	.	.	PUNCT
fnp-3790	354	1	https://doi.org/10.1093/brain/aws012	https://doi.org/10.1093/brain/aws012	ADJ
fnp-3790	354	2	pmid	pmid	PROPN
fnp-3790	354	3	:	:	PUNCT
fnp-3790	354	4	22366799	22366799	NUM
fnp-3790	354	5	;	;	PUNCT
fnp-3790	354	6	pmcid	pmcid	ADJ
fnp-3790	354	7	:	:	PUNCT
fnp-3790	354	8	pmc3286337	pmc3286337	NOUN
fnp-3790	354	9	.	.	PUNCT
fnp-3790	355	1	fowke	fowke	ADP
fnp-3790	355	2	tm	tm	NOUN
fnp-3790	355	3	,	,	PUNCT
fnp-3790	355	4	galinsky	galinsky	ADJ
fnp-3790	355	5	r	r	NOUN
fnp-3790	355	6	,	,	PUNCT
fnp-3790	355	7	davidson	davidson	PROPN
fnp-3790	355	8	jo	jo	PROPN
fnp-3790	355	9	,	,	PUNCT
fnp-3790	355	10	wassink	wassink	VERB
fnp-3790	355	11	g	g	PROPN
fnp-3790	355	12	,	,	PUNCT
fnp-3790	355	13	karunasinghe	karunasinghe	PROPN
fnp-3790	355	14	rn	rn	PROPN
fnp-3790	355	15	,	,	PUNCT
fnp-3790	355	16	prasad	prasad	PROPN
fnp-3790	355	17	jd	jd	PROPN
fnp-3790	355	18	,	,	PUNCT
fnp-3790	355	19	bennet	bennet	PROPN
fnp-3790	355	20	l	l	PROPN
fnp-3790	355	21	,	,	PUNCT
fnp-3790	355	22	gunn	gunn	PROPN
fnp-3790	355	23	aj	aj	PROPN
fnp-3790	355	24	,	,	PUNCT
fnp-3790	355	25	dean	dean	PROPN
fnp-3790	355	26	jm	jm	PROPN
fnp-3790	355	27	.	.	PROPN
fnp-3790	355	28	loss	loss	PROPN
fnp-3790	355	29	of	of	ADP
fnp-3790	355	30	interneurons	interneuron	NOUN
fnp-3790	355	31	and	and	CCONJ
fnp-3790	355	32	disruption	disruption	NOUN
fnp-3790	355	33	of	of	ADP
fnp-3790	355	34	perineuronal	perineuronal	ADJ
fnp-3790	355	35	nets	net	NOUN
fnp-3790	355	36	in	in	ADP
fnp-3790	355	37	the	the	DET
fnp-3790	355	38	cerebral	cerebral	ADJ
fnp-3790	355	39	cortex	cortex	NOUN
fnp-3790	355	40	following	follow	VERB
fnp-3790	355	41	hypoxia	hypoxia	NOUN
fnp-3790	355	42	-	-	PUNCT
fnp-3790	355	43	ischaemia	ischaemia	NOUN
fnp-3790	355	44	in	in	ADP
fnp-3790	355	45	near	near	ADJ
fnp-3790	355	46	-	-	PUNCT
fnp-3790	355	47	term	term	NOUN
fnp-3790	355	48	fetal	fetal	ADJ
fnp-3790	355	49	sheep	sheep	NOUN
fnp-3790	355	50	.	.	PUNCT
fnp-3790	356	1	sci	sci	PROPN
fnp-3790	356	2	rep	rep	PROPN
fnp-3790	356	3	.	.	PROPN
fnp-3790	356	4	2018;8:17686	2018;8:17686	PROPN
fnp-3790	356	5	.	.	PUNCT
fnp-3790	357	1	https://doi.org/10.1038/s41598-018-36083-y	https://doi.org/10.1038/s41598-018-36083-y	PROPN
fnp-3790	357	2	pmid	pmid	PROPN
fnp-3790	357	3	:	:	PUNCT
fnp-3790	357	4	30523273	30523273	NUM
fnp-3790	357	5	;	;	PUNCT
fnp-3790	357	6	pmcid	pmcid	ADJ
fnp-3790	357	7	:	:	PUNCT
fnp-3790	357	8	pmc6283845	pmc6283845	ADJ
fnp-3790	357	9	.	.	PUNCT
fnp-3790	358	1	gabriely	gabriely	ADV
fnp-3790	358	2	g	g	NOUN
fnp-3790	358	3	,	,	PUNCT
fnp-3790	358	4	da	da	PROPN
fnp-3790	358	5	cunha	cunha	PROPN
fnp-3790	358	6	ap	ap	PROPN
fnp-3790	358	7	,	,	PUNCT
fnp-3790	358	8	rezende	rezende	PROPN
fnp-3790	358	9	rm	rm	PROPN
fnp-3790	358	10	,	,	PUNCT
fnp-3790	358	11	kenyon	kenyon	PROPN
fnp-3790	358	12	b	b	PROPN
fnp-3790	358	13	,	,	PUNCT
fnp-3790	358	14	madi	madi	PROPN
fnp-3790	358	15	a	a	PROPN
fnp-3790	358	16	,	,	PUNCT
fnp-3790	358	17	vandeventer	vandeventer	PROPN
fnp-3790	358	18	t	t	PROPN
fnp-3790	358	19	,	,	PUNCT
fnp-3790	358	20	skillin	skillin	PROPN
fnp-3790	358	21	n	n	CCONJ
fnp-3790	358	22	,	,	PUNCT
fnp-3790	358	23	rubino	rubino	PROPN
fnp-3790	358	24	s	s	PART
fnp-3790	358	25	,	,	PUNCT
fnp-3790	358	26	garo	garo	NOUN
fnp-3790	358	27	l	l	NOUN
fnp-3790	358	28	,	,	PUNCT
fnp-3790	358	29	mazzola	mazzola	PROPN
fnp-3790	358	30	ma	ma	PROPN
fnp-3790	358	31	,	,	PUNCT
fnp-3790	358	32	kolypetri	kolypetri	VERB
fnp-3790	358	33	p	p	PROPN
fnp-3790	358	34	,	,	PUNCT
fnp-3790	358	35	lanser	lanser	PROPN
fnp-3790	358	36	aj	aj	PROPN
fnp-3790	358	37	,	,	PUNCT
fnp-3790	358	38	moreira	moreira	PROPN
fnp-3790	358	39	t	t	PROPN
fnp-3790	358	40	,	,	PUNCT
fnp-3790	358	41	faria	faria	PROPN
fnp-3790	358	42	amc	amc	PROPN
fnp-3790	358	43	,	,	PUNCT
fnp-3790	358	44	lassmann	lassmann	PROPN
fnp-3790	358	45	h	h	PROPN
fnp-3790	358	46	,	,	PUNCT
fnp-3790	358	47	kuchroo	kuchroo	ADJ
fnp-3790	358	48	v	v	NOUN
fnp-3790	358	49	,	,	PUNCT
fnp-3790	358	50	murugaiyan	murugaiyan	ADJ
fnp-3790	358	51	g	g	NOUN
fnp-3790	358	52	,	,	PUNCT
fnp-3790	358	53	weiner	weiner	NOUN
fnp-3790	358	54	hl	hl	NOUN
fnp-3790	358	55	.	.	PUNCT
fnp-3790	359	1	targeting	target	VERB
fnp-3790	359	2	latency	latency	NOUN
fnp-3790	359	3	-	-	PUNCT
fnp-3790	359	4	associated	associate	VERB
fnp-3790	359	5	peptide	peptide	NOUN
fnp-3790	359	6	promotes	promote	VERB
fnp-3790	359	7	antitumor	antitumor	PROPN
fnp-3790	359	8	immunity	immunity	NOUN
fnp-3790	359	9	.	.	PUNCT
fnp-3790	360	1	sci	sci	PROPN
fnp-3790	360	2	immunol	immunol	NOUN
fnp-3790	360	3	.	.	PUNCT
fnp-3790	361	1	2017;2	2017;2	NUM
fnp-3790	361	2	:	:	PUNCT
fnp-3790	361	3	eaaj1738	eaaj1738	PROPN
fnp-3790	361	4	.	.	PUNCT
fnp-3790	362	1	https://doi.org/10.1126/sciimmunol.aaj1738	https://doi.org/10.1126/sciimmunol.aaj1738	PROPN
fnp-3790	363	1	pmid	pmid	NOUN
fnp-3790	363	2	:	:	PUNCT
fnp-3790	363	3	28763794	28763794	NUM
fnp-3790	363	4	;	;	PUNCT
fnp-3790	363	5	pmcid	pmcid	ADJ
fnp-3790	363	6	:	:	PUNCT
fnp-3790	363	7	pmc5657397	pmc5657397	NOUN
fnp-3790	363	8	.	.	PUNCT
fnp-3790	364	1	gerrits	gerrit	NOUN
fnp-3790	364	2	e	e	PROPN
fnp-3790	364	3	,	,	PUNCT
fnp-3790	364	4	brouwer	brouwer	PROPN
fnp-3790	364	5	n	n	CCONJ
fnp-3790	364	6	,	,	PUNCT
fnp-3790	364	7	kooistra	kooistra	PROPN
fnp-3790	364	8	sm	sm	PROPN
fnp-3790	364	9	,	,	PUNCT
fnp-3790	364	10	woodbury	woodbury	PROPN
fnp-3790	364	11	me	i	PRON
fnp-3790	364	12	,	,	PUNCT
fnp-3790	364	13	vermeiren	vermeiren	PROPN
fnp-3790	364	14	y	y	PROPN
fnp-3790	364	15	,	,	PUNCT
fnp-3790	364	16	lambourne	lambourne	PROPN
fnp-3790	364	17	m	m	PROPN
fnp-3790	364	18	,	,	PUNCT
fnp-3790	364	19	mulder	mulder	PROPN
fnp-3790	364	20	j	j	PROPN
fnp-3790	364	21	,	,	PUNCT
fnp-3790	364	22	kummer	kummer	PROPN
fnp-3790	364	23	m	m	PROPN
fnp-3790	364	24	,	,	PUNCT
fnp-3790	364	25	möller	möller	PROPN
fnp-3790	364	26	t	t	PROPN
fnp-3790	364	27	,	,	PUNCT
fnp-3790	364	28	biber	biber	PROPN
fnp-3790	364	29	k	k	PROPN
fnp-3790	364	30	,	,	PUNCT
fnp-3790	364	31	dunnen	dunnen	NOUN
fnp-3790	364	32	wfad	wfad	PROPN
fnp-3790	364	33	,	,	PUNCT
fnp-3790	364	34	de	de	X
fnp-3790	364	35	deyn	deyn	NOUN
fnp-3790	364	36	pp	pp	ADV
fnp-3790	364	37	,	,	PUNCT
fnp-3790	364	38	eggen	eggen	NOUN
fnp-3790	364	39	bjl	bjl	NOUN
fnp-3790	364	40	,	,	PUNCT
fnp-3790	364	41	boddeke	boddeke	PROPN
fnp-3790	364	42	ewgm	ewgm	PROPN
fnp-3790	364	43	.	.	PUNCT
fnp-3790	365	1	distinct	distinct	ADJ
fnp-3790	365	2	amyloid	amyloid	NOUN
fnp-3790	365	3	-	-	PUNCT
fnp-3790	365	4	β	β	X
fnp-3790	365	5	and	and	CCONJ
fnp-3790	365	6	tau	tau	PROPN
fnp-3790	365	7	-	-	PUNCT
fnp-3790	365	8	associated	associate	VERB
fnp-3790	365	9	microglia	microglia	ADJ
fnp-3790	365	10	profiles	profile	NOUN
fnp-3790	365	11	in	in	ADP
fnp-3790	365	12	alzheimer	alzheimer	PROPN
fnp-3790	365	13	's	's	PART
fnp-3790	365	14	disease	disease	NOUN
fnp-3790	365	15	.	.	PUNCT
fnp-3790	366	1	acta	acta	PROPN
fnp-3790	366	2	neuropathol	neuropathol	PROPN
fnp-3790	366	3	.	.	PUNCT
fnp-3790	367	1	2021;141:681	2021;141:681	NUM
fnp-3790	367	2	-	-	SYM
fnp-3790	367	3	696	696	NUM
fnp-3790	367	4	.	.	PUNCT
fnp-3790	368	1	https://doi.org/10.1007/s00401-021-02263-w	https://doi.org/10.1007/s00401-021-02263-w	PROPN
fnp-3790	368	2	epub	epub	PROPN
fnp-3790	368	3	2021	2021	NUM
fnp-3790	368	4	feb	feb	NOUN
fnp-3790	368	5	20	20	NUM
fnp-3790	368	6	.	.	PUNCT
fnp-3790	369	1	pmid	pmid	NOUN
fnp-3790	369	2	:	:	PUNCT
fnp-3790	369	3	33609158	33609158	NUM
fnp-3790	369	4	;	;	PUNCT
fnp-3790	369	5	pmcid	pmcid	NOUN
fnp-3790	369	6	:	:	PUNCT
fnp-3790	369	7	pmc8043951	pmc8043951	NOUN
fnp-3790	369	8	.	.	PUNCT
fnp-3790	370	1	gonzález	gonzález	PROPN
fnp-3790	370	2	-	-	PUNCT
fnp-3790	370	3	tablas	tablas	PROPN
fnp-3790	370	4	pimenta	pimenta	PROPN
fnp-3790	370	5	m	m	PROPN
fnp-3790	370	6	,	,	PUNCT
fnp-3790	370	7	otero	otero	PROPN
fnp-3790	370	8	á	á	PROPN
fnp-3790	370	9	,	,	PUNCT
fnp-3790	370	10	arandia	arandia	PROPN
fnp-3790	370	11	guzman	guzman	PROPN
fnp-3790	370	12	da	da	PROPN
fnp-3790	370	13	,	,	PUNCT
fnp-3790	370	14	pascual	pascual	NOUN
fnp-3790	370	15	-	-	PUNCT
fnp-3790	370	16	argente	argente	NOUN
fnp-3790	370	17	d	d	NOUN
fnp-3790	370	18	,	,	PUNCT
fnp-3790	370	19	ruíz	ruíz	PROPN
fnp-3790	370	20	martín	martín	PROPN
fnp-3790	370	21	l	l	PROPN
fnp-3790	370	22	,	,	PUNCT
fnp-3790	370	23	sousa	sousa	NOUN
fnp-3790	370	24	-	-	PUNCT
fnp-3790	370	25	casasnovas	casasnovas	NOUN
fnp-3790	370	26	p	p	NOUN
fnp-3790	370	27	,	,	PUNCT
fnp-3790	370	28	garcía	garcía	NOUN
fnp-3790	370	29	-	-	PUNCT
fnp-3790	370	30	martin	martin	PROPN
fnp-3790	370	31	a	a	PRON
fnp-3790	370	32	,	,	PUNCT
fnp-3790	370	33	roa	roa	PROPN
fnp-3790	370	34	montes	montes	PROPN
fnp-3790	370	35	de	de	PROPN
fnp-3790	370	36	oca	oca	PROPN
fnp-3790	370	37	jc	jc	PROPN
fnp-3790	370	38	,	,	PUNCT
fnp-3790	370	39	villaseñor	villaseñor	PROPN
fnp-3790	370	40	-	-	PUNCT
fnp-3790	370	41	ledezma	ledezma	PROPN
fnp-3790	370	42	j	j	PROPN
fnp-3790	370	43	,	,	PUNCT
fnp-3790	370	44	torres	torre	VERB
fnp-3790	370	45	carretero	carretero	PROPN
fnp-3790	370	46	l	l	PROPN
fnp-3790	370	47	,	,	PUNCT
fnp-3790	370	48	almeida	almeida	PROPN
fnp-3790	370	49	m	m	PROPN
fnp-3790	370	50	,	,	PUNCT
fnp-3790	370	51	ortiz	ortiz	PROPN
fnp-3790	370	52	j	j	PROPN
fnp-3790	370	53	,	,	PUNCT
fnp-3790	370	54	nieto	nieto	PROPN
fnp-3790	370	55	a	a	PROPN
fnp-3790	370	56	,	,	PUNCT
fnp-3790	370	57	orfao	orfao	NOUN
fnp-3790	370	58	a	a	X
fnp-3790	370	59	,	,	PUNCT
fnp-3790	370	60	tabernero	tabernero	PROPN
fnp-3790	370	61	md	md	PROPN
fnp-3790	370	62	.	.	PROPN
fnp-3790	370	63	tumor	tumor	PROPN
fnp-3790	370	64	cell	cell	NOUN
fnp-3790	370	65	and	and	CCONJ
fnp-3790	370	66	immune	immune	ADJ
fnp-3790	370	67	cell	cell	NOUN
fnp-3790	370	68	profiles	profile	NOUN
fnp-3790	370	69	in	in	ADP
fnp-3790	370	70	primary	primary	ADJ
fnp-3790	370	71	human	human	ADJ
fnp-3790	370	72	glioblastoma	glioblastoma	NOUN
fnp-3790	370	73	:	:	PUNCT
fnp-3790	370	74	impact	impact	NOUN
fnp-3790	370	75	on	on	ADP
fnp-3790	370	76	patient	patient	ADJ
fnp-3790	370	77	outcome	outcome	NOUN
fnp-3790	370	78	.	.	PUNCT
fnp-3790	371	1	brain	brain	NOUN
fnp-3790	371	2	pathol	pathol	NOUN
fnp-3790	371	3	.	.	PUNCT
fnp-3790	372	1	2021;31:365	2021;31:365	X
fnp-3790	372	2	-	-	SYM
fnp-3790	372	3	380	380	NUM
fnp-3790	372	4	.	.	PUNCT
fnp-3790	373	1	https://doi.org/10.1111/bpa.12927	https://doi.org/10.1111/bpa.12927	PROPN
fnp-3790	373	2	epub	epub	PROPN
fnp-3790	373	3	2021	2021	NUM
fnp-3790	373	4	feb	feb	NOUN
fnp-3790	373	5	13	13	NUM
fnp-3790	373	6	.	.	PUNCT
fnp-3790	374	1	pmid	pmid	NOUN
fnp-3790	374	2	:	:	PUNCT
fnp-3790	374	3	33314398	33314398	NUM
fnp-3790	374	4	;	;	PUNCT
fnp-3790	374	5	pmcid	pmcid	ADJ
fnp-3790	374	6	:	:	PUNCT
fnp-3790	374	7	pmc8018082	pmc8018082	PROPN
fnp-3790	374	8	.	.	PUNCT
fnp-3790	375	1	hametner	hametner	PROPN
fnp-3790	375	2	s	s	PROPN
fnp-3790	375	3	,	,	PUNCT
fnp-3790	375	4	wimmer	wimmer	PROPN
fnp-3790	375	5	i	i	PROPN
fnp-3790	375	6	,	,	PUNCT
fnp-3790	375	7	haider	haider	PROPN
fnp-3790	375	8	l	l	PROPN
fnp-3790	375	9	,	,	PUNCT
fnp-3790	375	10	pfeifenbring	pfeifenbring	PROPN
fnp-3790	375	11	s	s	PROPN
fnp-3790	375	12	,	,	PUNCT
fnp-3790	375	13	brück	brück	PROPN
fnp-3790	375	14	w	w	PROPN
fnp-3790	375	15	,	,	PUNCT
fnp-3790	375	16	lassmann	lassmann	PROPN
fnp-3790	375	17	h.	h.	PROPN
fnp-3790	375	18	iron	iron	NOUN
fnp-3790	375	19	and	and	CCONJ
fnp-3790	375	20	neurodegeneration	neurodegeneration	NOUN
fnp-3790	375	21	in	in	ADP
fnp-3790	375	22	the	the	DET
fnp-3790	375	23	multiple	multiple	ADJ
fnp-3790	375	24	sclerosis	sclerosis	NOUN
fnp-3790	375	25	brain	brain	NOUN
fnp-3790	375	26	.	.	PUNCT
fnp-3790	376	1	ann	ann	PROPN
fnp-3790	376	2	neurol	neurol	PROPN
fnp-3790	376	3	.	.	PUNCT
fnp-3790	377	1	2013;74:848	2013;74:848	NUM
fnp-3790	377	2	-	-	SYM
fnp-3790	377	3	861	861	NUM
fnp-3790	377	4	.	.	PUNCT
fnp-3790	378	1	https://doi.org/10.1002/ana.23974	https://doi.org/10.1002/ana.23974	PROPN
fnp-3790	378	2	epub	epub	PROPN
fnp-3790	378	3	2013	2013	NUM
fnp-3790	378	4	oct	oct	NOUN
fnp-3790	378	5	7	7	NUM
fnp-3790	378	6	.	.	PUNCT
fnp-3790	378	7	pmid	pmid	NOUN
fnp-3790	378	8	:	:	PUNCT
fnp-3790	378	9	23868451	23868451	NUM
fnp-3790	378	10	;	;	PUNCT
fnp-3790	378	11	pmcid	pmcid	ADJ
fnp-3790	378	12	:	:	PUNCT
fnp-3790	378	13	pmc4223935	pmc4223935	X
fnp-3790	378	14	.	.	PUNCT
fnp-3790	379	1	jack	jack	PROPN
fnp-3790	379	2	as	as	ADP
fnp-3790	379	3	,	,	PUNCT
fnp-3790	379	4	lu	lu	PROPN
fnp-3790	379	5	j	j	PROPN
fnp-3790	379	6	-	-	PUNCT
fnp-3790	379	7	q.	q.	PROPN
fnp-3790	379	8	immune	immune	ADJ
fnp-3790	379	9	cell	cell	NOUN
fnp-3790	379	10	infiltrates	infiltrate	NOUN
fnp-3790	379	11	in	in	ADP
fnp-3790	379	12	the	the	DET
fnp-3790	379	13	central	central	ADJ
fnp-3790	379	14	nervous	nervous	ADJ
fnp-3790	379	15	system	system	NOUN
fnp-3790	379	16	tumors	tumor	NOUN
fnp-3790	379	17	.	.	PUNCT
fnp-3790	380	1	austin	austin	PROPN
fnp-3790	380	2	neurosurg	neurosurg	PROPN
fnp-3790	380	3	open	open	ADJ
fnp-3790	380	4	access	access	NOUN
fnp-3790	380	5	.	.	PUNCT
fnp-3790	381	1	2015;2:1024	2015;2:1024	NUM
fnp-3790	381	2	.	.	PUNCT
fnp-3790	382	1	kenkhuis	kenkhuis	PROPN
fnp-3790	382	2	b	b	PROPN
fnp-3790	382	3	,	,	PUNCT
fnp-3790	382	4	somarakis	somaraki	VERB
fnp-3790	382	5	a	a	DET
fnp-3790	382	6	,	,	PUNCT
fnp-3790	382	7	de	de	PROPN
fnp-3790	382	8	haan	haan	PROPN
fnp-3790	382	9	l	l	PROPN
fnp-3790	382	10	,	,	PUNCT
fnp-3790	382	11	dzyubachyk	dzyubachyk	ADJ
fnp-3790	382	12	o	o	NOUN
fnp-3790	382	13	,	,	PUNCT
fnp-3790	382	14	ijsselsteijn	ijsselsteijn	VERB
fnp-3790	382	15	me	i	PRON
fnp-3790	382	16	,	,	PUNCT
fnp-3790	382	17	de	de	PROPN
fnp-3790	382	18	miranda	miranda	PROPN
fnp-3790	382	19	nfcc	nfcc	PROPN
fnp-3790	382	20	,	,	PUNCT
fnp-3790	382	21	lelieveldt	lelieveldt	PROPN
fnp-3790	382	22	bpf	bpf	PROPN
fnp-3790	382	23	,	,	PUNCT
fnp-3790	382	24	dijkstra	dijkstra	PROPN
fnp-3790	382	25	j	j	PROPN
fnp-3790	382	26	,	,	PUNCT
fnp-3790	382	27	van	van	PROPN
fnp-3790	382	28	roon	roon	PROPN
fnp-3790	382	29	-	-	PUNCT
fnp-3790	382	30	mom	mom	NOUN
fnp-3790	382	31	wmc	wmc	PROPN
fnp-3790	382	32	,	,	PUNCT
fnp-3790	382	33	höllt	höllt	PROPN
fnp-3790	382	34	t	t	PROPN
fnp-3790	382	35	,	,	PUNCT
fnp-3790	382	36	van	van	PROPN
fnp-3790	382	37	der	der	PROPN
fnp-3790	382	38	weerd	weerd	PROPN
fnp-3790	382	39	l.	l.	PROPN
fnp-3790	382	40	iron	iron	NOUN
fnp-3790	382	41	loading	loading	NOUN
fnp-3790	382	42	is	be	AUX
fnp-3790	382	43	a	a	DET
fnp-3790	382	44	prominent	prominent	ADJ
fnp-3790	382	45	feature	feature	NOUN
fnp-3790	382	46	of	of	ADP
fnp-3790	382	47	activated	activate	VERB
fnp-3790	382	48	microglia	microglia	NOUN
fnp-3790	382	49	in	in	ADP
fnp-3790	382	50	alzheimer	alzheimer	PROPN
fnp-3790	382	51	's	's	PART
fnp-3790	382	52	disease	disease	NOUN
fnp-3790	382	53	patients	patient	NOUN
fnp-3790	382	54	.	.	PUNCT
fnp-3790	383	1	acta	acta	PROPN
fnp-3790	383	2	neuropathol	neuropathol	PROPN
fnp-3790	383	3	commun	commun	PROPN
fnp-3790	383	4	.	.	PUNCT
fnp-3790	384	1	2021;9:27	2021;9:27	PROPN
fnp-3790	384	2	.	.	PUNCT
fnp-3790	385	1	https://doi.org/10.1186/s40478-021-01126-5	https://doi.org/10.1186/s40478-021-01126-5	NUM
fnp-3790	385	2	pmid	pmid	NOUN
fnp-3790	385	3	:	:	PUNCT
fnp-3790	385	4	33597025	33597025	NUM
fnp-3790	385	5	;	;	PUNCT
fnp-3790	385	6	pmcid	pmcid	ADJ
fnp-3790	385	7	:	:	PUNCT
fnp-3790	385	8	pmc7887813	pmc7887813	NOUN
fnp-3790	385	9	.	.	PUNCT
fnp-3790	386	1	keren	keren	PROPN
fnp-3790	386	2	-	-	PUNCT
fnp-3790	386	3	shaul	shaul	PROPN
fnp-3790	386	4	h	h	NOUN
fnp-3790	386	5	,	,	PUNCT
fnp-3790	386	6	spinrad	spinrad	X
fnp-3790	386	7	a	a	DET
fnp-3790	386	8	,	,	PUNCT
fnp-3790	386	9	weiner	weiner	NOUN
fnp-3790	386	10	a	a	PRON
fnp-3790	386	11	,	,	PUNCT
fnp-3790	386	12	matcovitch	matcovitch	NOUN
fnp-3790	386	13	-	-	PUNCT
fnp-3790	386	14	natan	natan	PROPN
fnp-3790	386	15	o	o	PROPN
fnp-3790	386	16	,	,	PUNCT
fnp-3790	386	17	dvir	dvir	PROPN
fnp-3790	386	18	-	-	PUNCT
fnp-3790	386	19	szternfeld	szternfeld	PROPN
fnp-3790	386	20	r	r	PROPN
fnp-3790	386	21	,	,	PUNCT
fnp-3790	386	22	ulland	ulland	PROPN
fnp-3790	386	23	tk	tk	PROPN
fnp-3790	386	24	,	,	PUNCT
fnp-3790	386	25	david	david	PROPN
fnp-3790	386	26	e	e	PROPN
fnp-3790	386	27	,	,	PUNCT
fnp-3790	386	28	baruch	baruch	ADJ
fnp-3790	386	29	k	k	NOUN
fnp-3790	386	30	,	,	PUNCT
fnp-3790	386	31	lara	lara	NOUN
fnp-3790	386	32	-	-	PUNCT
fnp-3790	386	33	astaiso	astaiso	NOUN
fnp-3790	386	34	d	d	NOUN
fnp-3790	386	35	,	,	PUNCT
fnp-3790	386	36	toth	toth	PROPN
fnp-3790	386	37	b	b	PROPN
fnp-3790	386	38	,	,	PUNCT
fnp-3790	386	39	itzkovitz	itzkovitz	PROPN
fnp-3790	386	40	s	s	PART
fnp-3790	386	41	,	,	PUNCT
fnp-3790	386	42	colonna	colonna	NOUN
fnp-3790	386	43	m	m	PROPN
fnp-3790	386	44	,	,	PUNCT
fnp-3790	386	45	schwartz	schwartz	PROPN
fnp-3790	386	46	m	m	PROPN
fnp-3790	386	47	,	,	PUNCT
fnp-3790	386	48	amit	amit	PROPN
fnp-3790	386	49	i.	i.	PROPN
fnp-3790	386	50	a	a	DET
fnp-3790	386	51	unique	unique	ADJ
fnp-3790	386	52	microglia	microglia	ADJ
fnp-3790	386	53	type	type	NOUN
fnp-3790	386	54	associated	associate	VERB
fnp-3790	386	55	with	with	ADP
fnp-3790	386	56	restricting	restrict	VERB
fnp-3790	386	57	development	development	NOUN
fnp-3790	386	58	of	of	ADP
fnp-3790	386	59	alzheimer	alzheimer	PROPN
fnp-3790	386	60	's	's	PART
fnp-3790	386	61	disease	disease	NOUN
fnp-3790	386	62	.	.	PUNCT
fnp-3790	387	1	cell	cell	NOUN
fnp-3790	387	2	.	.	PUNCT
fnp-3790	388	1	2017;169:1276	2017;169:1276	NUM
fnp-3790	388	2	-	-	PUNCT
fnp-3790	388	3	1290.e17	1290.e17	PROPN
fnp-3790	388	4	.	.	PUNCT
fnp-3790	389	1	https://doi.org/10.1016/j.cell.2017.05.018	https://doi.org/10.1016/j.cell.2017.05.018	PROPN
fnp-3790	389	2	epub	epub	PROPN
fnp-3790	389	3	2017	2017	NUM
fnp-3790	389	4	jun	jun	PROPN
fnp-3790	389	5	8	8	NUM
fnp-3790	389	6	.	.	PUNCT
fnp-3790	390	1	pmid	pmid	NOUN
fnp-3790	390	2	:	:	PUNCT
fnp-3790	390	3	28602351	28602351	NUM
fnp-3790	390	4	.	.	PUNCT
fnp-3790	391	1	kiljan	kiljan	PROPN
fnp-3790	391	2	s	s	PART
fnp-3790	391	3	,	,	PUNCT
fnp-3790	391	4	prins	prins	PROPN
fnp-3790	391	5	m	m	PROPN
fnp-3790	391	6	,	,	PUNCT
fnp-3790	391	7	baselmans	baselmans	PROPN
fnp-3790	391	8	bm	bm	PROPN
fnp-3790	391	9	,	,	PUNCT
fnp-3790	391	10	bol	bol	VERB
fnp-3790	391	11	jgjm	jgjm	PROPN
fnp-3790	391	12	,	,	PUNCT
fnp-3790	391	13	schenk	schenk	PROPN
fnp-3790	391	14	gj	gj	PROPN
fnp-3790	391	15	,	,	PUNCT
fnp-3790	391	16	van	van	PROPN
fnp-3790	391	17	dam	dam	PROPN
fnp-3790	391	18	am	be	AUX
fnp-3790	391	19	.	.	PUNCT
fnp-3790	392	1	enhanced	enhance	VERB
fnp-3790	392	2	gabaergic	gabaergic	ADJ
fnp-3790	392	3	immunoreactivity	immunoreactivity	NOUN
fnp-3790	392	4	in	in	ADP
fnp-3790	392	5	hippocampal	hippocampal	ADJ
fnp-3790	392	6	neurons	neuron	NOUN
fnp-3790	392	7	and	and	CCONJ
fnp-3790	392	8	astroglia	astroglia	NOUN
fnp-3790	392	9	of	of	ADP
fnp-3790	392	10	multiple	multiple	ADJ
fnp-3790	392	11	sclerosis	sclerosis	NOUN
fnp-3790	392	12	patients	patient	NOUN
fnp-3790	392	13	.	.	PUNCT
fnp-3790	393	1	j	j	PROPN
fnp-3790	393	2	neuropathol	neuropathol	PROPN
fnp-3790	393	3	exp	exp	PROPN
fnp-3790	393	4	neurol	neurol	PROPN
fnp-3790	393	5	.	.	PUNCT
fnp-3790	394	1	2019;78:480	2019;78:480	NOUN
fnp-3790	394	2	-	-	PUNCT
fnp-3790	394	3	491	491	NUM
fnp-3790	394	4	.	.	PUNCT
fnp-3790	395	1	https://doi.org/10.1093/jnen/nlz028	https://doi.org/10.1093/jnen/nlz028	ADJ
fnp-3790	395	2	pmid	pmid	NOUN
fnp-3790	395	3	:	:	PUNCT
fnp-3790	395	4	31100147	31100147	NUM
fnp-3790	395	5	;	;	PUNCT
fnp-3790	395	6	pmcid	pmcid	ADJ
fnp-3790	395	7	:	:	PUNCT
fnp-3790	395	8	pmc6524632	pmc6524632	NOUN
fnp-3790	395	9	.	.	PUNCT
fnp-3790	396	1	kirschenbaum	kirschenbaum	PROPN
fnp-3790	396	2	d	d	PROPN
fnp-3790	396	3	,	,	PUNCT
fnp-3790	396	4	imbach	imbach	NOUN
fnp-3790	396	5	ll	ll	NOUN
fnp-3790	396	6	,	,	PUNCT
fnp-3790	396	7	rushing	rush	VERB
fnp-3790	396	8	ej	ej	PROPN
fnp-3790	396	9	,	,	PUNCT
fnp-3790	396	10	frauenknecht	frauenknecht	PROPN
fnp-3790	396	11	kbm	kbm	PROPN
fnp-3790	396	12	,	,	PUNCT
fnp-3790	396	13	gascho	gascho	PROPN
fnp-3790	396	14	d	d	PROPN
fnp-3790	396	15	,	,	PUNCT
fnp-3790	396	16	ineichen	ineichen	PROPN
fnp-3790	396	17	bv	bv	PROPN
fnp-3790	396	18	,	,	PUNCT
fnp-3790	396	19	keller	keller	PROPN
fnp-3790	396	20	e	e	PROPN
fnp-3790	396	21	,	,	PUNCT
fnp-3790	396	22	kohler	kohler	PROPN
fnp-3790	396	23	s	s	PROPN
fnp-3790	396	24	,	,	PUNCT
fnp-3790	396	25	lichtblau	lichtblau	PROPN
fnp-3790	396	26	m	m	PROPN
fnp-3790	396	27	,	,	PUNCT
fnp-3790	396	28	reimann	reimann	PROPN
fnp-3790	396	29	rr	rr	PROPN
fnp-3790	396	30	,	,	PUNCT
fnp-3790	396	31	schreib	schreib	PROPN
fnp-3790	396	32	k	k	PROPN
fnp-3790	396	33	,	,	PUNCT
fnp-3790	396	34	ulrich	ulrich	PROPN
fnp-3790	396	35	s	s	PROPN
fnp-3790	396	36	,	,	PUNCT
fnp-3790	396	37	steiger	steiger	PROPN
fnp-3790	396	38	p	p	PROPN
fnp-3790	396	39	,	,	PUNCT
fnp-3790	396	40	aguzzi	aguzzi	NOUN
fnp-3790	396	41	a	a	PRON
fnp-3790	396	42	,	,	PUNCT
fnp-3790	396	43	frontzek	frontzek	PROPN
fnp-3790	396	44	k.	k.	PROPN
fnp-3790	396	45	intracerebral	intracerebral	PROPN
fnp-3790	396	46	endotheliitis	endotheliitis	PROPN
fnp-3790	396	47	and	and	CCONJ
fnp-3790	396	48	microbleeds	microbleed	NOUN
fnp-3790	396	49	are	be	AUX
fnp-3790	396	50	neuropathological	neuropathological	ADJ
fnp-3790	396	51	features	feature	NOUN
fnp-3790	396	52	of	of	ADP
fnp-3790	396	53	covid-19	covid-19	PROPN
fnp-3790	396	54	.	.	PUNCT
fnp-3790	396	55	neuropathol	neuropathol	PROPN
fnp-3790	396	56	appl	appl	PROPN
fnp-3790	396	57	neurobiol	neurobiol	PROPN
fnp-3790	396	58	.	.	PUNCT
fnp-3790	397	1	2021;47:454	2021;47:454	X
fnp-3790	397	2	-	-	PUNCT
fnp-3790	397	3	459	459	NUM
fnp-3790	397	4	.	.	PUNCT
fnp-3790	398	1	https://doi.org/10.1111/nan.12677	https://doi.org/10.1111/nan.12677	PROPN
fnp-3790	398	2	epub	epub	PROPN
fnp-3790	398	3	2020	2020	NUM
fnp-3790	398	4	dec	dec	PROPN
fnp-3790	398	5	14	14	NUM
fnp-3790	398	6	.	.	PUNCT
fnp-3790	399	1	pmid	pmid	NOUN
fnp-3790	399	2	:	:	PUNCT
fnp-3790	399	3	33249605	33249605	NUM
fnp-3790	399	4	;	;	PUNCT
fnp-3790	399	5	pmcid	pmcid	ADJ
fnp-3790	399	6	:	:	PUNCT
fnp-3790	399	7	pmc7753688	pmc7753688	PROPN
fnp-3790	399	8	.	.	PUNCT
fnp-3790	400	1	kmiecik	kmiecik	PROPN
fnp-3790	400	2	j	j	PROPN
fnp-3790	400	3	,	,	PUNCT
fnp-3790	400	4	poli	poli	PROPN
fnp-3790	400	5	a	a	PROPN
fnp-3790	400	6	,	,	PUNCT
fnp-3790	400	7	brons	brons	PROPN
fnp-3790	400	8	nhc	nhc	PROPN
fnp-3790	400	9	,	,	PUNCT
fnp-3790	400	10	waha	waha	PROPN
fnp-3790	400	11	a	a	PROPN
fnp-3790	400	12	,	,	PUNCT
fnp-3790	400	13	eide	eide	PROPN
fnp-3790	400	14	ge	ge	PROPN
fnp-3790	400	15	,	,	PUNCT
fnp-3790	400	16	enger	enger	PROPN
fnp-3790	400	17	pø	pø	PROPN
fnp-3790	400	18	,	,	PUNCT
fnp-3790	400	19	zimmer	zimmer	PROPN
fnp-3790	400	20	j	j	PROPN
fnp-3790	400	21	,	,	PUNCT
fnp-3790	400	22	chekenya	chekenya	PROPN
fnp-3790	400	23	m.	m.	PROPN
fnp-3790	400	24	elevated	elevated	PROPN
fnp-3790	400	25	cd3	cd3	PROPN
fnp-3790	400	26	+	+	PROPN
fnp-3790	400	27	and	and	CCONJ
fnp-3790	400	28	cd8	cd8	PROPN
fnp-3790	400	29	+	+	NOUN
fnp-3790	400	30	tumor	tumor	NOUN
fnp-3790	400	31	-	-	PUNCT
fnp-3790	400	32	infiltrating	infiltrating	ADJ
fnp-3790	400	33	immune	immune	ADJ
fnp-3790	400	34	cells	cell	NOUN
fnp-3790	400	35	correlate	correlate	VERB
fnp-3790	400	36	with	with	ADP
fnp-3790	400	37	prolonged	prolonged	ADJ
fnp-3790	400	38	survival	survival	NOUN
fnp-3790	400	39	in	in	ADP
fnp-3790	400	40	glioblastoma	glioblastoma	NOUN
fnp-3790	400	41	patients	patient	NOUN
fnp-3790	400	42	despite	despite	SCONJ
fnp-3790	400	43	integrated	integrate	VERB
fnp-3790	400	44	immunosuppressive	immunosuppressive	ADJ
fnp-3790	400	45	mechanisms	mechanism	NOUN
fnp-3790	400	46	in	in	ADP
fnp-3790	400	47	the	the	DET
fnp-3790	400	48	tumor	tumor	NOUN
fnp-3790	400	49	microenvironment	microenvironment	NOUN
fnp-3790	400	50	and	and	CCONJ
fnp-3790	400	51	at	at	ADP
fnp-3790	400	52	the	the	DET
fnp-3790	400	53	systemic	systemic	ADJ
fnp-3790	400	54	level	level	NOUN
fnp-3790	400	55	.	.	PUNCT
fnp-3790	401	1	j	j	PROPN
fnp-3790	401	2	neuroimmunol	neuroimmunol	NOUN
fnp-3790	401	3	.	.	PUNCT
fnp-3790	402	1	2013;264:71–83	2013;264:71–83	X
fnp-3790	402	2	.	.	PUNCT
fnp-3790	403	1	https://doi.org/10.1016/j.jneuroim.2013.08.013	https://doi.org/10.1016/j.jneuroim.2013.08.013	NOUN
fnp-3790	403	2	epub	epub	NOUN
fnp-3790	403	3	2013	2013	NUM
fnp-3790	403	4	aug	aug	PROPN
fnp-3790	403	5	31	31	NUM
fnp-3790	403	6	.	.	PUNCT
fnp-3790	404	1	pmid	pmid	NOUN
fnp-3790	404	2	:	:	PUNCT
fnp-3790	404	3	24045166	24045166	NUM
fnp-3790	404	4	.	.	PUNCT
fnp-3790	405	1	kmiecik	kmiecik	PROPN
fnp-3790	405	2	j	j	PROPN
fnp-3790	405	3	,	,	PUNCT
fnp-3790	405	4	zimmer	zimmer	PROPN
fnp-3790	405	5	j	j	PROPN
fnp-3790	405	6	,	,	PUNCT
fnp-3790	405	7	chekenya	chekenya	PROPN
fnp-3790	405	8	m.	m.	NOUN
fnp-3790	405	9	natural	natural	ADJ
fnp-3790	405	10	killer	killer	NOUN
fnp-3790	405	11	cells	cell	NOUN
fnp-3790	405	12	in	in	ADP
fnp-3790	405	13	intracranial	intracranial	ADJ
fnp-3790	405	14	neoplasms	neoplasm	NOUN
fnp-3790	405	15	:	:	PUNCT
fnp-3790	405	16	presence	presence	NOUN
fnp-3790	405	17	and	and	CCONJ
fnp-3790	405	18	therapeutic	therapeutic	ADJ
fnp-3790	405	19	efficacy	efficacy	NOUN
fnp-3790	405	20	against	against	ADP
fnp-3790	405	21	brain	brain	NOUN
fnp-3790	405	22	tumours	tumour	NOUN
fnp-3790	405	23	.	.	PUNCT
fnp-3790	406	1	j	j	PROPN
fnp-3790	406	2	neurooncol	neurooncol	PROPN
fnp-3790	406	3	.	.	PUNCT
fnp-3790	407	1	2014;116:1–9	2014;116:1–9	NOUN
fnp-3790	407	2	.	.	PUNCT
fnp-3790	408	1	https://doi.org/10.1007/s11060-013-1265-5	https://doi.org/10.1007/s11060-013-1265-5	PROPN
fnp-3790	408	2	epub	epub	VERB
fnp-3790	408	3	2013	2013	NUM
fnp-3790	408	4	oct	oct	NOUN
fnp-3790	408	5	2	2	NUM
fnp-3790	408	6	.	.	PUNCT
fnp-3790	408	7	pmid	pmid	NOUN
fnp-3790	408	8	:	:	PUNCT
fnp-3790	408	9	24085644	24085644	NUM
fnp-3790	408	10	;	;	PUNCT
fnp-3790	408	11	pmcid	pmcid	ADJ
fnp-3790	408	12	:	:	PUNCT
fnp-3790	408	13	pmc3889498	pmc3889498	NOUN
fnp-3790	408	14	.	.	PUNCT
fnp-3790	409	1	koch	koch	PROPN
fnp-3790	409	2	m	m	PROPN
fnp-3790	409	3	,	,	PUNCT
fnp-3790	409	4	uyttenboogaart	uyttenboogaart	PROPN
fnp-3790	409	5	m	m	PROPN
fnp-3790	409	6	,	,	PUNCT
fnp-3790	409	7	polman	polman	NOUN
fnp-3790	409	8	s	s	PROPN
fnp-3790	409	9	,	,	PUNCT
fnp-3790	409	10	de	de	PROPN
fnp-3790	409	11	keyser	keyser	PROPN
fnp-3790	409	12	j.	j.	PROPN
fnp-3790	409	13	seizures	seizure	NOUN
fnp-3790	409	14	in	in	ADP
fnp-3790	409	15	multiple	multiple	ADJ
fnp-3790	409	16	sclerosis	sclerosis	NOUN
fnp-3790	409	17	.	.	PUNCT
fnp-3790	410	1	epilepsia	epilepsia	NOUN
fnp-3790	410	2	.	.	PUNCT
fnp-3790	411	1	2008;49:948	2008;49:948	PROPN
fnp-3790	411	2	-	-	SYM
fnp-3790	411	3	953	953	NUM
fnp-3790	411	4	.	.	PUNCT
fnp-3790	412	1	https://doi.org/10.1111/j.1528-1167.2008.01565.x	https://doi.org/10.1111/j.1528-1167.2008.01565.x	ADJ
fnp-3790	412	2	epub	epub	NOUN
fnp-3790	412	3	2008	2008	NUM
fnp-3790	412	4	mar	mar	PROPN
fnp-3790	412	5	11	11	NUM
fnp-3790	412	6	.	.	PUNCT
fnp-3790	413	1	pmid	pmid	NOUN
fnp-3790	413	2	:	:	PUNCT
fnp-3790	413	3	18336559	18336559	NUM
fnp-3790	413	4	.	.	PUNCT
fnp-3790	414	1	krasemann	krasemann	PROPN
fnp-3790	414	2	s	s	PART
fnp-3790	414	3	,	,	PUNCT
fnp-3790	414	4	madore	madore	NOUN
fnp-3790	414	5	c	c	NOUN
fnp-3790	414	6	,	,	PUNCT
fnp-3790	414	7	cialic	cialic	ADJ
fnp-3790	414	8	r	r	NOUN
fnp-3790	414	9	,	,	PUNCT
fnp-3790	414	10	baufeld	baufeld	NOUN
fnp-3790	414	11	c	c	NOUN
fnp-3790	414	12	,	,	PUNCT
fnp-3790	414	13	calcagno	calcagno	NOUN
fnp-3790	414	14	n	n	CCONJ
fnp-3790	414	15	,	,	PUNCT
fnp-3790	414	16	el	el	PROPN
fnp-3790	414	17	fatimy	fatimy	NOUN
fnp-3790	414	18	r	r	NOUN
fnp-3790	414	19	,	,	PUNCT
fnp-3790	414	20	beckers	beckers	PROPN
fnp-3790	414	21	l	l	PROPN
fnp-3790	414	22	,	,	PUNCT
fnp-3790	414	23	o'loughlin	o'loughlin	PROPN
fnp-3790	414	24	e	e	PROPN
fnp-3790	414	25	,	,	PUNCT
fnp-3790	414	26	xu	xu	PROPN
fnp-3790	414	27	y	y	PROPN
fnp-3790	414	28	,	,	PUNCT
fnp-3790	414	29	fanek	fanek	PROPN
fnp-3790	414	30	z	z	PROPN
fnp-3790	414	31	,	,	PUNCT
fnp-3790	414	32	greco	greco	PROPN
fnp-3790	414	33	dj	dj	PROPN
fnp-3790	414	34	,	,	PUNCT
fnp-3790	414	35	smith	smith	PROPN
fnp-3790	414	36	st	st	PROPN
fnp-3790	414	37	,	,	PUNCT
fnp-3790	414	38	tweet	tweet	NOUN
fnp-3790	414	39	g	g	NOUN
fnp-3790	414	40	,	,	PUNCT
fnp-3790	414	41	humulock	humulock	PROPN
fnp-3790	414	42	z	z	PROPN
fnp-3790	414	43	,	,	PUNCT
fnp-3790	414	44	zrzavy	zrzavy	PROPN
fnp-3790	414	45	t	t	PROPN
fnp-3790	414	46	,	,	PUNCT
fnp-3790	414	47	conde	conde	PROPN
fnp-3790	414	48	-	-	PUNCT
fnp-3790	414	49	sanroman	sanroman	NOUN
fnp-3790	414	50	p	p	NOUN
fnp-3790	414	51	,	,	PUNCT
fnp-3790	414	52	gacias	gacias	PROPN
fnp-3790	414	53	m	m	PROPN
fnp-3790	414	54	,	,	PUNCT
fnp-3790	414	55	weng	weng	PROPN
fnp-3790	414	56	z	z	PROPN
fnp-3790	414	57	,	,	PUNCT
fnp-3790	414	58	chen	chen	PROPN
fnp-3790	414	59	h	h	PROPN
fnp-3790	414	60	,	,	PUNCT
fnp-3790	414	61	tjon	tjon	NOUN
fnp-3790	414	62	e	e	NOUN
fnp-3790	414	63	,	,	PUNCT
fnp-3790	414	64	mazaheri	mazaheri	PROPN
fnp-3790	414	65	f	f	PROPN
fnp-3790	414	66	,	,	PUNCT
fnp-3790	414	67	hartmann	hartmann	PROPN
fnp-3790	414	68	k	k	PROPN
fnp-3790	414	69	,	,	PUNCT
fnp-3790	414	70	madi	madi	PROPN
fnp-3790	414	71	a	a	PROPN
fnp-3790	414	72	,	,	PUNCT
fnp-3790	414	73	ulrich	ulrich	PROPN
fnp-3790	414	74	jd	jd	PROPN
fnp-3790	414	75	,	,	PUNCT
fnp-3790	414	76	glatzel	glatzel	PROPN
fnp-3790	414	77	m	m	PROPN
fnp-3790	414	78	,	,	PUNCT
fnp-3790	414	79	worthmann	worthmann	PROPN
fnp-3790	414	80	a	a	X
fnp-3790	414	81	,	,	PUNCT
fnp-3790	414	82	heeren	heeren	PROPN
fnp-3790	414	83	j	j	PROPN
fnp-3790	414	84	,	,	PUNCT
fnp-3790	414	85	budnik	budnik	PROPN
fnp-3790	414	86	b	b	AUX
fnp-3790	414	87	,	,	PUNCT
fnp-3790	414	88	lemere	lemere	PROPN
fnp-3790	414	89	c	c	NOUN
fnp-3790	414	90	,	,	PUNCT
fnp-3790	414	91	ikezu	ikezu	PROPN
fnp-3790	414	92	t	t	PROPN
fnp-3790	414	93	,	,	PUNCT
fnp-3790	414	94	heppner	heppner	PROPN
fnp-3790	414	95	fl	fl	PROPN
fnp-3790	414	96	,	,	PUNCT
fnp-3790	414	97	litvak	litvak	ADJ
fnp-3790	414	98	v	v	NOUN
fnp-3790	414	99	,	,	PUNCT
fnp-3790	414	100	holtzman	holtzman	NOUN
fnp-3790	414	101	dm	dm	PROPN
fnp-3790	414	102	,	,	PUNCT
fnp-3790	414	103	lassmann	lassmann	PROPN
fnp-3790	414	104	h	h	NOUN
fnp-3790	414	105	,	,	PUNCT
fnp-3790	414	106	weiner	weiner	NOUN
fnp-3790	414	107	hl	hl	NOUN
fnp-3790	414	108	,	,	PUNCT
fnp-3790	414	109	ochando	ochando	PROPN
fnp-3790	414	110	j	j	PROPN
fnp-3790	414	111	,	,	PUNCT
fnp-3790	414	112	haass	haass	VERB
fnp-3790	414	113	c	c	NOUN
fnp-3790	414	114	,	,	PUNCT
fnp-3790	414	115	butovsky	butovsky	ADJ
fnp-3790	414	116	o.	o.	NOUN
fnp-3790	414	117	the	the	DET
fnp-3790	414	118	trem2	trem2	PROPN
fnp-3790	414	119	-	-	ADJ
fnp-3790	414	120	apoe	apoe	ADJ
fnp-3790	414	121	pathway	pathway	NOUN
fnp-3790	414	122	drives	drive	VERB
fnp-3790	414	123	the	the	DET
fnp-3790	414	124	transcriptional	transcriptional	ADJ
fnp-3790	414	125	phenotype	phenotype	NOUN
fnp-3790	414	126	of	of	ADP
fnp-3790	414	127	dysfunctional	dysfunctional	ADJ
fnp-3790	414	128	microglia	microglia	NOUN
fnp-3790	414	129	in	in	ADP
fnp-3790	414	130	neurodegenerative	neurodegenerative	ADJ
fnp-3790	414	131	diseases	disease	NOUN
fnp-3790	414	132	.	.	PUNCT
fnp-3790	415	1	immunity	immunity	NOUN
fnp-3790	415	2	.	.	PUNCT
fnp-3790	416	1	2017;47:566	2017;47:566	X
fnp-3790	416	2	-	-	PUNCT
fnp-3790	416	3	581.e9	581.e9	NUM
fnp-3790	416	4	.	.	PUNCT
fnp-3790	417	1	https://doi.org/10.1016/j.immuni.2017.08.008	https://doi.org/10.1016/j.immuni.2017.08.008	PROPN
fnp-3790	417	2	pmid	pmid	PROPN
fnp-3790	417	3	:	:	PUNCT
fnp-3790	417	4	28930663	28930663	NUM
fnp-3790	417	5	;	;	PUNCT
fnp-3790	417	6	pmcid	pmcid	ADJ
fnp-3790	417	7	:	:	PUNCT
fnp-3790	417	8	pmc5719893	pmc5719893	ADJ
fnp-3790	417	9	.	.	PUNCT
fnp-3790	418	1	lambert	lambert	PROPN
fnp-3790	418	2	jc	jc	PROPN
fnp-3790	418	3	,	,	PUNCT
fnp-3790	418	4	ibrahim	ibrahim	PROPN
fnp-3790	418	5	-	-	PUNCT
fnp-3790	418	6	verbaas	verbaas	PROPN
fnp-3790	418	7	ca	ca	PROPN
fnp-3790	418	8	,	,	PUNCT
fnp-3790	418	9	harold	harold	PROPN
fnp-3790	418	10	d	d	PROPN
fnp-3790	418	11	,	,	PUNCT
fnp-3790	418	12	naj	naj	PROPN
fnp-3790	418	13	ac	ac	PROPN
fnp-3790	418	14	,	,	PUNCT
fnp-3790	418	15	sims	sim	NOUN
fnp-3790	418	16	r	r	NOUN
fnp-3790	418	17	,	,	PUNCT
fnp-3790	418	18	bellenguez	bellenguez	PROPN
fnp-3790	418	19	c	c	AUX
fnp-3790	418	20	,	,	PUNCT
fnp-3790	418	21	destafano	destafano	PROPN
fnp-3790	418	22	al	al	PROPN
fnp-3790	418	23	,	,	PUNCT
fnp-3790	418	24	bis	bis	PROPN
fnp-3790	418	25	jc	jc	PROPN
fnp-3790	418	26	,	,	PUNCT
fnp-3790	418	27	beecham	beecham	PROPN
fnp-3790	418	28	gw	gw	PROPN
fnp-3790	418	29	,	,	PUNCT
fnp-3790	418	30	grenier	grenier	NOUN
fnp-3790	418	31	-	-	PUNCT
fnp-3790	418	32	boley	boley	PROPN
fnp-3790	418	33	b	b	PROPN
fnp-3790	418	34	,	,	PUNCT
fnp-3790	418	35	russo	russo	NOUN
fnp-3790	418	36	g	g	PROPN
fnp-3790	418	37	,	,	PUNCT
fnp-3790	418	38	thorton	thorton	PROPN
fnp-3790	418	39	-	-	PUNCT
fnp-3790	418	40	wells	wells	PROPN
fnp-3790	418	41	ta	ta	PROPN
fnp-3790	418	42	,	,	PUNCT
fnp-3790	418	43	jones	jones	PROPN
fnp-3790	418	44	n	n	PROPN
fnp-3790	418	45	,	,	PUNCT
fnp-3790	418	46	smith	smith	PROPN
fnp-3790	418	47	av	av	PROPN
fnp-3790	418	48	,	,	PUNCT
fnp-3790	418	49	chouraki	chouraki	ADV
fnp-3790	418	50	v	v	NOUN
fnp-3790	418	51	,	,	PUNCT
fnp-3790	418	52	thomas	thomas	PROPN
fnp-3790	418	53	c	c	PROPN
fnp-3790	418	54	,	,	PUNCT
fnp-3790	418	55	ikram	ikram	PROPN
fnp-3790	418	56	ma	ma	PROPN
fnp-3790	418	57	,	,	PUNCT
fnp-3790	418	58	zelenika	zelenika	PROPN
fnp-3790	418	59	d	d	PROPN
fnp-3790	418	60	,	,	PUNCT
fnp-3790	418	61	vardarajan	vardarajan	VERB
fnp-3790	418	62	bn	bn	NUM
fnp-3790	418	63	,	,	PUNCT
fnp-3790	418	64	kamatani	kamatani	PROPN
fnp-3790	418	65	y	y	PROPN
fnp-3790	418	66	,	,	PUNCT
fnp-3790	418	67	lin	lin	PROPN
fnp-3790	418	68	cf	cf	NOUN
fnp-3790	418	69	,	,	PUNCT
fnp-3790	418	70	gerrish	gerrish	VERB
fnp-3790	418	71	a	a	PRON
fnp-3790	418	72	,	,	PUNCT
fnp-3790	418	73	schmidt	schmidt	PROPN
fnp-3790	418	74	h	h	PROPN
fnp-3790	418	75	,	,	PUNCT
fnp-3790	418	76	kunkle	kunkle	PROPN
fnp-3790	418	77	b	b	PROPN
fnp-3790	418	78	,	,	PUNCT
fnp-3790	418	79	dunstan	dunstan	PROPN
fnp-3790	418	80	ml	ml	AUX
fnp-3790	418	81	,	,	PUNCT
fnp-3790	418	82	ruiz	ruiz	NOUN
fnp-3790	418	83	a	a	PRON
fnp-3790	418	84	,	,	PUNCT
fnp-3790	418	85	bihoreau	bihoreau	PROPN
fnp-3790	418	86	mt	mt	PROPN
fnp-3790	418	87	,	,	PUNCT
fnp-3790	418	88	choi	choi	PROPN
fnp-3790	418	89	sh	sh	PROPN
fnp-3790	418	90	,	,	PUNCT
fnp-3790	418	91	reitz	reitz	PROPN
fnp-3790	418	92	c	c	PROPN
fnp-3790	418	93	,	,	PUNCT
fnp-3790	418	94	pasquier	pasquier	NOUN
fnp-3790	418	95	f	f	PROPN
fnp-3790	418	96	,	,	PUNCT
fnp-3790	418	97	cruchaga	cruchaga	NOUN
fnp-3790	418	98	c	c	PROPN
fnp-3790	418	99	,	,	PUNCT
fnp-3790	418	100	craig	craig	PROPN
fnp-3790	418	101	d	d	PROPN
fnp-3790	418	102	,	,	PUNCT
fnp-3790	418	103	amin	amin	PROPN
fnp-3790	418	104	n	n	CCONJ
fnp-3790	418	105	,	,	PUNCT
fnp-3790	418	106	berr	berr	PROPN
fnp-3790	418	107	c	c	PROPN
fnp-3790	418	108	,	,	PUNCT
fnp-3790	418	109	lopez	lopez	PROPN
fnp-3790	418	110	ol	ol	PROPN
fnp-3790	418	111	,	,	PUNCT
fnp-3790	418	112	de	de	X
fnp-3790	418	113	jager	jager	PROPN
fnp-3790	418	114	pl	pl	PROPN
fnp-3790	418	115	,	,	PUNCT
fnp-3790	418	116	deramecourt	deramecourt	NOUN
fnp-3790	418	117	v	v	ADP
fnp-3790	418	118	,	,	PUNCT
fnp-3790	418	119	johnston	johnston	PROPN
fnp-3790	418	120	ja	ja	PROPN
fnp-3790	418	121	,	,	PUNCT
fnp-3790	418	122	evans	evans	PROPN
fnp-3790	418	123	d	d	PROPN
fnp-3790	418	124	,	,	PUNCT
fnp-3790	418	125	lovestone	lovestone	NOUN
fnp-3790	418	126	s	s	PROPN
fnp-3790	418	127	,	,	PUNCT
fnp-3790	418	128	letenneur	letenneur	PROPN
fnp-3790	418	129	l	l	PROPN
fnp-3790	418	130	,	,	PUNCT
fnp-3790	418	131	morón	morón	PROPN
fnp-3790	418	132	fj	fj	PROPN
fnp-3790	418	133	,	,	PUNCT
fnp-3790	418	134	rubinsztein	rubinsztein	PROPN
fnp-3790	418	135	dc	dc	PROPN
fnp-3790	418	136	,	,	PUNCT
fnp-3790	418	137	eiriksdottir	eiriksdottir	PROPN
fnp-3790	418	138	g	g	PROPN
fnp-3790	418	139	,	,	PUNCT
fnp-3790	418	140	sleegers	sleeger	NOUN
fnp-3790	418	141	k	k	PROPN
fnp-3790	418	142	,	,	PUNCT
fnp-3790	418	143	goate	goate	NOUN
fnp-3790	418	144	am	am	NOUN
fnp-3790	418	145	,	,	PUNCT
fnp-3790	418	146	fiévet	fiévet	NOUN
fnp-3790	418	147	n	n	CCONJ
fnp-3790	418	148	,	,	PUNCT
fnp-3790	418	149	huentelman	huentelman	NOUN
fnp-3790	418	150	mw	mw	PROPN
fnp-3790	418	151	,	,	PUNCT
fnp-3790	418	152	gill	gill	PROPN
fnp-3790	418	153	m	m	NOUN
fnp-3790	418	154	,	,	PUNCT
fnp-3790	418	155	brown	brown	PROPN
fnp-3790	418	156	k	k	PROPN
fnp-3790	418	157	,	,	PUNCT
fnp-3790	418	158	kamboh	kamboh	PROPN
fnp-3790	418	159	mi	mi	PROPN
fnp-3790	418	160	,	,	PUNCT
fnp-3790	418	161	keller	keller	PROPN
fnp-3790	418	162	l	l	PROPN
fnp-3790	418	163	,	,	PUNCT
fnp-3790	418	164	barberger	barberger	NOUN
fnp-3790	418	165	-	-	PUNCT
fnp-3790	418	166	gateau	gateau	PROPN
fnp-3790	418	167	p	p	PROPN
fnp-3790	418	168	,	,	PUNCT
fnp-3790	418	169	mcguiness	mcguiness	PROPN
fnp-3790	418	170	b	b	NOUN
fnp-3790	418	171	,	,	PUNCT
fnp-3790	418	172	larson	larson	PROPN
fnp-3790	418	173	eb	eb	PROPN
fnp-3790	418	174	,	,	PUNCT
fnp-3790	418	175	green	green	PROPN
fnp-3790	418	176	r	r	PROPN
fnp-3790	418	177	,	,	PUNCT
fnp-3790	418	178	myers	myers	PROPN
fnp-3790	418	179	aj	aj	PROPN
fnp-3790	418	180	,	,	PUNCT
fnp-3790	418	181	dufouil	dufouil	PROPN
fnp-3790	418	182	c	c	X
fnp-3790	418	183	,	,	PUNCT
fnp-3790	418	184	todd	todd	PROPN
fnp-3790	418	185	s	s	PART
fnp-3790	418	186	,	,	PUNCT
fnp-3790	418	187	wallon	wallon	PROPN
fnp-3790	418	188	d	d	PROPN
fnp-3790	418	189	,	,	PUNCT
fnp-3790	418	190	love	love	NOUN
fnp-3790	418	191	s	s	PROPN
fnp-3790	418	192	,	,	PUNCT
fnp-3790	418	193	rogaeva	rogaeva	NOUN
fnp-3790	418	194	e	e	NOUN
fnp-3790	418	195	,	,	PUNCT
fnp-3790	418	196	gallacher	gallacher	PROPN
fnp-3790	418	197	j	j	PROPN
fnp-3790	418	198	,	,	PUNCT
fnp-3790	418	199	st	st	PROPN
fnp-3790	418	200	george	george	PROPN
fnp-3790	418	201	-	-	PUNCT
fnp-3790	418	202	hyslop	hyslop	PROPN
fnp-3790	418	203	p	p	X
fnp-3790	418	204	,	,	PUNCT
fnp-3790	418	205	clarimon	clarimon	PROPN
fnp-3790	418	206	j	j	PROPN
fnp-3790	418	207	,	,	PUNCT
fnp-3790	418	208	lleo	lleo	PROPN
fnp-3790	418	209	a	a	PRON
fnp-3790	418	210	,	,	PUNCT
fnp-3790	418	211	bayer	bayer	PROPN
fnp-3790	418	212	a	a	PRON
fnp-3790	418	213	,	,	PUNCT
fnp-3790	418	214	tsuang	tsuang	PROPN
fnp-3790	418	215	dw	dw	PROPN
fnp-3790	418	216	,	,	PUNCT
fnp-3790	418	217	yu	yu	PROPN
fnp-3790	418	218	l	l	PROPN
fnp-3790	418	219	,	,	PUNCT
fnp-3790	418	220	tsolaki	tsolaki	NOUN
fnp-3790	418	221	m	m	PRON
fnp-3790	418	222	,	,	PUNCT
fnp-3790	418	223	bossù	bossù	PROPN
fnp-3790	418	224	p	p	X
fnp-3790	418	225	,	,	PUNCT
fnp-3790	418	226	spalletta	spalletta	ADJ
fnp-3790	418	227	g	g	PROPN
fnp-3790	418	228	,	,	PUNCT
fnp-3790	418	229	proitsi	proitsi	NOUN
fnp-3790	418	230	p	p	NOUN
fnp-3790	418	231	,	,	PUNCT
fnp-3790	418	232	collinge	collinge	NOUN
fnp-3790	418	233	j	j	PROPN
fnp-3790	418	234	,	,	PUNCT
fnp-3790	418	235	sorbi	sorbi	PROPN
fnp-3790	418	236	s	s	PROPN
fnp-3790	418	237	,	,	PUNCT
fnp-3790	418	238	sanchez	sanchez	PROPN
fnp-3790	418	239	-	-	PUNCT
fnp-3790	418	240	garcia	garcia	PROPN
fnp-3790	418	241	f	f	PROPN
fnp-3790	418	242	,	,	PUNCT
fnp-3790	418	243	fox	fox	PROPN
fnp-3790	418	244	nc	nc	PROPN
fnp-3790	418	245	,	,	PUNCT
fnp-3790	418	246	hardy	hardy	PROPN
fnp-3790	418	247	j	j	PROPN
fnp-3790	418	248	,	,	PUNCT
fnp-3790	418	249	deniz	deniz	PROPN
fnp-3790	418	250	naranjo	naranjo	PROPN
fnp-3790	418	251	mc	mc	PROPN
fnp-3790	418	252	,	,	PUNCT
fnp-3790	418	253	bosco	bosco	PROPN
fnp-3790	418	254	p	p	PROPN
fnp-3790	418	255	,	,	PUNCT
fnp-3790	418	256	clarke	clarke	PROPN
fnp-3790	418	257	r	r	PROPN
fnp-3790	418	258	,	,	PUNCT
fnp-3790	418	259	brayne	brayne	PROPN
fnp-3790	418	260	c	c	PROPN
fnp-3790	418	261	,	,	PUNCT
fnp-3790	418	262	galimberti	galimberti	PROPN
fnp-3790	418	263	d	d	PROPN
fnp-3790	418	264	,	,	PUNCT
fnp-3790	418	265	mancuso	mancuso	PROPN
fnp-3790	418	266	m	m	PROPN
fnp-3790	418	267	,	,	PUNCT
fnp-3790	418	268	matthews	matthews	PROPN
fnp-3790	418	269	f	f	PROPN
fnp-3790	418	270	;	;	PUNCT
fnp-3790	418	271	european	european	PROPN
fnp-3790	418	272	alzheimer	alzheimer	PROPN
fnp-3790	418	273	's	's	PART
fnp-3790	418	274	disease	disease	NOUN
fnp-3790	418	275	initiative	initiative	NOUN
fnp-3790	418	276	(	(	PUNCT
fnp-3790	418	277	eadi	eadi	NOUN
fnp-3790	418	278	)	)	PUNCT
fnp-3790	418	279	;	;	PUNCT
fnp-3790	418	280	genetic	genetic	ADJ
fnp-3790	418	281	and	and	CCONJ
fnp-3790	418	282	environmental	environmental	ADJ
fnp-3790	418	283	risk	risk	NOUN
fnp-3790	418	284	in	in	ADP
fnp-3790	418	285	alzheimer	alzheimer	PROPN
fnp-3790	418	286	's	's	PART
fnp-3790	418	287	disease	disease	NOUN
fnp-3790	418	288	;	;	PUNCT
fnp-3790	418	289	alzheimer	alzheimer	PROPN
fnp-3790	418	290	's	's	PART
fnp-3790	418	291	disease	disease	NOUN
fnp-3790	418	292	genetic	genetic	ADJ
fnp-3790	418	293	consortium	consortium	NOUN
fnp-3790	418	294	;	;	PUNCT
fnp-3790	418	295	cohorts	cohort	NOUN
fnp-3790	418	296	for	for	ADP
fnp-3790	418	297	heart	heart	NOUN
fnp-3790	418	298	and	and	CCONJ
fnp-3790	418	299	aging	age	VERB
fnp-3790	418	300	research	research	NOUN
fnp-3790	418	301	in	in	ADP
fnp-3790	418	302	genomic	genomic	ADJ
fnp-3790	418	303	epidemiology	epidemiology	NOUN
fnp-3790	418	304	,	,	PUNCT
fnp-3790	418	305	moebus	moebus	NOUN
fnp-3790	418	306	s	s	PROPN
fnp-3790	418	307	,	,	PUNCT
fnp-3790	418	308	mecocci	mecocci	NOUN
fnp-3790	418	309	p	p	NOUN
fnp-3790	418	310	,	,	PUNCT
fnp-3790	418	311	del	del	PROPN
fnp-3790	418	312	zompo	zompo	PROPN
fnp-3790	418	313	m	m	PROPN
fnp-3790	418	314	,	,	PUNCT
fnp-3790	418	315	maier	maier	PROPN
fnp-3790	418	316	w	w	PROPN
fnp-3790	418	317	,	,	PUNCT
fnp-3790	418	318	hampel	hampel	PROPN
fnp-3790	418	319	h	h	NOUN
fnp-3790	418	320	,	,	PUNCT
fnp-3790	418	321	pilotto	pilotto	NOUN
fnp-3790	418	322	a	a	PRON
fnp-3790	418	323	,	,	PUNCT
fnp-3790	418	324	bullido	bullido	PROPN
fnp-3790	418	325	m	m	PROPN
fnp-3790	418	326	,	,	PUNCT
fnp-3790	418	327	panza	panza	PROPN
fnp-3790	418	328	f	f	PROPN
fnp-3790	418	329	,	,	PUNCT
fnp-3790	418	330	caffarra	caffarra	VERB
fnp-3790	418	331	p	p	X
fnp-3790	418	332	,	,	PUNCT
fnp-3790	418	333	nacmias	nacmias	PROPN
fnp-3790	418	334	b	b	PROPN
fnp-3790	418	335	,	,	PUNCT
fnp-3790	418	336	gilbert	gilbert	PROPN
fnp-3790	418	337	jr	jr	PROPN
fnp-3790	418	338	,	,	PUNCT
fnp-3790	418	339	mayhaus	mayhaus	PROPN
fnp-3790	418	340	m	m	PROPN
fnp-3790	418	341	,	,	PUNCT
fnp-3790	418	342	lannefelt	lannefelt	VERB
fnp-3790	418	343	l	l	PROPN
fnp-3790	418	344	,	,	PUNCT
fnp-3790	418	345	hakonarson	hakonarson	PROPN
fnp-3790	418	346	h	h	PROPN
fnp-3790	418	347	,	,	PUNCT
fnp-3790	418	348	pichler	pichler	NOUN
fnp-3790	418	349	s	s	PART
fnp-3790	418	350	,	,	PUNCT
fnp-3790	418	351	carrasquillo	carrasquillo	PROPN
fnp-3790	418	352	mm	mm	PROPN
fnp-3790	418	353	,	,	PUNCT
fnp-3790	418	354	ingelsson	ingelsson	NOUN
fnp-3790	418	355	m	m	PROPN
fnp-3790	418	356	,	,	PUNCT
fnp-3790	418	357	beekly	beekly	PROPN
fnp-3790	418	358	d	d	PROPN
fnp-3790	418	359	,	,	PUNCT
fnp-3790	418	360	alvarez	alvarez	PROPN
fnp-3790	418	361	v	v	PROPN
fnp-3790	418	362	,	,	PUNCT
fnp-3790	418	363	zou	zou	PROPN
fnp-3790	418	364	f	f	PROPN
fnp-3790	418	365	,	,	PUNCT
fnp-3790	418	366	valladares	valladare	VERB
fnp-3790	418	367	o	o	NOUN
fnp-3790	418	368	,	,	PUNCT
fnp-3790	418	369	younkin	younkin	PROPN
fnp-3790	418	370	sg	sg	PROPN
fnp-3790	418	371	,	,	PUNCT
fnp-3790	418	372	coto	coto	PROPN
fnp-3790	418	373	e	e	PROPN
fnp-3790	418	374	,	,	PUNCT
fnp-3790	418	375	hamilton	hamilton	PROPN
fnp-3790	418	376	-	-	PUNCT
fnp-3790	418	377	nelson	nelson	PROPN
fnp-3790	418	378	kl	kl	PROPN
fnp-3790	418	379	,	,	PUNCT
fnp-3790	418	380	gu	gu	NOUN
fnp-3790	418	381	w	w	PROPN
fnp-3790	418	382	,	,	PUNCT
fnp-3790	418	383	razquin	razquin	PROPN
fnp-3790	418	384	c	c	NOUN
fnp-3790	418	385	,	,	PUNCT
fnp-3790	418	386	pastor	pastor	NOUN
fnp-3790	418	387	p	p	NOUN
fnp-3790	418	388	,	,	PUNCT
fnp-3790	418	389	mateo	mateo	VERB
fnp-3790	418	390	i	i	PRON
fnp-3790	418	391	,	,	PUNCT
fnp-3790	418	392	owen	owen	PROPN
fnp-3790	418	393	mj	mj	PROPN
fnp-3790	418	394	,	,	PUNCT
fnp-3790	418	395	faber	faber	PROPN
fnp-3790	418	396	km	km	PROPN
fnp-3790	418	397	,	,	PUNCT
fnp-3790	418	398	jonsson	jonsson	PROPN
fnp-3790	418	399	pv	pv	PROPN
fnp-3790	418	400	,	,	PUNCT
fnp-3790	418	401	combarros	combarros	PROPN
fnp-3790	418	402	o	o	NOUN
fnp-3790	418	403	,	,	PUNCT
fnp-3790	418	404	o'donovan	o'donovan	PROPN
fnp-3790	418	405	mc	mc	PROPN
fnp-3790	418	406	,	,	PUNCT
fnp-3790	418	407	cantwell	cantwell	PROPN
fnp-3790	418	408	lb	lb	PROPN
fnp-3790	418	409	,	,	PUNCT
fnp-3790	418	410	soininen	soininen	NOUN
fnp-3790	418	411	h	h	NOUN
fnp-3790	418	412	,	,	PUNCT
fnp-3790	418	413	blacker	black	ADJ
fnp-3790	418	414	d	d	NOUN
fnp-3790	418	415	,	,	PUNCT
fnp-3790	418	416	mead	mead	NOUN
fnp-3790	418	417	s	s	PROPN
fnp-3790	418	418	,	,	PUNCT
fnp-3790	418	419	mosley	mosley	PROPN
fnp-3790	418	420	th	th	PROPN
fnp-3790	418	421	jr	jr	PROPN
fnp-3790	418	422	,	,	PUNCT
fnp-3790	418	423	bennett	bennett	PROPN
fnp-3790	418	424	da	da	PROPN
fnp-3790	418	425	,	,	PUNCT
fnp-3790	418	426	harris	harris	PROPN
fnp-3790	418	427	tb	tb	PROPN
fnp-3790	418	428	,	,	PUNCT
fnp-3790	418	429	fratiglioni	fratiglioni	PROPN
fnp-3790	418	430	l	l	PROPN
fnp-3790	418	431	,	,	PUNCT
fnp-3790	418	432	holmes	holmes	PROPN
fnp-3790	418	433	c	c	PROPN
fnp-3790	418	434	,	,	PUNCT
fnp-3790	418	435	de	de	X
fnp-3790	418	436	bruijn	bruijn	NOUN
fnp-3790	418	437	rf	rf	NOUN
fnp-3790	418	438	,	,	PUNCT
fnp-3790	418	439	passmore	passmore	NOUN
fnp-3790	418	440	p	p	NOUN
fnp-3790	418	441	,	,	PUNCT
fnp-3790	418	442	montine	montine	PROPN
fnp-3790	418	443	tj	tj	NOUN
fnp-3790	418	444	,	,	PUNCT
fnp-3790	418	445	bettens	betten	VERB
fnp-3790	418	446	k	k	NOUN
fnp-3790	418	447	,	,	PUNCT
fnp-3790	418	448	rotter	rotter	PROPN
fnp-3790	418	449	ji	ji	PROPN
fnp-3790	418	450	,	,	PUNCT
fnp-3790	418	451	brice	brice	PROPN
fnp-3790	418	452	a	a	PROPN
fnp-3790	418	453	,	,	PUNCT
fnp-3790	418	454	morgan	morgan	PROPN
fnp-3790	418	455	k	k	PROPN
fnp-3790	418	456	,	,	PUNCT
fnp-3790	418	457	foroud	foroud	PROPN
fnp-3790	418	458	tm	tm	PROPN
fnp-3790	418	459	,	,	PUNCT
fnp-3790	418	460	kukull	kukull	PROPN
fnp-3790	418	461	wa	wa	PROPN
fnp-3790	418	462	,	,	PUNCT
fnp-3790	419	1	hannequin	hannequin	PROPN
fnp-3790	419	2	d	d	PROPN
fnp-3790	419	3	,	,	PUNCT
fnp-3790	419	4	powell	powell	PROPN
fnp-3790	419	5	jf	jf	PROPN
fnp-3790	419	6	,	,	PUNCT
fnp-3790	419	7	nalls	nalls	PROPN
fnp-3790	419	8	ma	ma	PROPN
fnp-3790	419	9	,	,	PUNCT
fnp-3790	419	10	ritchie	ritchie	PROPN
fnp-3790	419	11	k	k	PROPN
fnp-3790	419	12	,	,	PUNCT
fnp-3790	419	13	lunetta	lunetta	PROPN
fnp-3790	419	14	kl	kl	PROPN
fnp-3790	419	15	,	,	PUNCT
fnp-3790	419	16	kauwe	kauwe	PROPN
fnp-3790	419	17	js	js	PROPN
fnp-3790	419	18	,	,	PUNCT
fnp-3790	419	19	boerwinkle	boerwinkle	NOUN
fnp-3790	419	20	e	e	PROPN
fnp-3790	419	21	,	,	PUNCT
fnp-3790	419	22	riemenschneider	riemenschneider	PROPN
fnp-3790	419	23	m	m	PROPN
fnp-3790	419	24	,	,	PUNCT
fnp-3790	419	25	boada	boada	PROPN
fnp-3790	419	26	m	m	PROPN
fnp-3790	419	27	,	,	PUNCT
fnp-3790	419	28	hiltuenen	hiltuenen	PROPN
fnp-3790	419	29	m	m	PROPN
fnp-3790	419	30	,	,	PUNCT
fnp-3790	419	31	martin	martin	PROPN
fnp-3790	419	32	er	er	INTJ
fnp-3790	419	33	,	,	PUNCT
fnp-3790	419	34	schmidt	schmidt	PROPN
fnp-3790	419	35	r	r	PROPN
fnp-3790	419	36	,	,	PUNCT
fnp-3790	419	37	rujescu	rujescu	NOUN
fnp-3790	419	38	d	d	PROPN
fnp-3790	419	39	,	,	PUNCT
fnp-3790	419	40	wang	wang	PROPN
fnp-3790	419	41	ls	ls	PROPN
fnp-3790	419	42	,	,	PUNCT
fnp-3790	419	43	dartigues	dartigues	PROPN
fnp-3790	419	44	jf	jf	PROPN
fnp-3790	419	45	,	,	PUNCT
fnp-3790	419	46	mayeux	mayeux	PROPN
fnp-3790	419	47	r	r	PROPN
fnp-3790	419	48	,	,	PUNCT
fnp-3790	419	49	tzourio	tzourio	NOUN
fnp-3790	419	50	c	c	NOUN
fnp-3790	419	51	,	,	PUNCT
fnp-3790	419	52	hofman	hofman	PROPN
fnp-3790	419	53	a	a	DET
fnp-3790	419	54	,	,	PUNCT
fnp-3790	419	55	nöthen	nöthen	ADV
fnp-3790	419	56	mm	mm	INTJ
fnp-3790	419	57	,	,	PUNCT
fnp-3790	419	58	graff	graff	NOUN
fnp-3790	419	59	c	c	NOUN
fnp-3790	419	60	,	,	PUNCT
fnp-3790	419	61	psaty	psaty	PROPN
fnp-3790	419	62	bm	bm	PROPN
fnp-3790	419	63	,	,	PUNCT
fnp-3790	419	64	jones	jones	PROPN
fnp-3790	419	65	l	l	PROPN
fnp-3790	419	66	,	,	PUNCT
fnp-3790	419	67	haines	haine	NOUN
fnp-3790	419	68	jl	jl	NOUN
fnp-3790	419	69	,	,	PUNCT
fnp-3790	419	70	holmans	holmans	PROPN
fnp-3790	419	71	pa	pa	PROPN
fnp-3790	419	72	,	,	PUNCT
fnp-3790	419	73	lathrop	lathrop	PROPN
fnp-3790	419	74	m	m	PROPN
fnp-3790	419	75	,	,	PUNCT
fnp-3790	419	76	pericak	pericak	ADJ
fnp-3790	419	77	-	-	PUNCT
fnp-3790	419	78	vance	vance	NOUN
fnp-3790	419	79	ma	ma	PROPN
fnp-3790	419	80	,	,	PUNCT
fnp-3790	419	81	launer	launer	NOUN
fnp-3790	419	82	lj	lj	PROPN
fnp-3790	419	83	,	,	PUNCT
fnp-3790	419	84	farrer	farrer	PROPN
fnp-3790	419	85	la	la	PROPN
fnp-3790	419	86	,	,	PUNCT
fnp-3790	419	87	van	van	PROPN
fnp-3790	419	88	duijn	duijn	PROPN
fnp-3790	419	89	cm	cm	PROPN
fnp-3790	419	90	,	,	PUNCT
fnp-3790	419	91	van	van	PROPN
fnp-3790	419	92	broeckhoven	broeckhoven	NOUN
fnp-3790	419	93	c	c	PROPN
fnp-3790	419	94	,	,	PUNCT
fnp-3790	419	95	moskvina	moskvina	PROPN
fnp-3790	419	96	v	v	NOUN
fnp-3790	419	97	,	,	PUNCT
fnp-3790	419	98	seshadri	seshadri	PROPN
fnp-3790	419	99	s	s	PROPN
fnp-3790	419	100	,	,	PUNCT
fnp-3790	419	101	williams	williams	PROPN
fnp-3790	419	102	j	j	PROPN
fnp-3790	419	103	,	,	PUNCT
fnp-3790	419	104	schellenberg	schellenberg	PROPN
fnp-3790	419	105	gd	gd	PROPN
fnp-3790	419	106	,	,	PUNCT
fnp-3790	420	1	amouyel	amouyel	PROPN
fnp-3790	420	2	p.	p.	NOUN
fnp-3790	420	3	meta	meta	ADJ
fnp-3790	420	4	-	-	PUNCT
fnp-3790	420	5	analysis	analysis	NOUN
fnp-3790	420	6	of	of	ADP
fnp-3790	420	7	74,046	74,046	NUM
fnp-3790	420	8	individuals	individual	NOUN
fnp-3790	420	9	identifies	identify	VERB
fnp-3790	420	10	11	11	NUM
fnp-3790	420	11	new	new	ADJ
fnp-3790	420	12	susceptibility	susceptibility	NOUN
fnp-3790	420	13	loci	locus	NOUN
fnp-3790	420	14	for	for	ADP
fnp-3790	420	15	alzheimer	alzheimer	PROPN
fnp-3790	420	16	’s	’s	PART
fnp-3790	420	17	disease	disease	NOUN
fnp-3790	420	18	.	.	PUNCT
fnp-3790	421	1	nat	nat	PROPN
fnp-3790	421	2	genet	genet	PROPN
fnp-3790	421	3	.	.	PUNCT
fnp-3790	422	1	2013;45:1452–1458	2013;45:1452–1458	NOUN
fnp-3790	422	2	.	.	PUNCT
fnp-3790	423	1	https://doi.org/10.1038/ng.2802	https://doi.org/10.1038/ng.2802	PRON
fnp-3790	423	2	epub	epub	NOUN
fnp-3790	423	3	2013	2013	NUM
fnp-3790	423	4	oct	oct	NOUN
fnp-3790	423	5	27	27	NUM
fnp-3790	423	6	.	.	PUNCT
fnp-3790	424	1	pmid	pmid	NOUN
fnp-3790	424	2	:	:	PUNCT
fnp-3790	424	3	24162737	24162737	NUM
fnp-3790	424	4	;	;	PUNCT
fnp-3790	424	5	pmcid	pmcid	ADJ
fnp-3790	424	6	:	:	PUNCT
fnp-3790	424	7	pmc3896259	pmc3896259	PROPN
fnp-3790	424	8	.	.	PUNCT
fnp-3790	425	1	langenbruch	langenbruch	ADJ
fnp-3790	425	2	l	l	NOUN
fnp-3790	425	3	,	,	PUNCT
fnp-3790	425	4	krämer	krämer	PROPN
fnp-3790	425	5	j	j	PROPN
fnp-3790	425	6	,	,	PUNCT
fnp-3790	425	7	güler	güler	PROPN
fnp-3790	425	8	s	s	PROPN
fnp-3790	425	9	,	,	PUNCT
fnp-3790	425	10	möddel	möddel	PROPN
fnp-3790	425	11	g	g	PROPN
fnp-3790	425	12	,	,	PUNCT
fnp-3790	425	13	geβner	geβner	PROPN
fnp-3790	425	14	s	s	PROPN
fnp-3790	425	15	,	,	PUNCT
fnp-3790	425	16	melzer	melzer	PROPN
fnp-3790	425	17	n	n	CCONJ
fnp-3790	425	18	,	,	PUNCT
fnp-3790	425	19	elger	elger	PROPN
fnp-3790	425	20	ce	ce	PROPN
fnp-3790	425	21	,	,	PUNCT
fnp-3790	425	22	wiendl	wiendl	PROPN
fnp-3790	425	23	h	h	PROPN
fnp-3790	425	24	,	,	PUNCT
fnp-3790	425	25	budde	budde	PROPN
fnp-3790	425	26	t	t	PROPN
fnp-3790	425	27	,	,	PUNCT
fnp-3790	425	28	meuth	meuth	PROPN
fnp-3790	425	29	sg	sg	PROPN
fnp-3790	425	30	,	,	PUNCT
fnp-3790	425	31	kovac	kovac	PROPN
fnp-3790	425	32	s.	s.	PROPN
fnp-3790	425	33	seizures	seizures	PROPN
fnp-3790	425	34	and	and	CCONJ
fnp-3790	425	35	epilepsy	epilepsy	NOUN
fnp-3790	425	36	in	in	ADP
fnp-3790	425	37	multiple	multiple	ADJ
fnp-3790	425	38	sclerosis	sclerosis	NOUN
fnp-3790	425	39	:	:	PUNCT
fnp-3790	425	40	epidemiology	epidemiology	NOUN
fnp-3790	425	41	and	and	CCONJ
fnp-3790	425	42	prognosis	prognosis	NOUN
fnp-3790	425	43	in	in	ADP
fnp-3790	425	44	a	a	DET
fnp-3790	425	45	large	large	ADJ
fnp-3790	425	46	tertiary	tertiary	ADJ
fnp-3790	425	47	referral	referral	NOUN
fnp-3790	425	48	center	center	NOUN
fnp-3790	425	49	.	.	PUNCT
fnp-3790	426	1	j	j	PROPN
fnp-3790	426	2	neurol	neurol	PROPN
fnp-3790	426	3	.	.	PUNCT
fnp-3790	427	1	2019;266:1789	2019;266:1789	NUM
fnp-3790	427	2	-	-	SYM
fnp-3790	427	3	1795	1795	NUM
fnp-3790	427	4	.	.	PUNCT
fnp-3790	428	1	https://doi.org/10.1007/s00415-019-09332-x	https://doi.org/10.1007/s00415-019-09332-x	PROPN
fnp-3790	428	2	epub	epub	PROPN
fnp-3790	428	3	2019	2019	NUM
fnp-3790	428	4	may	may	PROPN
fnp-3790	428	5	8	8	NUM
fnp-3790	428	6	.	.	PUNCT
fnp-3790	429	1	pmid	pmid	NOUN
fnp-3790	429	2	:	:	PUNCT
fnp-3790	429	3	31069528	31069528	NUM
fnp-3790	429	4	.	.	PUNCT
fnp-3790	430	1	lapato	lapato	NOUN
fnp-3790	430	2	as	as	ADP
fnp-3790	430	3	,	,	PUNCT
fnp-3790	430	4	szu	szu	ADJ
fnp-3790	430	5	ji	ji	PROPN
fnp-3790	430	6	,	,	PUNCT
fnp-3790	430	7	hasselmann	hasselmann	PROPN
fnp-3790	430	8	jpc	jpc	PROPN
fnp-3790	430	9	,	,	PUNCT
fnp-3790	430	10	khalaj	khalaj	PROPN
fnp-3790	430	11	aj	aj	PROPN
fnp-3790	430	12	,	,	PUNCT
fnp-3790	430	13	binder	binder	NOUN
fnp-3790	430	14	dk	dk	PROPN
fnp-3790	430	15	,	,	PUNCT
fnp-3790	430	16	tiwari	tiwari	PROPN
fnp-3790	430	17	-	-	PUNCT
fnp-3790	430	18	woodruff	woodruff	PROPN
fnp-3790	430	19	sk	sk	PROPN
fnp-3790	430	20	.	.	PROPN
fnp-3790	430	21	chronic	chronic	ADJ
fnp-3790	430	22	demyelination	demyelination	NOUN
fnp-3790	430	23	-	-	PUNCT
fnp-3790	430	24	induced	induce	VERB
fnp-3790	430	25	seizures	seizure	NOUN
fnp-3790	430	26	.	.	PUNCT
fnp-3790	431	1	neuroscience	neuroscience	NOUN
fnp-3790	431	2	.	.	PUNCT
fnp-3790	432	1	2017;346:409	2017;346:409	NUM
fnp-3790	432	2	-	-	SYM
fnp-3790	432	3	422	422	NUM
fnp-3790	432	4	.	.	PUNCT
fnp-3790	433	1	https://doi.org/10.1016/j.neuroscience.2017.01.035	https://doi.org/10.1016/j.neuroscience.2017.01.035	PROPN
fnp-3790	433	2	epub	epub	PROPN
fnp-3790	433	3	2017	2017	NUM
fnp-3790	433	4	jan	jan	PROPN
fnp-3790	433	5	30	30	NUM
fnp-3790	433	6	.	.	PUNCT
fnp-3790	434	1	pmid	pmid	NOUN
fnp-3790	434	2	:	:	PUNCT
fnp-3790	434	3	28153692	28153692	NUM
fnp-3790	434	4	;	;	PUNCT
fnp-3790	434	5	pmcid	pmcid	ADJ
fnp-3790	434	6	:	:	PUNCT
fnp-3790	434	7	pmc5394933	pmc5394933	NOUN
fnp-3790	434	8	.	.	PUNCT
fnp-3790	435	1	lassmann	lassmann	PROPN
fnp-3790	435	2	h	h	PROPN
fnp-3790	435	3	,	,	PUNCT
fnp-3790	435	4	van	van	PROPN
fnp-3790	435	5	horssen	horssen	PROPN
fnp-3790	435	6	j.	j.	PROPN
fnp-3790	436	1	the	the	DET
fnp-3790	436	2	molecular	molecular	ADJ
fnp-3790	436	3	basis	basis	NOUN
fnp-3790	436	4	of	of	ADP
fnp-3790	436	5	neurodegeneration	neurodegeneration	NOUN
fnp-3790	436	6	in	in	ADP
fnp-3790	436	7	multiple	multiple	ADJ
fnp-3790	436	8	sclerosis	sclerosis	NOUN
fnp-3790	436	9	.	.	PUNCT
fnp-3790	437	1	febs	febs	PROPN
fnp-3790	437	2	lett	lett	PROPN
fnp-3790	437	3	.	.	PUNCT
fnp-3790	438	1	2011;585:3715	2011;585:3715	NUM
fnp-3790	438	2	-	-	SYM
fnp-3790	438	3	3723	3723	NUM
fnp-3790	438	4	.	.	PUNCT
fnp-3790	439	1	https://doi.org/10.1016/j.febslet.2011.08.004	https://doi.org/10.1016/j.febslet.2011.08.004	NOUN
fnp-3790	439	2	epub	epub	NOUN
fnp-3790	439	3	2011	2011	NUM
fnp-3790	439	4	aug	aug	PROPN
fnp-3790	439	5	16	16	NUM
fnp-3790	439	6	.	.	PUNCT
fnp-3790	440	1	pmid	pmid	NOUN
fnp-3790	440	2	:	:	PUNCT
fnp-3790	440	3	21854776	21854776	NUM
fnp-3790	440	4	.	.	PUNCT
fnp-3790	441	1	lee	lee	PROPN
fnp-3790	441	2	mh	mh	PROPN
fnp-3790	441	3	,	,	PUNCT
fnp-3790	441	4	perl	perl	PROPN
fnp-3790	441	5	dp	dp	PROPN
fnp-3790	441	6	,	,	PUNCT
fnp-3790	441	7	nair	nair	NOUN
fnp-3790	441	8	g	g	PROPN
fnp-3790	441	9	,	,	PUNCT
fnp-3790	441	10	li	li	PROPN
fnp-3790	441	11	w	w	PROPN
fnp-3790	441	12	,	,	PUNCT
fnp-3790	441	13	maric	maric	PROPN
fnp-3790	441	14	d	d	PROPN
fnp-3790	441	15	,	,	PUNCT
fnp-3790	441	16	murray	murray	PROPN
fnp-3790	441	17	h	h	PROPN
fnp-3790	441	18	,	,	PUNCT
fnp-3790	441	19	dodd	dodd	PROPN
fnp-3790	441	20	sj	sj	PROPN
fnp-3790	441	21	,	,	PUNCT
fnp-3790	441	22	koretsky	koretsky	PROPN
fnp-3790	441	23	ap	ap	PROPN
fnp-3790	441	24	,	,	PUNCT
fnp-3790	441	25	watts	watts	PROPN
fnp-3790	441	26	ja	ja	PROPN
fnp-3790	441	27	,	,	PUNCT
fnp-3790	441	28	cheung	cheung	PROPN
fnp-3790	441	29	v	v	PROPN
fnp-3790	441	30	,	,	PUNCT
fnp-3790	441	31	masliah	masliah	PROPN
fnp-3790	441	32	e	e	PROPN
fnp-3790	441	33	,	,	PUNCT
fnp-3790	441	34	horkayne	horkayne	NOUN
fnp-3790	441	35	-	-	PUNCT
fnp-3790	441	36	szakaly	szakaly	NOUN
fnp-3790	441	37	i	i	PROPN
fnp-3790	441	38	,	,	PUNCT
fnp-3790	441	39	jones	jones	PROPN
fnp-3790	441	40	r	r	PROPN
fnp-3790	441	41	,	,	PUNCT
fnp-3790	441	42	stram	stram	PROPN
fnp-3790	441	43	mn	mn	PROPN
fnp-3790	441	44	,	,	PUNCT
fnp-3790	441	45	moncur	moncur	PROPN
fnp-3790	441	46	j	j	PROPN
fnp-3790	441	47	,	,	PUNCT
fnp-3790	441	48	hefti	hefti	PROPN
fnp-3790	441	49	m	m	PROPN
fnp-3790	441	50	,	,	PUNCT
fnp-3790	441	51	folkerth	folkerth	PROPN
fnp-3790	441	52	rd	rd	PROPN
fnp-3790	441	53	,	,	PUNCT
fnp-3790	441	54	nath	nath	NOUN
fnp-3790	441	55	a.	a.	NOUN
fnp-3790	441	56	microvascular	microvascular	NOUN
fnp-3790	441	57	injury	injury	NOUN
fnp-3790	441	58	in	in	ADP
fnp-3790	441	59	the	the	DET
fnp-3790	441	60	brains	brain	NOUN
fnp-3790	441	61	of	of	ADP
fnp-3790	441	62	patients	patient	NOUN
fnp-3790	441	63	with	with	ADP
fnp-3790	441	64	covid-19	covid-19	PROPN
fnp-3790	441	65	.	.	PUNCT
fnp-3790	442	1	n	n	PROPN
fnp-3790	442	2	engl	engl	PROPN
fnp-3790	442	3	j	j	PROPN
fnp-3790	442	4	med	med	PROPN
fnp-3790	442	5	.	.	PUNCT
fnp-3790	443	1	2021;384:481	2021;384:481	NUM
fnp-3790	443	2	-	-	SYM
fnp-3790	443	3	483	483	NUM
fnp-3790	443	4	.	.	PUNCT
fnp-3790	444	1	https://doi.org/10.1056/nejmc2033369	https://doi.org/10.1056/nejmc2033369	PROPN
fnp-3790	444	2	epub	epub	PROPN
fnp-3790	444	3	2020	2020	NUM
fnp-3790	444	4	dec	dec	PROPN
fnp-3790	444	5	30	30	NUM
fnp-3790	444	6	.	.	PUNCT
fnp-3790	445	1	pmid	pmid	NOUN
fnp-3790	445	2	:	:	PUNCT
fnp-3790	445	3	33378608	33378608	NUM
fnp-3790	445	4	;	;	PUNCT
fnp-3790	445	5	pmcid	pmcid	ADJ
fnp-3790	445	6	:	:	PUNCT
fnp-3790	445	7	pmc7787217	pmc7787217	NOUN
fnp-3790	445	8	.	.	PUNCT
fnp-3790	446	1	lewcock	lewcock	PROPN
fnp-3790	446	2	jw	jw	PROPN
fnp-3790	446	3	,	,	PUNCT
fnp-3790	446	4	schlepckow	schlepckow	PROPN
fnp-3790	446	5	k	k	PROPN
fnp-3790	446	6	,	,	PUNCT
fnp-3790	446	7	di	di	PROPN
fnp-3790	446	8	paolo	paolo	PROPN
fnp-3790	446	9	g	g	PROPN
fnp-3790	446	10	,	,	PUNCT
fnp-3790	446	11	tahirovic	tahirovic	VERB
fnp-3790	446	12	s	s	PROPN
fnp-3790	446	13	,	,	PUNCT
fnp-3790	446	14	monroe	monroe	PROPN
fnp-3790	446	15	km	km	PROPN
fnp-3790	446	16	,	,	PUNCT
fnp-3790	446	17	haass	haass	VERB
fnp-3790	446	18	c.	c.	NOUN
fnp-3790	446	19	emerging	emerge	VERB
fnp-3790	446	20	microglia	microglia	ADJ
fnp-3790	446	21	biology	biology	NOUN
fnp-3790	446	22	defines	define	VERB
fnp-3790	446	23	novel	novel	ADJ
fnp-3790	446	24	therapeutic	therapeutic	ADJ
fnp-3790	446	25	approaches	approach	NOUN
fnp-3790	446	26	for	for	ADP
fnp-3790	446	27	alzheimer	alzheimer	NOUN
fnp-3790	446	28	's	's	PART
fnp-3790	446	29	disease	disease	NOUN
fnp-3790	446	30	.	.	PUNCT
fnp-3790	447	1	neuron	neuron	PROPN
fnp-3790	447	2	.	.	PUNCT
fnp-3790	448	1	2020;108:801	2020;108:801	NUM
fnp-3790	448	2	-	-	SYM
fnp-3790	448	3	821	821	NUM
fnp-3790	448	4	.	.	PUNCT
fnp-3790	449	1	https://doi.org/10.1016/j.neuron.2020.09.029	https://doi.org/10.1016/j.neuron.2020.09.029	NOUN
fnp-3790	449	2	epub	epub	PROPN
fnp-3790	449	3	2020	2020	NUM
fnp-3790	449	4	oct	oct	PROPN
fnp-3790	449	5	22	22	NUM
fnp-3790	449	6	.	.	PUNCT
fnp-3790	450	1	pmid	pmid	NOUN
fnp-3790	450	2	:	:	PUNCT
fnp-3790	450	3	33096024	33096024	NUM
fnp-3790	450	4	.	.	PUNCT
fnp-3790	451	1	lodder	lodder	PROPN
fnp-3790	451	2	c	c	PROPN
fnp-3790	451	3	,	,	PUNCT
fnp-3790	451	4	scheyltjens	scheyltjen	VERB
fnp-3790	451	5	i	i	PRON
fnp-3790	451	6	,	,	PUNCT
fnp-3790	451	7	stancu	stancu	PROPN
fnp-3790	451	8	ic	ic	PROPN
fnp-3790	451	9	,	,	PUNCT
fnp-3790	451	10	botella	botella	PROPN
fnp-3790	451	11	lucena	lucena	PROPN
fnp-3790	451	12	p	p	PROPN
fnp-3790	451	13	,	,	PUNCT
fnp-3790	451	14	gutiérrez	gutiérrez	PROPN
fnp-3790	451	15	de	de	X
fnp-3790	451	16	ravé	ravé	PROPN
fnp-3790	451	17	m	m	PROPN
fnp-3790	451	18	,	,	PUNCT
fnp-3790	451	19	vanherle	vanherle	PROPN
fnp-3790	451	20	s	s	PART
fnp-3790	451	21	,	,	PUNCT
fnp-3790	451	22	vanmierlo	vanmierlo	PROPN
fnp-3790	451	23	t	t	PROPN
fnp-3790	451	24	,	,	PUNCT
fnp-3790	451	25	cremers	cremer	NOUN
fnp-3790	451	26	n	n	CCONJ
fnp-3790	451	27	,	,	PUNCT
fnp-3790	451	28	vanrusselt	vanrusselt	VERB
fnp-3790	451	29	h	h	NOUN
fnp-3790	451	30	,	,	PUNCT
fnp-3790	451	31	brône	brône	PROPN
fnp-3790	451	32	b	b	PROPN
fnp-3790	451	33	,	,	PUNCT
fnp-3790	451	34	hanseeuw	hanseeuw	PROPN
fnp-3790	451	35	b	b	NUM
fnp-3790	451	36	,	,	PUNCT
fnp-3790	451	37	octave	octave	PROPN
fnp-3790	451	38	jn	jn	PROPN
fnp-3790	451	39	,	,	PUNCT
fnp-3790	451	40	bottelbergs	bottelberg	VERB
fnp-3790	451	41	a	a	DET
fnp-3790	451	42	,	,	PUNCT
fnp-3790	451	43	movahedi	movahedi	PROPN
fnp-3790	451	44	k	k	PROPN
fnp-3790	451	45	,	,	PUNCT
fnp-3790	451	46	dewachter	dewachter	PROPN
fnp-3790	451	47	i.	i.	PROPN
fnp-3790	451	48	csf1r	csf1r	PROPN
fnp-3790	451	49	inhibition	inhibition	NOUN
fnp-3790	451	50	rescues	rescue	NOUN
fnp-3790	451	51	tau	tau	PROPN
fnp-3790	451	52	pathology	pathology	NOUN
fnp-3790	451	53	and	and	CCONJ
fnp-3790	451	54	neurodegeneration	neurodegeneration	NOUN
fnp-3790	451	55	in	in	ADP
fnp-3790	451	56	an	an	DET
fnp-3790	451	57	a	a	PRON
fnp-3790	451	58	/	/	SYM
fnp-3790	451	59	t	t	NOUN
fnp-3790	451	60	/	/	SYM
fnp-3790	451	61	n	n	NOUN
fnp-3790	451	62	model	model	NOUN
fnp-3790	451	63	with	with	ADP
fnp-3790	451	64	combined	combine	VERB
fnp-3790	451	65	ad	ad	NOUN
fnp-3790	451	66	pathologies	pathology	NOUN
fnp-3790	451	67	,	,	PUNCT
fnp-3790	451	68	while	while	SCONJ
fnp-3790	451	69	preserving	preserve	VERB
fnp-3790	451	70	plaque	plaque	NOUN
fnp-3790	451	71	associated	associated	ADJ
fnp-3790	451	72	microglia	microglia	NOUN
fnp-3790	451	73	.	.	PUNCT
fnp-3790	452	1	acta	acta	PROPN
fnp-3790	452	2	neuropathol	neuropathol	PROPN
fnp-3790	452	3	commun	commun	PROPN
fnp-3790	452	4	.	.	PUNCT
fnp-3790	453	1	2021;9:108	2021;9:108	NUM
fnp-3790	453	2	.	.	PUNCT
fnp-3790	453	3	https://doi.org/10.1186/s40478-021-01204-8	https://doi.org/10.1186/s40478-021-01204-8	PROPN
fnp-3790	454	1	pmid	pmid	NOUN
fnp-3790	454	2	:	:	PUNCT
fnp-3790	454	3	34103079	34103079	NUM
fnp-3790	454	4	;	;	PUNCT
fnp-3790	454	5	pmcid	pmcid	NOUN
fnp-3790	454	6	:	:	PUNCT
fnp-3790	454	7	pmc8188790	pmc8188790	NOUN
fnp-3790	454	8	.	.	PUNCT
fnp-3790	455	1	lopes	lopes	PROPN
fnp-3790	455	2	ko	ko	PROPN
fnp-3790	455	3	,	,	PUNCT
fnp-3790	455	4	sparks	spark	VERB
fnp-3790	455	5	dl	dl	PROPN
fnp-3790	455	6	,	,	PUNCT
fnp-3790	455	7	streit	streit	PROPN
fnp-3790	455	8	wj	wj	PROPN
fnp-3790	455	9	.	.	PUNCT
fnp-3790	456	1	microglial	microglial	ADJ
fnp-3790	456	2	dystrophy	dystrophy	NOUN
fnp-3790	456	3	in	in	ADP
fnp-3790	456	4	the	the	DET
fnp-3790	456	5	aged	aged	ADJ
fnp-3790	456	6	and	and	CCONJ
fnp-3790	456	7	alzheimer	alzheimer	PROPN
fnp-3790	456	8	’s	’s	PART
fnp-3790	456	9	disease	disease	NOUN
fnp-3790	456	10	brain	brain	NOUN
fnp-3790	456	11	is	be	AUX
fnp-3790	456	12	associated	associate	VERB
fnp-3790	456	13	with	with	ADP
fnp-3790	456	14	ferritin	ferritin	ADJ
fnp-3790	456	15	immunoreactivity	immunoreactivity	NOUN
fnp-3790	456	16	.	.	PUNCT
fnp-3790	457	1	glia	glia	PROPN
fnp-3790	457	2	.	.	PUNCT
fnp-3790	458	1	2008;56:1048–1060	2008;56:1048–1060	PROPN
fnp-3790	458	2	.	.	PUNCT
fnp-3790	458	3	https://doi.org/10.1002/glia.20678	https://doi.org/10.1002/glia.20678	VERB
fnp-3790	459	1	pmid	pmid	NOUN
fnp-3790	459	2	:	:	PUNCT
fnp-3790	459	3	18442088	18442088	NUM
fnp-3790	459	4	.	.	PUNCT
fnp-3790	460	1	magliozzi	magliozzi	NOUN
fnp-3790	460	2	r	r	NOUN
fnp-3790	460	3	,	,	PUNCT
fnp-3790	460	4	pitteri	pitteri	NOUN
fnp-3790	460	5	m	m	PROPN
fnp-3790	460	6	,	,	PUNCT
fnp-3790	460	7	ziccardi	ziccardi	PROPN
fnp-3790	460	8	s	s	X
fnp-3790	460	9	,	,	PUNCT
fnp-3790	460	10	pisani	pisani	PROPN
fnp-3790	460	11	ai	ai	PROPN
fnp-3790	460	12	,	,	PUNCT
fnp-3790	460	13	montibeller	montibeller	ADJ
fnp-3790	460	14	l	l	NOUN
fnp-3790	460	15	,	,	PUNCT
fnp-3790	460	16	marastoni	marastoni	ADJ
fnp-3790	460	17	d	d	NOUN
fnp-3790	460	18	,	,	PUNCT
fnp-3790	460	19	rossi	rossi	PROPN
fnp-3790	460	20	s	s	PROPN
fnp-3790	460	21	,	,	PUNCT
fnp-3790	460	22	mazziotti	mazziotti	PROPN
fnp-3790	460	23	v	v	PROPN
fnp-3790	460	24	,	,	PUNCT
fnp-3790	460	25	guandalini	guandalini	PROPN
fnp-3790	460	26	m	m	PROPN
fnp-3790	460	27	,	,	PUNCT
fnp-3790	460	28	dapor	dapor	PROPN
fnp-3790	460	29	c	c	NOUN
fnp-3790	460	30	,	,	PUNCT
fnp-3790	460	31	schiavi	schiavi	VERB
fnp-3790	460	32	g	g	NOUN
fnp-3790	460	33	,	,	PUNCT
fnp-3790	460	34	tamanti	tamanti	VERB
fnp-3790	460	35	a	a	PRON
fnp-3790	460	36	,	,	PUNCT
fnp-3790	460	37	nicholas	nicholas	PROPN
fnp-3790	460	38	r	r	PROPN
fnp-3790	460	39	,	,	PUNCT
fnp-3790	460	40	reynolds	reynolds	PROPN
fnp-3790	460	41	r	r	PROPN
fnp-3790	460	42	,	,	PUNCT
fnp-3790	460	43	calabrese	calabrese	ADJ
fnp-3790	460	44	m.	m.	NOUN
fnp-3790	460	45	csf	csf	PROPN
fnp-3790	460	46	parvalbumin	parvalbumin	PROPN
fnp-3790	460	47	levels	level	NOUN
fnp-3790	460	48	reflect	reflect	VERB
fnp-3790	460	49	interneuron	interneuron	NOUN
fnp-3790	460	50	loss	loss	NOUN
fnp-3790	460	51	linked	link	VERB
fnp-3790	460	52	with	with	ADP
fnp-3790	460	53	cortical	cortical	ADJ
fnp-3790	460	54	pathology	pathology	NOUN
fnp-3790	460	55	in	in	ADP
fnp-3790	460	56	multiple	multiple	ADJ
fnp-3790	460	57	sclerosis	sclerosis	NOUN
fnp-3790	460	58	.	.	PUNCT
fnp-3790	461	1	ann	ann	PROPN
fnp-3790	461	2	clin	clin	PROPN
fnp-3790	461	3	transl	transl	PROPN
fnp-3790	461	4	neurol	neurol	PROPN
fnp-3790	461	5	.	.	PUNCT
fnp-3790	462	1	2021;8:534	2021;8:534	NOUN
fnp-3790	462	2	-	-	PUNCT
fnp-3790	462	3	547	547	NUM
fnp-3790	462	4	.	.	PUNCT
fnp-3790	463	1	https://doi.org/10.1002/acn3.51298	https://doi.org/10.1002/acn3.51298	X
fnp-3790	464	1	epub	epub	PROPN
fnp-3790	464	2	2021	2021	NUM
fnp-3790	464	3	jan	jan	PROPN
fnp-3790	464	4	23	23	NUM
fnp-3790	464	5	.	.	PUNCT
fnp-3790	465	1	pmid	pmid	NOUN
fnp-3790	465	2	:	:	PUNCT
fnp-3790	465	3	33484486	33484486	NUM
fnp-3790	465	4	;	;	PUNCT
fnp-3790	465	5	pmcid	pmcid	ADJ
fnp-3790	465	6	:	:	PUNCT
fnp-3790	465	7	pmc7951111	pmc7951111	ADJ
fnp-3790	465	8	.	.	PUNCT
fnp-3790	466	1	mahad	mahad	PROPN
fnp-3790	466	2	dh	dh	PROPN
fnp-3790	466	3	,	,	PUNCT
fnp-3790	466	4	trapp	trapp	PROPN
fnp-3790	466	5	bd	bd	PROPN
fnp-3790	466	6	,	,	PUNCT
fnp-3790	466	7	lassmann	lassmann	PROPN
fnp-3790	466	8	h.	h.	PROPN
fnp-3790	466	9	pathological	pathological	ADJ
fnp-3790	466	10	mechanisms	mechanism	NOUN
fnp-3790	466	11	in	in	ADP
fnp-3790	466	12	progressive	progressive	ADJ
fnp-3790	466	13	multiple	multiple	ADJ
fnp-3790	466	14	sclerosis	sclerosis	NOUN
fnp-3790	466	15	.	.	PUNCT
fnp-3790	467	1	lancet	lancet	PROPN
fnp-3790	467	2	neurol	neurol	PROPN
fnp-3790	467	3	.	.	PUNCT
fnp-3790	468	1	2015;14:183	2015;14:183	NUM
fnp-3790	468	2	-	-	SYM
fnp-3790	468	3	193	193	NUM
fnp-3790	468	4	.	.	PUNCT
fnp-3790	469	1	https://doi.org/10.1016/s1474-4422(14)70256-x	https://doi.org/10.1016/s1474-4422(14)70256-x	PROPN
fnp-3790	469	2	pmid	pmid	PROPN
fnp-3790	469	3	:	:	PUNCT
fnp-3790	469	4	25772897	25772897	NUM
fnp-3790	469	5	.	.	PUNCT
fnp-3790	470	1	maiese	maiese	PROPN
fnp-3790	470	2	a	a	PRON
fnp-3790	470	3	,	,	PUNCT
fnp-3790	470	4	manetti	manetti	ADJ
fnp-3790	470	5	ac	ac	PROPN
fnp-3790	470	6	,	,	PUNCT
fnp-3790	470	7	bosetti	bosetti	ADJ
fnp-3790	470	8	c	c	PROPN
fnp-3790	470	9	,	,	PUNCT
fnp-3790	470	10	del	del	PROPN
fnp-3790	470	11	duca	duca	PROPN
fnp-3790	470	12	f	f	PROPN
fnp-3790	470	13	,	,	PUNCT
fnp-3790	470	14	la	la	PRON
fnp-3790	470	15	russa	russa	NOUN
fnp-3790	470	16	r	r	NOUN
fnp-3790	470	17	,	,	PUNCT
fnp-3790	470	18	frati	frati	NOUN
fnp-3790	470	19	p	p	X
fnp-3790	470	20	,	,	PUNCT
fnp-3790	470	21	di	di	PROPN
fnp-3790	470	22	paolo	paolo	PROPN
fnp-3790	470	23	m	m	PROPN
fnp-3790	470	24	,	,	PUNCT
fnp-3790	470	25	turillazzi	turillazzi	NOUN
fnp-3790	470	26	e	e	NOUN
fnp-3790	470	27	,	,	PUNCT
fnp-3790	470	28	fineschi	fineschi	PROPN
fnp-3790	470	29	v.	v.	ADP
fnp-3790	470	30	sars	sar	NOUN
fnp-3790	470	31	-	-	PUNCT
fnp-3790	470	32	cov-2	cov-2	PUNCT
fnp-3790	470	33	and	and	CCONJ
fnp-3790	470	34	the	the	DET
fnp-3790	470	35	brain	brain	NOUN
fnp-3790	470	36	:	:	PUNCT
fnp-3790	470	37	a	a	DET
fnp-3790	470	38	review	review	NOUN
fnp-3790	470	39	of	of	ADP
fnp-3790	470	40	the	the	DET
fnp-3790	470	41	current	current	ADJ
fnp-3790	470	42	knowledge	knowledge	NOUN
fnp-3790	470	43	on	on	ADP
fnp-3790	470	44	neuropathology	neuropathology	NOUN
fnp-3790	470	45	in	in	ADP
fnp-3790	470	46	covid-19	covid-19	PROPN
fnp-3790	470	47	.	.	PUNCT
fnp-3790	470	48	brain	brain	NOUN
fnp-3790	470	49	pathol	pathol	NOUN
fnp-3790	470	50	.	.	PUNCT
fnp-3790	471	1	2021;31	2021;31	NUM
fnp-3790	471	2	:	:	PUNCT
fnp-3790	471	3	e13013	e13013	PROPN
fnp-3790	471	4	.	.	PUNCT
fnp-3790	472	1	https://doi.org/10.1111/bpa.13013	https://doi.org/10.1111/bpa.13013	PROPN
fnp-3790	472	2	epub	epub	PROPN
fnp-3790	472	3	2021	2021	NUM
fnp-3790	472	4	aug	aug	PROPN
fnp-3790	472	5	13	13	NUM
fnp-3790	472	6	.	.	PUNCT
fnp-3790	473	1	pmid	pmid	NOUN
fnp-3790	473	2	:	:	PUNCT
fnp-3790	473	3	34390282	34390282	NUM
fnp-3790	473	4	;	;	PUNCT
fnp-3790	473	5	pmcid	pmcid	ADJ
fnp-3790	473	6	:	:	PUNCT
fnp-3790	473	7	pmc8420197	pmc8420197	PROPN
fnp-3790	473	8	.	.	PUNCT
fnp-3790	474	1	martinez	martinez	PROPN
fnp-3790	474	2	fo	fo	PROPN
fnp-3790	474	3	,	,	PUNCT
fnp-3790	474	4	helming	helm	VERB
fnp-3790	474	5	l	l	PROPN
fnp-3790	474	6	,	,	PUNCT
fnp-3790	474	7	gordon	gordon	PROPN
fnp-3790	474	8	s.	s.	PROPN
fnp-3790	474	9	alternative	alternative	ADJ
fnp-3790	474	10	activation	activation	NOUN
fnp-3790	474	11	of	of	ADP
fnp-3790	474	12	macrophages	macrophage	NOUN
fnp-3790	474	13	:	:	PUNCT
fnp-3790	474	14	an	an	DET
fnp-3790	474	15	immunologic	immunologic	ADJ
fnp-3790	474	16	functional	functional	ADJ
fnp-3790	474	17	perspective	perspective	NOUN
fnp-3790	474	18	.	.	PUNCT
fnp-3790	475	1	annu	annu	PROPN
fnp-3790	475	2	rev	rev	VERB
fnp-3790	475	3	immunol	immunol	NOUN
fnp-3790	475	4	.	.	PUNCT
fnp-3790	476	1	2009;27:451–483	2009;27:451–483	NOUN
fnp-3790	476	2	.	.	PUNCT
fnp-3790	477	1	https://doi.org/10.1146/annurev.immunol.021908.132532	https://doi.org/10.1146/annurev.immunol.021908.132532	PROPN
fnp-3790	477	2	pmid	pmid	PROPN
fnp-3790	477	3	:	:	PUNCT
fnp-3790	477	4	19105661	19105661	NUM
fnp-3790	477	5	.	.	PUNCT
fnp-3790	478	1	mathys	mathy	NOUN
fnp-3790	478	2	h	h	PROPN
fnp-3790	478	3	,	,	PUNCT
fnp-3790	478	4	davila	davila	PROPN
fnp-3790	478	5	-	-	PUNCT
fnp-3790	478	6	velderrain	velderrain	PROPN
fnp-3790	478	7	j	j	PROPN
fnp-3790	478	8	,	,	PUNCT
fnp-3790	478	9	peng	peng	PROPN
fnp-3790	478	10	z	z	PROPN
fnp-3790	478	11	,	,	PUNCT
fnp-3790	478	12	gao	gao	PROPN
fnp-3790	478	13	f	f	PROPN
fnp-3790	478	14	,	,	PUNCT
fnp-3790	478	15	mohammadi	mohammadi	PROPN
fnp-3790	478	16	s	s	PROPN
fnp-3790	478	17	,	,	PUNCT
fnp-3790	478	18	young	young	PROPN
fnp-3790	478	19	jz	jz	PROPN
fnp-3790	478	20	,	,	PUNCT
fnp-3790	478	21	menon	menon	PROPN
fnp-3790	478	22	m	m	PROPN
fnp-3790	478	23	,	,	PUNCT
fnp-3790	478	24	he	he	PRON
fnp-3790	478	25	l	l	NOUN
fnp-3790	478	26	,	,	PUNCT
fnp-3790	478	27	abdurrob	abdurrob	VERB
fnp-3790	478	28	f	f	PROPN
fnp-3790	478	29	,	,	PUNCT
fnp-3790	478	30	jiang	jiang	PROPN
fnp-3790	478	31	x	x	PROPN
fnp-3790	478	32	,	,	PUNCT
fnp-3790	478	33	martorell	martorell	PROPN
fnp-3790	478	34	aj	aj	PROPN
fnp-3790	478	35	,	,	PUNCT
fnp-3790	478	36	ransohoff	ransohoff	PROPN
fnp-3790	478	37	rm	rm	PROPN
fnp-3790	478	38	,	,	PUNCT
fnp-3790	478	39	hafler	hafler	PROPN
fnp-3790	478	40	bp	bp	PROPN
fnp-3790	478	41	,	,	PUNCT
fnp-3790	478	42	bennett	bennett	PROPN
fnp-3790	478	43	da	da	PROPN
fnp-3790	478	44	,	,	PUNCT
fnp-3790	478	45	kellis	kellis	PROPN
fnp-3790	478	46	m	m	PROPN
fnp-3790	478	47	,	,	PUNCT
fnp-3790	478	48	tsai	tsai	PROPN
fnp-3790	478	49	lh	lh	PROPN
fnp-3790	478	50	.	.	PUNCT
fnp-3790	479	1	single	single	ADJ
fnp-3790	479	2	-	-	PUNCT
fnp-3790	479	3	cell	cell	NOUN
fnp-3790	479	4	transcriptomic	transcriptomic	ADJ
fnp-3790	479	5	analysis	analysis	NOUN
fnp-3790	479	6	of	of	ADP
fnp-3790	479	7	alzheimer	alzheimer	PROPN
fnp-3790	479	8	's	's	PART
fnp-3790	479	9	disease	disease	NOUN
fnp-3790	479	10	.	.	PUNCT
fnp-3790	480	1	nature	nature	NOUN
fnp-3790	480	2	.	.	PUNCT
fnp-3790	481	1	2019;570:332	2019;570:332	X
fnp-3790	481	2	-	-	SYM
fnp-3790	481	3	337	337	NUM
fnp-3790	481	4	.	.	PUNCT
fnp-3790	482	1	https://doi.org/10.1038/s41586-019-1195-2	https://doi.org/10.1038/s41586-019-1195-2	PROPN
fnp-3790	483	1	epub	epub	NOUN
fnp-3790	483	2	2019	2019	NUM
fnp-3790	483	3	may	may	PROPN
fnp-3790	483	4	1	1	NUM
fnp-3790	483	5	.	.	PUNCT
fnp-3790	483	6	erratum	erratum	PROPN
fnp-3790	483	7	in	in	ADP
fnp-3790	483	8	:	:	PUNCT
fnp-3790	483	9	nature	nature	NOUN
fnp-3790	483	10	.	.	PUNCT
fnp-3790	484	1	2019;571	2019;571	NUM
fnp-3790	484	2	:	:	PUNCT
fnp-3790	484	3	e1	e1	NOUN
fnp-3790	484	4	.	.	PUNCT
fnp-3790	485	1	pmid	pmid	NOUN
fnp-3790	485	2	:	:	PUNCT
fnp-3790	485	3	31042697	31042697	NUM
fnp-3790	485	4	;	;	PUNCT
fnp-3790	485	5	pmcid	pmcid	ADJ
fnp-3790	485	6	:	:	PUNCT
fnp-3790	485	7	pmc6865822	pmc6865822	NOUN
fnp-3790	485	8	.	.	PUNCT
fnp-3790	486	1	matschke	matschke	PROPN
fnp-3790	486	2	j	j	PROPN
fnp-3790	486	3	,	,	PUNCT
fnp-3790	486	4	lütgehetmann	lütgehetmann	PROPN
fnp-3790	486	5	m	m	PROPN
fnp-3790	486	6	,	,	PUNCT
fnp-3790	486	7	hagel	hagel	PROPN
fnp-3790	486	8	c	c	NOUN
fnp-3790	486	9	,	,	PUNCT
fnp-3790	486	10	sperhake	sperhake	NOUN
fnp-3790	486	11	jp	jp	PROPN
fnp-3790	486	12	,	,	PUNCT
fnp-3790	486	13	schröder	schröder	NOUN
fnp-3790	486	14	as	as	SCONJ
fnp-3790	486	15	,	,	PUNCT
fnp-3790	486	16	edler	edler	PROPN
fnp-3790	486	17	c	c	PROPN
fnp-3790	486	18	,	,	PUNCT
fnp-3790	486	19	mushumba	mushumba	PROPN
fnp-3790	486	20	h	h	PROPN
fnp-3790	486	21	,	,	PUNCT
fnp-3790	486	22	fitzek	fitzek	VERB
fnp-3790	486	23	a	a	DET
fnp-3790	486	24	,	,	PUNCT
fnp-3790	486	25	allweiss	allweiss	ADJ
fnp-3790	486	26	l	l	NOUN
fnp-3790	486	27	,	,	PUNCT
fnp-3790	486	28	dandri	dandri	PROPN
fnp-3790	486	29	m	m	PROPN
fnp-3790	486	30	,	,	PUNCT
fnp-3790	486	31	dottermusch	dottermusch	PROPN
fnp-3790	486	32	m	m	PROPN
fnp-3790	486	33	,	,	PUNCT
fnp-3790	486	34	heinemann	heinemann	PROPN
fnp-3790	486	35	a	a	X
fnp-3790	486	36	,	,	PUNCT
fnp-3790	486	37	pfefferle	pfefferle	PROPN
fnp-3790	486	38	s	s	PART
fnp-3790	486	39	,	,	PUNCT
fnp-3790	486	40	schwabenland	schwabenland	PROPN
fnp-3790	486	41	m	m	PROPN
fnp-3790	486	42	,	,	PUNCT
fnp-3790	486	43	sumner	sumner	PROPN
fnp-3790	486	44	magruder	magruder	PROPN
fnp-3790	486	45	d	d	PROPN
fnp-3790	486	46	,	,	PUNCT
fnp-3790	486	47	bonn	bonn	PROPN
fnp-3790	486	48	s	s	PROPN
fnp-3790	486	49	,	,	PUNCT
fnp-3790	486	50	prinz	prinz	PROPN
fnp-3790	486	51	m	m	PROPN
fnp-3790	486	52	,	,	PUNCT
fnp-3790	486	53	gerloff	gerloff	PROPN
fnp-3790	486	54	c	c	PROPN
fnp-3790	486	55	,	,	PUNCT
fnp-3790	486	56	püschel	püschel	PROPN
fnp-3790	486	57	k	k	PROPN
fnp-3790	486	58	,	,	PUNCT
fnp-3790	486	59	krasemann	krasemann	PROPN
fnp-3790	486	60	s	s	PROPN
fnp-3790	486	61	,	,	PUNCT
fnp-3790	486	62	aepfelbacher	aepfelbacher	PROPN
fnp-3790	486	63	m	m	PROPN
fnp-3790	486	64	,	,	PUNCT
fnp-3790	486	65	glatzel	glatzel	ADJ
fnp-3790	486	66	m.	m.	NOUN
fnp-3790	486	67	neuropathology	neuropathology	NOUN
fnp-3790	486	68	of	of	ADP
fnp-3790	486	69	patients	patient	NOUN
fnp-3790	486	70	with	with	ADP
fnp-3790	486	71	covid-19	covid-19	PROPN
fnp-3790	486	72	in	in	ADP
fnp-3790	486	73	germany	germany	PROPN
fnp-3790	486	74	:	:	PUNCT
fnp-3790	486	75	a	a	DET
fnp-3790	486	76	post	post	ADJ
fnp-3790	486	77	-	-	ADJ
fnp-3790	486	78	mortem	mortem	ADJ
fnp-3790	486	79	case	case	NOUN
fnp-3790	486	80	series	series	NOUN
fnp-3790	486	81	.	.	PUNCT
fnp-3790	487	1	lancet	lancet	PROPN
fnp-3790	487	2	neurol	neurol	PROPN
fnp-3790	487	3	.	.	PUNCT
fnp-3790	488	1	2020;19:919	2020;19:919	NOUN
fnp-3790	488	2	-	-	SYM
fnp-3790	488	3	929	929	NUM
fnp-3790	488	4	.	.	PUNCT
fnp-3790	489	1	https://doi.org/10.1016/s1474-4422(20)30308-2	https://doi.org/10.1016/s1474-4422(20)30308-2	NOUN
fnp-3790	489	2	epub	epub	NOUN
fnp-3790	489	3	2020	2020	NUM
fnp-3790	489	4	oct	oct	PROPN
fnp-3790	489	5	5	5	NUM
fnp-3790	489	6	.	.	PUNCT
fnp-3790	489	7	pmid	pmid	NOUN
fnp-3790	489	8	:	:	PUNCT
fnp-3790	489	9	33031735	33031735	NUM
fnp-3790	489	10	;	;	PUNCT
fnp-3790	489	11	pmcid	pmcid	PROPN
fnp-3790	489	12	:	:	PUNCT
fnp-3790	489	13	pmc7535629	pmc7535629	X
fnp-3790	489	14	.	.	PUNCT
fnp-3790	490	1	mayo	mayo	PROPN
fnp-3790	490	2	l	l	PROPN
fnp-3790	490	3	,	,	PUNCT
fnp-3790	490	4	cunha	cunha	PROPN
fnp-3790	490	5	ap	ap	PROPN
fnp-3790	490	6	,	,	PUNCT
fnp-3790	490	7	madi	madi	PROPN
fnp-3790	490	8	a	a	PRON
fnp-3790	490	9	,	,	PUNCT
fnp-3790	490	10	beynon	beynon	NOUN
fnp-3790	490	11	v	v	PROPN
fnp-3790	490	12	,	,	PUNCT
fnp-3790	490	13	yang	yang	PROPN
fnp-3790	490	14	z	z	PROPN
fnp-3790	490	15	,	,	PUNCT
fnp-3790	490	16	alvarez	alvarez	PROPN
fnp-3790	490	17	ji	ji	PROPN
fnp-3790	490	18	,	,	PUNCT
fnp-3790	490	19	prat	prat	NOUN
fnp-3790	490	20	a	a	PRON
fnp-3790	490	21	,	,	PUNCT
fnp-3790	490	22	sobel	sobel	PROPN
fnp-3790	490	23	ra	ra	PROPN
fnp-3790	490	24	,	,	PUNCT
fnp-3790	490	25	kobzik	kobzik	NOUN
fnp-3790	490	26	l	l	NOUN
fnp-3790	490	27	,	,	PUNCT
fnp-3790	490	28	lassmann	lassmann	PROPN
fnp-3790	490	29	h	h	PROPN
fnp-3790	490	30	,	,	PUNCT
fnp-3790	490	31	quintana	quintana	PROPN
fnp-3790	490	32	fj	fj	PROPN
fnp-3790	490	33	,	,	PUNCT
fnp-3790	490	34	weiner	weiner	NOUN
fnp-3790	490	35	hl	hl	NOUN
fnp-3790	490	36	.	.	PUNCT
fnp-3790	491	1	il-10	il-10	NOUN
fnp-3790	491	2	-	-	PUNCT
fnp-3790	491	3	dependent	dependent	ADJ
fnp-3790	491	4	tr1	tr1	NOUN
fnp-3790	491	5	cells	cell	NOUN
fnp-3790	491	6	attenuate	attenuate	VERB
fnp-3790	491	7	astrocyte	astrocyte	NOUN
fnp-3790	491	8	activation	activation	NOUN
fnp-3790	491	9	and	and	CCONJ
fnp-3790	491	10	ameliorate	ameliorate	VERB
fnp-3790	491	11	chronic	chronic	ADJ
fnp-3790	491	12	central	central	ADJ
fnp-3790	491	13	nervous	nervous	ADJ
fnp-3790	491	14	system	system	NOUN
fnp-3790	491	15	inflammation	inflammation	NOUN
fnp-3790	491	16	.	.	PUNCT
fnp-3790	492	1	brain	brain	NOUN
fnp-3790	492	2	.	.	PUNCT
fnp-3790	493	1	2016;139:1939	2016;139:1939	NUM
fnp-3790	493	2	-	-	SYM
fnp-3790	493	3	1957	1957	NUM
fnp-3790	493	4	.	.	PUNCT
fnp-3790	494	1	https://doi.org/10.1093/brain/aww113	https://doi.org/10.1093/brain/aww113	PROPN
fnp-3790	494	2	epub	epub	PROPN
fnp-3790	494	3	2016	2016	NUM
fnp-3790	494	4	may	may	AUX
fnp-3790	494	5	31	31	NUM
fnp-3790	494	6	.	.	PUNCT
fnp-3790	495	1	pmid	pmid	NOUN
fnp-3790	495	2	:	:	PUNCT
fnp-3790	495	3	27246324	27246324	NUM
fnp-3790	495	4	;	;	PUNCT
fnp-3790	495	5	pmcid	pmcid	ADJ
fnp-3790	495	6	:	:	PUNCT
fnp-3790	495	7	pmc4939696	pmc4939696	NOUN
fnp-3790	495	8	.	.	PUNCT
fnp-3790	496	1	mcgeer	mcgeer	PROPN
fnp-3790	496	2	pl	pl	PROPN
fnp-3790	496	3	,	,	PUNCT
fnp-3790	496	4	itagaki	itagaki	PROPN
fnp-3790	496	5	s	s	PROPN
fnp-3790	496	6	,	,	PUNCT
fnp-3790	496	7	mcgeer	mcgeer	PROPN
fnp-3790	496	8	eg	eg	NOUN
fnp-3790	496	9	.	.	PUNCT
fnp-3790	497	1	expression	expression	NOUN
fnp-3790	497	2	of	of	ADP
fnp-3790	497	3	the	the	DET
fnp-3790	497	4	histocompatibility	histocompatibility	ADJ
fnp-3790	497	5	glycoprotein	glycoprotein	NOUN
fnp-3790	497	6	hla	hla	PROPN
fnp-3790	497	7	-	-	PUNCT
fnp-3790	497	8	dr	dr	PROPN
fnp-3790	497	9	in	in	ADP
fnp-3790	497	10	neurological	neurological	ADJ
fnp-3790	497	11	disease	disease	NOUN
fnp-3790	497	12	.	.	PUNCT
fnp-3790	498	1	acta	acta	PROPN
fnp-3790	498	2	neuropathol	neuropathol	PROPN
fnp-3790	498	3	.	.	PUNCT
fnp-3790	499	1	1988;76:550	1988;76:550	NUM
fnp-3790	499	2	-	-	SYM
fnp-3790	499	3	557	557	NUM
fnp-3790	499	4	.	.	PUNCT
fnp-3790	500	1	https://doi.org/10.1007/bf00689592	https://doi.org/10.1007/bf00689592	VERB
fnp-3790	500	2	pmid	pmid	NOUN
fnp-3790	500	3	:	:	PUNCT
fnp-3790	500	4	2974227	2974227	NUM
fnp-3790	500	5	.	.	PUNCT
fnp-3790	501	1	mehta	mehta	PROPN
fnp-3790	501	2	v	v	PROPN
fnp-3790	501	3	,	,	PUNCT
fnp-3790	501	4	pei	pei	PROPN
fnp-3790	501	5	w	w	PROPN
fnp-3790	501	6	,	,	PUNCT
fnp-3790	501	7	yang	yang	PROPN
fnp-3790	501	8	g	g	PROPN
fnp-3790	501	9	,	,	PUNCT
fnp-3790	501	10	li	li	PROPN
fnp-3790	501	11	s	s	PROPN
fnp-3790	501	12	,	,	PUNCT
fnp-3790	501	13	swamy	swamy	PROPN
fnp-3790	501	14	e	e	NOUN
fnp-3790	501	15	,	,	PUNCT
fnp-3790	501	16	boster	boster	ADV
fnp-3790	501	17	a	a	NOUN
fnp-3790	501	18	,	,	PUNCT
fnp-3790	501	19	schmalbrock	schmalbrock	NOUN
fnp-3790	501	20	p	p	NOUN
fnp-3790	501	21	,	,	PUNCT
fnp-3790	501	22	pitt	pitt	PROPN
fnp-3790	501	23	d.	d.	PROPN
fnp-3790	501	24	iron	iron	NOUN
fnp-3790	501	25	is	be	AUX
fnp-3790	501	26	a	a	DET
fnp-3790	501	27	sensitive	sensitive	ADJ
fnp-3790	501	28	biomarker	biomarker	NOUN
fnp-3790	501	29	for	for	ADP
fnp-3790	501	30	inflammation	inflammation	NOUN
fnp-3790	501	31	in	in	ADP
fnp-3790	501	32	multiple	multiple	ADJ
fnp-3790	501	33	sclerosis	sclerosis	NOUN
fnp-3790	501	34	lesions	lesion	NOUN
fnp-3790	501	35	.	.	PUNCT
fnp-3790	502	1	plos	plos	PROPN
fnp-3790	502	2	one	one	NUM
fnp-3790	502	3	.	.	PUNCT
fnp-3790	503	1	2013;8	2013;8	NUM
fnp-3790	503	2	:	:	PUNCT
fnp-3790	503	3	e57573	e57573	NOUN
fnp-3790	503	4	.	.	PROPN
fnp-3790	503	5	https://doi.org/10.1371/journal.pone.0057573	https://doi.org/10.1371/journal.pone.0057573	PROPN
fnp-3790	503	6	epub	epub	PROPN
fnp-3790	503	7	2013	2013	NUM
fnp-3790	503	8	mar	mar	PROPN
fnp-3790	503	9	14	14	NUM
fnp-3790	503	10	.	.	PUNCT
fnp-3790	504	1	pmid	pmid	NOUN
fnp-3790	504	2	:	:	PUNCT
fnp-3790	504	3	23516409	23516409	NUM
fnp-3790	504	4	;	;	PUNCT
fnp-3790	504	5	pmcid	pmcid	PROPN
fnp-3790	504	6	:	:	PUNCT
fnp-3790	504	7	pmc3597727	pmc3597727	NOUN
fnp-3790	504	8	.	.	PUNCT
fnp-3790	505	1	michailidou	michailidou	PROPN
fnp-3790	505	2	i	i	PROPN
fnp-3790	505	3	,	,	PUNCT
fnp-3790	505	4	naessens	naessens	PROPN
fnp-3790	505	5	dm	dm	PROPN
fnp-3790	505	6	,	,	PUNCT
fnp-3790	505	7	hametner	hametner	X
fnp-3790	505	8	s	s	PART
fnp-3790	505	9	,	,	PUNCT
fnp-3790	505	10	guldenaar	guldenaar	PROPN
fnp-3790	505	11	w	w	PROPN
fnp-3790	505	12	,	,	PUNCT
fnp-3790	505	13	kooi	kooi	PROPN
fnp-3790	505	14	ej	ej	PROPN
fnp-3790	505	15	,	,	PUNCT
fnp-3790	505	16	geurts	geurts	PROPN
fnp-3790	505	17	jj	jj	PROPN
fnp-3790	505	18	,	,	PUNCT
fnp-3790	505	19	baas	baas	PROPN
fnp-3790	505	20	f	f	PROPN
fnp-3790	505	21	,	,	PUNCT
fnp-3790	505	22	lassmann	lassmann	PROPN
fnp-3790	505	23	h	h	PROPN
fnp-3790	505	24	,	,	PUNCT
fnp-3790	505	25	ramaglia	ramaglia	PROPN
fnp-3790	505	26	v.	v.	ADP
fnp-3790	505	27	complement	complement	PROPN
fnp-3790	505	28	c3	c3	PROPN
fnp-3790	505	29	on	on	ADP
fnp-3790	505	30	microglial	microglial	ADJ
fnp-3790	505	31	clusters	cluster	NOUN
fnp-3790	505	32	in	in	ADP
fnp-3790	505	33	multiple	multiple	ADJ
fnp-3790	505	34	sclerosis	sclerosis	NOUN
fnp-3790	505	35	occur	occur	VERB
fnp-3790	505	36	in	in	ADP
fnp-3790	505	37	chronic	chronic	ADJ
fnp-3790	505	38	but	but	CCONJ
fnp-3790	505	39	not	not	PART
fnp-3790	505	40	acute	acute	NOUN
fnp-3790	505	41	disease	disease	NOUN
fnp-3790	505	42	:	:	PUNCT
fnp-3790	505	43	implication	implication	NOUN
fnp-3790	505	44	for	for	ADP
fnp-3790	505	45	disease	disease	NOUN
fnp-3790	505	46	pathogenesis	pathogenesis	NOUN
fnp-3790	505	47	.	.	PUNCT
fnp-3790	506	1	glia	glia	PROPN
fnp-3790	506	2	.	.	PUNCT
fnp-3790	507	1	2017;65:264	2017;65:264	NUM
fnp-3790	507	2	-	-	PUNCT
fnp-3790	507	3	277	277	NUM
fnp-3790	507	4	.	.	PUNCT
fnp-3790	508	1	https://doi.org/10.1002/glia.23090	https://doi.org/10.1002/glia.23090	PROPN
fnp-3790	508	2	epub	epub	PROPN
fnp-3790	508	3	2016	2016	NUM
fnp-3790	508	4	oct	oct	PROPN
fnp-3790	508	5	25	25	NUM
fnp-3790	508	6	.	.	PUNCT
fnp-3790	509	1	pmid	pmid	NOUN
fnp-3790	509	2	:	:	PUNCT
fnp-3790	509	3	27778395	27778395	NUM
fnp-3790	509	4	;	;	PUNCT
fnp-3790	509	5	pmcid	pmcid	ADJ
fnp-3790	509	6	:	:	PUNCT
fnp-3790	509	7	pmc5215693	pmc5215693	NOUN
fnp-3790	509	8	.	.	PUNCT
fnp-3790	510	1	nalugo	nalugo	PROPN
fnp-3790	510	2	m	m	PROPN
fnp-3790	510	3	,	,	PUNCT
fnp-3790	510	4	schulte	schulte	PROPN
fnp-3790	510	5	lj	lj	PROPN
fnp-3790	510	6	,	,	PUNCT
fnp-3790	510	7	masood	masood	PROPN
fnp-3790	510	8	mf	mf	PROPN
fnp-3790	510	9	,	,	PUNCT
fnp-3790	510	10	zayed	zayed	PROPN
fnp-3790	510	11	ma	ma	PROPN
fnp-3790	510	12	.	.	PROPN
fnp-3790	511	1	microvascular	microvascular	ADJ
fnp-3790	511	2	angiopathic	angiopathic	ADJ
fnp-3790	511	3	consequences	consequence	NOUN
fnp-3790	511	4	of	of	ADP
fnp-3790	511	5	covid-19	covid-19	PROPN
fnp-3790	511	6	.	.	PUNCT
fnp-3790	512	1	front	front	PROPN
fnp-3790	512	2	cardiovasc	cardiovasc	PROPN
fnp-3790	512	3	med	me	VERB
fnp-3790	512	4	.	.	PUNCT
fnp-3790	513	1	2021;8:636843	2021;8:636843	PROPN
fnp-3790	513	2	.	.	PUNCT
fnp-3790	514	1	https://doi.org/10.3389/fcvm.2021.636843	https://doi.org/10.3389/fcvm.2021.636843	PROPN
fnp-3790	514	2	pmid	pmid	PROPN
fnp-3790	514	3	:	:	PUNCT
fnp-3790	514	4	33604359	33604359	NUM
fnp-3790	514	5	;	;	PUNCT
fnp-3790	514	6	pmcid	pmcid	NOUN
fnp-3790	514	7	:	:	PUNCT
fnp-3790	514	8	pmc7884319	pmc7884319	PROPN
fnp-3790	514	9	.	.	PUNCT
fnp-3790	515	1	nicholas	nicholas	PROPN
fnp-3790	515	2	r	r	PROPN
fnp-3790	515	3	,	,	PUNCT
fnp-3790	515	4	magliozzi	magliozzi	NOUN
fnp-3790	515	5	r	r	NOUN
fnp-3790	515	6	,	,	PUNCT
fnp-3790	515	7	campbell	campbell	PROPN
fnp-3790	515	8	g	g	PROPN
fnp-3790	515	9	,	,	PUNCT
fnp-3790	515	10	mahad	mahad	PROPN
fnp-3790	515	11	d	d	PROPN
fnp-3790	515	12	,	,	PUNCT
fnp-3790	515	13	reynolds	reynolds	PROPN
fnp-3790	515	14	r.	r.	PROPN
fnp-3790	515	15	temporal	temporal	PROPN
fnp-3790	515	16	lobe	lobe	VERB
fnp-3790	515	17	cortical	cortical	ADJ
fnp-3790	515	18	pathology	pathology	NOUN
fnp-3790	515	19	and	and	CCONJ
fnp-3790	515	20	inhibitory	inhibitory	ADJ
fnp-3790	515	21	gaba	gaba	PROPN
fnp-3790	515	22	interneuron	interneuron	NOUN
fnp-3790	515	23	cell	cell	NOUN
fnp-3790	515	24	loss	loss	NOUN
fnp-3790	515	25	are	be	AUX
fnp-3790	515	26	associated	associate	VERB
fnp-3790	515	27	with	with	ADP
fnp-3790	515	28	seizures	seizure	NOUN
fnp-3790	515	29	in	in	ADP
fnp-3790	515	30	multiple	multiple	ADJ
fnp-3790	515	31	sclerosis	sclerosis	NOUN
fnp-3790	515	32	.	.	PUNCT
fnp-3790	516	1	mult	mult	PROPN
fnp-3790	516	2	scler	scler	NOUN
fnp-3790	516	3	.	.	PUNCT
fnp-3790	517	1	2016;22:25	2016;22:25	NUM
fnp-3790	517	2	-	-	SYM
fnp-3790	517	3	35	35	NUM
fnp-3790	517	4	.	.	PUNCT
fnp-3790	517	5	https://doi.org/10.1177/1352458515579445	https://doi.org/10.1177/1352458515579445	NOUN
fnp-3790	517	6	epub	epub	PROPN
fnp-3790	517	7	2015	2015	NUM
fnp-3790	517	8	apr	apr	NOUN
fnp-3790	517	9	28	28	NUM
fnp-3790	517	10	.	.	PUNCT
fnp-3790	518	1	pmid	pmid	NOUN
fnp-3790	518	2	:	:	PUNCT
fnp-3790	518	3	25921040	25921040	NUM
fnp-3790	518	4	;	;	PUNCT
fnp-3790	518	5	pmcid	pmcid	ADJ
fnp-3790	518	6	:	:	PUNCT
fnp-3790	518	7	pmc4702245	pmc4702245	PROPN
fnp-3790	518	8	.	.	PUNCT
fnp-3790	519	1	orrego	orrego	PROPN
fnp-3790	519	2	e	e	PROPN
fnp-3790	519	3	,	,	PUNCT
fnp-3790	519	4	castaneda	castaneda	PROPN
fnp-3790	519	5	ca	ca	PROPN
fnp-3790	519	6	,	,	PUNCT
fnp-3790	519	7	castillo	castillo	PROPN
fnp-3790	519	8	m	m	PROPN
fnp-3790	519	9	,	,	PUNCT
fnp-3790	519	10	bernabe	bernabe	ADV
fnp-3790	519	11	la	la	X
fnp-3790	519	12	,	,	PUNCT
fnp-3790	519	13	casavilca	casavilca	PROPN
fnp-3790	519	14	s	s	PROPN
fnp-3790	519	15	,	,	PUNCT
fnp-3790	519	16	chakravarti	chakravarti	VERB
fnp-3790	519	17	a	a	NOUN
fnp-3790	519	18	,	,	PUNCT
fnp-3790	519	19	meng	meng	PROPN
fnp-3790	519	20	w	w	PROPN
fnp-3790	519	21	,	,	PUNCT
fnp-3790	519	22	garcia	garcia	PROPN
fnp-3790	519	23	-	-	PUNCT
fnp-3790	519	24	corrochano	corrochano	PROPN
fnp-3790	519	25	p	p	NOUN
fnp-3790	519	26	,	,	PUNCT
fnp-3790	519	27	villa	villa	PROPN
fnp-3790	519	28	-	-	PUNCT
fnp-3790	519	29	robles	robles	PROPN
fnp-3790	519	30	mr	mr	PROPN
fnp-3790	519	31	,	,	PUNCT
fnp-3790	519	32	zevallos	zevallos	X
fnp-3790	519	33	r	r	NOUN
fnp-3790	519	34	,	,	PUNCT
fnp-3790	519	35	mejia	mejia	PROPN
fnp-3790	519	36	o	o	NOUN
fnp-3790	519	37	,	,	PUNCT
fnp-3790	519	38	deza	deza	ADV
fnp-3790	519	39	p	p	NOUN
fnp-3790	519	40	,	,	PUNCT
fnp-3790	519	41	belmar	belmar	PROPN
fnp-3790	519	42	-	-	PUNCT
fnp-3790	519	43	lopez	lopez	PROPN
fnp-3790	519	44	c	c	PROPN
fnp-3790	519	45	,	,	PUNCT
fnp-3790	519	46	ojeda	ojeda	PROPN
fnp-3790	519	47	l.	l.	PROPN
fnp-3790	519	48	distribution	distribution	NOUN
fnp-3790	519	49	of	of	ADP
fnp-3790	519	50	tumor	tumor	NOUN
fnp-3790	519	51	-	-	PUNCT
fnp-3790	519	52	infiltrating	infiltrating	ADJ
fnp-3790	519	53	immune	immune	ADJ
fnp-3790	519	54	cells	cell	NOUN
fnp-3790	519	55	in	in	ADP
fnp-3790	519	56	glioblastoma	glioblastoma	NOUN
fnp-3790	519	57	.	.	PUNCT
fnp-3790	520	1	cns	cns	PROPN
fnp-3790	520	2	oncol	oncol	ADJ
fnp-3790	520	3	.	.	PUNCT
fnp-3790	521	1	2018;7	2018;7	NUM
fnp-3790	521	2	:	:	PUNCT
fnp-3790	521	3	cns21	cns21	PROPN
fnp-3790	521	4	.	.	PUNCT
fnp-3790	522	1	https://doi.org/10.2217/cns-2017-0037	https://doi.org/10.2217/cns-2017-0037	PROPN
fnp-3790	522	2	epub	epub	PROPN
fnp-3790	522	3	2018	2018	NUM
fnp-3790	522	4	oct	oct	NOUN
fnp-3790	522	5	9	9	NUM
fnp-3790	522	6	.	.	PUNCT
fnp-3790	523	1	pmid	pmid	NOUN
fnp-3790	523	2	:	:	PUNCT
fnp-3790	523	3	30299157	30299157	NUM
fnp-3790	523	4	;	;	PUNCT
fnp-3790	523	5	pmcid	pmcid	ADJ
fnp-3790	523	6	:	:	PUNCT
fnp-3790	523	7	pmc6331699	pmc6331699	NOUN
fnp-3790	523	8	.	.	PUNCT
fnp-3790	524	1	pajo	pajo	INTJ
fnp-3790	524	2	at	at	ADP
fnp-3790	524	3	,	,	PUNCT
fnp-3790	524	4	espiritu	espiritu	PROPN
fnp-3790	524	5	ai	ai	NOUN
fnp-3790	524	6	,	,	PUNCT
fnp-3790	524	7	apor	apor	ADJ
fnp-3790	524	8	adao	adao	PROPN
fnp-3790	524	9	,	,	PUNCT
fnp-3790	524	10	jamora	jamora	PROPN
fnp-3790	524	11	rdg	rdg	PROPN
fnp-3790	524	12	.	.	PUNCT
fnp-3790	525	1	neuropathologic	neuropathologic	ADJ
fnp-3790	525	2	findings	finding	NOUN
fnp-3790	525	3	of	of	ADP
fnp-3790	525	4	patients	patient	NOUN
fnp-3790	525	5	with	with	ADP
fnp-3790	525	6	covid-19	covid-19	PROPN
fnp-3790	525	7	:	:	PUNCT
fnp-3790	525	8	a	a	DET
fnp-3790	525	9	systematic	systematic	ADJ
fnp-3790	525	10	review	review	NOUN
fnp-3790	525	11	.	.	PUNCT
fnp-3790	526	1	neurol	neurol	PROPN
fnp-3790	526	2	sci	sci	PROPN
fnp-3790	526	3	.	.	PUNCT
fnp-3790	527	1	2021;42:1255	2021;42:1255	NUM
fnp-3790	527	2	-	-	SYM
fnp-3790	527	3	1266	1266	NUM
fnp-3790	527	4	.	.	PUNCT
fnp-3790	528	1	https://doi.org/10.1007/s10072-021-05068-7	https://doi.org/10.1007/s10072-021-05068-7	PROPN
fnp-3790	528	2	epub	epub	PROPN
fnp-3790	528	3	2021	2021	NUM
fnp-3790	528	4	jan	jan	PROPN
fnp-3790	528	5	22	22	NUM
fnp-3790	528	6	.	.	PUNCT
fnp-3790	529	1	pmid	pmid	NOUN
fnp-3790	529	2	:	:	PUNCT
fnp-3790	529	3	33483885	33483885	NUM
fnp-3790	529	4	;	;	PUNCT
fnp-3790	529	5	pmcid	pmcid	ADJ
fnp-3790	529	6	:	:	PUNCT
fnp-3790	529	7	pmc7822400	pmc7822400	NOUN
fnp-3790	529	8	.	.	PUNCT
fnp-3790	530	1	petrache	petrache	PROPN
fnp-3790	530	2	al	al	PROPN
fnp-3790	530	3	,	,	PUNCT
fnp-3790	530	4	rajulawalla	rajulawalla	NOUN
fnp-3790	530	5	a	a	NOUN
fnp-3790	530	6	,	,	PUNCT
fnp-3790	530	7	shi	shi	PROPN
fnp-3790	530	8	a	a	PROPN
fnp-3790	530	9	,	,	PUNCT
fnp-3790	530	10	wetzel	wetzel	PROPN
fnp-3790	530	11	a	a	PROPN
fnp-3790	530	12	,	,	PUNCT
fnp-3790	530	13	saito	saito	PROPN
fnp-3790	530	14	t	t	PROPN
fnp-3790	530	15	,	,	PUNCT
fnp-3790	530	16	saido	saido	PROPN
fnp-3790	530	17	tc	tc	PROPN
fnp-3790	530	18	,	,	PUNCT
fnp-3790	530	19	harvey	harvey	PROPN
fnp-3790	530	20	k	k	PROPN
fnp-3790	530	21	,	,	PUNCT
fnp-3790	530	22	ali	ali	PROPN
fnp-3790	530	23	ab	ab	AUX
fnp-3790	530	24	.	.	PROPN
fnp-3790	530	25	aberrant	aberrant	ADJ
fnp-3790	530	26	excitatory	excitatory	NOUN
fnp-3790	530	27	-	-	PUNCT
fnp-3790	530	28	inhibitory	inhibitory	ADJ
fnp-3790	530	29	synaptic	synaptic	ADJ
fnp-3790	530	30	mechanisms	mechanism	NOUN
fnp-3790	530	31	in	in	ADP
fnp-3790	530	32	entorhinal	entorhinal	ADJ
fnp-3790	530	33	cortex	cortex	NOUN
fnp-3790	530	34	microcircuits	microcircuit	NOUN
fnp-3790	530	35	during	during	ADP
fnp-3790	530	36	the	the	DET
fnp-3790	530	37	pathogenesis	pathogenesis	NOUN
fnp-3790	530	38	of	of	ADP
fnp-3790	530	39	alzheimer	alzheimer	PROPN
fnp-3790	530	40	's	's	PART
fnp-3790	530	41	disease	disease	NOUN
fnp-3790	530	42	.	.	PUNCT
fnp-3790	531	1	cereb	cereb	PROPN
fnp-3790	531	2	cortex	cortex	NOUN
fnp-3790	531	3	.	.	PUNCT
fnp-3790	532	1	2019;29:1834	2019;29:1834	NUM
fnp-3790	532	2	-	-	SYM
fnp-3790	532	3	1850	1850	NUM
fnp-3790	532	4	.	.	PUNCT
fnp-3790	533	1	https://doi.org/10.1093/cercor/bhz016	https://doi.org/10.1093/cercor/bhz016	PROPN
fnp-3790	533	2	pmid	pmid	NOUN
fnp-3790	533	3	:	:	PUNCT
fnp-3790	533	4	30766992	30766992	NUM
fnp-3790	533	5	;	;	PUNCT
fnp-3790	533	6	pmcid	pmcid	NOUN
fnp-3790	533	7	:	:	PUNCT
fnp-3790	533	8	pmc6418384	pmc6418384	PROPN
fnp-3790	533	9	.	.	PUNCT
fnp-3790	534	1	potter	potter	PROPN
fnp-3790	534	2	le	le	PROPN
fnp-3790	534	3	,	,	PUNCT
fnp-3790	534	4	paylor	paylor	PROPN
fnp-3790	534	5	jw	jw	PROPN
fnp-3790	534	6	,	,	PUNCT
fnp-3790	534	7	suh	suh	PROPN
fnp-3790	534	8	js	js	PROPN
fnp-3790	534	9	,	,	PUNCT
fnp-3790	534	10	tenorio	tenorio	PROPN
fnp-3790	534	11	g	g	PROPN
fnp-3790	534	12	,	,	PUNCT
fnp-3790	534	13	caliaperumal	caliaperumal	PROPN
fnp-3790	534	14	j	j	PROPN
fnp-3790	534	15	,	,	PUNCT
fnp-3790	534	16	colbourne	colbourne	NOUN
fnp-3790	534	17	f	f	PROPN
fnp-3790	534	18	,	,	PUNCT
fnp-3790	534	19	baker	baker	PROPN
fnp-3790	534	20	g	g	PROPN
fnp-3790	534	21	,	,	PUNCT
fnp-3790	534	22	winship	winship	VERB
fnp-3790	534	23	i	i	PRON
fnp-3790	534	24	,	,	PUNCT
fnp-3790	534	25	kerr	kerr	PROPN
fnp-3790	534	26	bj	bj	PROPN
fnp-3790	534	27	.	.	PUNCT
fnp-3790	535	1	altered	alter	VERB
fnp-3790	535	2	excitatory	excitatory	NOUN
fnp-3790	535	3	-	-	PUNCT
fnp-3790	535	4	inhibitory	inhibitory	ADJ
fnp-3790	535	5	balance	balance	NOUN
fnp-3790	535	6	within	within	ADP
fnp-3790	535	7	somatosensory	somatosensory	NOUN
fnp-3790	535	8	cortex	cortex	NOUN
fnp-3790	535	9	is	be	AUX
fnp-3790	535	10	associated	associate	VERB
fnp-3790	535	11	with	with	ADP
fnp-3790	535	12	enhanced	enhanced	ADJ
fnp-3790	535	13	plasticity	plasticity	NOUN
fnp-3790	535	14	and	and	CCONJ
fnp-3790	535	15	pain	pain	NOUN
fnp-3790	535	16	sensitivity	sensitivity	NOUN
fnp-3790	535	17	in	in	ADP
fnp-3790	535	18	a	a	DET
fnp-3790	535	19	mouse	mouse	NOUN
fnp-3790	535	20	model	model	NOUN
fnp-3790	535	21	of	of	ADP
fnp-3790	535	22	multiple	multiple	ADJ
fnp-3790	535	23	sclerosis	sclerosis	NOUN
fnp-3790	535	24	.	.	PUNCT
fnp-3790	536	1	j	j	PROPN
fnp-3790	536	2	neuroinflammation	neuroinflammation	PROPN
fnp-3790	536	3	.	.	PUNCT
fnp-3790	537	1	2016;13:142	2016;13:142	X
fnp-3790	537	2	.	.	PUNCT
fnp-3790	538	1	https://doi.org/10.1186/s12974-016-0609-4	https://doi.org/10.1186/s12974-016-0609-4	NUM
fnp-3790	538	2	pmid	pmid	NOUN
fnp-3790	538	3	:	:	PUNCT
fnp-3790	538	4	27282914	27282914	NUM
fnp-3790	538	5	;	;	PUNCT
fnp-3790	538	6	pmcid	pmcid	ADJ
fnp-3790	538	7	:	:	PUNCT
fnp-3790	538	8	pmc4901403	pmc4901403	NOUN
fnp-3790	538	9	.	.	PUNCT
fnp-3790	539	1	povysheva	povysheva	PROPN
fnp-3790	539	2	n	n	PRON
fnp-3790	539	3	,	,	PUNCT
fnp-3790	539	4	nigam	nigam	PROPN
fnp-3790	539	5	a	a	PROPN
fnp-3790	539	6	,	,	PUNCT
fnp-3790	539	7	brisbin	brisbin	PROPN
fnp-3790	539	8	ak	ak	PROPN
fnp-3790	539	9	,	,	PUNCT
fnp-3790	539	10	johnson	johnson	PROPN
fnp-3790	539	11	jw	jw	PROPN
fnp-3790	539	12	,	,	PUNCT
fnp-3790	539	13	barrionuevo	barrionuevo	VERB
fnp-3790	539	14	g.	g.	PROPN
fnp-3790	539	15	oxygen	oxygen	NOUN
fnp-3790	539	16	-	-	PUNCT
fnp-3790	539	17	glucose	glucose	NOUN
fnp-3790	539	18	deprivation	deprivation	NOUN
fnp-3790	539	19	differentially	differentially	ADV
fnp-3790	539	20	affects	affect	VERB
fnp-3790	539	21	neocortical	neocortical	ADJ
fnp-3790	539	22	pyramidal	pyramidal	ADJ
fnp-3790	539	23	neurons	neuron	NOUN
fnp-3790	539	24	and	and	CCONJ
fnp-3790	539	25	parvalbumin	parvalbumin	ADJ
fnp-3790	539	26	-	-	PUNCT
fnp-3790	539	27	positive	positive	ADJ
fnp-3790	539	28	interneurons	interneuron	NOUN
fnp-3790	539	29	.	.	PUNCT
fnp-3790	540	1	neuroscience	neuroscience	NOUN
fnp-3790	540	2	.	.	PUNCT
fnp-3790	541	1	2019;412:72	2019;412:72	NUM
fnp-3790	541	2	-	-	SYM
fnp-3790	541	3	82	82	NUM
fnp-3790	541	4	.	.	PUNCT
fnp-3790	542	1	https://doi.org/10.1016/j.neuroscience.2019.05.042	https://doi.org/10.1016/j.neuroscience.2019.05.042	NOUN
fnp-3790	542	2	epub	epub	PROPN
fnp-3790	542	3	2019	2019	NUM
fnp-3790	542	4	may	may	PROPN
fnp-3790	542	5	30	30	NUM
fnp-3790	542	6	.	.	PUNCT
fnp-3790	543	1	pmid	pmid	NOUN
fnp-3790	543	2	:	:	PUNCT
fnp-3790	543	3	31152933	31152933	NUM
fnp-3790	543	4	;	;	PUNCT
fnp-3790	543	5	pmcid	pmcid	NOUN
fnp-3790	543	6	:	:	PUNCT
fnp-3790	543	7	pmc6818263	pmc6818263	ADJ
fnp-3790	543	8	.	.	PUNCT
fnp-3790	544	1	ramaglia	ramaglia	PROPN
fnp-3790	544	2	v	v	PROPN
fnp-3790	544	3	,	,	PUNCT
fnp-3790	544	4	dubey	dubey	PROPN
fnp-3790	544	5	m	m	PROPN
fnp-3790	544	6	,	,	PUNCT
fnp-3790	544	7	malpede	malpede	PROPN
fnp-3790	544	8	ma	ma	PROPN
fnp-3790	544	9	,	,	PUNCT
fnp-3790	544	10	petersen	petersen	PROPN
fnp-3790	544	11	n	n	CCONJ
fnp-3790	544	12	,	,	PUNCT
fnp-3790	544	13	de	de	PROPN
fnp-3790	544	14	vries	vries	PROPN
fnp-3790	544	15	si	si	PROPN
fnp-3790	544	16	,	,	PUNCT
fnp-3790	544	17	ahmed	ahmed	PROPN
fnp-3790	544	18	sm	sm	PROPN
fnp-3790	544	19	,	,	PUNCT
fnp-3790	544	20	lee	lee	PROPN
fnp-3790	544	21	dsw	dsw	PROPN
fnp-3790	544	22	,	,	PUNCT
fnp-3790	544	23	schenk	schenk	PROPN
fnp-3790	544	24	gj	gj	PROPN
fnp-3790	544	25	,	,	PUNCT
fnp-3790	544	26	gold	gold	NOUN
fnp-3790	544	27	sm	sm	PROPN
fnp-3790	544	28	,	,	PUNCT
fnp-3790	544	29	huitinga	huitinga	PROPN
fnp-3790	544	30	i	i	NOUN
fnp-3790	544	31	,	,	PUNCT
fnp-3790	544	32	gommerman	gommerman	NOUN
fnp-3790	544	33	jl	jl	PROPN
fnp-3790	544	34	,	,	PUNCT
fnp-3790	544	35	geurts	geurts	PROPN
fnp-3790	544	36	jjg	jjg	PROPN
fnp-3790	544	37	,	,	PUNCT
fnp-3790	544	38	kole	kole	PROPN
fnp-3790	544	39	mhp	mhp	PROPN
fnp-3790	544	40	.	.	PUNCT
fnp-3790	544	41	complement	complement	NOUN
fnp-3790	544	42	-	-	PUNCT
fnp-3790	544	43	associated	associate	VERB
fnp-3790	544	44	loss	loss	NOUN
fnp-3790	544	45	of	of	ADP
fnp-3790	544	46	ca2	ca2	PROPN
fnp-3790	544	47	inhibitory	inhibitory	ADJ
fnp-3790	544	48	synapses	synapsis	NOUN
fnp-3790	544	49	in	in	ADP
fnp-3790	544	50	the	the	DET
fnp-3790	544	51	demyelinated	demyelinate	VERB
fnp-3790	544	52	hippocampus	hippocampus	NOUN
fnp-3790	544	53	impairs	impair	VERB
fnp-3790	544	54	memory	memory	NOUN
fnp-3790	544	55	.	.	PUNCT
fnp-3790	545	1	acta	acta	PROPN
fnp-3790	545	2	neuropathol	neuropathol	PROPN
fnp-3790	545	3	.	.	PUNCT
fnp-3790	546	1	2021;142:643	2021;142:643	NUM
fnp-3790	546	2	-	-	SYM
fnp-3790	546	3	667	667	NUM
fnp-3790	546	4	.	.	PUNCT
fnp-3790	547	1	https://doi.org/10.1007/s00401-021-02338-8	https://doi.org/10.1007/s00401-021-02338-8	NUM
fnp-3790	547	2	epub	epub	PROPN
fnp-3790	547	3	2021	2021	NUM
fnp-3790	547	4	jun	jun	PROPN
fnp-3790	547	5	25	25	NUM
fnp-3790	547	6	.	.	PUNCT
fnp-3790	548	1	pmid	pmid	NOUN
fnp-3790	548	2	:	:	PUNCT
fnp-3790	548	3	34170374	34170374	NUM
fnp-3790	548	4	;	;	PUNCT
fnp-3790	548	5	pmcid	pmcid	ADJ
fnp-3790	548	6	:	:	PUNCT
fnp-3790	548	7	pmc8423657	pmc8423657	PROPN
fnp-3790	548	8	.	.	PUNCT
fnp-3790	549	1	schartz	schartz	PROPN
fnp-3790	549	2	nd	nd	PRON
fnp-3790	549	3	,	,	PUNCT
fnp-3790	549	4	tenner	tenner	NOUN
fnp-3790	549	5	aj	aj	PROPN
fnp-3790	549	6	.	.	PUNCT
fnp-3790	550	1	the	the	DET
fnp-3790	550	2	good	good	NOUN
fnp-3790	550	3	,	,	PUNCT
fnp-3790	550	4	the	the	DET
fnp-3790	550	5	bad	bad	ADJ
fnp-3790	550	6	,	,	PUNCT
fnp-3790	550	7	and	and	CCONJ
fnp-3790	550	8	the	the	DET
fnp-3790	550	9	opportunities	opportunity	NOUN
fnp-3790	550	10	of	of	ADP
fnp-3790	550	11	the	the	DET
fnp-3790	550	12	complement	complement	NOUN
fnp-3790	550	13	system	system	NOUN
fnp-3790	550	14	in	in	ADP
fnp-3790	550	15	neurodegenerative	neurodegenerative	ADJ
fnp-3790	550	16	disease	disease	NOUN
fnp-3790	550	17	.	.	PUNCT
fnp-3790	551	1	j	j	PROPN
fnp-3790	551	2	neuroinflammation	neuroinflammation	PROPN
fnp-3790	551	3	.	.	PUNCT
fnp-3790	552	1	2020;17:354	2020;17:354	X
fnp-3790	552	2	.	.	PROPN
fnp-3790	552	3	https://doi.org/10.1186/s12974-020-02024-8	https://doi.org/10.1186/s12974-020-02024-8	NUM
fnp-3790	553	1	pmid	pmid	NOUN
fnp-3790	553	2	:	:	PUNCT
fnp-3790	553	3	33239010	33239010	NUM
fnp-3790	553	4	;	;	PUNCT
fnp-3790	553	5	pmcid	pmcid	ADJ
fnp-3790	553	6	:	:	PUNCT
fnp-3790	553	7	pmc7690210	pmc7690210	NOUN
fnp-3790	553	8	.	.	PUNCT
fnp-3790	554	1	schirmer	schirmer	PROPN
fnp-3790	554	2	l	l	PROPN
fnp-3790	554	3	,	,	PUNCT
fnp-3790	554	4	velmeshev	velmeshev	PROPN
fnp-3790	554	5	d	d	PROPN
fnp-3790	554	6	,	,	PUNCT
fnp-3790	554	7	holmqvist	holmqvist	PROPN
fnp-3790	554	8	s	s	PROPN
fnp-3790	554	9	,	,	PUNCT
fnp-3790	554	10	kaufmann	kaufmann	PROPN
fnp-3790	554	11	m	m	PROPN
fnp-3790	554	12	,	,	PUNCT
fnp-3790	554	13	werneburg	werneburg	PROPN
fnp-3790	554	14	s	s	NOUN
fnp-3790	554	15	,	,	PUNCT
fnp-3790	554	16	jung	jung	PROPN
fnp-3790	554	17	d	d	PROPN
fnp-3790	554	18	,	,	PUNCT
fnp-3790	554	19	vistnes	vistne	NOUN
fnp-3790	554	20	s	s	PROPN
fnp-3790	554	21	,	,	PUNCT
fnp-3790	554	22	stockley	stockley	PROPN
fnp-3790	554	23	jh	jh	PROPN
fnp-3790	554	24	,	,	PUNCT
fnp-3790	554	25	young	young	ADJ
fnp-3790	554	26	a	a	DET
fnp-3790	554	27	,	,	PUNCT
fnp-3790	554	28	steindel	steindel	NOUN
fnp-3790	554	29	m	m	PROPN
fnp-3790	554	30	,	,	PUNCT
fnp-3790	554	31	tung	tung	PROPN
fnp-3790	554	32	b	b	PROPN
fnp-3790	554	33	,	,	PUNCT
fnp-3790	554	34	goyal	goyal	PROPN
fnp-3790	554	35	n	n	CCONJ
fnp-3790	554	36	,	,	PUNCT
fnp-3790	554	37	bhaduri	bhaduri	PROPN
fnp-3790	554	38	a	a	PROPN
fnp-3790	554	39	,	,	PUNCT
fnp-3790	554	40	mayer	mayer	PROPN
fnp-3790	554	41	s	s	PROPN
fnp-3790	554	42	,	,	PUNCT
fnp-3790	554	43	engler	engler	PROPN
fnp-3790	554	44	jb	jb	PROPN
fnp-3790	554	45	,	,	PUNCT
fnp-3790	554	46	bayraktar	bayraktar	PROPN
fnp-3790	554	47	oa	oa	PROPN
fnp-3790	554	48	,	,	PUNCT
fnp-3790	554	49	franklin	franklin	PROPN
fnp-3790	554	50	rjm	rjm	PROPN
fnp-3790	554	51	,	,	PUNCT
fnp-3790	554	52	haeussler	haeussler	NOUN
fnp-3790	554	53	m	m	PROPN
fnp-3790	554	54	,	,	PUNCT
fnp-3790	554	55	reynolds	reynolds	PROPN
fnp-3790	554	56	r	r	PROPN
fnp-3790	554	57	,	,	PUNCT
fnp-3790	554	58	schafer	schafer	PROPN
fnp-3790	554	59	dp	dp	PROPN
fnp-3790	554	60	,	,	PUNCT
fnp-3790	554	61	friese	friese	PROPN
fnp-3790	554	62	ma	ma	PROPN
fnp-3790	554	63	,	,	PUNCT
fnp-3790	554	64	shiow	shiow	PROPN
fnp-3790	554	65	lr	lr	PROPN
fnp-3790	554	66	,	,	PUNCT
fnp-3790	554	67	kriegstein	kriegstein	PROPN
fnp-3790	554	68	ar	ar	PROPN
fnp-3790	554	69	,	,	PUNCT
fnp-3790	554	70	rowitch	rowitch	VERB
fnp-3790	554	71	dh	dh	NOUN
fnp-3790	554	72	.	.	PUNCT
fnp-3790	554	73	neuronal	neuronal	ADJ
fnp-3790	554	74	vulnerability	vulnerability	NOUN
fnp-3790	554	75	and	and	CCONJ
fnp-3790	554	76	multilineage	multilineage	NOUN
fnp-3790	554	77	diversity	diversity	NOUN
fnp-3790	554	78	in	in	ADP
fnp-3790	554	79	multiple	multiple	ADJ
fnp-3790	554	80	sclerosis	sclerosis	NOUN
fnp-3790	554	81	.	.	PUNCT
fnp-3790	555	1	nature	nature	NOUN
fnp-3790	555	2	.	.	PUNCT
fnp-3790	556	1	2019;573:75	2019;573:75	NUM
fnp-3790	556	2	-	-	SYM
fnp-3790	556	3	82	82	NUM
fnp-3790	556	4	.	.	PUNCT
fnp-3790	557	1	https://doi.org/10.1038/s41586-019-1404-z	https://doi.org/10.1038/s41586-019-1404-z	PROPN
fnp-3790	557	2	epub	epub	PROPN
fnp-3790	557	3	2019	2019	NUM
fnp-3790	557	4	jul	jul	PROPN
fnp-3790	557	5	17	17	NUM
fnp-3790	557	6	.	.	PUNCT
fnp-3790	558	1	pmid	pmid	NOUN
fnp-3790	558	2	:	:	PUNCT
fnp-3790	558	3	31316211	31316211	NUM
fnp-3790	558	4	;	;	PUNCT
fnp-3790	558	5	pmcid	pmcid	NOUN
fnp-3790	558	6	:	:	PUNCT
fnp-3790	558	7	pmc6731122	pmc6731122	PROPN
fnp-3790	558	8	.	.	PUNCT
fnp-3790	559	1	schwabenland	schwabenland	PROPN
fnp-3790	559	2	m	m	PROPN
fnp-3790	559	3	,	,	PUNCT
fnp-3790	559	4	salié	salié	VERB
fnp-3790	559	5	h	h	PROPN
fnp-3790	559	6	,	,	PUNCT
fnp-3790	559	7	tanevski	tanevski	PROPN
fnp-3790	559	8	j	j	PROPN
fnp-3790	559	9	,	,	PUNCT
fnp-3790	559	10	killmer	killmer	NOUN
fnp-3790	559	11	s	s	PROPN
fnp-3790	559	12	,	,	PUNCT
fnp-3790	559	13	lago	lago	PROPN
fnp-3790	559	14	ms	ms	NOUN
fnp-3790	559	15	,	,	PUNCT
fnp-3790	559	16	schlaak	schlaak	NOUN
fnp-3790	559	17	ae	ae	PROPN
fnp-3790	559	18	,	,	PUNCT
fnp-3790	559	19	mayer	mayer	PROPN
fnp-3790	559	20	l	l	PROPN
fnp-3790	559	21	,	,	PUNCT
fnp-3790	559	22	matschke	matschke	PROPN
fnp-3790	559	23	j	j	PROPN
fnp-3790	559	24	,	,	PUNCT
fnp-3790	559	25	püschel	püschel	PROPN
fnp-3790	559	26	k	k	PROPN
fnp-3790	559	27	,	,	PUNCT
fnp-3790	559	28	fitzek	fitzek	VERB
fnp-3790	559	29	a	a	PRON
fnp-3790	559	30	,	,	PUNCT
fnp-3790	559	31	ondruschka	ondruschka	PROPN
fnp-3790	559	32	b	b	PROPN
fnp-3790	559	33	,	,	PUNCT
fnp-3790	559	34	mei	mei	PROPN
fnp-3790	559	35	he	he	PRON
fnp-3790	559	36	,	,	PUNCT
fnp-3790	559	37	boettler	boettler	VERB
fnp-3790	559	38	t	t	PROPN
fnp-3790	559	39	,	,	PUNCT
fnp-3790	559	40	neumann	neumann	PROPN
fnp-3790	559	41	-	-	PUNCT
fnp-3790	559	42	haefelin	haefelin	PROPN
fnp-3790	559	43	c	c	PROPN
fnp-3790	559	44	,	,	PUNCT
fnp-3790	559	45	hofmann	hofmann	PROPN
fnp-3790	559	46	m	m	PROPN
fnp-3790	559	47	,	,	PUNCT
fnp-3790	559	48	breithaupt	breithaupt	PROPN
fnp-3790	559	49	a	a	X
fnp-3790	559	50	,	,	PUNCT
fnp-3790	559	51	genc	genc	PROPN
fnp-3790	559	52	n	n	CCONJ
fnp-3790	559	53	,	,	PUNCT
fnp-3790	559	54	stadelmann	stadelmann	PROPN
fnp-3790	559	55	c	c	PROPN
fnp-3790	559	56	,	,	PUNCT
fnp-3790	559	57	saez	saez	PROPN
fnp-3790	559	58	-	-	PUNCT
fnp-3790	559	59	rodriguez	rodriguez	PROPN
fnp-3790	559	60	j	j	PROPN
fnp-3790	559	61	,	,	PUNCT
fnp-3790	559	62	bronsert	bronsert	NOUN
fnp-3790	559	63	p	p	NOUN
fnp-3790	559	64	,	,	PUNCT
fnp-3790	559	65	knobeloch	knobeloch	PROPN
fnp-3790	559	66	kp	kp	PROPN
fnp-3790	559	67	,	,	PUNCT
fnp-3790	559	68	blank	blank	PROPN
fnp-3790	559	69	t	t	PROPN
fnp-3790	559	70	,	,	PUNCT
fnp-3790	559	71	thimme	thimme	PROPN
fnp-3790	559	72	r	r	NOUN
fnp-3790	559	73	,	,	PUNCT
fnp-3790	559	74	glatzel	glatzel	PROPN
fnp-3790	559	75	m	m	PROPN
fnp-3790	559	76	,	,	PUNCT
fnp-3790	559	77	prinz	prinz	PROPN
fnp-3790	559	78	m	m	PROPN
fnp-3790	559	79	,	,	PUNCT
fnp-3790	559	80	bengsch	bengsch	PROPN
fnp-3790	559	81	b.	b.	PROPN
fnp-3790	560	1	deep	deep	ADJ
fnp-3790	560	2	spatial	spatial	ADJ
fnp-3790	560	3	profiling	profiling	NOUN
fnp-3790	560	4	of	of	ADP
fnp-3790	560	5	human	human	ADJ
fnp-3790	560	6	covid-19	covid-19	PROPN
fnp-3790	560	7	brains	brain	NOUN
fnp-3790	560	8	reveals	reveal	VERB
fnp-3790	560	9	neuroinflammation	neuroinflammation	NOUN
fnp-3790	560	10	with	with	ADP
fnp-3790	560	11	distinct	distinct	ADJ
fnp-3790	560	12	microanatomical	microanatomical	ADJ
fnp-3790	560	13	microglia	microglia	ADJ
fnp-3790	560	14	-	-	PUNCT
fnp-3790	560	15	t	t	NOUN
fnp-3790	560	16	-	-	PUNCT
fnp-3790	560	17	cell	cell	NOUN
fnp-3790	560	18	interactions	interaction	NOUN
fnp-3790	560	19	.	.	PUNCT
fnp-3790	561	1	immunity	immunity	NOUN
fnp-3790	561	2	.	.	PUNCT
fnp-3790	562	1	2021;54:1594	2021;54:1594	NUM
fnp-3790	562	2	-	-	SYM
fnp-3790	562	3	1610.e11	1610.e11	NUM
fnp-3790	562	4	.	.	PUNCT
fnp-3790	563	1	https://doi.org/10.1016/j.immuni.2021.06.002	https://doi.org/10.1016/j.immuni.2021.06.002	NOUN
fnp-3790	563	2	epub	epub	NOUN
fnp-3790	563	3	2021	2021	NUM
fnp-3790	563	4	jun	jun	PROPN
fnp-3790	563	5	9	9	NUM
fnp-3790	563	6	.	.	PUNCT
fnp-3790	563	7	pmid	pmid	NOUN
fnp-3790	563	8	:	:	PUNCT
fnp-3790	563	9	34174183	34174183	NUM
fnp-3790	563	10	;	;	PUNCT
fnp-3790	563	11	pmcid	pmcid	NOUN
fnp-3790	563	12	:	:	PUNCT
fnp-3790	563	13	pmc8188302	pmc8188302	PROPN
fnp-3790	563	14	.	.	PUNCT
fnp-3790	564	1	sobue	sobue	PROPN
fnp-3790	564	2	a	a	PRON
fnp-3790	564	3	,	,	PUNCT
fnp-3790	564	4	komine	komine	NOUN
fnp-3790	564	5	o	o	NOUN
fnp-3790	564	6	,	,	PUNCT
fnp-3790	564	7	hara	hara	PROPN
fnp-3790	564	8	y	y	PROPN
fnp-3790	564	9	,	,	PUNCT
fnp-3790	564	10	endo	endo	PROPN
fnp-3790	564	11	f	f	PROPN
fnp-3790	564	12	,	,	PUNCT
fnp-3790	564	13	mizoguchi	mizoguchi	PROPN
fnp-3790	564	14	h	h	PROPN
fnp-3790	564	15	,	,	PUNCT
fnp-3790	564	16	watanabe	watanabe	PROPN
fnp-3790	564	17	s	s	PROPN
fnp-3790	564	18	,	,	PUNCT
fnp-3790	564	19	murayama	murayama	PROPN
fnp-3790	564	20	s	s	PROPN
fnp-3790	564	21	,	,	PUNCT
fnp-3790	564	22	saito	saito	PROPN
fnp-3790	564	23	t	t	PROPN
fnp-3790	564	24	,	,	PUNCT
fnp-3790	564	25	saido	saido	PROPN
fnp-3790	564	26	tc	tc	PROPN
fnp-3790	564	27	,	,	PUNCT
fnp-3790	564	28	sahara	sahara	PROPN
fnp-3790	564	29	n	n	CCONJ
fnp-3790	564	30	,	,	PUNCT
fnp-3790	564	31	higuchi	higuchi	PROPN
fnp-3790	564	32	m	m	PROPN
fnp-3790	564	33	,	,	PUNCT
fnp-3790	564	34	ogi	ogi	PROPN
fnp-3790	564	35	t	t	PROPN
fnp-3790	564	36	,	,	PUNCT
fnp-3790	564	37	yamanaka	yamanaka	PROPN
fnp-3790	564	38	k.	k.	PROPN
fnp-3790	565	1	microglial	microglial	PROPN
fnp-3790	565	2	gene	gene	NOUN
fnp-3790	565	3	signature	signature	NOUN
fnp-3790	565	4	reveals	reveal	VERB
fnp-3790	565	5	loss	loss	NOUN
fnp-3790	565	6	of	of	ADP
fnp-3790	565	7	homeostatic	homeostatic	ADJ
fnp-3790	565	8	microglia	microglia	NOUN
fnp-3790	565	9	associated	associate	VERB
fnp-3790	565	10	with	with	ADP
fnp-3790	565	11	neurodegeneration	neurodegeneration	NOUN
fnp-3790	565	12	of	of	ADP
fnp-3790	565	13	alzheimer	alzheimer	PROPN
fnp-3790	565	14	's	's	PART
fnp-3790	565	15	disease	disease	NOUN
fnp-3790	565	16	.	.	PUNCT
fnp-3790	566	1	acta	acta	PROPN
fnp-3790	566	2	neuropathol	neuropathol	PROPN
fnp-3790	566	3	commun	commun	PROPN
fnp-3790	566	4	.	.	PUNCT
fnp-3790	567	1	2021;9:1	2021;9:1	NOUN
fnp-3790	567	2	.	.	PUNCT
fnp-3790	568	1	https://doi.org/10.1186/s40478-020-01099-x	https://doi.org/10.1186/s40478-020-01099-x	PROPN
fnp-3790	568	2	pmid	pmid	NOUN
fnp-3790	568	3	:	:	PUNCT
fnp-3790	568	4	33402227	33402227	NUM
fnp-3790	568	5	;	;	PUNCT
fnp-3790	568	6	pmcid	pmcid	ADJ
fnp-3790	568	7	:	:	PUNCT
fnp-3790	568	8	pmc7786928	pmc7786928	NOUN
fnp-3790	568	9	.	.	PUNCT
fnp-3790	569	1	stolp	stolp	PROPN
fnp-3790	569	2	hb	hb	PROPN
fnp-3790	569	3	,	,	PUNCT
fnp-3790	569	4	fleiss	fleiss	PROPN
fnp-3790	569	5	b	b	NUM
fnp-3790	569	6	,	,	PUNCT
fnp-3790	569	7	arai	arai	PROPN
fnp-3790	569	8	y	y	PROPN
fnp-3790	569	9	,	,	PUNCT
fnp-3790	569	10	supramaniam	supramaniam	VERB
fnp-3790	569	11	v	v	NOUN
fnp-3790	569	12	,	,	PUNCT
fnp-3790	569	13	vontell	vontell	NOUN
fnp-3790	569	14	r	r	NOUN
fnp-3790	569	15	,	,	PUNCT
fnp-3790	569	16	birtles	birtle	NOUN
fnp-3790	569	17	s	s	PART
fnp-3790	569	18	,	,	PUNCT
fnp-3790	569	19	yates	yates	PROPN
fnp-3790	569	20	ag	ag	PROPN
fnp-3790	569	21	,	,	PUNCT
fnp-3790	569	22	baburamani	baburamani	PROPN
fnp-3790	569	23	aa	aa	PROPN
fnp-3790	569	24	,	,	PUNCT
fnp-3790	569	25	thornton	thornton	PROPN
fnp-3790	569	26	c	c	PROPN
fnp-3790	569	27	,	,	PUNCT
fnp-3790	569	28	rutherford	rutherford	PROPN
fnp-3790	569	29	m	m	PROPN
fnp-3790	569	30	,	,	PUNCT
fnp-3790	569	31	edwards	edwards	PROPN
fnp-3790	569	32	ad	ad	NOUN
fnp-3790	569	33	,	,	PUNCT
fnp-3790	569	34	gressens	gressen	VERB
fnp-3790	569	35	p.	p.	PROPN
fnp-3790	569	36	interneuron	interneuron	PROPN
fnp-3790	569	37	development	development	NOUN
fnp-3790	569	38	is	be	AUX
fnp-3790	569	39	disrupted	disrupt	VERB
fnp-3790	569	40	in	in	ADP
fnp-3790	569	41	preterm	preterm	ADJ
fnp-3790	569	42	brains	brain	NOUN
fnp-3790	569	43	with	with	ADP
fnp-3790	569	44	diffuse	diffuse	PROPN
fnp-3790	569	45	white	white	ADJ
fnp-3790	569	46	matter	matter	NOUN
fnp-3790	569	47	injury	injury	NOUN
fnp-3790	569	48	:	:	PUNCT
fnp-3790	569	49	observations	observation	NOUN
fnp-3790	569	50	in	in	ADP
fnp-3790	569	51	mouse	mouse	NOUN
fnp-3790	569	52	and	and	CCONJ
fnp-3790	569	53	human	human	NOUN
fnp-3790	569	54	.	.	PUNCT
fnp-3790	570	1	front	front	ADJ
fnp-3790	570	2	physiol	physiol	PROPN
fnp-3790	570	3	.	.	PUNCT
fnp-3790	571	1	2019;10:955	2019;10:955	X
fnp-3790	571	2	.	.	PUNCT
fnp-3790	572	1	https://doi.org/10.3389/fphys.2019.00955	https://doi.org/10.3389/fphys.2019.00955	PROPN
fnp-3790	572	2	pmid	pmid	PROPN
fnp-3790	572	3	:	:	PUNCT
fnp-3790	572	4	31417418	31417418	NUM
fnp-3790	572	5	;	;	PUNCT
fnp-3790	572	6	pmcid	pmcid	NOUN
fnp-3790	572	7	:	:	PUNCT
fnp-3790	572	8	pmc6683859	pmc6683859	ADJ
fnp-3790	572	9	.	.	PUNCT
fnp-3790	573	1	szulzewsky	szulzewsky	PROPN
fnp-3790	573	2	f	f	PROPN
fnp-3790	573	3	,	,	PUNCT
fnp-3790	573	4	pelz	pelz	PROPN
fnp-3790	573	5	a	a	PROPN
fnp-3790	573	6	,	,	PUNCT
fnp-3790	573	7	feng	feng	PROPN
fnp-3790	573	8	x	x	SYM
fnp-3790	573	9	,	,	PUNCT
fnp-3790	573	10	synowitz	synowitz	PROPN
fnp-3790	573	11	m	m	PROPN
fnp-3790	573	12	,	,	PUNCT
fnp-3790	573	13	markovic	markovic	PROPN
fnp-3790	573	14	d	d	PROPN
fnp-3790	573	15	,	,	PUNCT
fnp-3790	573	16	langmann	langmann	PROPN
fnp-3790	573	17	t	t	PROPN
fnp-3790	573	18	,	,	PUNCT
fnp-3790	573	19	holtman	holtman	PROPN
fnp-3790	573	20	ir	ir	PROPN
fnp-3790	573	21	,	,	PUNCT
fnp-3790	573	22	wang	wang	PROPN
fnp-3790	573	23	x	x	PROPN
fnp-3790	573	24	,	,	PUNCT
fnp-3790	573	25	eggen	eggen	NOUN
fnp-3790	573	26	bj	bj	NOUN
fnp-3790	573	27	,	,	PUNCT
fnp-3790	573	28	boddeke	boddeke	PROPN
fnp-3790	573	29	hw	hw	PROPN
fnp-3790	573	30	,	,	PUNCT
fnp-3790	573	31	hambardzumyan	hambardzumyan	PROPN
fnp-3790	573	32	d	d	NOUN
fnp-3790	573	33	,	,	PUNCT
fnp-3790	573	34	wolf	wolf	PROPN
fnp-3790	573	35	sa	sa	PROPN
fnp-3790	573	36	,	,	PUNCT
fnp-3790	573	37	kettenmann	kettenmann	PROPN
fnp-3790	573	38	h	h	PROPN
fnp-3790	573	39	..	..	PUNCT
fnp-3790	573	40	glioma	glioma	NOUN
fnp-3790	573	41	-	-	PUNCT
fnp-3790	573	42	associated	associate	VERB
fnp-3790	573	43	microglia	microglia	ADJ
fnp-3790	573	44	/	/	SYM
fnp-3790	573	45	macrophages	macrophage	NOUN
fnp-3790	573	46	display	display	VERB
fnp-3790	573	47	an	an	DET
fnp-3790	573	48	expression	expression	NOUN
fnp-3790	573	49	profile	profile	NOUN
fnp-3790	573	50	different	different	ADJ
fnp-3790	573	51	from	from	ADP
fnp-3790	573	52	m1	m1	PROPN
fnp-3790	573	53	and	and	CCONJ
fnp-3790	573	54	m2	m2	PROPN
fnp-3790	573	55	polarization	polarization	NOUN
fnp-3790	573	56	and	and	CCONJ
fnp-3790	573	57	highly	highly	ADV
fnp-3790	573	58	express	express	ADJ
fnp-3790	573	59	gpnmb	gpnmb	NOUN
fnp-3790	573	60	and	and	CCONJ
fnp-3790	573	61	spp1	spp1	PROPN
fnp-3790	573	62	.	.	PUNCT
fnp-3790	574	1	plos	plos	PROPN
fnp-3790	574	2	one	one	NUM
fnp-3790	574	3	.	.	PUNCT
fnp-3790	575	1	2015;10	2015;10	NUM
fnp-3790	575	2	:	:	PUNCT
fnp-3790	575	3	e0116644	e0116644	NUM
fnp-3790	575	4	.	.	PUNCT
fnp-3790	575	5	https://doi.org/10.1371/journal.pone.0116644	https://doi.org/10.1371/journal.pone.0116644	VERB
fnp-3790	575	6	pmid	pmid	NOUN
fnp-3790	575	7	:	:	PUNCT
fnp-3790	575	8	25658639	25658639	NUM
fnp-3790	575	9	;	;	PUNCT
fnp-3790	575	10	pmcid	pmcid	NOUN
fnp-3790	575	11	:	:	PUNCT
fnp-3790	575	12	pmc4320099	pmc4320099	ADJ
fnp-3790	575	13	.	.	PUNCT
fnp-3790	576	1	thakur	thakur	PROPN
fnp-3790	576	2	kt	kt	PROPN
fnp-3790	576	3	,	,	PUNCT
fnp-3790	576	4	miller	miller	PROPN
fnp-3790	576	5	eh	eh	INTJ
fnp-3790	576	6	,	,	PUNCT
fnp-3790	576	7	glendinning	glendinne	VERB
fnp-3790	576	8	md	md	PROPN
fnp-3790	576	9	,	,	PUNCT
fnp-3790	576	10	al	al	PROPN
fnp-3790	576	11	-	-	PUNCT
fnp-3790	576	12	dalahmah	dalahmah	PROPN
fnp-3790	576	13	o	o	NOUN
fnp-3790	576	14	,	,	PUNCT
fnp-3790	576	15	banu	banu	PROPN
fnp-3790	576	16	ma	ma	PROPN
fnp-3790	576	17	,	,	PUNCT
fnp-3790	576	18	boehme	boehme	PROPN
fnp-3790	576	19	ak	ak	PROPN
fnp-3790	576	20	,	,	PUNCT
fnp-3790	576	21	boubour	boubour	PROPN
fnp-3790	576	22	al	al	PROPN
fnp-3790	576	23	,	,	PUNCT
fnp-3790	576	24	bruce	bruce	PROPN
fnp-3790	576	25	ss	ss	PROPN
fnp-3790	576	26	,	,	PUNCT
fnp-3790	576	27	chong	chong	PROPN
fnp-3790	576	28	am	be	AUX
fnp-3790	576	29	,	,	PUNCT
fnp-3790	576	30	claassen	claassen	PROPN
fnp-3790	576	31	j	j	PROPN
fnp-3790	576	32	,	,	PUNCT
fnp-3790	576	33	faust	faust	PROPN
fnp-3790	576	34	pl	pl	PROPN
fnp-3790	576	35	,	,	PUNCT
fnp-3790	576	36	hargus	hargus	ADJ
fnp-3790	576	37	g	g	PROPN
fnp-3790	576	38	,	,	PUNCT
fnp-3790	576	39	hickman	hickman	PROPN
fnp-3790	576	40	ra	ra	PROPN
fnp-3790	576	41	,	,	PUNCT
fnp-3790	576	42	jambawalikar	jambawalikar	PROPN
fnp-3790	576	43	s	s	PROPN
fnp-3790	576	44	,	,	PUNCT
fnp-3790	576	45	khandji	khandji	PROPN
fnp-3790	576	46	ag	ag	PROPN
fnp-3790	576	47	,	,	PUNCT
fnp-3790	576	48	kim	kim	PROPN
fnp-3790	576	49	cy	cy	PROPN
fnp-3790	576	50	,	,	PUNCT
fnp-3790	576	51	klein	klein	PROPN
fnp-3790	576	52	rs	rs	PROPN
fnp-3790	576	53	,	,	PUNCT
fnp-3790	576	54	lignelli	lignelli	NOUN
fnp-3790	576	55	-	-	PUNCT
fnp-3790	576	56	dipple	dipple	PROPN
fnp-3790	576	57	a	a	PRON
fnp-3790	576	58	,	,	PUNCT
fnp-3790	576	59	lin	lin	PROPN
fnp-3790	576	60	cc	cc	PROPN
fnp-3790	576	61	,	,	PUNCT
fnp-3790	576	62	liu	liu	PROPN
fnp-3790	576	63	y	y	PROPN
fnp-3790	576	64	,	,	PUNCT
fnp-3790	576	65	miller	miller	PROPN
fnp-3790	576	66	ml	ml	PROPN
fnp-3790	576	67	,	,	PUNCT
fnp-3790	576	68	moonis	moonis	PROPN
fnp-3790	576	69	g	g	PROPN
fnp-3790	576	70	,	,	PUNCT
fnp-3790	576	71	nordvig	nordvig	ADP
fnp-3790	576	72	as	as	SCONJ
fnp-3790	576	73	,	,	PUNCT
fnp-3790	576	74	overdevest	overdevest	VERB
fnp-3790	576	75	jb	jb	PROPN
fnp-3790	576	76	,	,	PUNCT
fnp-3790	576	77	prust	prust	PROPN
fnp-3790	576	78	ml	ml	AUX
fnp-3790	576	79	,	,	PUNCT
fnp-3790	576	80	przedborski	przedborski	PROPN
fnp-3790	576	81	s	s	PROPN
fnp-3790	576	82	,	,	PUNCT
fnp-3790	576	83	roth	roth	PROPN
fnp-3790	576	84	wh	wh	PROPN
fnp-3790	576	85	,	,	PUNCT
fnp-3790	576	86	soung	soung	VERB
fnp-3790	576	87	a	a	PRON
fnp-3790	576	88	,	,	PUNCT
fnp-3790	576	89	tanji	tanji	NOUN
fnp-3790	576	90	k	k	NOUN
fnp-3790	576	91	,	,	PUNCT
fnp-3790	576	92	teich	teich	ADV
fnp-3790	576	93	af	af	PROPN
fnp-3790	576	94	,	,	PUNCT
fnp-3790	576	95	agalliu	agalliu	VERB
fnp-3790	576	96	d	d	PROPN
fnp-3790	576	97	,	,	PUNCT
fnp-3790	576	98	uhlemann	uhlemann	PROPN
fnp-3790	576	99	ac	ac	PROPN
fnp-3790	576	100	,	,	PUNCT
fnp-3790	576	101	goldman	goldman	PROPN
fnp-3790	576	102	je	je	PROPN
fnp-3790	576	103	,	,	PUNCT
fnp-3790	576	104	canoll	canoll	PROPN
fnp-3790	576	105	p.	p.	PROPN
fnp-3790	576	106	covid-19	covid-19	PROPN
fnp-3790	576	107	neuropathology	neuropathology	NOUN
fnp-3790	576	108	at	at	ADP
fnp-3790	576	109	columbia	columbia	PROPN
fnp-3790	576	110	university	university	PROPN
fnp-3790	576	111	irving	irving	PROPN
fnp-3790	576	112	medical	medical	ADJ
fnp-3790	576	113	center	center	PROPN
fnp-3790	576	114	/	/	SYM
fnp-3790	576	115	new	new	PROPN
fnp-3790	576	116	york	york	PROPN
fnp-3790	576	117	presbyterian	presbyterian	PROPN
fnp-3790	576	118	hospital	hospital	NOUN
fnp-3790	576	119	.	.	PUNCT
fnp-3790	577	1	brain	brain	NOUN
fnp-3790	577	2	.	.	PUNCT
fnp-3790	578	1	2021;144:2696	2021;144:2696	NUM
fnp-3790	578	2	-	-	PUNCT
fnp-3790	578	3	2708	2708	NUM
fnp-3790	578	4	.	.	PUNCT
fnp-3790	579	1	https://doi.org/10.1093/brain/awab148	https://doi.org/10.1093/brain/awab148	X
fnp-3790	580	1	pmid	pmid	NOUN
fnp-3790	580	2	:	:	PUNCT
fnp-3790	580	3	33856027	33856027	NUM
fnp-3790	580	4	;	;	PUNCT
fnp-3790	580	5	pmcid	pmcid	NOUN
fnp-3790	580	6	:	:	PUNCT
fnp-3790	580	7	pmc8083258	pmc8083258	PROPN
fnp-3790	580	8	.	.	PUNCT
fnp-3790	581	1	togo	togo	PROPN
fnp-3790	581	2	t	t	PROPN
fnp-3790	581	3	,	,	PUNCT
fnp-3790	581	4	akiyama	akiyama	PROPN
fnp-3790	581	5	h	h	PROPN
fnp-3790	581	6	,	,	PUNCT
fnp-3790	581	7	iseki	iseki	PROPN
fnp-3790	581	8	e	e	PROPN
fnp-3790	581	9	,	,	PUNCT
fnp-3790	581	10	kondo	kondo	PROPN
fnp-3790	581	11	h	h	PROPN
fnp-3790	581	12	,	,	PUNCT
fnp-3790	581	13	ikeda	ikeda	PROPN
fnp-3790	581	14	k	k	PROPN
fnp-3790	581	15	,	,	PUNCT
fnp-3790	581	16	kato	kato	PROPN
fnp-3790	581	17	m	m	PROPN
fnp-3790	581	18	,	,	PUNCT
fnp-3790	581	19	oda	oda	PROPN
fnp-3790	581	20	t	t	PROPN
fnp-3790	581	21	,	,	PUNCT
fnp-3790	581	22	tsuchiya	tsuchiya	PROPN
fnp-3790	582	1	k	k	PROPN
fnp-3790	582	2	,	,	PUNCT
fnp-3790	582	3	kosaka	kosaka	PROPN
fnp-3790	582	4	k.	k.	PROPN
fnp-3790	582	5	occurrence	occurrence	PROPN
fnp-3790	582	6	of	of	ADP
fnp-3790	582	7	t	t	PROPN
fnp-3790	582	8	cells	cell	NOUN
fnp-3790	582	9	in	in	ADP
fnp-3790	582	10	the	the	DET
fnp-3790	582	11	brain	brain	NOUN
fnp-3790	582	12	of	of	ADP
fnp-3790	582	13	alzheimer	alzheimer	PROPN
fnp-3790	582	14	's	's	PART
fnp-3790	582	15	disease	disease	NOUN
fnp-3790	582	16	and	and	CCONJ
fnp-3790	582	17	other	other	ADJ
fnp-3790	582	18	neurological	neurological	ADJ
fnp-3790	582	19	diseases	disease	NOUN
fnp-3790	582	20	.	.	PUNCT
fnp-3790	583	1	j	j	PROPN
fnp-3790	583	2	neuroimmunol	neuroimmunol	NOUN
fnp-3790	583	3	.	.	PUNCT
fnp-3790	584	1	2002;124:83	2002;124:83	NUM
fnp-3790	584	2	-	-	SYM
fnp-3790	584	3	92	92	NUM
fnp-3790	584	4	.	.	PUNCT
fnp-3790	585	1	https://doi.org/10.1016/s0165-5728(01)00496-9	https://doi.org/10.1016/s0165-5728(01)00496-9	PROPN
fnp-3790	585	2	pmid	pmid	PROPN
fnp-3790	585	3	:	:	PUNCT
fnp-3790	585	4	11958825	11958825	NUM
fnp-3790	585	5	.	.	PUNCT
fnp-3790	586	1	vaes	vaes	PROPN
fnp-3790	586	2	jeg	jeg	PROPN
fnp-3790	586	3	,	,	PUNCT
fnp-3790	586	4	kosmeijer	kosmeijer	NOUN
fnp-3790	586	5	cm	cm	NOUN
fnp-3790	586	6	,	,	PUNCT
fnp-3790	586	7	kaal	kaal	PROPN
fnp-3790	586	8	m	m	PROPN
fnp-3790	586	9	,	,	PUNCT
fnp-3790	586	10	van	van	PROPN
fnp-3790	586	11	vliet	vliet	PROPN
fnp-3790	586	12	r	r	PROPN
fnp-3790	586	13	,	,	PUNCT
fnp-3790	586	14	brandt	brandt	PROPN
fnp-3790	586	15	mjv	mjv	PROPN
fnp-3790	586	16	,	,	PUNCT
fnp-3790	586	17	benders	bender	NOUN
fnp-3790	586	18	mjnl	mjnl	PROPN
fnp-3790	586	19	,	,	PUNCT
fnp-3790	586	20	nijboer	nijboer	PROPN
fnp-3790	586	21	ch	ch	PROPN
fnp-3790	586	22	.	.	PROPN
fnp-3790	586	23	regenerative	regenerative	ADJ
fnp-3790	586	24	therapies	therapy	NOUN
fnp-3790	586	25	to	to	PART
fnp-3790	586	26	restore	restore	VERB
fnp-3790	586	27	interneuron	interneuron	NOUN
fnp-3790	586	28	disturbances	disturbance	NOUN
fnp-3790	586	29	in	in	ADP
fnp-3790	586	30	experimental	experimental	ADJ
fnp-3790	586	31	models	model	NOUN
fnp-3790	586	32	of	of	ADP
fnp-3790	586	33	encephalopathy	encephalopathy	NOUN
fnp-3790	586	34	of	of	ADP
fnp-3790	586	35	prematurity	prematurity	NOUN
fnp-3790	586	36	.	.	PUNCT
fnp-3790	587	1	int	int	PROPN
fnp-3790	587	2	j	j	PROPN
fnp-3790	587	3	mol	mol	ADP
fnp-3790	587	4	sci	sci	PROPN
fnp-3790	587	5	.	.	PUNCT
fnp-3790	588	1	2020;22:211	2020;22:211	PROPN
fnp-3790	588	2	.	.	PUNCT
fnp-3790	589	1	https://doi.org/10.3390/ijms22010211	https://doi.org/10.3390/ijms22010211	PROPN
fnp-3790	589	2	pmid	pmid	NOUN
fnp-3790	589	3	:	:	PUNCT
fnp-3790	589	4	33379239	33379239	NUM
fnp-3790	589	5	;	;	PUNCT
fnp-3790	589	6	pmcid	pmcid	NOUN
fnp-3790	589	7	:	:	PUNCT
fnp-3790	590	1	pmc7795049	pmc7795049	ADJ
fnp-3790	590	2	.	.	PUNCT
fnp-3790	591	1	van	van	PROPN
fnp-3790	591	2	duijn	duijn	PROPN
fnp-3790	591	3	s	s	PROPN
fnp-3790	591	4	,	,	PUNCT
fnp-3790	591	5	bulk	bulk	NOUN
fnp-3790	591	6	m	m	NOUN
fnp-3790	591	7	,	,	PUNCT
fnp-3790	591	8	van	van	PROPN
fnp-3790	591	9	duinen	duinen	PROPN
fnp-3790	591	10	sg	sg	PROPN
fnp-3790	591	11	,	,	PUNCT
fnp-3790	591	12	nabuurs	nabuurs	PROPN
fnp-3790	591	13	rja	rja	PROPN
fnp-3790	591	14	,	,	PUNCT
fnp-3790	591	15	van	van	PROPN
fnp-3790	591	16	buchem	buchem	PROPN
fnp-3790	591	17	ma	ma	PROPN
fnp-3790	591	18	,	,	PUNCT
fnp-3790	591	19	van	van	PROPN
fnp-3790	591	20	der	der	PROPN
fnp-3790	591	21	weerd	weerd	PROPN
fnp-3790	591	22	l	l	PROPN
fnp-3790	591	23	,	,	PUNCT
fnp-3790	591	24	natté	natté	PROPN
fnp-3790	591	25	r.	r.	PROPN
fnp-3790	591	26	cortical	cortical	ADJ
fnp-3790	591	27	iron	iron	NOUN
fnp-3790	591	28	reflects	reflect	VERB
fnp-3790	591	29	severity	severity	NOUN
fnp-3790	591	30	of	of	ADP
fnp-3790	591	31	alzheimer	alzheimer	PROPN
fnp-3790	591	32	’s	’s	PART
fnp-3790	591	33	disease	disease	NOUN
fnp-3790	591	34	.	.	PUNCT
fnp-3790	592	1	j	j	PROPN
fnp-3790	592	2	alzheimers	alzheimers	PROPN
fnp-3790	592	3	dis	dis	PROPN
fnp-3790	592	4	.	.	PUNCT
fnp-3790	593	1	2017;60:1533–1545	2017;60:1533–1545	PROPN
fnp-3790	593	2	.	.	PUNCT
fnp-3790	594	1	https://doi.org/10.3233/jad-161143	https://doi.org/10.3233/jad-161143	PROPN
fnp-3790	595	1	pmid	pmid	NOUN
fnp-3790	595	2	:	:	PUNCT
fnp-3790	595	3	29081415	29081415	NUM
fnp-3790	595	4	;	;	PUNCT
fnp-3790	595	5	pmcid	pmcid	NOUN
fnp-3790	595	6	:	:	PUNCT
fnp-3790	595	7	pmc5676973	pmc5676973	ADJ
fnp-3790	595	8	.	.	PUNCT
fnp-3790	596	1	weber	weber	PROPN
fnp-3790	596	2	ce	ce	PROPN
fnp-3790	596	3	,	,	PUNCT
fnp-3790	596	4	krämer	krämer	PROPN
fnp-3790	596	5	j	j	PROPN
fnp-3790	596	6	,	,	PUNCT
fnp-3790	596	7	wittayer	wittayer	PROPN
fnp-3790	596	8	m	m	PROPN
fnp-3790	596	9	,	,	PUNCT
fnp-3790	596	10	gregori	gregori	PROPN
fnp-3790	596	11	j	j	PROPN
fnp-3790	596	12	,	,	PUNCT
fnp-3790	596	13	randoll	randoll	NOUN
fnp-3790	596	14	s	s	PROPN
fnp-3790	596	15	,	,	PUNCT
fnp-3790	596	16	weiler	weiler	PROPN
fnp-3790	596	17	f	f	PROPN
fnp-3790	596	18	,	,	PUNCT
fnp-3790	596	19	heldmann	heldmann	PROPN
fnp-3790	596	20	s	s	PROPN
fnp-3790	596	21	,	,	PUNCT
fnp-3790	596	22	roβmanith	roβmanith	PROPN
fnp-3790	596	23	c	c	PROPN
fnp-3790	596	24	,	,	PUNCT
fnp-3790	596	25	platten	platten	PROPN
fnp-3790	596	26	m	m	PROPN
fnp-3790	596	27	,	,	PUNCT
fnp-3790	596	28	gass	gass	PROPN
fnp-3790	596	29	a	a	X
fnp-3790	596	30	,	,	PUNCT
fnp-3790	596	31	eisele	eisele	PROPN
fnp-3790	596	32	p.	p.	PROPN
fnp-3790	596	33	association	association	PROPN
fnp-3790	596	34	of	of	ADP
fnp-3790	596	35	iron	iron	NOUN
fnp-3790	596	36	rim	rim	NOUN
fnp-3790	596	37	lesions	lesion	NOUN
fnp-3790	596	38	with	with	ADP
fnp-3790	596	39	brain	brain	NOUN
fnp-3790	596	40	and	and	CCONJ
fnp-3790	596	41	cervical	cervical	ADJ
fnp-3790	596	42	cord	cord	NOUN
fnp-3790	596	43	volume	volume	NOUN
fnp-3790	596	44	in	in	ADP
fnp-3790	596	45	relapsing	relapse	VERB
fnp-3790	596	46	multiple	multiple	ADJ
fnp-3790	596	47	sclerosis	sclerosis	NOUN
fnp-3790	596	48	.	.	PUNCT
fnp-3790	597	1	eur	eur	NOUN
fnp-3790	597	2	radiol	radiol	NOUN
fnp-3790	597	3	.	.	PUNCT
fnp-3790	598	1	2021	2021	NUM
fnp-3790	598	2	sep	sep	NOUN
fnp-3790	598	3	22	22	NUM
fnp-3790	598	4	.	.	PUNCT
fnp-3790	599	1	https://doi.org/10.1007/s00330-021-08233-w	https://doi.org/10.1007/s00330-021-08233-w	PROPN
fnp-3790	599	2	epub	epub	VERB
fnp-3790	599	3	ahead	ahead	ADV
fnp-3790	599	4	of	of	ADP
fnp-3790	599	5	print	print	NOUN
fnp-3790	599	6	.	.	PUNCT
fnp-3790	600	1	pmid	pmid	NOUN
fnp-3790	600	2	:	:	PUNCT
fnp-3790	600	3	34549326	34549326	NUM
fnp-3790	600	4	.	.	PUNCT
fnp-3790	601	1	weiner	weiner	NOUN
fnp-3790	601	2	hl	hl	PROPN
fnp-3790	601	3	,	,	PUNCT
fnp-3790	601	4	da	da	PROPN
fnp-3790	601	5	cunha	cunha	PROPN
fnp-3790	601	6	ap	ap	PROPN
fnp-3790	601	7	,	,	PUNCT
fnp-3790	601	8	quintana	quintana	PROPN
fnp-3790	601	9	f	f	PROPN
fnp-3790	601	10	,	,	PUNCT
fnp-3790	601	11	wu	wu	PROPN
fnp-3790	601	12	h.	h.	PROPN
fnp-3790	601	13	oral	oral	ADJ
fnp-3790	601	14	tolerance	tolerance	NOUN
fnp-3790	601	15	.	.	PUNCT
fnp-3790	602	1	immunol	immunol	PROPN
fnp-3790	602	2	rev	rev	PROPN
fnp-3790	602	3	.	.	PROPN
fnp-3790	602	4	2011;241:241	2011;241:241	NUM
fnp-3790	602	5	-	-	SYM
fnp-3790	602	6	259	259	NUM
fnp-3790	602	7	.	.	PUNCT
fnp-3790	603	1	https://doi.org/10.1111/j.1600-065x.2011.01017.x	https://doi.org/10.1111/j.1600-065x.2011.01017.x	X
fnp-3790	604	1	pmid	pmid	NOUN
fnp-3790	604	2	:	:	PUNCT
fnp-3790	604	3	21488901	21488901	NUM
fnp-3790	604	4	;	;	PUNCT
fnp-3790	604	5	pmcid	pmcid	ADJ
fnp-3790	604	6	:	:	PUNCT
fnp-3790	604	7	pmc3296283	pmc3296283	PROPN
fnp-3790	604	8	.	.	PUNCT
fnp-3790	605	1	wekerle	wekerle	PROPN
fnp-3790	605	2	h	h	PROPN
fnp-3790	605	3	,	,	PUNCT
fnp-3790	605	4	bradl	bradl	NOUN
fnp-3790	605	5	m	m	PROPN
fnp-3790	605	6	,	,	PUNCT
fnp-3790	605	7	linington	linington	PROPN
fnp-3790	605	8	c	c	PROPN
fnp-3790	605	9	,	,	PUNCT
fnp-3790	605	10	kääb	kääb	PROPN
fnp-3790	605	11	g	g	PROPN
fnp-3790	605	12	,	,	PUNCT
fnp-3790	605	13	kojima	kojima	PROPN
fnp-3790	605	14	k.	k.	PROPN
fnp-3790	606	1	the	the	DET
fnp-3790	606	2	shaping	shaping	NOUN
fnp-3790	606	3	of	of	ADP
fnp-3790	606	4	the	the	DET
fnp-3790	606	5	brain	brain	NOUN
fnp-3790	606	6	-	-	PUNCT
fnp-3790	606	7	specific	specific	ADJ
fnp-3790	606	8	t	t	NOUN
fnp-3790	606	9	lymphocyte	lymphocyte	NOUN
fnp-3790	606	10	repertoire	repertoire	NOUN
fnp-3790	606	11	in	in	ADP
fnp-3790	606	12	the	the	DET
fnp-3790	606	13	thymus	thymus	NOUN
fnp-3790	606	14	.	.	PUNCT
fnp-3790	607	1	immunol	immunol	PROPN
fnp-3790	607	2	rev	rev	PROPN
fnp-3790	607	3	.	.	PROPN
fnp-3790	607	4	1996;149:231	1996;149:231	PROPN
fnp-3790	607	5	-	-	SYM
fnp-3790	607	6	243	243	NUM
fnp-3790	607	7	.	.	PUNCT
fnp-3790	608	1	https://doi.org/10.1111/j.1600-065x.1996.tb00907.x	https://doi.org/10.1111/j.1600-065x.1996.tb00907.x	X
fnp-3790	609	1	pmid	pmid	NOUN
fnp-3790	609	2	:	:	PUNCT
fnp-3790	609	3	9005217	9005217	NUM
fnp-3790	609	4	.	.	PUNCT
fnp-3790	610	1	williams	williams	PROPN
fnp-3790	610	2	gp	gp	PROPN
fnp-3790	610	3	,	,	PUNCT
fnp-3790	610	4	schonhoff	schonhoff	PROPN
fnp-3790	610	5	am	be	AUX
fnp-3790	610	6	,	,	PUNCT
fnp-3790	610	7	jurkuvenaite	jurkuvenaite	VERB
fnp-3790	610	8	a	a	PRON
fnp-3790	610	9	,	,	PUNCT
fnp-3790	610	10	gallups	gallups	PROPN
fnp-3790	610	11	nj	nj	PROPN
fnp-3790	610	12	,	,	PUNCT
fnp-3790	610	13	standaert	standaert	PROPN
fnp-3790	610	14	dg	dg	PROPN
fnp-3790	610	15	,	,	PUNCT
fnp-3790	610	16	harms	harm	VERB
fnp-3790	610	17	as	as	ADP
fnp-3790	610	18	.	.	PUNCT
fnp-3790	611	1	cd4	cd4	PROPN
fnp-3790	611	2	t	t	PROPN
fnp-3790	611	3	cells	cell	NOUN
fnp-3790	611	4	mediate	mediate	VERB
fnp-3790	611	5	brain	brain	NOUN
fnp-3790	611	6	inflammation	inflammation	NOUN
fnp-3790	611	7	and	and	CCONJ
fnp-3790	611	8	neurodegeneration	neurodegeneration	NOUN
fnp-3790	611	9	in	in	ADP
fnp-3790	611	10	a	a	DET
fnp-3790	611	11	mouse	mouse	NOUN
fnp-3790	611	12	model	model	NOUN
fnp-3790	611	13	of	of	ADP
fnp-3790	611	14	parkinson	parkinson	NOUN
fnp-3790	611	15	's	's	PART
fnp-3790	611	16	disease	disease	NOUN
fnp-3790	611	17	.	.	PUNCT
fnp-3790	612	1	brain	brain	NOUN
fnp-3790	612	2	.	.	PUNCT
fnp-3790	613	1	2021;144:2047	2021;144:2047	NUM
fnp-3790	613	2	-	-	SYM
fnp-3790	613	3	2059	2059	NUM
fnp-3790	613	4	.	.	PUNCT
fnp-3790	614	1	https://doi.org/10.1093/brain/awab103	https://doi.org/10.1093/brain/awab103	PUNCT
fnp-3790	615	1	pmid	pmid	NOUN
fnp-3790	615	2	:	:	PUNCT
fnp-3790	615	3	33704423	33704423	NUM
fnp-3790	615	4	;	;	PUNCT
fnp-3790	615	5	pmcid	pmcid	ADJ
fnp-3790	615	6	:	:	PUNCT
fnp-3790	615	7	pmc8370411	pmc8370411	NOUN
fnp-3790	615	8	.	.	PUNCT
fnp-3790	616	1	wimmer	wimmer	PROPN
fnp-3790	616	2	i	i	PRON
fnp-3790	616	3	,	,	PUNCT
fnp-3790	616	4	zrzavy	zrzavy	PROPN
fnp-3790	616	5	t	t	PROPN
fnp-3790	616	6	,	,	PUNCT
fnp-3790	616	7	lassmann	lassmann	PROPN
fnp-3790	616	8	h.	h.	PROPN
fnp-3790	616	9	neuroinflammatory	neuroinflammatory	PROPN
fnp-3790	616	10	responses	response	NOUN
fnp-3790	616	11	in	in	ADP
fnp-3790	616	12	experimental	experimental	ADJ
fnp-3790	616	13	and	and	CCONJ
fnp-3790	616	14	human	human	ADJ
fnp-3790	616	15	stroke	stroke	NOUN
fnp-3790	616	16	lesions	lesion	NOUN
fnp-3790	616	17	.	.	PUNCT
fnp-3790	617	1	j	j	PROPN
fnp-3790	617	2	neuroimmunol	neuroimmunol	PROPN
fnp-3790	617	3	.	.	PUNCT
fnp-3790	618	1	2018;323:10	2018;323:10	NUM
fnp-3790	618	2	-	-	SYM
fnp-3790	618	3	18	18	NUM
fnp-3790	618	4	.	.	PUNCT
fnp-3790	619	1	https://doi.org/10.1016/j.jneuroim.2018.07.003	https://doi.org/10.1016/j.jneuroim.2018.07.003	PROPN
fnp-3790	619	2	epub	epub	PROPN
fnp-3790	619	3	2018	2018	NUM
fnp-3790	619	4	jul	jul	PROPN
fnp-3790	619	5	6	6	NUM
fnp-3790	619	6	.	.	PUNCT
fnp-3790	619	7	pmid	pmid	NOUN
fnp-3790	619	8	:	:	PUNCT
fnp-3790	619	9	30196821	30196821	NUM
fnp-3790	619	10	.	.	PUNCT
fnp-3790	620	1	yuan	yuan	PROPN
fnp-3790	620	2	l	l	PROPN
fnp-3790	620	3	,	,	PUNCT
fnp-3790	620	4	wu	wu	PROPN
fnp-3790	620	5	j	j	PROPN
fnp-3790	620	6	,	,	PUNCT
fnp-3790	620	7	liu	liu	PROPN
fnp-3790	620	8	j	j	PROPN
fnp-3790	620	9	,	,	PUNCT
fnp-3790	620	10	li	li	PROPN
fnp-3790	620	11	g	g	PROPN
fnp-3790	620	12	,	,	PUNCT
fnp-3790	620	13	liang	liang	PROPN
fnp-3790	620	14	d.	d.	PROPN
fnp-3790	620	15	intermittent	intermittent	PROPN
fnp-3790	620	16	hypoxia	hypoxia	NOUN
fnp-3790	620	17	-	-	PUNCT
fnp-3790	620	18	induced	induce	VERB
fnp-3790	620	19	parvalbumin	parvalbumin	ADJ
fnp-3790	620	20	-	-	PUNCT
fnp-3790	620	21	immunoreactive	immunoreactive	ADJ
fnp-3790	620	22	interneurons	interneuron	NOUN
fnp-3790	620	23	loss	loss	NOUN
fnp-3790	620	24	and	and	CCONJ
fnp-3790	620	25	neurobehavioral	neurobehavioral	ADJ
fnp-3790	620	26	impairment	impairment	NOUN
fnp-3790	620	27	is	be	AUX
fnp-3790	620	28	mediated	mediate	VERB
fnp-3790	620	29	by	by	ADP
fnp-3790	620	30	nadph	nadph	PROPN
fnp-3790	620	31	-	-	PUNCT
fnp-3790	620	32	oxidase-2	oxidase-2	PROPN
fnp-3790	620	33	.	.	PUNCT
fnp-3790	621	1	neurochem	neurochem	PROPN
fnp-3790	621	2	res	re	NOUN
fnp-3790	621	3	.	.	PUNCT
fnp-3790	622	1	2015;40:1232	2015;40:1232	NUM
fnp-3790	622	2	-	-	SYM
fnp-3790	622	3	1242	1242	NUM
fnp-3790	622	4	.	.	PUNCT
fnp-3790	623	1	https://doi.org/10.1007/s11064-015-1586-1	https://doi.org/10.1007/s11064-015-1586-1	NUM
fnp-3790	623	2	epub	epub	NOUN
fnp-3790	623	3	2015	2015	NUM
fnp-3790	623	4	apr	apr	NOUN
fnp-3790	623	5	25	25	NUM
fnp-3790	623	6	.	.	PUNCT
fnp-3790	624	1	pmid	pmid	NOUN
fnp-3790	624	2	:	:	PUNCT
fnp-3790	624	3	25911467	25911467	NUM
fnp-3790	624	4	.	.	PUNCT
fnp-3790	625	1	zhang	zhang	PROPN
fnp-3790	625	2	b	b	PROPN
fnp-3790	625	3	,	,	PUNCT
fnp-3790	625	4	shen	shen	PROPN
fnp-3790	625	5	r	r	PROPN
fnp-3790	625	6	,	,	PUNCT
fnp-3790	625	7	cheng	cheng	PROPN
fnp-3790	625	8	s	s	PROPN
fnp-3790	625	9	,	,	PUNCT
fnp-3790	625	10	feng	feng	PROPN
fnp-3790	625	11	l.	l.	PROPN
fnp-3790	625	12	immune	immune	PROPN
fnp-3790	625	13	microenvironments	microenvironment	NOUN
fnp-3790	625	14	differ	differ	VERB
fnp-3790	625	15	in	in	ADP
fnp-3790	625	16	immune	immune	ADJ
fnp-3790	625	17	characteristics	characteristic	NOUN
fnp-3790	625	18	and	and	CCONJ
fnp-3790	625	19	outcome	outcome	NOUN
fnp-3790	625	20	of	of	ADP
fnp-3790	625	21	glioblastoma	glioblastoma	NOUN
fnp-3790	625	22	multiforme	multiforme	NOUN
fnp-3790	625	23	.	.	PUNCT
fnp-3790	626	1	cancer	cancer	NOUN
fnp-3790	626	2	med	med	PROPN
fnp-3790	626	3	.	.	PUNCT
fnp-3790	627	1	2019;8:2897–2907	2019;8:2897–2907	NUM
fnp-3790	627	2	.	.	PUNCT
fnp-3790	628	1	https://doi.org/10.1002/cam4.2192	https://doi.org/10.1002/cam4.2192	PROPN
fnp-3790	628	2	epub	epub	VERB
fnp-3790	628	3	2019	2019	NUM
fnp-3790	628	4	apr	apr	NOUN
fnp-3790	628	5	30	30	NUM
fnp-3790	628	6	.	.	PUNCT
fnp-3790	629	1	pmid	pmid	NOUN
fnp-3790	629	2	:	:	PUNCT
fnp-3790	629	3	31038851	31038851	NUM
fnp-3790	629	4	;	;	PUNCT
fnp-3790	629	5	pmcid	pmcid	PROPN
fnp-3790	629	6	:	:	PUNCT
fnp-3790	629	7	pmc6558448	pmc6558448	X
fnp-3790	629	8	.	.	PUNCT
fnp-3790	630	1	zoupi	zoupi	PROPN
fnp-3790	630	2	l	l	PROPN
fnp-3790	630	3	,	,	PUNCT
fnp-3790	630	4	booker	booker	PROPN
fnp-3790	630	5	sa	sa	PROPN
fnp-3790	630	6	,	,	PUNCT
fnp-3790	630	7	eigel	eigel	NOUN
fnp-3790	630	8	d	d	PROPN
fnp-3790	630	9	,	,	PUNCT
fnp-3790	630	10	werner	werner	PROPN
fnp-3790	630	11	c	c	PROPN
fnp-3790	630	12	,	,	PUNCT
fnp-3790	630	13	kind	kind	ADJ
fnp-3790	630	14	pc	pc	NOUN
fnp-3790	630	15	,	,	PUNCT
fnp-3790	630	16	spires	spire	NOUN
fnp-3790	630	17	-	-	PUNCT
fnp-3790	630	18	jones	jones	PROPN
fnp-3790	630	19	tl	tl	PROPN
fnp-3790	630	20	,	,	PUNCT
fnp-3790	630	21	newland	newland	PROPN
fnp-3790	630	22	b	b	PROPN
fnp-3790	630	23	,	,	PUNCT
fnp-3790	630	24	williams	williams	PROPN
fnp-3790	630	25	ac	ac	PROPN
fnp-3790	630	26	.	.	PROPN
fnp-3790	630	27	selective	selective	ADJ
fnp-3790	630	28	vulnerability	vulnerability	NOUN
fnp-3790	630	29	of	of	ADP
fnp-3790	630	30	inhibitory	inhibitory	ADJ
fnp-3790	630	31	networks	network	NOUN
fnp-3790	630	32	in	in	ADP
fnp-3790	630	33	multiple	multiple	ADJ
fnp-3790	630	34	sclerosis	sclerosis	NOUN
fnp-3790	630	35	.	.	PUNCT
fnp-3790	631	1	acta	acta	PROPN
fnp-3790	631	2	neuropathol	neuropathol	PROPN
fnp-3790	631	3	.	.	PUNCT
fnp-3790	632	1	2021;141:415	2021;141:415	NUM
fnp-3790	632	2	-	-	SYM
fnp-3790	632	3	429	429	NUM
fnp-3790	632	4	.	.	PUNCT
fnp-3790	633	1	https://doi.org/10.1007/s00401-020-02258-z	https://doi.org/10.1007/s00401-020-02258-z	PROPN
fnp-3790	633	2	epub	epub	PROPN
fnp-3790	633	3	2021	2021	NUM
fnp-3790	633	4	jan	jan	PROPN
fnp-3790	633	5	15	15	NUM
fnp-3790	633	6	.	.	PUNCT
fnp-3790	634	1	pmid	pmid	NOUN
fnp-3790	634	2	:	:	PUNCT
fnp-3790	634	3	33449171	33449171	NUM
fnp-3790	634	4	;	;	PUNCT
fnp-3790	634	5	pmcid	pmcid	NOUN
fnp-3790	634	6	:	:	PUNCT
fnp-3790	634	7	pmc7882577	pmc7882577	ADJ
fnp-3790	634	8	.	.	PUNCT
fnp-3790	635	1	zrzavy	zrzavy	PROPN
fnp-3790	635	2	t	t	PROPN
fnp-3790	635	3	,	,	PUNCT
fnp-3790	635	4	hametner	hametner	PROPN
fnp-3790	635	5	s	s	PROPN
fnp-3790	635	6	,	,	PUNCT
fnp-3790	635	7	wimmer	wimmer	PROPN
fnp-3790	635	8	i	i	PROPN
fnp-3790	635	9	,	,	PUNCT
fnp-3790	635	10	butovsky	butovsky	ADJ
fnp-3790	635	11	o	o	NOUN
fnp-3790	635	12	,	,	PUNCT
fnp-3790	635	13	weiner	weiner	NOUN
fnp-3790	635	14	hl	hl	NOUN
fnp-3790	635	15	,	,	PUNCT
fnp-3790	635	16	lassmann	lassmann	PROPN
fnp-3790	635	17	h.	h.	PROPN
fnp-3790	635	18	loss	loss	NOUN
fnp-3790	635	19	of	of	ADP
fnp-3790	635	20	'	'	PUNCT
fnp-3790	635	21	homeostatic	homeostatic	ADJ
fnp-3790	635	22	'	'	PUNCT
fnp-3790	635	23	microglia	microglia	NOUN
fnp-3790	635	24	and	and	CCONJ
fnp-3790	635	25	patterns	pattern	NOUN
fnp-3790	635	26	of	of	ADP
fnp-3790	635	27	their	their	PRON
fnp-3790	635	28	activation	activation	NOUN
fnp-3790	635	29	in	in	ADP
fnp-3790	635	30	active	active	ADJ
fnp-3790	635	31	multiple	multiple	ADJ
fnp-3790	635	32	sclerosis	sclerosis	NOUN
fnp-3790	635	33	.	.	PUNCT
fnp-3790	636	1	brain	brain	NOUN
fnp-3790	636	2	.	.	PUNCT
fnp-3790	637	1	2017;140:1900	2017;140:1900	NUM
fnp-3790	637	2	-	-	SYM
fnp-3790	637	3	1913	1913	NUM
fnp-3790	637	4	.	.	PUNCT
fnp-3790	638	1	https://doi.org/10.1093/brain/awx113	https://doi.org/10.1093/brain/awx113	PROPN
fnp-3790	638	2	pmid	pmid	PROPN
fnp-3790	638	3	:	:	PUNCT
fnp-3790	638	4	28541408	28541408	NUM
fnp-3790	638	5	;	;	PUNCT
fnp-3790	638	6	pmcid	pmcid	ADJ
fnp-3790	638	7	:	:	PUNCT
fnp-3790	638	8	pmc6057548	pmc6057548	ADJ
fnp-3790	638	9	.	.	PUNCT
fnp-3790	639	1	zrzavy	zrzavy	PROPN
fnp-3790	639	2	t	t	PROPN
fnp-3790	639	3	,	,	PUNCT
fnp-3790	639	4	machado	machado	PROPN
fnp-3790	639	5	-	-	PUNCT
fnp-3790	639	6	santos	santos	PROPN
fnp-3790	639	7	j	j	PROPN
fnp-3790	639	8	,	,	PUNCT
fnp-3790	639	9	christine	christine	PROPN
fnp-3790	639	10	s	s	PROPN
fnp-3790	639	11	,	,	PUNCT
fnp-3790	639	12	baumgartner	baumgartner	PROPN
fnp-3790	639	13	c	c	PROPN
fnp-3790	639	14	,	,	PUNCT
fnp-3790	639	15	weiner	weiner	NOUN
fnp-3790	639	16	hl	hl	NOUN
fnp-3790	639	17	,	,	PUNCT
fnp-3790	639	18	butovsky	butovsky	NOUN
fnp-3790	639	19	o	o	NOUN
fnp-3790	639	20	,	,	PUNCT
fnp-3790	639	21	lassmann	lassmann	PROPN
fnp-3790	639	22	h.	h.	PROPN
fnp-3790	639	23	dominant	dominant	ADJ
fnp-3790	639	24	role	role	NOUN
fnp-3790	639	25	of	of	ADP
fnp-3790	639	26	microglial	microglial	ADJ
fnp-3790	639	27	and	and	CCONJ
fnp-3790	639	28	macrophage	macrophage	ADJ
fnp-3790	639	29	innate	innate	ADJ
fnp-3790	639	30	immune	immune	ADJ
fnp-3790	639	31	responses	response	NOUN
fnp-3790	639	32	in	in	ADP
fnp-3790	639	33	human	human	ADJ
fnp-3790	639	34	ischemic	ischemic	ADJ
fnp-3790	639	35	infarcts	infarct	NOUN
fnp-3790	639	36	.	.	PUNCT
fnp-3790	640	1	brain	brain	NOUN
fnp-3790	640	2	pathol	pathol	NOUN
fnp-3790	640	3	.	.	PUNCT
fnp-3790	641	1	2018;28:791	2018;28:791	NUM
fnp-3790	641	2	-	-	PUNCT
fnp-3790	641	3	805	805	NUM
fnp-3790	641	4	.	.	PUNCT
fnp-3790	642	1	https://doi.org/10.1111/bpa.12583	https://doi.org/10.1111/bpa.12583	NOUN
fnp-3790	642	2	epub	epub	NOUN
fnp-3790	642	3	2017	2017	NUM
fnp-3790	642	4	dec	dec	PROPN
fnp-3790	642	5	28	28	NUM
fnp-3790	642	6	.	.	PUNCT
fnp-3790	643	1	pmid	pmid	NOUN
fnp-3790	643	2	:	:	PUNCT
fnp-3790	643	3	29222823	29222823	NUM
fnp-3790	643	4	;	;	PUNCT
fnp-3790	643	5	pmcid	pmcid	ADJ
fnp-3790	643	6	:	:	PUNCT
fnp-3790	643	7	pmc6334527	pmc6334527	PROPN
fnp-3790	643	8	.	.	PUNCT
fnp-3790	644	1	copyright	copyright	NOUN
fnp-3790	644	2	:	:	PUNCT
fnp-3790	644	3	©	©	PROPN
fnp-3790	644	4	2022	2022	NUM
fnp-3790	644	5	the	the	DET
fnp-3790	644	6	author(s	author(s	NOUN
fnp-3790	644	7	)	)	PUNCT
fnp-3790	644	8	.	.	PUNCT
fnp-3790	645	1	this	this	PRON
fnp-3790	645	2	is	be	AUX
fnp-3790	645	3	an	an	DET
fnp-3790	645	4	open	open	ADJ
fnp-3790	645	5	access	access	NOUN
fnp-3790	645	6	article	article	NOUN
fnp-3790	645	7	distributed	distribute	VERB
fnp-3790	645	8	under	under	ADP
fnp-3790	645	9	the	the	DET
fnp-3790	645	10	terms	term	NOUN
fnp-3790	645	11	of	of	ADP
fnp-3790	645	12	the	the	DET
fnp-3790	645	13	creative	creative	ADJ
fnp-3790	645	14	commons	common	NOUN
fnp-3790	645	15	attribution	attribution	NOUN
fnp-3790	645	16	4.0	4.0	NUM
fnp-3790	645	17	international	international	ADJ
fnp-3790	645	18	license	license	NOUN
fnp-3790	645	19	(	(	PUNCT
fnp-3790	645	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-3790	645	21	)	)	PUNCT
fnp-3790	645	22	,	,	PUNCT
fnp-3790	645	23	which	which	PRON
fnp-3790	645	24	permits	permit	VERB
fnp-3790	645	25	unrestricted	unrestricted	ADJ
fnp-3790	645	26	use	use	NOUN
fnp-3790	645	27	,	,	PUNCT
fnp-3790	645	28	distribution	distribution	NOUN
fnp-3790	645	29	,	,	PUNCT
fnp-3790	645	30	and	and	CCONJ
fnp-3790	645	31	reproduction	reproduction	NOUN
fnp-3790	645	32	in	in	ADP
fnp-3790	645	33	any	any	DET
fnp-3790	645	34	medium	medium	NOUN
fnp-3790	645	35	,	,	PUNCT
fnp-3790	645	36	provided	provide	VERB
fnp-3790	645	37	the	the	DET
fnp-3790	645	38	original	original	ADJ
fnp-3790	645	39	author	author	NOUN
fnp-3790	645	40	and	and	CCONJ
fnp-3790	645	41	source	source	NOUN
fnp-3790	645	42	are	be	AUX
fnp-3790	645	43	credited	credit	VERB
fnp-3790	645	44	,	,	PUNCT
fnp-3790	645	45	a	a	DET
fnp-3790	645	46	link	link	NOUN
fnp-3790	645	47	to	to	ADP
fnp-3790	645	48	the	the	DET
fnp-3790	645	49	creative	creative	ADJ
fnp-3790	645	50	commons	common	NOUN
fnp-3790	645	51	license	license	NOUN
fnp-3790	645	52	is	be	AUX
fnp-3790	645	53	provided	provide	VERB
fnp-3790	645	54	,	,	PUNCT
fnp-3790	645	55	and	and	CCONJ
fnp-3790	645	56	any	any	DET
fnp-3790	645	57	changes	change	NOUN
fnp-3790	645	58	are	be	AUX
fnp-3790	645	59	indicated	indicate	VERB
fnp-3790	645	60	.	.	PUNCT
fnp-3790	646	1	the	the	DET
fnp-3790	646	2	creative	creative	ADJ
fnp-3790	646	3	commons	common	NOUN
fnp-3790	646	4	public	public	ADJ
fnp-3790	646	5	domain	domain	NOUN
fnp-3790	646	6	dedication	dedication	NOUN
fnp-3790	646	7	waiver	waiver	NOUN
fnp-3790	646	8	(	(	PUNCT
fnp-3790	646	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-3790	646	10	)	)	PUNCT
fnp-3790	646	11	applies	apply	VERB
fnp-3790	646	12	to	to	ADP
fnp-3790	646	13	the	the	DET
fnp-3790	646	14	data	datum	NOUN
fnp-3790	646	15	made	make	VERB
fnp-3790	646	16	available	available	ADJ
fnp-3790	646	17	in	in	ADP
fnp-3790	646	18	this	this	DET
fnp-3790	646	19	article	article	NOUN
fnp-3790	646	20	,	,	PUNCT
fnp-3790	646	21	unless	unless	SCONJ
fnp-3790	646	22	otherwise	otherwise	ADV
fnp-3790	646	23	stated	state	VERB
fnp-3790	646	24	.	.	PUNCT